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  per	  minute	  RA	   	   	   	   	   Retinoic	  acid	  
R1;R2cHetSox17	  	  	  	   	   	   Sox17ice/+;Fgfr1;flox/+;Fgfr2;flox+-­‐	  
R1cKO;R2cHetSox17	  	  	  	   	   	   Sox17ice/+;Fgfr1;flox/-­‐;Fgfr2;flox/+	  
R1cHet;R2cKOSox17	  	  	  	   	   	   Sox17ice/+;Fgfr1;flox/+;Fgfr2;flox/-­‐	  
R1;R2cKOSox17	  	  	  	   	   	   Sox17ice/+;Fgfr1;flox/-­‐;Fgfr2;flox/-­‐	  
Spry1;Spry2;Tbx1cHetSox17	   	   Sox17ice/+;	  Spry1	  flox/+;Spry2	  flox/+;Tbx1flox/+	  
Spry1;Spry2cHet;	  
Tbx1cKOSox17	   	   	   	   Sox17ice/+;	  Spry1	  flox/+;Spry2	  flox/+;Tbx1flox/-­‐	  S	   	   	   	   	   Somite	  stage	  SEM	   	   	   	   	   Standard	  error	  of	  the	  mean	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SDS	   	   	   	   	   Sodium	  dodecyl	  sulphate	  SHH	   	   	   	   	   Sonic	  Hedgehog	  SSC	   	   	   	   	   Standard	  saline	  citrate	  TBST	   	   	   	   	   Tris	  buffered	  salts	  with	  Tween-­‐20	  
Tbx1cHetSox17	   	   	   	   Sox17ice/+;Tbx1flox/+	  
Tbx1cKOSox17	   	   	   	   Sox17ice/+;Tbx1flox/-­‐	  TE	   	   	   	   	   Tris-­‐EDTA	  buffer	  Tris	   	   	   	   	   Tris	  hydroxymethylaminomethane	  Tween-­‐20	   	   	   	   Polyoxyethylenesorbitan	  monolaurate	  v/v	   	   	   	   	   Volume/volume	  w/v	   	   	   	   	   Weight/volume	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Abstract	  
The	  pharyngeal	  apparatus	   is	  comprised	  of	  a	  series	  of	  pharyngeal	  arches	  that	  are	  defined	  by	  the	  evagination	  of	  endodermal	  pouches	  toward	  the	  ectoderm.	  Whilst	  the	  transcription	  factor	   T-­‐box	   1	   (Tbx1)	   and	   the	   Fibroblast	   growth	   factor	   8	   (Fgf8)	   are	   both	   required	   for	  caudal	   pouch	   formation,	   a	   role	   for	   these	   factors	   in	   the	   endoderm	   during	   pouch	  morphogenesis	   has	   not	   been	   confirmed.	   The	   observation	   that	  Fgf8	   expression	   is	   lost	   in	  
Tbx1	  homozygous	   null	  mutant	   embryos	   has	   lead	   to	   the	   hypothesis	   that	   FGF8	   functions	  directly	  downstream	  of	  TBX1	  during	  pouch	  formation.	  	  To	  test	  this	  hypothesis	  the	  Sox17-­‐
2A-­‐icre	   line	   was	   used	   to	   delete	   Fgf8,	   Fibroblast	   growth	   factor	   receptor	   1	   (Fgfr1)	   and	  
Fibroblast	   growth	   factor	   receptor	   2	   (Fgfr2)	   and	  Tbx1	   in	   the	   endoderm,	   and	   analyse	   the	  development	   of	   the	   pouches	   and	   their	   derivatives.	   In	   all	   embryos	   with	   an	   endoderm	  specific	  deletion	  of	  Tbx1,	  the	  caudal	  PA	  remained	  un-­‐segmented	  as	  caudal	  pouches	  3	  and	  4	  do	  not	  form.	  	  The	  deletion	  of	  endodermal	  Tbx1	  severely	  reduced	  the	  expression	  of	  Fgf8	  in	  the	   endoderm;	   however,	   the	   expression	   of	   Fibroblast	   Growth	   Factor	   (FGF)	   signalling	  readouts	  was	  maintained.	  	  All	  rostral	  and	  caudal	  pouches	  are	  present	  in	  embryos	  with	  an	  endoderm	   specific	   deletion	   of	   Fgf8,	   indicating	   that	   the	   loss	   of	   Fgf8	   alone	   from	   this	  epithelium	   is	   not	   sufficient	   to	   disrupt	   the	   process	   of	   pouch	   evagination.	   The	   compound	  deletion	  of	  Fgfr1	  and	  Fgfr2	  from	  the	  endoderm	  did	  not	  prevent	  pouch	  evagination	  but	  did	  cause	  3rd	  pouch	  hypoplasia	  and	  the	  rostral	  pouches	  to	  fuse.	  	  These	  data	  indicate	  that	  FGF	  signalling	  downstream	  of	  Fgfr1	  and	  Fgfr2	  and	  Tbx1	  are	  important	  for	  pouch	  formation	  but	  that	   they	   are	   likely	   to	   function	   in	   parallel	   pathways	  within	   the	   endoderm.	   Further	   data	  suggests	  that	  TBX1	  may	  be	  acting	  in	  an	  FGF	  independent	  manner	  to	  control	  the	  polarity	  of	  actin	  within	   the	   endodermal	   epithelia.	   Overall	   this	   data	   reveals	   that	   both	   cell	   signalling	  and	   actin	   polarity	   must	   be	   tightly	   regulated	   within	   the	   endoderm	   for	   the	   pharyngeal	  pouches	  to	  form	  correctly.	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1.1	  Overview	  of	  the	  pharyngeal	  apparatus	  
All	   vertebrate	   species	   have	   a	   segmented	   body	   plan	   (Maroto	   et	   al.,	   2012).	  Segmentation	   is	   the	  process	  of	  dividing	  an	  area	  of	   tissue	   into	   smaller	   sections,	   a	  process	  that	  is	  often	  reiterated	  many	  times	  during	  development.	  Many	  examples	  of	  segmentation	  are	  visible	  along	  the	  anterior-­‐posterior	  (A-­‐P)	  axis	  of	   the	  vertebrate	  embryo’s	   body,	   from	   the	   hindbrain	   to	   the	   somites	   at	   the	   posterior	   tip	   of	   the	  embryo’s	   trunk	   (Alexander	   et	   al.,	   2009;	   Tumpel	   et	   al.,	   2009).	   A	   classic,	   well	  understood,	   example	   of	   segmentation	   is	   somitogenesis,	   the	   process	   of	   forming	  successive	   pairs	   of	   somites	   from	   the	   un-­‐segmented	   paraxial	   or	   presomitic	  mesoderm	   (PSM)	   (Maroto	   et	   al.,	   2012).	   The	   division	   of	   the	   PSM	   into	   somites	  compartmentalises	  the	  embryo’s	   trunk	  along	   its	  A-­‐P	  axis,	  enabling	  a	  multitude	  of	  derivatives	   to	   differentiate	   from	   this	   tissue,	   including	   vertebrae,	   skeletal	  muscle,	  and	  dermis	  (Maroto	  et	  al.,	  2012).	  The	  modularity	  of	  the	  vertebrate	  body	  is	  key	  to	  the	   evolution	   and	   diversity	   of	   vertebrates,	   as	   alterations	   to	   the	   process	   of	  segmentation	  can	  dramatically	  change	  the	  embryos	  body	  plan	  (Carroll,	  2001).	  For	  example,	   the	  dramatic	   increase	  in	  somite	  number	  in	  snakes’	  bodies	  enabled	  their	  limbless	  bodies	  to	  remain	  mobile	  (Gomez	  and	  Pourquie,	  2009).	  	  The	  pharyngeal	  apparatus	  (PA)	  is	  another	  example	  of	  a	  segmented	  structure	  in	  the	  vertebrate	   embryo	   whose	   modularity	   has	   altered	   during	   evolution	   (Graham,	  2001).	  The	  PA	  is	  a	  transient	  structure	  common	  to	  all	  chordates	  that	  is	  comprised	  of	  a	   series	   of	   metameric	   segments,	   the	   pharyngeal	   arches,	   segregated	   by	   the	   out	  pocketing	  of	  the	  pharyngeal	  endoderm	  (the	  pharyngeal	  pouches)	  (Graham,	  2001).	  A	  reduction	  in	  the	  number	  of	  pouches	  is	  evident	  in	  Amniotes,	  relative	  to	  the	  more	  primitive	   Gnathostomes.	   	   The	   reduction	   and	   diversification	   of	   the	   pharyngeal	  pouches	   during	   Amniote	   evolution	   was	   likely	   an	   adaptive	   advantage	   to	   the	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amniotes	   during	   their	   transition	   to	   land	   (Graham,	   2001)	   however,	   the	   loss	   of	  pharyngeal	  pouches	  during	  development	  is	  disadvantageous	  (see	  section	  1.2).	  	  	  Pharyngeal	   pouches	   are	   formed	   as	   cells	   of	   the	   pharyngeal	   endoderm	   migrate	  laterally	   toward	   the	   pharyngeal	   ectoderm	   (Graham,	   2001;	   Graham,	   2003).	   The	  pharyngeal	   pouches	  develop	   as	  part	   of	   a	   greater	   structure,	   the	  PA.	   	   Superficially	  the	  PA	  appears	  as	  iterative	  bulges	  flanking	  the	  embryo’s	  head	  in	  an	  area	  between	  the	  primitive	  heart	   (ventrally)	  and	   the	  rhombomeres	  of	   the	  hindbrain	  (dorsally),	  (see	   Fig	   1a).	   The	   PA	   is	   identifiable	   from	   embryonic	   day	   of	   development	   (E)	   8.5	  until	  E11.0	  when	  the	  majority	  of	  this	  transient	  structure	  has	  become	  incorporated	  into	   structures	   essential	   for	   postnatal	   survival	   (see	   section	   1.1.1)	   (Tamarin	   and	  Boyde,	  1977).	  Despite	   the	   transient	  presence	  of	   the	  PA,	   the	   structure	   is	   complex	  and	  its	  correct	  development	  is	  essential	  for	  embryonic	  viability.	  	  A	   longitudinal	   cross-­‐section	   reveals	   that	   the	   apparatus	   is	   composed	   of	   six	   cell	  types;	   ectoderm,	  mesoderm	  and	  endoderm	  and	   cranial	   neural	   crest	   cells	   (CNCC)	  that	  differentiate	  into	  mesenchyme	  and	  endothelial	  cells	  (see	  Fig	  1b).	  Each	  ‘bulge’,	  defined	  as	  a	  pharyngeal	  arch,	  is	  covered	  in	  an	  external	  ectodermal	  epithelium	  and	  is	   populated	   by	   CNCC	   from	   the	   mid	   and	   hindbrain	   that	   form	   the	   arch	  ectomesenchyme	   (Graham,	   2001;	   Graham,	   2003).	   A	   core	   of	   mesodermal	   cells	  forms	  within	  each	  arch,	  adjacent	   to	   the	  pharyngeal	  arch	  artery	   (PAA).	  CNCC	  also	  contribute	   to	   the	   PAAs,	   differentiating	   into	   smooth	   muscle	   cells	   that	   line	   each	  vessel.	  The	  innermost	  tissue	  of	  the	  PA	  is	  the	  endodermal	  epithelium	  that	  lines	  the	  pharyngeal	   arches,	   separating	   them	   from	   the	   pharyngeal	   cavity	   (Graham,	   2003;	  Graham	   et	   al.,	   2004).	   Finger-­‐like	   projections	   of	   pharyngeal	   endoderm,	   the	  pharyngeal	   pouches,	   divide	   the	  mesenchymal	   tissue	   of	   the	   PA	   as	   they	   evaginate	  laterally	   toward	   the	   ectoderm	   (Graham,	   2001;	   Graham,	   2003).	   When	   the	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evaginating	   endoderm	   contacts	   the	   invaginating	   ectoderm,	   individual	   arches	   are	  segregated	   and	   become	   defined	   as	   separate	   entities.	   	   In	   mouse	   and	   man	   five	  pharyngeal	  arches	  (I-­‐IV	  and	  VI)	  and	  four	  pharyngeal	  pouches	  (pp1-­‐4)	  form	  along	  the	  A-­‐P	  axis	  of	  the	  embryo’s	  body	  (see	  Fig	  1a	  and	  1b)	  (Graham,	  2001).	  	  In	  a	  manner	  akin	  to	  digit	  formation	  there	  is	  a	  temporal	  and	  positional	  requisite	  for	  correct	  development	  of	  the	  PA	  over	  3	  axes;	  anterior-­‐posterior	  [A-­‐P],	  ventral-­‐dorsal	  [V-­‐D]	   and	   proximal-­‐distal	   [P-­‐D].	   However,	   the	   PA	   has	   to	   co-­‐ordinate	   the	  integration	  of	  a	  much	  higher	  number	  of	  individual	  cell	  types,	  not	  just	  ectoderm	  and	  mesenchyme,	   as	   is	   the	   case	   for	  digit	   development	   (Graham,	   2003;	  Tickle,	   2006).	  Signalling	  between	  and	  within	  all	  cell	  types	  must	  be	  tightly	  regulated	  to	  ensure	  the	  PA	  and	  its	  derivatives	  develop	  appropriately	  (Graham	  et	  al.,	  2004).	  It	  is	  becoming	  apparent	   that	   the	   pharyngeal	   endoderm	   plays	   a	   prominent,	   key	   role	   in	   the	  patterning	   of	   the	   pharyngeal	   arches	   and	   has	   the	   ability	   to	   influence	   the	  development	  of	  multiple	  cell	  types	  within	  the	  PA	  (Graham	  et	  al.,	  2004).	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Fig	  	  1a	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Fig	  1a.	  A	  schematic	  of	  an	  E9.5	  mouse	  embryo	  viewed	   from	  the	  side,	  adapted	   from	  Graham	  
2001,	   depicting	   the	   pharyngeal	   apparatus.	   The	   pharyngeal	   aches	   appear	   as	   bulges	   forming	  between	   the	  heart	   (ht)	  ventrally	  and	   the	  rhombomeres/midbrain	  dorsally	   in	  a	  position	  caudal	   to	  the	   eye.	   	   Three	   pharyngeal	   pouches	   can	   be	   distinguished	   externally	   at	   this	   stage	   of	   mouse	  development	   and	   are	   highlighted	   in	   colour	   in	   the	   schematic	   to	   aid	   identification:	   red	   =	   1st	  pharyngeal	  pouch,	  orange	  =	  2nd	  pharyngeal	  pouch,	  yellow	  =	  3rd	  pharyngeal	  pouch.	  Each	  arch	  (I	   to	  IV)	   is	  defined	  and	  segregated	  by	   the	   formation	  of	   a	  pharyngeal	  pouch.	   	  Arrows	   represent	   cranial	  neural	  crest	  migrating	  into	  the	  arches	  from	  the	  midbrain	  and	  rhombomeres	  of	  the	  hindbrain	  (see	  Fig	   3	   for	   a	   summary	   of	   the	   CNCC	   streams).	   Arrows	   to	   the	   right	   of	   the	   schematic	   determine	   the	  orientation	   of	   the	   schematised	   embryo;	   A	   =	   anterior,	   P	   =	   posterior,	   L	   =	   lateral,	   M	   =	   medial,	   V=	  ventral,	   D	   =	   dorsal.	   	   The	   grey	   dashed	   line	   through	   the	   pharyngeal	   apparatus	   represents	   the	  level/position	  of	  the	  schematic	  section	  displayed	  in	  Fig	  1b.	  
	  
Fig	  1b:	  A	  schematic	  of	  a	  frontal	  section	  cut	  through	  the	  pharyngeal	  apparatus	  of	  a	  vertebrate	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1.1.1	  The	  pharyngeal	  endoderm	  
Anatomical	   studies,	   including	   those	   conducted	  as	   early	   as	   the	  19th	  Century,	  have	  documented	   the	   development	   of	   the	   pharyngeal	   pouches	   in	   various	   species	   of	  vertebrate	   embryos,	   including	   the	   pig,	   rat	   and	   in	   humans	   (Badertscher,	   1915;	  Kingsbury,	  1915;	  Rogers,	  1927).	  The	  fundamentals	  of	  pouch	  morphogenesis,	  such	  as	   the	   A-­‐P	   evagination	   of	   the	   pharyngeal	   endoderm	   that	   defines	   a	   series	   of	  pharyngeal	   arches	   to	   generate	   a	   basic	   pattern	   of	   facial	   development,	   is	   relative	  between	   the	   species.	   However,	   subtle	   differences	   exist	   between	   the	   size	   and	  patterning	  of	  pouches	  between	  vertebrate	  species	  and	  in	  the	  derivatives	  they	  form,	  (Badertscher,	  1915;	  Kingsbury,	  1915;	  Rogers,	  1927;	  Grevellec	  and	  Tucker,	  2010).	  The	  origin	  and	  number	  of	  parathyroid	  organs	  are	  one	  example	  of	  such	  differences.	  The	  parathyroid	  is	  formed	  from	  the	  3rd	  pouch	  in	  the	  mouse	  embryo,	  whereas	  two	  parathyroid	  organs	  develop	  in	  the	  chick	  embryo,	  one	  from	  the	  3rd	  pouch	  and	  one	  from	  the	  4th	  pouch	  (Grevellec	  and	  Tucker,	  2010).	  	  A	  recent	  paper	  by	  Grevellec	  et	  al.	  suggests	   the	   location	   of	   parathyroid	   development	   in	   the	   pharyngeal	   endoderm	  may	  be	  regulated	  by	  a	  SHH	  mediated	  repression	  of	   the	  presumptive	  parathyroid	  marker	  Glial	   cells	  missing	   homolog	   2	   (Gcm2)	   (Grevellec	   et	   al.,	   2011).	   This	   thesis	  utilises	  mouse	  embryos	  to	  study	  the	  mechanisms	  that	  regulate	  mammalian	  pouch	  morphogenesis,	  thus	  the	  text	  below	  details	  the	  pertinent	  points	  of	  this	  process	  in	  this	  species.	  	  The	  definitive	  endoderm	  is	  established	  during	  gastrulation	  as	  cells	  of	  the	  epiblast	  (an	   epithelial	   structure	   formed	   at	   E4.0)	   migrate	   through	   and	   exit	   the	   primitive	  streak	  (PS)	  (Zorn	  and	  Wells,	  2009).	  Lineage	  tracing	  experiments	  have	  determined	  that	  the	  order	  the	  cells	  leave	  the	  PS	  partially	  determines	  their	  fate.	  The	  medial	  and	  lateral	  anterior-­‐definitive	  endoderm	  (and	  axial	  mesoderm)	  exits	  the	  PS	  first.	  	  Cells	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that	  egress	  later	  from	  the	  streak	  form	  the	  posterior	  definitive	  endoderm.	  A	  number	  of	   genes	   are	   also	   essential	   for	   the	   specification	   of	   endoderm	   at	   blastula	   and	  gastrula	  stages	  of	  development,	  such	  as	  Nodal,	  as	  reviewed	  by	  Grappin-­‐Botton	  et	  al.	   (Grapin-­‐Botton,	   2008;	   Zorn	   and	   Wells,	   2009).	   The	   anterior	   and	   posterior	  subtypes	  of	  definitive	  endoderm	  both	  contribute	  to	  the	  formation	  of	  the	  primitive	  gut	  tube	  that	  by	  stage	  E8.0	  is	  regionalised	  and	  extends	  from	  the	  1st	  branchial	  arch	  to	   the	   hindgut	   (Tremblay	   and	   Zaret,	   2005;	   Franklin	   et	   al.,	   2008).	   The	   posterior	  portion	  of	  this	  endodermal	  tube	  can	  be	  divided	  into	  the	  hindgut	  (which	  generates	  the	   large	   intestine)	   and	   the	  midgut,	   (which	   generates	   the	   small	   intestine).	   From	  the	  anterior	  portion	  of	  the	  endodermal	  tube	  the	  foregut	  will	  give	  rise	  to	  the	  lungs	  and	   liver,	   the	   stomach,	   biliary	   system	   and	   the	   pancreas;	   each	   organ	   forms	   by	  budding	   out	   of	   the	   endodermal	   tube	   (Tremblay	   and	   Zaret,	   2005).	   At	   the	   most	  rostral	   position	   of	   the	   gut	   tube	   the	   pharyngeal	   pouches	   emerge.	   	   As	   with	   all	  derivatives	  of	  the	  anterior	  gut	  tube	  the	  pouches	  are	  initially	  identifiable	  as	  areas	  of	  endodermal	  ‘out-­‐pocketing’.	  	  	  During	   the	   transient	   period	   of	   pharyngeal	   pouch	   development	   (E8.5-­‐E11.0)	   the	  ‘out	   pocketing’	   or	   evagination	   of	   the	   pharyngeal	   endoderm	   generates	   four	  pharyngeal	  pouches,	  described	  in	  detail	  below	  (Tamarin	  and	  Boyde,	  1977).	  Time-­‐lapse	  photography	  of	   evaginating	   endodermal	   cells	   in	   zebrafish	   embryos	  depicts	  the	  lateral	  movement	  of	  the	  cells	  away	  from	  the	  midline	  of	  the	  embryo	  (after	  their	  initial	   coalescence	   here),	   (Crump	   et	   al.,	   2004).	   This	   is	   in	   agreement	   with	   the	  description	   of	   endodermal	   evagination	   inferred	   from	   histological	   and	  topographical	  analysis	  of	   fixed	  PA	   tissue.	   	   In	  addition	   to	  evaginating	   laterally	   the	  pharyngeal	   endoderm	   must	   become	   constrained	   to	   form	   a	   narrow	   slit-­‐like	  morphology.	  In	  chick	  embryos	  this	  process	  has	  found	  to	  require	  a	  network	  of	  actin	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cables	  enriched	  along	  the	  apical	  side	  of	  the	  evaginating	  endoderm	  (Quinlan	  et	  al.,	  2004).	  Exposing	  the	  pharyngeal	  endoderm	  of	  a	  chick	  embryo	  to	  cytochlasin	  D,	  (a	  context	   dependent	   inhibitor	   of	   actin	   polymerisation),	   prevents	   the	   formation	   of	  actin	   supracables	   in	   this	   epithelia	   (Cooper,	   1987).	   Depending	   on	   the	   time	   of	  exposure	   (prior	   to	   or	   during	   pouch	   evagination)	   the	   cytochlasin	   D	   exposed	  pouches	  form	  but	  do	  so	  with	  a	  splayed	  or	  convoluted	  morphology	  (Quinlan	  et	  al.,	  2004).	   It	   is	   hypothesised	   that	   the	   actin	   supracables	   in	   the	   endoderm	   act	   to	  constrain	   and	   support	   the	   epithelium	   as	   it	   evaginates,	   giving	   this	   process	  directionality.	  	  Post-­‐E8.5	  in	  an	  area	  posterior	  to	  the	  telencephalon	  and	  anterior	  to	  the	  embryonic	  heart,	   the	   evagination	   of	   the	   pharyngeal	   endoderm	   begins	   (Tamarin	   and	   Boyde,	  1977).	   Over	   the	   next	   four	   days	   of	   development	   endodermal	   ‘out-­‐pocketing’	   is	  initiated	  sequentially	  along	  the	  A-­‐P	  axis	  of	  the	  embryo.	   	  By	  E9.0	  the	  first	  pouch	  is	  evident	   as	   a	   prominent	   groove	   that	   defines	   the	  now	  enlarged	  1st	   arch	   anteriorly	  and	  the	  2nd	  arch	  posteriorly,	  the	  2nd	  pouch	  is	  just	  emerging.	  Half	  a	  day	  later	  the	  2nd	  arch	   has	   enlarged	   and	   appears	   more	   distinct	   as	   the	   2nd	   pouch	   anterior	   to	   it	  lengthens	   laterally	   and	   narrows	   (Tamarin	   and	   Boyde,	   1977).	   At	   E9.5	   the	  evagination	  of	   the	   third	  pouch	  has	  also	  begun.	   	  Between	  E10.0	  and	  E10.5	   the	  4th	  pouch	  evaginates	   from	  the	  endoderm	   in	  close	  proximity	   to	   the	  3rd	  pouch,	   the	  3rd	  and	  4th	  arch	  (defined	  by	  the	  caudal	  pouches)	  are	  less	  pronounced	  than	  the	  rostral	  arches	   (Tamarin	   and	   Boyde,	   1977).	   By	   E11.5	   all	   the	   pharyngeal	   pouches	   have	  contacted	  the	  ectoderm	  giving	  the	  arches	  identity	  and	  shape	  that	  is	  permissive	  to	  CNCC,	  ectoderm	  and	  mesodermal	  cell	  differentiation.	  The	  caudal	  arches	  evident	  at	  E10.5	  are	  masked	  at	  E11.5	  by	  the	  posterior	  outgrowth	  of	  the	  caudal	  ectoderm	  (the	  cervical	   sinus)	   (Tamarin	   and	   Boyde,	   1977).	   Post	   E11.5	   the	   four	   pharyngeal	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pouches	  and	  the	  five	  pharyngeal	  arches	  (1st	  –	  4th	  and	  6th	  arch,	  the	  5th	  arch	  does	  not	  form	   in	   mammals)	   of	   the	   PA	   have	   begun	   to	   metamorphose	   into	   the	   various	  primordia	   to	   which	   they	   contribute	   (see	   Fig	   3	   and	   Table	   1	   for	   an	   overview	   of	  structure	  derived	  from	  aspects	  of	  the	  PA)	  (Tamarin	  and	  Boyde,	  1977).	  	  The	  pharyngeal	  endoderm	  gives	  rise	  to	  endocrine	  organs	  of	  the	  postnatal	  embryo.	  	  The	  thyroid	  forms	  from	  a	  ventral	  segment	  of	  Nkx2.1	  positive	  endoderm,	  proximal	  to	   the	   2nd	   pharyngeal	   pouch	   and	   opposing	   the	   aortic	   sac	   (Biddinger	   and	   Ray,	  1993;	   Manley	   and	   Capecchi,	   1995).	   The	   thymus	   forms	   from	   Forkhead	   box	   N1,	  (Foxn1)	   positive	   cells	   (visible	   at	  E11.5)	   in	   the	   ventral	   posterior	   aspect	   of	   the	  3rd	  pharyngeal	   pouch	   (Gordon	   et	   al.,	   2001).	   The	   parathyroid	   cells	   arise	   from	   a	  complementary	  dorsal-­‐anterior	   aspect	   of	   the	   third	  pouch	   in	  mice	   that	   is	  marked	  from	  E9.5	  by	  Glial	  cells	  missing	  homolog	  2	  (Drosophila)	  (Gcm2),	  expression	  (Gordon	  et	   al.,	   2001).	   At	   approximately	   E12.5	   the	   parathyroid	   and	   thymus	   prymordia	  detach	   from	   the	   endoderm	  of	   the	   pharynx	   and	  migrate	   caudally	   (Blackburn	   and	  Manley,	  2004;	  Grigorieva	  and	  Thakker,	  2011).	  The	  thymus	  migrates	  most	  caudally	  to	  its	  final	  location	  above	  the	  heart	  and	  the	  parathyroid	  migrates	  to	  an	  area	  lateral	  to	  the	  thyroid	  in	  the	  neck	  (Blackburn	  and	  Manley,	  2004;	  Grigorieva	  and	  Thakker,	  2011).	   In	   mouse	   embryos	   the	   ultimobranchial	   bodies	   (UBs)	   arise	   from	   the	   4th	  pharyngeal	  pouch	  (Kusakabe	  et	  al.,	  2006).	  By	  E12.5	   the	  UBs	  have	  begun	  to	  grow	  ventral-­‐laterally,	  as	  they	  migrate	  caudally	  (Kusakabe	  et	  al.,	  2006).	  They	  reach	  the	  thyroid	  around	  E13.5/14.0	  and	  are	  fused	  to	  the	  thyroid	  by	  E14.5.	  	  Post	  E14.5	  cells	  of	   the	   UB	   disseminate	   through	   the	   thyroid,	   giving	   rise	   to	   an	   even	   coverage	   of	  calcitonin	  cells	  (C-­‐cells)	  by	  E19.0	  (Kusakabe	  et	  al.,	  2006).	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Fig	  2	  Identifies	  an	  overview	  of	  anatomical	  structures	  present	  in	  the	  postnatal	  mouse	  that	  are	  
derived	   from	   specific	   pharyngeal	   arches	   and	   pouches	  within	   the	   pharyngeal	   apparatus	   of	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1.1.2	  The	  Pharyngeal	  Mesoderm	  
The	  pharynx	  is	  populated	  by	  cells	  of	  the	  splanchnic	  mesoderm,	  which	  coalesce	  to	  form	   a	   core	   within	   each	   of	   the	   pharyngeal	   arch	   (Tzahor	   and	   Evans,	   2011).	   The	  pharyngeal	   mesoderm	   gives	   rise	   to	   cranial	   muscles	   and	   contributes	   to	   the	  formation	  of	  the	  vessels	  of	  the	  heart,	  such	  as	  the	  aorta	  (Tzahor	  and	  Evans,	  2011).	  The	   aorta	   is	   derived	   from	   a	   primitive	   conduit	   present	   early	   in	   gestation,	   the	  outflow	   tract	   (OFT)	   and	   is	   contributed	   to	   by	   CNCC	   and	  mesodermal	   cells	   (Kirby	  and	  Waldo,	   1995;	  Xu	   et	   al.,	   2004).	   The	  myocardium	  of	   the	  OFT	   is	  mesodermally	  derived,	   it	   forms	   from	   an	   area	   of	   splanchnic	   mesoderm	   caudal	   to	   the	   pharynx	  (defined	   as	   the	   secondary	   heart	   field,	   SHF)	   that	   gives	   rise	   to	   cardiomyocyte	  precursors	   (Waldo	   et	   al.,	   2001).	   The	   OFT	  myocardium	   acts	   as	   a	   primitive	   valve	  whose	   contraction	   within	   the	   OFT	   enables	   blood	   to	   circulate	   from	   the	   right	  ventricle	   to	   the	  aortic	   sac.	  Defects	   in	   the	  morphogenesis	  or	   septation	  of	   the	  OFT	  result	   in	   defects	   of	   the	   aorta.	   The	   current	   view	   is	   that	   the	   development	   of	   the	  craniofacial	   muscles	   and	   the	   aorta	   is	   regulated	   tissue-­‐specifically	   by	   the	  pharyngeal	   mesoderm,	   although	   the	   role	   of	   the	   pharyngeal	   endoderm	   has	   not	  definitively	  been	  ruled	  out	  (Zhang	  et	  al.,	  2006).	  	  In	  contrast,	  there	  is	  evidence	  that	  signalling	  from	  mesodermal	  cells	  can	  perturb	  pharyngeal	  pouch	  formation.	  TBX1	  is	  a	  T-­‐box	  transcription	  factor	  that	  is	  essential	  to	  the	  formation	  of	  the	  caudal	  PA	  (see	  1.3.1.4).	  Zhang	  et	  al.	  demonstrated	  that	  the	  loss	  of	  Tbx1	  expression	  from	  the	  mesoderm,	  (using	  the	  MESP1Cre	  	  that	  has	  mesodermal	  activity	  in	  a	  Tbx1	  heterozygous	  background),	  results	  in	  caudal	  pouch	  aplasia	  (Zhang	  et	  al.,	  2006).	  Re-­‐activation	  of	  Tbx1	  expression	  in	  mesodermal	  cells	  was	  sufficient	  to	  rescue	  2nd	  pouch	  formation	  and	  partially	  rescue	  3rd	  and	  4th	  pouch	  hypoplasia	  in	  Tbx1	  hypomorphs.	  Interestingly,	  however,	  the	  pouch	  phenotype	  of	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embryos	  deficient	  of	  mesodermal	  Tbx1	  (Mesp1cre/+;Tbx1ΔE5/flox	  embryos,	  here	  after	  referred	  to	  as	  M-­‐KO	  [mesodermal	  Tbx1	  knock	  out]embryos),	  is	  different	  to	  that	  of	  embryos	  homozygous	  null	  for	  the	  Tbx1	  allele,	  Tbx1tm1Bld	  (referred	  to	  as	  Tbx1-­‐/-­‐	  embryos	  from	  here	  after).	  M-­‐KO	  embryos	  form	  a	  hypoplastic	  4th	  pouch	  but	  do	  not	  form	  a	  2nd	  pouch,	  the	  converse	  is	  true	  of	  Tbx1-­‐/-­‐	  embryos	  (Zhang	  et	  al.,	  2006).	  	  The	  difference	  in	  pouch	  phenotypes	  and	  the	  observation	  that	  reactivation	  of	  Tbx1	  expression	  in	  mesodermal	  cells	  is	  not	  sufficient	  to	  fully	  rescue	  pouch	  defects	  suggests	  that	  other	  sources	  of	  Tbx1	  also	  play	  a	  role	  in	  pouch	  evagination.	  	  
	  
1.1.3	  The	  Cranial	  Neural	  Crest	  Cells	  
In	  contrast	  to	  the	  pharyngeal	  mesoderm,	  the	  CNCC	  that	  infiltrate	  the	  PA	  appears	  to	  be	  greatly	   influenced	  by	   the	  pharyngeal	  endoderm.	  There	  are	   four	  main	   steps	   in	  Cranial	   Neural	   Crest	   Cells	   (CNCC)	   development:	   1)	   Induction;	   2)	   Epithelial	   to	  Mesenchymal	   transition	   (EMT);	   3)	   Migration;	   4)	   Differentiation	   (Cordero	   et	   al.,	  2011).	  	  A	  multitude	   of	   genetic	   components	   govern	   the	   steps	   of	   CNCC	   development	   that	  researchers	   are	   compiling	   into	   a	   gene	   network	   hierarchy	   (Sauka-­‐Spengler	   and	  Bronner-­‐Fraser,	  2008).	  The	  genetic	  requirements	  for	  each	  step	  are	  too	  complex	  to	  discuss	  here	   (they	  are	   reviewed	  by	  Sauka-­‐Spengler	   and	  Bronner-­‐Fraser)	   (Sauka-­‐Spengler	   and	   Bronner-­‐Fraser,	   2008).	   	   However,	   it	   is	   of	   interest	   to	   this	   thesis	   to	  note	  that	  the	  pharyngeal	  endoderm	  plays	  a	  role	   in	  the	  development	  of	   the	  CNCC.	  	  The	  first	  two	  steps	  of	  CNCC	  development	  occur	  within	  or	  in	  close	  proximity	  to	  the	  neural	  tissue	  from	  which	  they	  are	  derived;	  i.e.	  the	  midbrain	  and	  rhombomeres	  of	  the	  hindbrain	   (Graham	  et	  al.,	  2004).	  As	  such,	   the	  pharyngeal	  endoderm	  does	  not	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appear	   to	   influence	   these	   processes.	   Once	   the	   CNCC	   have	   acquired	   the	  characteristics	   of	   a	  migratory	   cell,	   they	  move	   in	   distinct	   streams	   to	   appropriate	  locations	  within	  the	  PA	  and	  differentiate	  (Cordero	  et	  al.,	  2011).	  	  	  The	   most	   anterior	   stream	   of	   CNCC,	   the	   trigeminal	   crest,	   emanate	   from	  rhombomeres	   1	   and	   2	   of	   the	   hindbrain	   and	   from	   the	  midbrain.	   	   The	   trigeminal	  stream	   migrates	   ventrally	   and	   ingresses	   under	   the	   ectoderm	   into	   the	   first	  pharyngeal	  arch	  (Serbedzija	  et	  al.,	  1992;	  Graham	  et	  al.,	  2004).	  Within	  the	  1st	  arch	  CNCC	  differentiate	  to	  produce	  elements	  of	  the	  jaw	  and	  middle	  ear	  such	  as	  the	  incus	  (i.e.	  skeletal	  elements),	  and	  neurones	  of	  the	  trigeminal	  ganglion.	  The	  hyoid	  bone	  of	  the	  neck	  and	  the	  stapes	  of	  the	  ear	  are	  skeletal	  structures	  derived	  from	  the	  CNCC	  of	  the	  2nd	  arch	  (Graham	  et	  al.,	  2004;	  Santagati	  et	  al.,	  2005).	  Differentiation	  of	  the	  2nd	  arch	  CNCC	  into	  neuronal	  cell	  types	  generates	  the	  distal	  axons	  of	  the	  facial	  ganglion.	  The	  CNCC	   that	   locate	   to	   the	  2nd	  arch	   initially	  emanate	   from	  the	  4th	   rhombomere,	  migrating	  to	  the	  2nd	  arch	  as	  the	  hyoid	  stream	  (Serbedzija	  et	  al.,	  1992;	  Graham	  et	  al.,	  2004).	   The	  most	   posterior	   CNCC	   stream,	   the	   post-­‐otic	   stream,	   populates	   all	   the	  remaining	  caudal	  arches	  (3,4	  and	  6).	  	  This	  caudal	  stream	  of	  cells	  delaminates	  from	  rhombomeres	   6	   and	   7	   of	   the	   hindbrain	   (i.e.	   those	   caudal	   to	   the	   otic	   vesicle)	  (Serbedzija	  et	  al.,	  1992).	  	  A	  multitude	  of	  structures	  are	  derived	  from	  the	  post-­‐otic	  CNCC,	  unsurprisingly,	  as	  they	  populate	  three	  separate	  branchial	  arches	  (Graham	  et	  al.,	  2004).	  In	  addition	  to	  neuronal	  and	  skeletal	  cell	  types	  the	  CNCC	  also	  contribute	  to	  each	  of	  the	  PAA	  as	  smooth	  muscle	  cell	  and	  as	  aspects	  of	  the	  OFT	  and	  the	  heart,	  for	   example,	   the	   neural	   crest	   cells	   of	   the	   6th	   PAA	   are	   defined	   as	   cardiac	   NCC	  because	  they	  specifically	  contribute	  to	  the	  cardiac	  cushion	  of	  the	  heart	  (Vincentz	  et	  al.,	  2005)	  (See	  Fig	  3	  which	  gives	  an	  overview	  of	  the	  trajectories	  of	  each	  stream	  of	  crest	  cells).	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Migrating	  CNCC	  were	  thought	  to	  induce	  segmentation	  and	  impose	  identity	  on	  the	  PA.	  However,	   in	   the	   past	   decade	   the	   importance	   of	   the	   pharyngeal	   endoderm	   to	  CNCC	  migration	   and	   differentiation	   has	   begun	   to	   emerge	   (Graham	   et	   al.,	   2004).	  Evolutionary	  data	  has	  shown	  that	  basal	  chordates,	  which	  lack	  a	  jaw	  and	  CNCC,	  still	  develop	   a	   segmented,	   regionalised	   PA	   in	   the	   absence	   of	   CNCC	   (Graham,	   2001).	  Experimental	   data	   has	   confirmed	   that	   in	   the	   absence	   of	   the	   CNCC,	   patterned	  pharyngeal	  pouch	  morphogenesis	  occurs	  (Veitch	  et	  al.,	  1999).	  Genes	  such	  as	  Bmp7	  and	  Pax1	  were	  maintained	  and	  restricted	  to	  their	  correct	  endodermal	  expression	  domains	   within	   the	   pouches	   of	   chick	   embryos	   where	   CNCC	   had	   been	   ablated	  (Veitch	   et	   al.,	   1999).	   This	   data	   indicates	   that	   CNCC	   are	   not	   required	   for	   the	  segmentation	  of	  patterning	  of	  the	  pharyngeal	  endoderm.	  	  	  The	   pharyngeal	   endoderm	   has	   also	   been	   found	   to	   play	   a	   role	   in	   directing	   CNCC	  differentiation,	  the	  4th	  step	  in	  CNCC	  development.	  Zebrafish	  deficient	  in	  the	  (S1P)	  type	   2	   receptor	   (s1pr2)	   display	   ectopic	   or	   reduced	   Meckel’s	   cartilage,	   which	   is	  derived	  from	  CNCC	  in	  the	  mandibular	  half	  of	  the	  1st	  arch	  (Balczerski	  et	  al.,	  2012).	  This	   defect	   correlated	  with	   either	   a	   shift	   or	   reduction	   in	   the	   expression	   of	   sonic	  
hedgehog	  (shh)	  in	  the	  anterior	  pharyngeal	  endoderm	  and	  the	  same	  trend	  observed	  in	   the	  expression	  of	   fibroblast	  growth	   factor	  8	   (fgf8)	  within	   the	  ectoderm.	   It	  was	  found	  that	  transplantation	  of	  wild	  type	  endoderm	  into	  the	  s1pr2	  mutants	  rescued	  the	  Meckel's	  cartilage	  defects	  (Balczerski	  et	  al.,	  2012).	  	  Although	  the	  pharyngeal	  endoderm	  influences	  CNCC	  development	  it	  is	  also	  evident	  that	   the	   CNCC	   are	   not	   passive	   once	   they	   enter	   the	   PA.	   	   Each	   stream	   of	   CNCC	  expresses	  a	  different	  repertoire	  of	  genes	  that	  sensitises	  or	  de-­‐sensitises	  the	  cells	  to	  signalling	   from	  adjacent	   tissues	   i.e.	   the	   endoderm	   (Couly	   et	   al.,	   2002).	  Moreover	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the	  interaction	  between	  different	  cell	  types	  of	  the	  PA	  is	  often	  reciprocal.	   	  As	  such	  there	   is	   evidence	   that	   the	   CNCC	   can	   affect	   the	   regionalisation	   of	   the	   pharyngeal	  pouches	  once	  they	  have	  formed.	  This	  is	  evident	  in	  the	  3rd	  pouch	  of	  mouse	  embryos	  homozygous	   null	   for	  Pax3	   (Splotch	  mutants).	   	   The	   3rd	   pouch	   of	  Splotch	  mutant’s	  forms	   but	   does	   not	   pattern	   appropriately	   into	   presumptive	   parathyroid	   and	  thymus	   expression	   domains	   (Conway	   et	   al.,	   1997;	   Griffith	   et	   al.,	   2009).	   The	  expanded	   thymus	   progenitor	   domain	   is	   attributed	   to	   the	   CNCC	   deficiencies	   of	  
Splotch	  mutants,	  as	  Pax3	   is	  only	  expressed	   in	   this	  cell	   type	  (Conway	  et	  al.,	  1997;	  Griffith	  et	  al.,	  2009).	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Fig	  3	  
	  	  	  	  	  	  	  	  	  	  	  
Fig	  3:	  An	  overview	  of	   the	  trajectories	  of	  neural	  crest	  streams,	  (adapted	   from	  Graham,	  2003).	  	  The	  migration	  of	  CNCC	  from	  the	  rhombomeres	  to	  the	  pharyngeal	  arches	  occurs	  in	  specific	  streams.	  	  The	  trajectory	  of	  each	  stream	  is	  distinguished	  using	  different	  colours.	  	  The	  1st	  arch	  is	  populated	  by	  CNCC	   derived	   primarily	   from	   the	   rhombomeres	   1	   and	   2	   (highlighted	   in	   red).	   	   CNCC	   from	  rhombomere	  4	  migrate	  into	  the	  2nd	  arch	  (highlighted	  in	  orange).	  	  The	  caudal	  arches	  are	  populated	  by	   the	   post-­‐otic	   crest	   that	   emanates	   from	   rhombomeres	   6	   and	   7	   (highlighted	   in	   yellow).	  Annotations:	   Heart	   (ht),	   Rhombomeres	   (Rh),	   Red	   oval=	   1st	   pharyngeal	   pouch,	   orange	   oval	   =	   2nd	  pharyngeal	  pouch,	  yellow	  oval	  =	  3rd	  pharyngeal	  pouch.	  Pharyngeal	  arches	  labelled	  I	  to	  IV.	  Arrows	  to	  the	  right	  of	  the	  schematic	  determine	  the	  orientation	  of	  the	  schematised	  embryo;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  
	  	  	  	  	  	  A	  
	  	  	  P	  
V	  	  	  	  D	  
	  	  	  	  	  	  	  	  L	  	  
	  	  	  L	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1.1.4	  The	  pharyngeal	  ectoderm	  
Mirroring	   the	   evagination	   of	   the	   pharyngeal	   endoderm	   is	   the	   (less	   pronounced)	  invagination	  of	  the	  pharyngeal	  ectoderm	  (Grevellec	  and	  Tucker,	  2010).	  The	  fusion	  of	   the	   invaginating	   ectoderm	  with	   the	   lateral	   tip	   of	   the	   evaginating	   endodermal	  pouch	  forms	  an	  epithelial	  border	  that	  defines	  each	  pharyngeal	  arch	  (Quinlan	  et	  al.,	  2004).	   The	   invaginating	   ectoderm	   of	   the	   1st	   arch	   forms	   a	   cleft	   that,	  with	   the	   1st	  pouch,	  generates	  the	  external	  auditory	  meatus	  (EAM),	  a	  portion	  of	  the	  canal	  of	  the	  external	  ear	  (Mallo	  and	  Gridley,	  1996).	  The	  2nd,	  3rd	  and	  4th	  clefts	  of	  the	  pharyngeal	  ectoderm	   become	   incorporated	   into	   the	   cervical	   sinus	   (an	   expansion	   of	   the	   2nd	  arch)	  that	  does	  not	  appear	  to	  give	  rise	  to	  any	  structures	  (Rogers,	  1927).	  Although	  some	  genes	  important	  for	  the	  formation	  of	  the	  EAM,	  such	  as	  Tbx1,	  are	  known	  the	  tissue	   specific	   requirements	   for	   the	   formation	   of	   the	   clefts	   are	   not.	   Medical	  conditions	  characterised	  by	  defects	   in	  branchial	  clefting	  illustrate	  the	  importance	  of	   ectodermal	   invagination	   during	   development	   (Bajaj	   et	   al.,	   2011).	   It	   would	   be	  interesting	   to	   determine	  whether	   the	   pharyngeal	   endoderm	   induces	   ectodermal	  cleft	   formation	  as	   it	  does	  the	   formation	  of	   the	  epibranchial	  placodes	   in	  ectoderm	  proximal	  to	  the	  PA.	  	  Placodes	  are	  regions	  of	  ectodermal	  thickenings	  that	  give	  rise	  to	  the	  sense	  organs	  and	  neurones.	  	  The	  sensory	  organs,	  the	  ears,	  eyes	  and	  nose	  develop	  from	  the	  otic,	  lens	  and	  olfactory	  placodes,	  respectively	  (i.e.	  the	  sensory	  placodes)	  (Ladher	  et	  al.,	  2010).	   Distal	   elements	   of	   the	   cranial	   ganglia	   are	   derived	   from	   the	   neurogenic	  placodes	  (that	  also	  includes	  the	  lateral	  line	  in	  aquatic	  embryos):	  the	  Vth	  arises	  from	  the	   trigeminal,	   the	   VIIIth	   (auditory)	   from	   the	   otic	   and	   the	   VIIth	   (facial),	   IXth	  (glossopharyngeal),	   Xth	   (vagal)	   from	   the	   epibranchial	   placodes	   (Ladher	   et	   al.,	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2010).	   The	   cranial	   nerves	   are	   of	   dual	   origin	   and	   their	   proximal	   elements	   are	  derived	  from	  CNCC	  (see	  section	  1.1.3).	  	  	  The	  epibranchial	  placode	  consists	  of	   three	   individual	   thickenings	  (the	  geniculate,	  petrosal	  and	  nodose	  in	  order	  of	  position	  along	  the	  A-­‐P	  axis	  of	  the	  embryos	  body)	  of	  ectoderm	   located	   dorso-­‐caudally	   to	   the	   ectodermal	   clefts	   (described	   above)	  (Ladher	  et	  al.,	  2010).	  Development	  of	  the	  epibranchial	  placode	  requires:	  	  
1)	  Induction	  of	  placode	  cell	  identity,	  akin	  to	  the	  induction	  of	  the	  CNCC,	  induction	  of	  this	  placode	  is	  thought	  to	  be	  driven	  by	  signals	  from	  the	  hindbrain	  and	  the	  cephalic	  mesoderm	   that	   are	   in	   close	   proximity	   to	   the	   forming	   pre-­‐placodal	   regions	  (Nechiporuk	  et	  al.,	  2007).	  
2)	  Commitment	   to	  a	  neuronal	   cell	   type.	  After	   induction	   the	  placodal	   cells	   adopt	  a	  neurogenic	  fate	  (as	  neuroblast	  cells)	  and	  delaminate	  through	  the	  basal	  membrane	  toward	  the	  hindbrain.	  It	  has	  been	  found	  that	  neuroblast	  cells	  from	  the	  epibranchial	  placode,	   in	   the	   chick,	   are	   committed	   to	   generate	   a	   specific	   ganglion	   before	  delamination	   (Blentic	   et	   al.,	   2011).	   Begbie	   et	   al.	   found	   that	   Bmp7	   from	   the	  pharyngeal	   endoderm	   was	   capable	   of	   inducing	   neuronal	   commitment	   within	  ectodermal	   explants.	   Only	   explants	   cultured	  with	   endoderm	   or	   BMP7	   expressed	  the	  epibranchial	  marker	  Phox2a	  and	  produced	  neurones	  (Begbie	  et	  al.,	  1999),	  thus	  proving	   that	   the	  pharyngeal	  endoderm	  controls	   the	  neuronal	  commitment	  of	   the	  epibranchial	  placode.	  Data	  from	  more	  recent	  zebrafish	  studies	  support	  the	  findings	  of	  the	  seminal	  paper	  from	  Begbie	  et	  al.	  For	   instance,	  endodermal	  pouches	  do	  not	  form	   in	   sox23	   mutants,	   and	   although	   the	   epibranchial	   placodes	   form	   they	   are	  unable	  to	  initiate	  neurogenesis	  (marked	  by	  neurogenin1	  expression)	  (Holzschuh	  et	  al.,	   2005).	   These	   defects	   can	   be	   rescued	   by	   the	   transplantation	   of	   ‘wild	   type’	  endodermal	   cells	   into	   sox23	   deficient	   mutants.	   	   Fgf3,	   Bmp2	   and	   Bmp5	   have	   all	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been	  proposed	  as	  endodermally	  derived	  signalling	  molecules	  that	  are	  required	  for	  epibranchial	   placode	   neurogenesis	   in	   the	   zebrafish	   (Holzschuh	   et	   al.,	   2005;	  Nechiporuk	  et	  al.,	  2005).	  
3)	   Migration	   and	   simultaneous	   formation	   of	   the	   proximal	   cranial	   nerves	   that	  innervate	  the	  hindbrain	  has	  been	  shown	  to	  be	  dependent	  on	  the	  hindbrain	  target	  tissue	   and	   the	   CNCC	   emigrating	   from	   this	   region	   (Begbie	   and	   Graham,	   2001;	  Blentic	  et	  al.,	  2011).	  	  Understanding	   the	   mechanisms	   that	   control	   the	   formation	   of	   the	   pharyngeal	  pouches	   and	   the	   structures	   they	   influence	   is	   not	   just	   interesting	   from	   a	  developmental	   context	   but	   is	   also	   relevant	   to	   the	   understanding	   of	   a	   number	   of	  congenital	  syndromes	  that	  are	  characterised	  by	  defects	  of	  PA	  derivatives.	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1.2	  DiGeorge	  syndrome	  	  
Microdeletions	   of	   Chromosome	   22q11	   are	   the	   cause	   of	   a	   number	   of	   syndromes	  that	   all	   share	   a	   similar	   aetiology,	   the	   22q11	   syndromes	   (McDonald-­‐McGinn	   and	  Sullivan,	   2011).	   Digeorge	   syndrome	   (DGS),	   Velocardiofacial	   syndrome	   (VCFS),	  CATCH	  22	  syndrome,	   (Cardiac	  defects,	  Abnormal	   facies,	  Thymic	  hypoplasia,	  Cleft	  palate,	   and	  Hypocalcaemia)	   and	  Conotruncal	   anomaly	   face	   syndrome	   (CTAF)	  are	  all	   classified	   as	   22q11	   deletion	   syndromes	   (Shprintzen	   et	   al.,	   1981;	   Burn	   et	   al.,	  1993;	   Driscoll	   et	   al.,	   1993;	   Wilson	   et	   al.,	   1993).	   As	   the	   names	   VCFS	   and	   CTAF	  suggest,	   the	   common	   afflictions	   suffered	   by	   22q11	   deletion	   patients	   are	  craniofacial	   dysmorphia	   and	   cardiac	   defects	   (Driscoll	   et	   al.,	   1993).	   DGS	   is	   also	  characterised	   by	   immune	   deficiencies	   as	   the	   patient’s	   thymus	   is	   aplastic	   or	  hypoplastic	  (Ryan	  et	  al.,	  1997;	  Scambler,	  2000).	  The	  frequency	  of	  these	  congenital	  syndromes	   is	   relatively	   high,	   (1	   in	   3000	   to	   1	   in	   4000	   live	   births),	   hence	  understanding	   the	   basis	   of	   the	   pathogenesis	   underlying	   these	   syndromes	   is	   of	  great	  importance	  (McDonald-­‐McGinn	  and	  Sullivan,	  2011).	  
	  DGS	   was	   first	   characterised	   in	   1965	   by	   the	   clinician	   Dr	   Angelo	   DiGeorge	   who	  described	   thymus	   and	   parathyroid	   agenesis	   in	   a	   group	   of	   children	   (Finley	   et	   al.,	  1977).	  Most	  of	  the	  structures	  affected	  in	  patients	  with	  DGS	  originate	  embryonically	  from	   the	   PA	   (see	   Table	   2),	   as	   such	   the	   syndrome	  was	   often	   termed	   pharyngeal	  pouch	  syndrome	  (Vesterhus	  et	  al.,	  1975;	  Wurdak	  et	  al.,	  2006).	  Defects	  of	  structures	  that	   are	   not	   derived	   from	   the	   PA	   also	   manifest	   in	   DGS	   patients,	   for	   example	  patients	  may	  develop	  multi-­‐cystic	   kidneys	   and	   renal	   atresia.	   	   In	   addition,	   low	   IQ	  and	   psychosis	   can	   persist	   in	   individuals	   with	   DGS,	   these	   mental	   defects	   are	  possibly	  due	  to	  poor	  development	  of	  the	  cerebellum	  (Ryan	  et	  al.,	  1997;	  McDonald-­‐McGinn	  and	  Sullivan,	  2011).	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  In	  the	  1980’s	  many	  DGS	  patients	  were	  found	  to	  have	  a	  Chromosome	  22	  karyotype,	  characterized	   by	   monosomy	   from	   unbalanced	   translocations	   and/or	   interstitial	  deletions	  (Driscoll	  et	  al.,	  1993).	  Further	  cytogenetic	  analysis	  pinpointed	  a	  segment	  on	  the	  long	  arm	  of	  Chromosome	  22,	  22q11.2,	  which	  typically	  caused	  DGS	  (Driscoll	  et	   al.,	   1993;	   Scambler,	   2000).	   Over	  35	   genes	  have	   subsequently	   been	  mapped	   to	  this	   ‘typically	  deleted	   region’	   (TDR)	  on	  Chromosome	  22q11.2.	  The	  penetrance	  of	  all	  DGS	  defects	  between	  individuals	  is	  highly	  variable,	  as	  is	  the	  degree	  of	  severity.	  	  This	  suggests	  that	  DGS	  may	  be	  caused	  by	  defects	  in	  multiple	  genes	  within	  the	  TDR	  or	   by	   defects	   in	   genetic	   modifiers	   outside	   the	   TDR	   that	   are	   perturbed	   by	   the	  translocation/mutations	   within	   the	   TDR	   (Carey	   et	   al.,	   1990;	   Scambler,	   2000).	  Currently	  the	  loss	  of	  TBX1,	  a	  gene	  found	  within	  the	  TDR,	  is	  the	  main	  candidate	  for	  a	  genetic	  cause	  of	  DGS	  (Scambler,	  2010).	  
	  The	   22q11	   region	   affected	   in	   DGS	  was	   found	   to	  map	   to	  mouse	   Chromosome	   16	  (MU16)	  (Galili	  et	  al.,	  1997).	  There	  are	  some	  differences	   in	  gene	  synteny	  between	  the	   two	   species,	   but	   to	   a	   large	   extent	   gene	   organisation	   is	   maintained	   between	  22q11	   and	   MU16	   (Sutherland	   et	   al.,	   1998).	   Lindsay	   et	   al.	   utilised	   this	   genetic	  synteny	   and	   created	  mouse	   lines	  with	   a	   deletion	   (Df1)	   or	   reciprocal	   duplication	  (Dpl)	   in	   a	   1.2MB	   region	   on	   MU16	   (Lindsay	   et	   al.,	   1999).	   The	   Df1/+	   animals	  analysed	  at	  E11.5	  had	  absent	  or	  severely	  reduced	  4th	  PAAs	  that	  resulted	  in	  thoracic	  vessel	  defects,	  such	  as	  interrupted	  aortic	  arch	  type	  B	  (IAA-­‐B),	  at	  E18.5	  (Lindsay	  et	  al.,	  1999).	  These	  data	  indicated	  that	  the	  deletion	  of	  gene(s)	  in	  the	  Dfl	  segment	  are	  likely	  to	  be	  the	  cause	  of	  thoracic	  vessel	  defects	  that	  are	  present	  in	  DGS	  (Chieffo	  et	  al.,	  1997).	  Supporting	  this	  prediction	  was	  the	  observation	  that	  deleting	  one	  allele	  of	  Tbx1	  generated	  embryos	  with	  PAA	  defects	  that	  are	  the	  cause	  of	  thoracic	  vessel	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defects	   observed	   in	   DGS	   (and	   in	   Dfl/+	   mice),	   i.e.	   IAA-­‐B	   (Prescott	   et	   al.,	   2005).	  Embryos	   homozygous	   null	   for	   Tbx1	   (Tbx1-­‐/-­‐	   embryos)	   developed	   the	   full	  complement	  of	  DGS	  phenotypes	  (see	  Table	  2).	  Despite	  differences	  in	  the	  threshold	  of	  TBX1	  that	  causes	  DGS	  defects	  in	  mouse	  and	  man	  (hemizygosity	  of	  TBX1	  causes	  DGS	  in	  humans,	  whereas	  the	  same	  defects	  only	  arise	  in	  mice	  homozygous	  null	  for	  
Tbx1	  in	  the	  mouse),	  some	  cohorts	  of	  DGS	  patients	  were	  found	  to	  have	  mutations	  in	  
TBX1	  (Stoller	  and	  Epstein,	  2005).	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Table	   2:	   A	   summary	   of	   the	   defects	   that	  manifest	   in	  DGS	   patients	   and	   their	  
origin	  within	  the	  PA	  (adapted	  from	  
	  
DGS	  defect	   Pharyngeal	  element	  the	  
structure	  is	  derived	  from	  Otolaryngeal	   abnormalities,	   cleft	   palate	   and	  cleft	  lip	   1st	  pharyngeal	  arch	  defect	  Otolaryngeal	   abnormalities,	   otitis	   media	   a	  middle	  ear	  defect	  and	  low	  set	  ears	  an	  external	  ear	  defect	  
1st	   and	   2nd	   pharyngeal	   arch	  defects	  
Cranial	  nerve	  palsies	   CNCC/placodal	   cranial	   nerve	  defect	  Craniofacial	   dysmorphia	   due	   to	   skeletal	   or	  musculature	  defects	   Mesodermal/	   CNCC	   defects	   of	  various	  arches	  Parathyroid	   hypoplasia/aplasia	   with	  associated	  hypocalcaemia.	   3rd	  pharyngeal	  pouch	  defect	  Thymus	   hypoplasia/aplasia	   with	   associated	  immune	  deficiencies.	   3rd	   and	   4th	   pharyngeal	   pouch	  defect	  Malformation	  of	  the	  great	  vessels	  of	  the	  heart.	   Pharyngeal	   arch	   artery	   defects,	  primarily	  associated	  with	  the	  4th	  PAA.	  Cardiac	   defects;	   defects	   in	   the	   division	   of	   the	  aorta	  and	  the	  formation	  of	  the	  cardiac	  cushions	  of	  the	  heart	  
Out	   flow	   tract/cardiac	   NCC	  defect.	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1.3	  Genes	  and	  signalling	  cascades	  that	  affect	  the	  
formation	  of	  the	  pharyngeal	  pouches	  
	  
1.3.1	  T-­‐box	  1	  (Tbx1)	  
One	  of	  the	  distinguishing	  features	  of	  Tbx1-­‐/-­‐	  embryos	  is	  the	  lack	  of	  pouch	  formation	  and	   thus	   arch	   formation	   caudal	   to	   the	   1st	   pharyngeal	   pouch	   and	   arch.	   	   This	  identifies	  TBX1	  as	  a	  key	  regulator	  of	  pharyngeal	  pouch	  morphogenesis,	  discussed	  further	   in	   section	   1.3.1.3d.	   However,	   the	  mechanisms	   and	   interactions	   by	  which	  TBX1	  regulates	  PA	  development	  are	  still	  not	  fully	  understood	  some	  90	  years	  after	  the	  first	  T-­‐box	  protein,	  BRACHYURY,	  was	  discovered	  (Korzh	  and	  Grunwald,	  2001).	  	  
1.3.1.1	  TBX1	  structure	  Central	  to	  the	  function	  and	  characterisation	  of	  TBX1	  and	  its	  family	  member	  is	  the	  T-­‐domain,	   containing	   the	   T-­‐box	   motif,	   a	   17-­‐26kDa	   protein	   domain	   required	   for	  DNA	  binding.	   	  This	  domain	  has	  been	  maintained	  in	  all	  T-­‐box	  proteins	  throughout	  the	   600	   million	   year	   period	   of	   metazoan	   evolution,	   indicative	   of	   the	   functional	  importance	   this	   domain	   conveys	   (Agulnik	   et	   al.,	   1996;	   Minguillon	   and	   Logan,	  2003).	   Kispert,	   amongst	   other	   researchers,	   helped	   to	   determine	   that	   the	   T-­‐Box	  domain,	  located	  in	  the	  N-­‐terminal	  of	  the	  protein,	  has	  DNA	  binding	  activity	  (Kispert	  et	   al.,	   1995).	  The	  T-­‐box	   recognises	  a	  20bp	  palindromic	   sequence	   in	   target	  genes,	  the	  T-­‐consensus	  motif.	  	  To	  initiate	  trans-­‐activation	  or	  repression	  of	  transcription	  T-­‐box	  proteins	  also	  require	  domains	  in	  their	  C-­‐terminal	  (Kispert	  et	  al.,	  1995).	  	  The	  conserved	  motif	  of	  the	  T-­‐box	  was	  a	  key	  tool	  in	  identifying	  other	  T-­‐box	  proteins	  both	  between	  species	  and	  within	  the	  same	  species	  (Agulnik	  et	  al.,	  1996).	  To	  date	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17	  T-­‐box	  genes,	   classified	   into	  5	   subfamilies	   (Brachyury,	  T-­‐brain,	  Tbx1,	  Tbx2	   and	  
Tbx6),	  have	  been	   identified	   in	   the	  mouse	  and	  human	  genome.	  Tbx1	   is	  part	  of	   the	  
Tbx1	   subfamily,	  which	   also	   includes	  Tbx12,	   Tbx18,	   Tbx20	   and	  Tbx22	   (Minguillon	  and	  Logan,	  2003).	  There	  are	  two	  splice	  forms	  of	  Tbx1	  in	  humans	  that	  produce	  an	  mRNA	   transcript	   with	   either	   9	   or	   10	   exons	   (Chieffo	   et	   al.,	   1997).	   The	   main	  difference	   observed	   between	   TBX1	   other	   T-­‐box	   proteins	   whose	   structures	   have	  been	  solved	  is	  in	  the	  ‘dimerization’	  region.	  The	  crystal	  structure	  predicts	  that	  TBX1	  binds	   the	   palindromic	   T-­‐consensus	   site	   as	   two	   monomers	   that	   connect	   via	   the	  bound	  DNA,	   rather	   than	   binding	  DNA	   directly	   as	   a	   TBX1	   dimer	   (El	   Omari	   et	   al.,	  2011).	   In	  addition	  to	  its	  role	  as	  a	  classic	  transcription	  factor,	  TBX1	  is	  also	  able	  to	  regulate	  signalling	  independently	  from	  its	  transcriptional	  function.	  TBX1	  regulates	  BMP	   signalling	   by	   competitively	   binding	   to	   SMAD1,	   thus	   interfering	  with	  BMP4-­‐SMAD1	   binding	   and	   the	   downstream	   SMAD1-­‐SMAD4	   interactions	   (Fulcoli	   et	   al.,	  2009).	  The	  competitive	  binding	  of	  SMAD1	  also	  occurs	  in	  TBX1	  proteins	  that	  lack	  a	  T-­‐box	  domain.	  Interestingly,	  the	  F148Y	  mutation	  of	  TBX1	  (found	  in	  DGS	  patients)	  maps	   to	   the	   T-­‐box	   domain,	   but	   disrupts	   a	   residue	   at	   the	   surface	   of	   the	   protein.	  	  This	   data	   suggests	   that	   the	   perturbation	   of	   TBX1	   mediated	   protein-­‐protein	  interactions	  may	  underlie	  the	  DGS	  syndrome	  phenotype	  (El	  Omari	  et	  al.,	  2011).	  
	  
1.3.1.2	  Tbx1	  expression	  
Tbx1	  expression	  in	  the	  mouse	  is	  first	  detected	  in	  the	  rostral	  mesoderm	  of	  the	  egg	  cylinder	  at	  E7.5.	   	  Two	  days	   later	  Tbx1	   is	  almost	  exclusively	  expressed	  within	   the	  craniofacial	   region	   (e.g.	   within	   the	   otic	   vesicle,	   the	   PA	   and	   the	   hindbrain)	  (Chapman	  et	  al.,	  1996).	  Later	  in	  gestation	  Tbx1	  expression	  is	  detected	  in	  structures	  that	   are	   re-­‐iterated,	   segmented	   or	   branching,	   for	   instance,	   the	   tooth	   buds,	   rib	  cartilages	   and	   the	   lung	   buds	   (Chapman	   et	   al.,	   1996).	   Chapman	   noted	   that	   the	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expression	   patterns	   of	   Tbx1-­‐Tbx6	   were,	   on	   the	   whole,	   localised	   to	   areas	   where	  ‘inductive	   interactions’	   are	   taking	   place	   (Chapman	   et	   al.,	   1996).	   This	   trend	   is	  exemplified	  by	  the	  expression	  pattern	  of	  Tbx1	   in	  the	  PA	  between	  E8.5	  and	  E10.5.	  
Tbx1	  is	  expressed	  in	  all	  cell	  types	  of	  the	  PA	  apart	  from	  the	  CNCCs:	  the	  mesodermal	  core	  of	  the	  pharyngeal	  arches,	  the	  endothelium	  of	  the	  PAA	  and	  the	  ectodermal	  and	  endodermal	   pharyngeal	   epithelia	   (Vitelli	   et	   al.,	   2002;	   Zhang	   et	   al.,	   2005).	  Interestingly,	   Tbx1	   expression	   is	   extensive	   in	   the	   evaginating	   pharyngeal	  endoderm	  of	  the	  caudal	  most	  forming	  pouch.	  	  For	  example,	  at	  E9.5	  Tbx1	  expression	  is	  confined	  to	  the	  distal	  tip	  of	  the	  1st	  and	  2nd	  pouches	  pharyngeal	  pouches,	  whereas	  
Tbx1	  expression	  is	  visible	  throughout	  the	  just	  forming	  3rd	  pouch	  (Garg	  et	  al.,	  2001;	  Vitelli	  et	  al.,	  2002).	  	  	  
	  
1.3.1.3	  A	  requirement	  for	  Tbx1	  in	  the	  development	  of	  the	  PA	  The	   dynamic,	  widespread	   expression	   of	  Tbx1	   within	   the	   PA	   is	   a	   predictor	   of	   its	  importance	   to	   the	   formation	   of	   this	   structure	   and	   accounts	   for	   the	   extensive	  defects	  observed	  in	  the	  PA	  and	  PA	  derivatives	  of	  Tbx1-­‐/-­‐	  embryos.	  	  
	  
1.3.1.3a	  Defects	  in	  the	  development	  of	  the	  pharyngeal	  mesoderm	  
caused	  by	  a	  loss	  of	  Tbx1	  Musculature	  derived	  from	  mesodermal	  cells	  of	  the	  caudal	  arches	  is	  unable	  to	  form	  in	  Tbx1-­‐/-­‐	  embryos	  because	  of	   the	  distorted	  morphology	  of	  the	  caudal	  PA	  (i.e.	   the	  muscles	   of	   the	   pharynx	   and	   larynx).	   In	   the	   rostral	   arches	  mesodermal	   cells	   are	  unable	   to	   express	   Tbx1-­‐dependent	   myogenic	   regulatory	   factors	   such	   as	   Myf5,	  consequently	  hypoplastic	  mandibular	  muscles	  develop	  in	  Tbx1-­‐/-­‐	  embryos	  (Kelly	  et	  al.,	  2004;	  Grifone	  et	  al.,	  2008).	  Loss	  of	  Tbx1	  also	  results	  in	  hypoplasia	  of	  the	  distal	  portion	  of	  the	  OFT.	  	  Hypoplasia	  of	  the	  OFT	  of	  Tbx1-­‐/-­‐	  embryos	  is	  partially	  attributed	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to	   defects	   in	   the	   expansion	   of	   cardiomyocyte	   precursors	   that	   arise	   from	   the	  splanchnic	   mesoderm	   of	   the	   SHF	   (Xu	   et	   al.,	   2004).	   Defects	   in	   the	   growth	   and	  septation	   of	   the	  OFT	   affect	   the	   formation	   of	   the	   aorta	   and	   cause	   cardiac	   defects	  such	  as	  persistent	  truncus	  arterious	  (PTA)	  (Bajolle	  et	  al.,	  2006).	  	  PTA	  is	  evident	  in	  the	   embryo	   as	   a	   single	   vessel	   arising	   from	   the	  heart.	   	   This	   cardiac	  defect	   occurs	  because	  septation	  of	  the	  aorta	  has	  failed,	  preventing	  the	  segregation	  of	  pulmonary	  and	   systemic	   aspects	   of	   the	   heart	   and	   thus	   the	   circulatory	   system	   (Kirby	   et	   al.,	  2008).	  	  
1.3.1.3b	  Defects	  in	  the	  development	  of	  the	  pharyngeal	  ectoderm	  
caused	  by	  a	  loss	  of	  Tbx1	  The	   distal	   aspects	   of	   IXth	   and	   Xth	   cranial	   nerves	   derived,	   respectively,	   from	   the	  petrosal	  and	  nodose	  epibranchial	  placodes,	  are	  fused	  in	  Tbx1-­‐/-­‐	  embryos	  (Vitelli	  et	  al.,	  2002).	  The	  functional	  consequence	  of	   this	   fusion	  for	  the	  tongue,	  carotid	  sinus	  and	  carotid	  body,	  which	  are	  innervated	  by	  the	  IXth	  and	  Xth	  cranial	  nerves,	  has	  not	  been	  assessed,	  (Ladher	  et	  al.,	  2010).	  However,	  the	  aberrant	  development	  of	  the	  Xth	  cranial	  nerve	  in	  Tbx1-­‐/-­‐	  embryos	  results	  in	  a	  loss	  of	  vagal	  nerve	  innervation	  of	  the	  stomach	  (Calmont	  et	  al.,	  2011).	  	  
	  
1.3.1.3c	  Defects	  in	  the	  development	  of	  the	  CNCC	  caused	  by	  a	  loss	  of	  
Tbx1	  Although	  CNCCs	  do	  not	   express	  Tbx1	   the	   loss	  of	   this	   gene	   from	   the	   surrounding	  niche	   severely	   perturbs	   CNCC	   migration	   into	   and	   differentiation	   within	   the	  pharyngeal	   arches.	   In	   Tbx1-­‐/-­‐	   embryos	   streams	   of	   Crabp1	   expressing	   CNCC	   are	  merged	  and	  often	  ectopic	  as	  they	  migrate	  towards	  the	  PA;	  Dlx2	  marked	  CNCC	  are	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absent	   from	  the	  caudal	  PA	  (Vitelli	  et	  al.,	  2002).	  These	  CNCC	  defects	   impact	  upon	  the	   normal	   development	   of	   cranial	   nerves,	   craniofacial	   skeletal	   elements	   and	  pharyngeal	   arch	   arteries.	   Neurofilament	   staining	   reveals	   that	   the	   proximal	  projections	  Tbx1-­‐/-­‐	  embryos	  cranial	  nerves	  are	  also	  fused	  to	  one	  another	  (Vitelli	  et	  al,	   2002).	   	   Abnormal	   fusion	   of	   the	   Vth	   cranial	   nerve	   with	   the	   VIIth/VIIIth	   cranial	  nerve	   is	   attributed	   to	   the	   ectopic	   migration	   of	   the	   hyoid	   CNCCs	   (Hoxa2/Sox3	  positive),	   that	   enter	   the	   1st	   arch.	   The	   aberrant	   migration	   of	   the	   CNCC	   into	   the	  rostral	  arches	  also	  perturbs	  the	  formation	  of	  the	  CNCC	  derived	  skeletal	  elements	  of	  the	  middle	  and	  outer	  ear	  (Mallo	  and	  Gridley,	  1996).	  In	  Tbx1-­‐/-­‐	  embryos	  the	  2nd	  arch	  derived	  ossicle,	  the	  stapes,	   is	  aplastic	  and	  the	  first	  branchial	  arch	  derived	  ossicle,	  the	   incus,	   is	  hypoplastic	   (Moraes	  et	  al.,	  2005).	  Defects	   in	  CNCC	   that	  populate	   the	  caudal	  PA	  affect	  the	  formation	  of	  the	  3rd,	  4th	  and	  6th	  pharyngeal	  arch	  arteries,	  none	  of	  which	  are	  able	   to	   form	   in	  Tbx1-­‐/-­‐	   embryos	   (Lindsay	  et	  al.,	  2001).	  Although	   the	  lack	  of	  arch	  morphology	  is	  the	  primary	  cause	  of	  the	  caudal	  PAA	  aplasia,	  CNCC	  also	  differentiate	   into	   smooth	  muscle	   cells	  of	   the	  PAA,	   a	  process	   that	   is	  perturbed	  by	  the	  loss	  of	  one	  allele	  of	  Tbx1	  (Zhang	  et	  al.,	  2005).	  
	  
1.3.1.3d	  Defects	  in	  the	  development	  of	  the	  pharyngeal	  endoderm	  
caused	  by	  a	  loss	  of	  Tbx1	  The	   dynamic	   pattern	   of	   Tbx1	   expression	   in	   the	   pharyngeal	   endoderm	   indicates	  that	   Tbx1	   may	   be	   required	   within	   the	   endoderm	   to	   regulate	   pharyngeal	   pouch	  morphogenesis.	   Certainly	   the	   loss	   of	   Tbx1	   prevents	   the	   evagination	   of	   the	  pharyngeal	  endoderm	  caudal	  to	  the	  1st	  pouch	  (Jerome	  and	  Papaioannou,	  2001).	  As	  such,	  the	  organs	  that	  normally	  metamorphose	  from	  the	  pharyngeal	  endoderm	  are	  aplastic	   or	   hypoplastic	   in	   Tbx1-­‐/-­‐	   embryos.	   Thyroid	   development	   is	   initiated	  normally	  in	  Tbx1-­‐/-­‐	  embryos	  and	  the	  precursor	  domain	  is	  of	  correct	  size	  and	  place	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in	   the	   pharyngeal	   endoderm,	   likely	   because	   Tbx1	   is	   normally	   only	   weakly	  expressed	  in	  this	  domain	  (Liao	  et	  al.,	  2004;	  Fagman	  et	  al.,	  2007).	  	  However,	  thyroid	  hypoplasia	   and	   hemiagenesis	   manifests	   in	   embryos	   absent	   of	   Tbx1	   expression.	  	  These	  thyroid	  defects	  are	  partially	  attributed	  to	  the	  thyroid	  primordium’s	  inability,	  in	  a	  Tbx1	  devoid	  environment,	  to	  associate	  with	  the	  surrounding	  vasculature.	  	  The	  vasculature	  with	  which	  the	  thyroid	  should	  associate	  has	  been	  shown	  to	  influence	  the	  growth,	  lobulation	  and	  migration	  of	  the	  gland,	  (Liao	  et	  al.,	  2004;	  Fagman	  et	  al.,	  2007).	  Aplasia	  of	  the	  4th	  pouch	  in	  Tbx1-­‐/-­‐	  embryos	  also	  contributes	  to	  the	  thyroid	  hypoplasia	   because	   C-­‐cells	   derived	   from	   the	   UB	   are	   unable	   to	   form	   if	   this	  most	  caudal	  pouch	  is	  absent	  during	  development	  (Liao	  et	  al.,	  2004).	  Similarly,	  aplasia	  of	  the	   3rd	   pouch	   in	   Tbx1-­‐/-­‐	   embryos	   prevents	   the	   thymus	   and	   parathyroid	   from	  developing	  (Jerome	  and	  Papaioannou,	  2001;	  Liao	  et	  al.,	  2004).	  	  It	   is	  difficult	  to	  determine	  from	  an	  analysis	  of	  Tbx1-­‐/-­‐	  embryos	  whether	  TBX1	  has	  tissue	   specific	   roles	   during	   PA	   development.	   As	   discussed	   in	   section	   1.1,	   the	  pharyngeal	  endoderm	  can	   influence	   the	  development	  of	  non-­‐endodermal	   cells	   in	  the	  PA	  and	  thus	  the	  structures	  they	  contribute	  to	   later	   in	  gestation.	   It	   is	  possible	  that	   caudal	   pouch	   aplasia	   is	   caused	   by	   the	   loss	   of	   Tbx1	   expression	   from	   the	  endoderm	   and	   that	   this	   in	   turn	   perturbs	   the	   development	   of	   the	   adjacent	  pharyngeal	  tissues.	  To	  elucidate	  this,	  first	  the	  requirement	  and	  role	  of	  TBX1	  in	  the	  endoderm	   during	   pharyngeal	   pouch	   outgrowth	   needs	   to	   be	   established.	   The	  generation	   of	  mouse	   lines	   that	   drive	   the	   deletion	   of	  Tbx1	   in	   a	   defined	   spatial	   or	  temporal	  manner	  have	  enabled	   researchers	   to	   address	   the	   tissue	   specific	   role	  of	  TBX1	   at	   different	   time	  points	   in	   development.	   	   In	   all	   cases	   'Cre-­‐loxP'	   technology	  has	  been	  used	  to	  delete	  genetically	  engineered	  Tbx1	  alleles	  in	  which	  critical	  exons,	  such	   as	   the	   T-­‐box	   containing	   exon	   5,	   are	   flanked	   by	   loxP	   sites	   (Xu	   et	   al.,	   2004;	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Arnold	  et	  al.,	  2006).	   	  CRE	  enzymes	  recognize	  the	   lox-­‐P	  sites	  and	  act	  to	  recombine	  and	   thus	   delete	   the	   exons	   that	   are	   essential	   to	   the	   function	   of	   TBX1	   (Ray	   et	   al.,	  2000).	  By	  driving	   the	   expression	  of	  Cre	  with	   a	   cell-­‐specific	   promoter	   it	   is	   hoped	  that	  the	  activity	  of	  the	  CRE	  enzyme	  and	  thus	  the	  deletion	  of	  the	  ‘floxed’	  target	  gene	  is	  restricted	  (Feil,	  2007).	  Whilst	  a	  number	  of	  tissue	  specific	  Cre	  lines	  are	  available,	  a	  requirement	  for	  Tbx1	  in	  the	  endoderm	  has	  still	  not	  been	  established.	  
	  
1.3.1.4	  Dissecting	  the	  tissue	  specific	  requirements	  for	  Tbx1	  during	  
pharyngeal	  pouch	  development	  The	  deletion	  of	  Tbx1	  using	  WNT1Cre,	  (the	  name	  is	  derived	  from	  the	  genes	  Wingless	  and	   Integrase-­‐1;	   this	   enzyme	   is	   only	   active	   in	   CNCC)	   does	   not	   recapitulate	   any	  phenotypes	  of	  the	  Tbx1-­‐/-­‐	  embryos,	  including	  caudal	  pouch	  aplasia	  (Kochilas	  et	  al.,	  2002).	   This	   finding	   was	   in	   agreement	   with	   the	   observation	   that	   Tbx1	   is	   not	  expressed	   in	   the	   CNCC	   (Garg	   et	   al.,	   2001;	   Vitelli	   et	   al.,	   2002).	   Thus,	   TBX1	   in	   the	  endoderm,	  ectoderm	  or	  mesoderm,	  or	  in	  a	  combination	  of	  all	  three	  of	  these	  tissue	  types,	  must	  regulate	  pharyngeal	  pouch	  morphogenesis.	  	  Pharyngeal	  pouch	  defects	  have	  not	  been	  documented	  in	  embryos	  that	  are	  unable	  to	   express	  Tbx1	   in	   the	   ectoderm,	   (Ap2alphaIREScre/+;Tbx1flox/-­‐	   embryos	   named	   as	  
PSE-­‐KO	   embryos	   from	  here	   onward)	   (Calmont	   et	   al.,	   2009;	  Randall	   et	   al.,	   2009).	  However,	   thymus	   hypoplasia	   does	   manifest	   in	   PSE-­‐KO	   embryos	   (Randall	   et	   al.,	  2009).	   	   It	   is	   likely	   that	   the	   documented	   defects	   of	   CNCC	   migration	   into	   the	  pharyngeal	   arches	   of	   PSE-­‐KO	   embryos	   accounts	   for	   the	   hypoplasia	   of	   this	  endocrine	  organ.	   	  However,	  until	  pouch	  morphogenesis	   is	  analysed	  and	  noted	  as	  normal	   in	  the	  PSE-­‐KO	  mutants,	  a	  role	   for	  ectodermal	  Tbx1	   in	  pouch	  development	  cannot	  be	  completely	  excluded	  (Calmont	  et	  al.,	  2009).	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  Surprisingly,	  a	  MESP1Cre	  (Mesodermal	  posterior	  1	  homolog)	  driven	  recombination	  of	   Tbx1	   within	   mesodermal	   cells	   results	   in	   non-­‐cell	   autonomous	   endodermal	  pouch	  defects,	  (Zhang	  et	  al.,	  2006).	  	  The	  2nd	  and	  3rd	  pouches	  of	  M-­‐KO	  embryos	  were	  aplastic	   (hence	   so	   were	   the	   majority	   of	   thymi	   examined)	   and	   the	   4th	   was	  hypoplastic.	   Conversely,	   the	   reactivation	   of	   Tbx1	   in	   the	   mesoderm	   in	   a	   Tbx1	  hypomorphic	   background	   partially	   rescued	   the	   pouch	   abnormalities;	   embryos	  develop	  a	  hypoplastic	  3rd	  and	  4th	  pouch	  and	  a	  normalised	  2nd	  pouch	  (Zhang,	  2006).	  	  However,	   the	   thymic	   defects	   are	   not	   rescued	   by	   the	  mesodermal	   reactivation	   of	  
Tbx1,	   indicating	   that	  Tbx1	   is	   required	   in	   the	  pharyngeal	   epithelia	  during	   thymus	  organogenesis.	  The	  partial	   rescue	  of	  pouch	  morphogenesis	  by	   the	  reactivation	  of	  mesodermal	   Tbx1	   expression	   was	   surprising	   and	   illustrates	   that	   Tbx1	   in	   the	  mesoderm	  influences	  pouch	  (Zhang	  et	  al.,	  2006).	  However,	  it	  is	  uncertain	  whether	  the	   low	   level	   of	   Tbx1	   transcription	   from	   the	   hypomophic-­‐Tbx1	   allele,	   combined	  with	  mesodermal	  Tbx1	   expression,	   is	   enabling	  pouch	  morphogenesis	   to	  proceed,	  rather	  than	  expression	  from	  mesoderm	  alone.	  	  The	  Foxg1cre	   line	  has	  been	  used	   to	  drive	   the	  deletion	  of	  Tbx1	   specifically	   in	   the	  endoderm	  (Foxg1Cre/+;Tbx1flox/-­‐	  now	  referred	   to	  as	  PE-­‐KO	  embryos)	   (Arnold	  et	  al.,	  2006).	   As	   expected,	   the	  PE-­‐KO	  embryos	   recapitulated	   the	   endodermal	   defects	   of	  
Tbx1-­‐/-­‐	  embryos.	  	  Surprisingly,	  PE-­‐KO	  mutants	  also	  phenocopy	  the	  non-­‐endodermal	  defects	  observed	  in	  Tbx1-­‐/-­‐	  mutants,	  such	  as	  the	  loss	  of	  the	  muscles	  of	  mastication	  (Arnold	  et	  al.,	  2006).	  Whilst	  the	  use	  of	  FOXG1Cre	  (Forkhead	  box	  G1),	  on	  the	  Swiss-­‐Webster	   (S-­‐W)	   genetic	   background	   attenuates	   any	   non-­‐endodermal	   activity,	   on	  other	  backgrounds	  this	  driver	  induces	  recombination	  in	  multiple	  cell	  types	  within	  the	   PA	   (Zhang	   et	   al.,	   2005).	   The	   NKX2.5Cre	   (Nk2	   homoeobox	   5)	   induces	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recombination	   of	   Tbx1	  within	   discreet	   domains	   of	   the	   3rd	   and	   4th	   pharyngeal	  pouches	   and	   results	   in	   4th	   arch	   and	   thymus	   hypoplasia.	   Severe	   endodermal	  defects	  were	  not	  observed	  in	  these	  mutants	  because	  the	  endodermal	  domains	  of	  
Nkx2.5	  and	  Tbx1	   only	  partially	  overlap	   in	   the	   caudal	  pouches	   (Xu	  et	   al.,	   2004).	  Moreover,	   the	   deletion	   of	  Tbx1	   from	  mesodermal	   domains,	   where	  Nkx2.5Cre	   is	  expressed	  in	  addition	  to	  the	  endoderm,	  may	  also	  contribute	  to	  the	  pouch	  defects	  observed	   (Moses	   et	   al.,	   2001).	  As	   such,	   the	   role	   Tbx1	   plays	   in	   the	   endoderm	  during	  pouch	  morphogenesis	  and	  indeed	  in	  the	  development	  of	  non-­‐endodermal	  structures	  within	  the	  PA	  is	  still	  questioned.	  	  It	   is	   clear	   that	   to	  elucidate	   the	   role	  of	  TBX1	  specifically	   in	   the	  endoderm	  a	  Cre	  line	   that	   is	   highly	   efficient	   at	   recombining	   Tbx1	   specifically	   throughout	   the	  pharyngeal	   endoderm	   is	   required.	   In	   addition,	   Tbx1-­‐dependent	   signalling	  molecules	   and	   cellular	   processes	   that	   regulate	   pouch	   outgrowth	   within	   the	  endoderm	  also	  need	  to	  be	  identified.	  Signalling	  cascades	  that	  may	  be	  able	  to	  fulfil	  this	  role	  are	  discussed	  below.	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1.3.2	  The	  FGF	  signalling	  cascade	  	  
Members	  of	  the	  Fibroblast	  Growth	  Factor	  (FGF)	  signalling	  cascade	  are	  expressed	  in	   the	   endoderm	   and	   their	   deletion	   affects	   pouch	   morphogenesis	   (discussed	  below).	   	  As	   such	   signalling	   from	   this	   cascade	  within	   the	  pharyngeal	   endoderm	  may	  be	  able	  to	  regulate	  pouch	  morphogenesis.	  
	  
1.3.2.1	  FGF	  structure	  and	  function	  Fibroblast	   growth	   factors	   (FGFs)	   are	   a	   group	   of	   signalling	   molecules	   that	   in	  mouse	   and	   man	   are	   comprised	   of	   22	   genes	   (Dorey	   and	   Amaya,	   2010).	   FGFs	  function	  as	  ligands	  that,	  on	  binding	  to	  their	  target	  receptor,	  activate	  a	  signalling	  cascade	   that	   can	   regulate	   a	   number	   of	   cellular	   mechanisms,	   including;	  proliferation,	  differentiation,	  cell	  survival	  and	  even	  cell	  death	  (Dorey	  and	  Amaya,	  2010).	  	  The	  high	  degree	   of	   conservation	  between	  Fgf	  transcripts	   and	   the	   expansion	   of	  the	   FGF	   family	   through	   evolution	   highlights	   the	   importance	   of	   this	   signalling	  cascade	  (Ornitz	  and	  Itoh,	  2001).	  Phylogeny	  and	  sequence	  homology	  studies	  have	  divided	   the	  22	  FGF	   ligands	   into	  7	  subfamilies	  determined	  by	   the	  similarities	   in	  their	  nucleotide	  and	  amino	  acid	  sequences.	  The	  families	  are	  grouped	  as	  follows:	  FGF1/2,	   FGF4/5/6,	   FGF3/7/10/22,	   FGF9/16/20,	   FGF8/17/18,	  FGF15/19/21/23	  and	  FGF11/12/13/14	  (Itoh	  and	  Ornitz,	  2004).	  As	  amino	  acid	  sequences	   are	   indicative	   of	   protein	   function,	   FGFs	   with	   similar	   functions	   and	  characteristics	   are	   logically	   grouped	   together.	   	   Each	   group	   also	   tends	   to	   be	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characterised	  by	  the	  FGF	  protein’s	  ability	  to	  function	  as	  intracrine,	  paracrine	  or	  endocrine	   factors	   (Itoh	   and	   Ornitz,	   2011).	   Paracrine	   FGFs	   are	   the	   most	  numerous	   consisting	   of	   FGF/1/2/5,	   FGF3/4/6,	   FGF7/10/22,	   FGF8/17/18	   and	  FGF9/16/20	   subfamilies.	   Predominantly,	   the	   N-­‐terminal	   peptides	   are	   cleaved	  from	   the	   paracrine	   FGFs	   and	   secreted	   from	   the	   cells	   in	   which	   they	   were	  synthesised	   (Revest	   et	   al.,	   2000;	   Tulin	   and	   Stathopoulos,	   2010).	   The	   ability	   of	  paracrine	  FGFs	   to	  act	  extracellularly	  enables	   the	   ligands	   to	  bind	   to	   cell	   surface	  tyrosine	  kinase	  FGFRs	  on	  neighbouring	   cells,	   activating	  FGF	   signalling	  non-­‐cell	  autonomously	   (Revest	   et	   al.,	   2000;	   Scholpp	   and	   Brand,	   2004).	   Despite	  differences	   in	  their	  mode	  of	  signalling,	  FGF	  members	  all	  have	  a	  conserved	  core	  structure	  that	  identifies	  them	  as	  an	  FGF	  protein.	  	  Vertebrate	  FGFs	  are	  17	  to	  34kDa	  proteins	  consisting	  of	  variant	  N-­‐	  and	  C-­‐	  termini	  that	  flank	  a	  highly	  invariant	  section	  –	  the	  ‘conserved	  core’-­‐	  which	  permits	  an	  FGF	  to	   function	   as	   a	   signalling	   molecule	   (Ornitz,	   2000;	   Dorey	   and	   Amaya,	   2010).	  Typically	   the	   conserved	   core	   consists	   of	   12	   beta-­‐strands,	   that	   on	   folding	   to	   a	  tertiary	   structure	   (a	   B-­‐trefoil	   shape),	   appears	   almost	   pyramidal,	   (Zhu	   et	   al.,	  1991;	  Ornitz	  and	   Itoh,	  2001).	  Amino	  acids	  within	   the	   conserved	  FGF	  core	  have	  been	   identified	   as	   sites	   required	   for	   FGF	   receptor	   (FGFR)	   binding	   and	  independent	   sites	   for	  heparin/heparan	  sulfate	  proteoglycan	  binding	   (Plotnikov	  et	   al.,	   2000).	   Unlike	   other	   tyrosine	   kinase	   receptor	   ligands,	   FGFs	   exist	   as	  monomers	  rather	  than	  dimers	  and,	  if	  not	  present	  in	  excess,	  require	  other	  factors	  such	   as	   heparan	   sulfate	   (HS)	   to	   facilitate	   receptor	   binding	   (Mohammadi	   et	   al.,	  2005).	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Four	  Fgfr	   genes	   have	   been	   identified	   in	  mouse	   and	  man,	   (Fgfr1-­‐4).	   	   Each	  Fgfr	  transcript	  is	  comprised	  of	  three	  domains;	  an	  extracellular	  ligand	  binding	  domain,	  a	   transmembrane	   domain	   and	   a	   tyrosine	   kinase	   domain	   that	   is	   located	  intracellularly,	  (Itoh	  and	  Ornitz,	  2004).	  Within	  the	  C-­‐terminal	  of	  the	  protein	  (the	  extracellular	   ligand	   binding	   domain	   in	   the	   Fgfr	   mRNA)	   there	   are	   three	  immunoglobulin-­‐like	   (Ig)	   domains	   that	   all	   function	   in	   ligand	   binding.	   	   The	  alternate	  splicing	  of	  exons	  in	  the	  Ig-­‐like	  III	  domain	  generates	  FGFR	  isoforms	  type	  -­‐	   IIIa,	   -­‐IIIb	   and	   –IIIc,	  which	   appear	   to	  have	  distinct	   expression	  patterns	   (Groth	  and	   Lardelli,	   2002).	   	   Whilst	   isoforms	   -­‐IIIa	   are	   not	   known	   to	   function	   in	   FGF	  signalling,	   isoforms	  –IIIb	   and	   –IIIc	   are	   restricted,	   respectively	   to	   epithelial	   and	  mesenchymal	   tissue	   types	   (Orr-­‐Urtreger	   et	   al.,	   1993).	   In	   addition	   to	   regulating	  FGF	   signalling	   in	   a	   tissue	   specific	   manner,	   alternative	   splicing	   of	   the	   Fgfr	  transcripts	  also	   regulates	   the	  binding	  affinity	  between	  a	   ligand	  and	   its	   cognate	  receptor,	  (Yeh	  et	  al.,	  2003;	  Beenken	  et	  al.,	  2012).	  	  For	  instance,	  the	  splicing	  event	  that	  occurs	  in	  Fgfr2	  to	  form	  FGFR2(III)b	  retains	  and	  reveals	  the	  amino	  acid	  Ser-­‐315	   in	   the	  receptors	  D3	  binding	  domain.	   	  Ser-­‐315	   forms	  strong,	  highly	  specific	  hydrogen	   bonds	   with	   the	   Asp-­‐76	   amino	   acid	   in	   the	   ligand	   FGF10	   (and	   other	  FGF7	   family	  members)	   (Yeh	  et	   al.,	   2003).	  Consequently,	   interchanging	  Ser-­‐315	  for	   the	  relative	  D3	  amino	  acid	   in	  FGFR2(III)c,	   (alanine-­‐315)	  drastically	  reduces	  the	  binding	  affinity	  between	  FGFR2(III)b	  and	  FGF7	  (Wang	  et	  al.,	  1995).	  	  	  The	   crystal	   structures	  of	  many	  FGF-­‐FGFR-­‐HS	   structures	  have	  now	  been	   solved	  revealing	  that	  these	  factors	  interact	  in	  a	  2:2:2	  conformation	  to	  induce	  signalling	  (Plotnikov	  et	  al.,	  2000).	  Upon	  the	  trans-­‐autophosphorylation	  of	  tyrosine	  residues	  within	   the	   intracellular	   domain	   of	   the	   FGFR	   (induced	   by	   FGF	   ligand	   binding),	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many	   downstream	   intracellular	   pathways	   are	   activated	   (Thisse	   and	   Thisse,	  2005).	  Specific	  signalling	  pathways	  are	  activated	  when	  intracellular	  proteins	  are	  recruited	   to	   specific,	   (now	   phosphorylated),	   recognition	   motifs	   within	   the	  receptor,	  (Thisse	  and	  Thisse,	  2005).	  	  	  The	   Ras/Map	   Kinase	   pathway	   is	   one	   of	   three	   major	   cascades	   stimulated	  downstream	   of	   activated	   FGFRs	   (see	   Fig	   4),	   the	   other	   two	   being	   the	   PLCg	  pathway	   and	   the	   PI3K/PKB	   pathway	   (Dorey	   and	   Amaya,	   2010).	   Signal	  transduction	   is	   induced	  by	   the	   (activated)	  FGFR-­‐dependent	  phosphorylation	  of	  the	  membrane-­‐anchored	  docking	  protein,	  FGFR	  substrate	  2α	  (FRS2α)	  (Kouhara	  et	  al.,	  1997).	  The	  tyrosine	  phosphorylation	  of	  FRS2α	  facilitates	  the	  binding	  of	  a	  GRB2-­‐SOS	   complex	   (Clark	   et	   al.,	   1992;	   Lowenstein	   et	   al.,	   1992).	   This	   step	  initiates	  the	  Ras-­‐Raf-­‐MEK-­‐MAP	  kinase	  (ERK1/2)	  phosphorylation	  cascade,	  which	  is	   catalysed	   by	   the	   exchange	   of	   GDP	   for	   GTP	   on	   RAS	   via	   SOS	   (a	   nucleotide	  exchange	  factor)	  (Thisse	  and	  Thisse,	  2005).	  	  Phosphorylated	  MAP	  kinase	  is	  able	  to	  enter	  the	  nucleus	  where	  it	  phosphorylates	  and	  complexes	  with	  transcription	  factors	  such	  as	   the	  Ets	  domain	  containing	   factors	  ERM	  and	  PEA3	  (Janknecht	  et	  al.,	  1996;	  Sharrocks,	  2001).	  This	   initiates	   the	   transcription	  of	  FGF	  target	  genes,	  including	   Erm	   and	   Pea3	   themselves,	   and	   regulates	   FGF	   dependent	   cellular	  functions	  (Raible	  and	  Brand,	  2001;	  Thisse	  and	  Thisse,	  2005).	  The	  protein	  kinase	  C	  pathway	  has	  been	  implicated	  in	  cell	  migration,	   the	  Akt	  pathway	  is	  associated	  with	   cell	   survival	   and	   proliferation	   is	   linked	   to	   the	   Ras/ERK	   pathway.	   FGF	  signalling	  is	  controlled	  at	  many	  levels	  in	  each	  pathway	  (Dorey	  and	  Amaya,	  2010).	  One	   way	   FGF	   signalling	   can	   be	   attenuated	   is	   through	   the	   FGF-­‐dependent	  transcription	  of	  negative	   feedback	   regulators,	   such	  as	   the	  Sprouty	   (Spry)	   genes	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Fig	  4.	  A	  summary	  of	  the	  Ras/Map	  Kinase	  pathway	  of	  the	  FGF	  signalling	  cascade,	  taken	  from	  
Thisse	   and	   Thisse,	   2005.	   	   Phosphorylated	   FGFRs	   enable	   the	   recruitment	   of	   Grb2	   to	  phosphorylated	   Frs2α.	   The	   Ras-­‐Raf-­‐MEK-­‐MAP	   kinase	   (ERK1/2)	   phosphorylation	   cascade	   is	  initiated	   by	   the	   conversion	   of	   Ras	   bound	   GDP	   to	   GTP,	   facilitated	   by	   SOS.	   	   The	   subsequent	  phosphorylation	   steps	   culminate	  with	  MAPK	   entering	   the	   nucleus	   and	   activating	   transcription	  factors	  such	  as	  the	  Ets	  protein	  Pea3.	  	  The	  expression	  of	  the	  Ets	  genes	  can	  also	  be	  induced	  by	  the	  PLCg	  pathway	  (activated	  downstream	  of	  FGFR	  dimerization).	  	  The	  latter	  pathway	  is	  facilitated	  by	  PLCg	   which,	   by	   virtue	   of	   catalysing	   the	   conversion	   of	   the	   phosphatidtylinositol	   lipid,	   PIP2,	   to	  Inositol	  tri-­‐phosphate	  (IP3)	  and	  the	  secondary	  messenger	  DAG	  (diacylglycerol)	  activates	  Protein	  Kinase	  C	  (PKC).	  	  In	  the	  otic	  epithelium,	  activation	  of	  the	  PLCg	  pathway	  also	  induces	  the	  activation	  of	  Phospho-­‐Myosin	  Light	  Chain	  that	  maintains	  actin	  polarity	  within	  this	  tissue.	  	  
binding sequence (Lee et al., 1989; Johnson et al., 1990, Fig.
1). FGFR forms are expressed in two possible ways: by the
expression of splice variants of a given FGFR gene or by the
expression of different FGFR genes (Johnson and Williams,
1993). Alternative splicing specifies the sequence of the
carboxy-terminal half of the Ig domain III, resulting in either
IIIb or IIIc isoforms (Miki et al., 1992; Chellaiah et al., 1994).
This alternative splicing event is regulated in a tissue-specific
manner and dramatically affects ligand–receptor binding
specificity (see Powers et al., 2000).
Fig. 1. FGF receptors and FGF signal transduction. FGFRs are modular proteins comprising 3 immunoglobulin domains (IgI, IgII and IgIII). IgI and IgII are
separated by an acidic box (AD). IgII contains a heparin binding domain (HBD). The IgIII domain is followed by a unique transmembrane (TM), a juxtamembrane
(JM) and a kinase domain (KD) interrupted by an interkinase domain (IKD). FGF ligands linked to heparin sulfate proteoglycan (HSPG) bind to IgII and IgIII of
FGFR. This results in the dimerization and the subsequent transactivation by phosphorylation of specific tyrosine residues. The main two transduction pathways
involve the phospholipase C-g (PLCg) and the Ras/MAP kinase. The SH2 domain of the PLCg interacts with the phosphorylated Y766 of the activated receptor. The
activated PLCg hydrolyzes the phosphatidyl-inositol-4,5-diphosphate (PIP2) to inositol-1,4,5-triphophate (IP3) and the diacylglycerol (DAG). IP3 releases Ca2+
while DAG activates the protein kinase C-y (PKCy). Activated PKCy activates Raf by phosphorylating its S338 and stimulates the downstream pathway in a Ras
independent manner. The main pathway involves the interaction of the docking protein FRS2a with the amino-acid residues 407–433 (Xu et al., 1998). This protein
is activated by phosphorylation on multiple tyrosine residues and subsequently interacts and activates Grb2 linked to Sos, a nucleotide exchange factor involved in
the activation of Ras. Activated Ras then activates Raf which stimulates MEK which in turn phosphorylates the MAP kinase ERK. This last activated component
translocates to the nucleus and phosphorylates specific transcription factors of the Ets family which in turn activate expression of specific FGF target genes. P:
phosphorylation.
B. Thisse, C. Thisse / Developmental Biology 287 (2005) 390–402 391
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1.3.2.2	  A	  number	  of	  FGF	  ligands	  are	  expressed	  within	  the	  
pharyngeal	  endoderm	  during	  PA	  development	  A	   number	   of	   Fgf	   ligands	   are	   expressed	   in	   the	   pharyngeal	   endoderm	   during	   PA	  development,	   indicating	   that	   they	  may	  be	  able	   to	   function	   in	   this	  epithelium	  (via	  the	  activation	  of	  FGF	  signalling)	  to	  drive	  or	  regulate	  pouch	  formation.	  	  The	   loss	   of	  Fgf10	   affects	   the	   development	   of	   some	   of	   the	   endodermally	   derived	  endocrine	   organs.	   The	   thyroid	   is	   absent	   and	   the	   thymi	   are	   reduced	   in	   size	   in	  embryos	   homozygous	   null	   for	   Fgf10,	   (Fgf10-­‐/-­‐	   embryos)	   (Ohuchi	   et	   al.,	   2000).	  However,	   unless	   pouch	   morphogenesis	   is	   regulated	   non-­‐cell	   autonomously	   by	  
Fgf10	  that	  is	  expressed	  in	  the	  mesoderm	  of	  the	  caudal	  arches,	  it	  is	  unlikely	  that	  the	  endocrine	   gland	   aberrancies	   of	   Fgf10-­‐/-­‐	   embryos	   arise	   as	   a	   result	   of	   pharyngeal	  endoderm	   defects.	   For,	   Fgf10	   is	   predominantly	   expressed	   in	   the	  mesoderm	   and	  mesenchyme	  of	  the	  pharyngeal	  aches	  and	  is	  only	  expressed	  within	  the	  endoderm	  of	  the	  1st	  pharyngeal	  pouch	  (Kelly	  et	  al.,	  2001).	  	  
Fgf15	   is	   expressed	   more	   extensively	   in	   the	   pharyngeal	   endoderm	   than	   Fgf10.	  	  Expression	  of	  Fgf15	   is	  detected	   in	   the	  pharyngeal	  endoderm	  from	  approximately	  E8.25	  (at	  the	  10s	  somite	  stage	  of	  development)	  and	  is	  maintained	  in	  the	  posterior	  half	  of	  each	  pouch	  throughout	  PA	  development	  (Trokovic	  et	  al.,	  2005;	  Vincentz	  et	  al.,	  2005).	  The	  loss	  of	  Fgf15	  results	  in	  defects	  of	  the	  cardiac	  cushion	  (and	  thus	  OFT	  defects),	  due	  to	  a	  reduced	  number	  of	  CNCC	  entering	  the	  aortic	  sac	  from	  the	  6th	  PAA	  at	  E11.5	  (Vincentz	  et	  al.,	  2005).	  However,	  no	  pouch	  defects	  have	  been	  described	  in	  embryos	  homozygous	  null	  for	  Fgf15	  (Fgf15-­‐/-­‐	  embryos).	  
	  The	   expression	   domains	   of	  Fgf3	   and	  Fgf15	   in	   the	   pharyngeal	   endoderm	   overlap	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largely	  in	  the	  posterior	  half	  of	  each	  pouch	  at	  E9.5	  (Vincentz	  et	  al.,	  2005;	  Aggarwal	  et	   al.,	   2006).	   	   Moreover,	   akin	   to	   Fgf15-­‐/-­‐	   mutants,	   embryos	   homozygous	   null	   for	  
Fgf3,	   (Fgf3-­‐/-­‐	   embryos),	   are	   not	   reported	   to	   have	   pouch	   defects.	   	   However,	  structures	  within	  the	  PA	  influenced	  by	  the	  endoderm	  are	  perturbed	  by	  the	  loss	  of	  
Fgf3.	  For	  instance,	  chick	  embryos	  exposed	  to	  Fgf3	  antisense	  oligodeoxynucleotides	  were	  not	  able	  to	  form	  the	  nodose	  placode,	  nor	  the	  vagal	  ganglion	  that	  this	  placode	  gives	   rise	   to	   (Culbertson	   et	   al.,	   2011).	   	   Moreover,	   thymus	   hypoplasia	   was	   also	  detected	   in	   Fgf3-­‐/-­‐	   embryos,	   the	   cause	   of	   which,	   in	   contrast	   to	   Fgf10-­‐/-­‐	   embryos,	  may	  be	  due	  to	  the	  loss	  of	  Fgf3	  from	  the	  endoderm	  of	  the	  3rd	  pouch	  (Aggarwal	  et	  al.,	  2006).	  
	  The	   expression	   domain	   of	  Fgf8	   overlaps	  with	  Fgf3	   and	  Fgf15	   at	   E9.5	  within	   the	  pharyngeal	   endoderm	   (Vincentz	   et	   al.,	   2005;	   Aggarwal	   et	   al.,	   2006).	   As	   the	  pharyngeal	  pouch	  matures	  and	  narrows,	  Fgf8	  becomes	  restricted	  laterally	  toward	  the	  tip	  of	  the	  pouch,	  as	  observed	  in	  the	  1st	  and	  2nd	  pouches	  at	  E9.5	  (Crossley	  and	  Martin,	  1995).	  However,	  in	  contrast	  to	  Fgf3	  and	  Fgf15,	  reducing	  Fgf8	  expression	  in	  development	   perturbs	   pharyngeal	   pouch	  morphogenesis.	   Mice	   homozygous	   null	  for	   (Fgf8-­‐/-­‐	   embryos)	   fail	   to	   gastrulate	   properly,	   therefore	   to	   analyse	   the	   role	   of	  
Fgf8	   post-­‐gastrulation,	   embryos	   that	   have	   a	   significant	   reduction	   in	   the	   level	   of	  
Fgf8	   expression	   were	   generated	   (Fgf8	   hypomorphs)	   (Sun	   et	   al.,	   1999).	   A	  hypomorphic	   allele	   was	   created	   by	   the	   CRE	   mediated	   insertion	   of	   a	   neomycin	  resistance	   expression	   cassette	   (flanked	  by	   frt	   sites)	  between	   the	   floxed	  exons	   (2	  and	  3)	  of	  the	  Fgf8	  allele	  (Meyers	  et	  al.,	  1998).	  Fgf8	  mild	  hypomorphs	  only	  form	  an	  aplastic	  3rd	  pouch,	  resulting	  in	  the	  3rd	  and	  4th	  arches	  appearing	  fused	  (Frank	  et	  al.,	  2002).	   In	   50%	   of	   the	   mutant	   embryos	   thymus	   aplasia	   was	   observed,	   in	   the	  remaining	   50%	   the	   thymi	   were	   ectopic	   and	   hypoplastic	   with	   only	   20%	   of	   the	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‘normal’	  T-­‐cell	  numbers	  being	  obtained	   from	   the	   lobes	   that	   formed	   (Frank	  et	  al.,	  2002).	  In	  severe	  Fgf8	  hypomorphs	  pharyngeal	  pouch	  defects	  were	  more	  extensive,	  in	  keeping	  with	  a	  greater	  loss	  in	  Fgf8	  expression	  (Abu-­‐Issa	  et	  al.,	  2002).	  At	  E9.5	  the	  1st	   and	  2nd	   pouches	   of	   severe	   Fgf8	   hypomorphs	   form	  but	   appear	   splayed,	   rather	  than	  ‘slit-­‐like’,	  and	  fused	  to	  one	  another.	  	  By	  E10.5	  a	  very	  hypoplastic	  3rd	  pouch	  is	  present	  but	   the	   loss	  of	  Pax1	  expression,	   that	  normally	  outlines	   the	  pouch,	  makes	  identification	  difficult	  (Abu-­‐Issa	  et	  al.,	  2002).	  In	  accordance	  with	  the	  disorganised	  1st	  and	  2nd	  pouch	  formation	  the	  rostral	  arches	  appear	  hypoplastic.	  	  	  
	  
Fgf8	   is	   a	   secreted	   ligand	   that	   is	   expressed	   in	   the	   mesenchyme,	   ectoderm	   and	  endoderm	  of	   the	  PA,	   thus	   it	   is	  possible	  that	  non-­‐cell	  autonomous	  sources	  of	  Fgf8	  could	  play	  a	   role	   in	  pouch	  morphogenesis.	  To	  confirm	  which	  sources	  of	  Fgf8	   are	  required	  for	  pouch	  morphogenesis,	  as	  is	  the	  case	  for	  Tbx1,	  mouse	  lines	  that	  carry	  tissue	  specific	  deletions	  of	  Fgf8	  have	  been	  utilised.	  	  	  	  
1.3.2.3	  Dissecting	  the	  tissue	  specific	  requirements	  for	  Fgf8	  during	  
pharyngeal	  pouch	  development	  Although	   Fgf8-­‐severe	   hypomorphs	   display	   a	   reduction	   in	   the	   amount	   of	   CNCC	  migrating	  into	  the	  caudal	  PA,	  this	  defect	  is	  not	  cell-­‐autonomous	  because	  Fgf8	  is	  not	  expressed	   in	   the	   CNCC	   (Abu-­‐Issa	   et	   al.,	   2002).	   The	   deletion	   of	   Fgf8	   from	   the	  mesoderm	  (Mesp1Cre/+;Fgf8flox/-­‐	   embryos)	  causes	  OFT	  hypoplasia	  and	  PAA	  defects	  (Park	  et	  al.,	  2006;	  Watanabe	  et	  al.,	  2010).	  Pouch	  formation	  was	  not	  assessed	  in	  the	  
Mesp1cre;Fgf8flox/-­‐	   embryos.	   Interestingly,	   however,	   although	   arch	   and	   pouch	  development	   was	   not	   analysed	   in	   detail,	  Mesp1cre;Fgf8flox/-­‐Fgf10+/-­‐	   embryos	   are	  described	  as	  having	  hypoplastic	  2nd	  and	  3rd	  arches	  (Watanabe	  et	  al.,	  2010).	  Thus,	  the	   role	   of	   FGFs	   in	   the	   mesoderm	   during	   pouch	   formation	   remains	   unclear.	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Similarly,	  Islet1Cre/+Fgf8flox/-­‐	  embryos,	  that	  are	  deficient	  of	  Fgf8	  in	  the	  anterior	  heart	  field	  and	  endoderm,	  are	  described	  as	  having	  hypoplastic	  arches,	  however	  neither	  arch	  nor	  pouch	  development	  was	  analysed	  in	  detail	  (Park	  et	  al.,	  2006).	  
	  An	  analysis	  of	  Ap2alphaIREScre/+;Fgf8flox/-­‐	  embryos,	  that	  are	  deficient	  for	  Fgf8	  in	  the	  ectoderm,	   indicated	   that	  Fgf8	   in	   the	  outer	  pharyngeal	  epithelium	   is	  not	   required	  for	   pouch	   formation	   nor	   endocrine	   organ	   formation	   (Macatee	   et	   al.,	   2003).	  
Ap2alphaIREScre/+;Fgf8flox/-­‐	   mutants	   were	   not	   documented	   as	   having	   pharyngeal	  pouch	  defects	  or	  significant	  defects	  in	  thymi	  or	  parathyroid	  development	  (Macatee	  et	   al.,	   2003).	   In	   contrast,	   the	   thymi	   and	   parathyroid’s	   of	   Hoxa3Cre/+;Fgf8flox/-­‐	  embryos	  were	  hypoplastic	  and/or	  ectopic	  (in	  addition	  some	  embryo’s	  parathyroid	  	  lobes	  were	  also	  aplastic),	  (Macatee	  et	  al.,	  2003).	  	  HOXA3Cre	  drives	  Fgf8	  ablation	  in	  the	  endoderm	  and	  ectoderm	  caudal	  to	  the	  2nd	  arch	  and	  pouch.	  	  As	  the	  ectodermal	  deletion	   of	   Fgf8	   did	   not	   generate	   significant	   endocrine	   gland	   defects,	   this	   data	  indicates	   that	   Fgf8	   within	   the	   endoderm,	   (at	   least	   the	   caudal	   endoderm),	   is	  required	   for	  3rd	  pouch	  derived	  endocrine	  gland	   formation	  (Macatee	  et	  al.,	  2003).	  Whether	  there	  is	  a	  requirement	  for	  Fgf8	  in	  the	  endoderm	  during	  pouch	  formation	  was	  not	  addressed	  in	  the	  Hoxa3Cre/+;Fgf8flox/-­‐	  mutants.	  	  The	  dynamic	  expression	  of	  Fgf8	   throughout	   the	  pharyngeal	   endoderm	  combined	  with	  the	  disorganised	  pouch	  morphogenesis	  of	  severe	  Fgf8	  hypomorphs	  indicates	  that	  Fgf8	  may	   be	   required	   in	   the	   endoderm	   for	   pouch	   formation.	   A	   lack	   of	   data	  analysing	   pouch	   formation	   in	   conditional	   Fgf8	   mouse	   lines	   that	   recombine	   Fgf8	  only	   in	   non-­‐endodermal	   cells	   prevents	   a	   role	   for	   Fgf8	   in	   the	   mesoderm	   and	  ectoderm	   during	   pouch	   outgrowth	   from	   being	   discounted.	   	   Furthermore,	   a	  conditional	   mutant	   line	   in	   which	   Fgf8	   is	   efficiently	   deleted	   through	   the	   entire	  
	  pharyngeal	  endoderm	  (rather	   than	   in	  small	  domains	  of	  pharyngeal	  endoderm)	   is	  required	   to	   determine	   whether	   endodermal	   Fgf8	   is	   required	   during	   pouch	  morphogenesis.	  
	  
1.3.2.4	  FGF	  receptor	  1	  is	  required	  for	  pharyngeal	  pouch	  morphogenesis	  It	  is	  likely	  that	  the	  reduction	  of	  Fgf8	  expression	  within	  the	  PA	  of	  Fgf8-­‐hypomorphs	  results	  in	  a	  loss	  of	  FGFR	  mediated	  signalling.	  Fgfrs	  1-­‐3	  are	  all	  expressed	  within	  the	  PA	  (Walshe	  and	  Mason,	  2000).	  Mice	  homozygous	  null	  for	  Fgfr3	  survive	  to	  term	  but	  have	  malformed	   skeletons	   (Deng	   et	   al.,	   1996).	  Fgfr1	   homozygous	   null	   and	  Fgfr2	  homozygous	  null	  embryos	  both	  die	  early	  in	  development	  as	  FGF	  signalling	  through	  these	   receptors	   is	   required,	   respectively,	   during	   gastrulation	   and	   implantation	  (Deng	   et	   al.,	   1994;	   Yamaguchi	   et	   al.,	   1994;	   Arman	   et	   al.,	   1998).	   Despite	   their	  overlapping	   expression	   domains	   within	   the	   PA,	   pouch	   morphogenesis	   has	   only	  been	   analysed	   (or	   documented)	   in	   Fgfr1	   deficient	   mice	   (Fgfr1	   hypomorphs).	  Although	  it	  has	  been	  demonstrated	  that	  the	  Fgfr2	  isoform,	  Fgfr2-­‐IIIb	  is	  required	  for	  the	  stroma	  of	   the	  thymi	  to	  proliferate,	  an	  earlier	  role	   for	  FGFR2-­‐IIIb	   in	  3rd	  pouch	  morphogenesis	  has	  not	  been	  analysed	  (Dooley	  et	  al.,	  2007).	  	  Mice	  hypomorphic	   for	  Fgfr1	  were	  generated	  by	   insertion	  of	   a	  neomycin	   cassette	  into	   either	   exon	   7	   or	   exon	   15	   of	   the	   Fgfr1	   allele,	   (respectively,	   Fgfr1n7/n7	   and	  
Fgfr1n15/n15	  embryos)	  resulting	  in	  a	  reduction	  in	  the	  level	  of	  Fgfr1	  transcription	  to	  20%	   of	   the	   level	   normally	   produced	   (Partanen	   et	   al.,	   1998).	   Surprisingly,	   only	  rostral	  pouch	  formation	  was	  affected	  Fgfr1n7/n7	  embryos	  (from	  here	  on	  referred	  to	  as	   Fgfr1	  hypomorphs)	  with	   the	  1st	   and	  2nd	  pouches	  appearing	  splayed	  and	   fused	  (Trokovic	   et	   al.,	   2003;	   Trokovic	   et	   al.,	   2005).	   Concordant	   with	   rostral	   pouch	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phenotype,	   the	   2nd	   arch	   of	   the	  Fgfr1	  hypomorphs	  was	   hypoplastic	  with	   only	   the	  distal	  region	  identifiable	  at	  E10.5	  (Trokovic	  et	  al.,	  2003;	  Trokovic	  et	  al.,	  2005).	  The	  absence	  of	  the	  proximal	  arch	  coincided	  with	  a	  loss	  of	  CNCC	  migrating	  to	  this	  area	  and	   high	   levels	   of	   apoptosis	   in	   a	   region	   adjacent	   to	   the	   malformed	   2nd	   arch	  (Trokovic	   et	   al.,	   2003).	   	  However,	   a	  CNCC	   specific	  deletion	  of	  Fgfr1,	  mediated	  by	  WNT1Cre,	   did	   not	   recapitulate	   the	   2nd	   pharyngeal	   arch	   hypoplasia	   of	   the	   Fgfr1	  hypomorphs.	   Conversely,	   reactivating	   Fgfr1	   expression	   in	   the	   CNCC	   of	   Fgfr1	  hypomorphs	   could	   not	   rescue	   the	   2nd	   arch	   hypoplasia	   (Trokovic	   et	   al.,	   2003).	  Trokovic	   et	   al.	   propose	   that	   the	   loss	   of	   FGF	   signalling	   in	   the	   ectoderm	   of	   Fgfr1	  hypomorphs,	   (at	   stages	   preceding	   the	   outgrowth	   of	   the	   hypoplastic	   2nd	   arch)	  underlies	   the	   2nd	   arch	   defects	   (Trokovic	   et	   al.,	   2003;	   Trokovic	   et	   al.,	   2005).	  	  However,	   it	   is	   possible	   that	   the	   loss	   of	   endodermal	   FGF	   signalling	   and/or	   the	  perturbed	   endoderm	   morphology	   underlies	   the	   2nd	   arch	   hypoplasia.	   	   The	  reduction	  of	  Fgfr1	   produces	   a	   relatively	   localised	  pharyngeal	  pouch	  defect	  when	  compared	  to	  the	  pharyngeal	  pouch	  defects	  of	  severe	  Fgf8	  hypomorphs.	  	  Thus,	  it	  is	  possible	   that	   FGF8	   may	   also	   signal	   through	   other	   receptors	   during	   pouch	  morphogenesis,	  such	  as	  FGFR2.	  	  
	  
1.3.2.5	   FGF8	   is	   hypothesized	   to	   act	   downstream	   of	   TBX1	   within	   the	  
endoderm	  during	  pouch	  formation	  The	  caudal	  pouch	  aplasia	  of	  Fgf8	  hypomorphs	  and	  Tbx1-­‐/-­‐	  embryos	   indicates	  that	  both	  genes	  are	  required	  for	  pouch	  formation.	  The	  overlapping	  domains	  of	  Fgf8	  and	  
Tbx1	  expression	  in	  the	  endoderm	  of	  the	  caudal	  most	  forming	  pouch	  suggests	  that	  both	  factors	  may	  function	  in	  the	  endoderm	  during	  pouch	  morphogenesis	  (Vitelli	  et	  al.,	  2002).	  Furthermore,	  the	  loss	  of	  Fgf8	  expression	  specifically	  in	  the	  endoderm	  of	  
Tbx1-­‐/-­‐	  embryos	  indicates	  that	  FGF8	  may	  act	  downstream	  of	  TBX1	  in	  the	  endoderm	  
	   62	  







	   63	  
1.3.3	  The	  Retinoic	  Acid	  Signalling	  Pathway	  Retinoic	   acid	   (RA)	   is	   the	   biologically	   active	   form	   of	   Vitamin	   A,	   (retinol),	   a	  compound	  whose	  level	  must	  be	  tightly	  regulated	  to	  ensure	  that	  viable	  embryonic	  development	  proceeds	  (Duester,	  2008).	  	  The	  level	  of	  RA	  a	  cell	  is	  exposed	  to	  can	  be	  regulated	  by	  coupling	   the	  extent	  of	  RA	  synthesis	   to	   the	  extent	  of	  RA	  breakdown.	  Metabolism	  of	  RA	  is	  a	  3-­‐step	  process	  that	  requires	  the	  stepwise	  conversion	  of	  an	  alcohol	   (retinol)	   to	   an	   aldehyde	   (retinaldehyde),	   which	   in	   turn	   is	   oxidized	   to	   a	  carboxylic	   acid	   (RA)	   (Kam	   et	   al.,	   2012).	   	   RA	   is	   deemed	   the	   ‘biologically	   active’	  component	  of	   the	  pathway	  as	   it	  directly	  binds	   to	  retinoic	  acid	  receptor	   (RAR)	  or	  retinoid	  X	  receptor	  (RXR)	  complexes	  to	  regulate	  the	  transcription	  of	  target	  genes	  (Kam	   et	   al.,	   2012).	   In	   the	   absence	   of	   RA,	   the	   receptor	   complex	   acts	   as	   a	  transcriptional	   repressor	   by	   binding	   to	   specific	   motifs	   (retinoic	   acid	   response	  elements,	  RAREs)	  within	  the	  promoter	  of	  a	  gene	  (Kam	  et	  al.,	  2012).	  Once	  RA	  binds	  to	  the	  DNA:RAR:RXR	  complex	  a	  conformational	  change	  is	  elicited;	  the	  chromatin	  is	  relaxed,	   the	   transcriptional	   co-­‐repressors	   are	   released	   and	   the	   pre-­‐initiation	  complex	  is	  recruited	  to	  enable	  transcription	  of	  the	  RA	  signalling	  target	  gene	  (Kam	  et	  al.,	  2012).	  RA	  signalling	  dependent	  transcription	  can	  thus	  be	  attenuated	  by	  the	  catabolism	   of	   RA.	   The	   cytochrome-­‐P450	   26-­‐subfamily	   can	   achieve	   the	   latter	  through	   oxidative	   metabolism	   that	   degrades	   RA	   into	   the	   polar	   metabolites	   4-­‐hydroxy-­‐RA	   and	   4-­‐oxo-­‐RA.	   	   Thus,	   cells	   expressing	   the	   Cyp26a1,	   Cyp26b1	   or	  
Cyp26c1	  will	  be	  rendered	  insensitive	  to	  RA	  signalling	  (Kam	  et	  al.,	  2012).	  	  
	  
1.3.3.1	  A	  requirement	  for	  RA	  signalling	  during	  pharyngeal	  pouch	  
morphogenesis	  The	  level	  of	  RA	  signalling	  during	  embryogenesis	  has	  been	  shown	  to	  be	  important	  for	   the	   correct	   formation	   of	   the	   pharyngeal	   pouches.	   	   RA	   is	   synthesised	   in	   the	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pharyngeal	   mesenchyme,	   adjacent	   to	   the	   endoderm,	   where	   Retinaldehyde	  
dehydrogenase	   2	   (Raldh2)	   is	   expressed	   up	   to	   the	   level	   of	   the	   2nd	   arch	  (Niederreither	  et	  al.,	  1997).	  RA	  signalling	   is	   then	  elicited	   in	  the	  endoderm	  by	  the	  binding	   of	   RA	   to	   RAR/RXRs	   expressed	   in	   the	   pharyngeal	   endoderm,	   such	   as	  Retinoic	   acid	   receptor-­‐ß	   (RARB)	   (Niederreither	   and	   Dolle,	   1998;	   Matt,	   2003).	  Signalling	   is	   restricted	   to	   specific	   areas	   of	   pharyngeal	   endoderm,	   in	   part,	   by	   the	  differential	   expression	   of	   RAR/RXRs	   within	   the	   endoderm	   (Matt,	   2003).	   This	  results	   in	   the	   pharyngeal	   pouches	   having	   varying	   sensitivity	   for	   RA	   signalling;	  broadly	  the	  anterior	  2	  pouches	  are	  less	  sensitive	  to	  RA	  than	  the	  posterior	  pouches.	  	  	  	  The	   first	   pouch	   appears	   to	   have	   its	   own	   developmental	   program	   that	   does	   not	  require	   RA.	   As	   such,	   even	   in	   complete	   absence	   of	   RA	   the	   first	   pouch	   appears	   to	  form	  normally	  (Quinlan	  et	  al.,	  2002).	  However,	  it	  is	  interesting	  to	  note	  that	  excess	  RA	  can	  inhibit	  the	  formation	  of	  this	  pouch	  and	  the	  genes	  expressed	  within	  it.	  The	  second	  pouch	  is	  sensitive	  to	  the	  level	  of	  RA	  signalling	  but	  in	  a	  complex	  manner.	  	  In	  complete	  absence	  of	  RA,	  Vitamin	  A	  deficient	  quails	  only	  develop	  a	  partially	  formed,	  but	   regionally	   patterned,	   second	   pouch	   (Quinlan	   et	   al.,	   2002).	   In	   embryos	  hypomorphic	   for	  Raldh2	   (Raldh2neo/-­‐	   embryos)	   the	  second	  pouch	   forms	  normally,	  presumably	   because	  Raldh1	  and	  Raldh3	   are	   expressed	   after	   E8.5,	   enabling	   some	  RA	   signalling	   in	   the	   endoderm	   to	   occur	   (Niederreither	   et	   al.,	   2003).	   Yet,	   mouse	  embryos	   deficient	   in	   RARα1	   and	   RARß1,	   that	   are	   expressed	   exclusively	   in	   the	  caudal	  PA,	  develop	  an	  expanded	  of	  second	  pouch	  (Matt,	  2003).	  This	  indicates	  that	  outgrowth	  of	  the	  second	  pouch	  is	  controlled	  by	  RA	  signalling	  through	  specific	  RAR	  isoforms.	  Genetic	  and	  pharmacological	  studies	  have	  provided	  evidence	  to	  indicate	  that	  the	  3rd	  and	  4th	  pharyngeal	  pouches	  are	  highly	  sensitive	  to	  a	  loss	  or	  gain	  in	  the	  level	  of	  RA	  (Dupe	  et	  al.,	  1999;	  Wendling	  et	  al.,	  2000;	  Roberts	  et	  al.,	  2005;	  Roberts	  et	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al.,	   2006).	   	   If	   RA	   signalling	   is	   inhibited	   or	   reduced	   then	   the	   caudal	   pouches	   are	  unable	  to	  evaginate	  (Dupe	  et	  al.,	  1999;	  Wendling	  et	  al.,	  2000).	  This	  is	  highlighted	  in	  
Raldh2neo/-­‐	  mutant	  mice	  that	  display	  thymus	  and	  parathyroid	  aplasia	  due	  to	  lack	  of	  third	  pouch	  formation	  (Niederreither	  et	  al.,	  2003).	  	  
1.3.3.2	  A	  reciprocal	  inhibition	  of	  Tbx1	  expression	  and	  RA	  signalling	  
is	  evident	  in	  the	  pharyngeal	  endoderm	  during	  pharyngeal	  pouch	  
morphogenesis	  Caudal	   pouch	   aplasia,	   similar	   to	   that	   exhibited	   in	   Tbx1-­‐/-­‐	   embryos,	   manifests	   in	  embryos	   that	   lack,	   or	   have	   increased,	   RA	   signalling.	   Data	   in	   the	   literature	  demonstrates	   that	   Tbx1	   expression	   and	   RA	   signalling	   are	   mutually	   inhibitory	  (Guris	  et	  al.,	  2006).	  Retinol	   soaked	  beads	  grafted	   into	   the	  pharyngeal	  pouches	  of	  quail	  embryos	  results	  in	  a	  decrease	  in	  the	  level	  of	  Tbx1	  expression	  around	  the	  bead	  and	   VAD	   quails	   lack	   Tbx1	   expression	   (Roberts	   et	   al.,	   2005).	   Conversely,	   the	  expression	   of	  Raldh2	   (an	   enzyme	   that	   synthesises	  RA),	   is	   extended	   anteriorly	   in	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos	  (Guris	  et	  al.,	  2006).	   	  The	   latter	  coincides	  with	  a	   loss	   in	  expression	  of	  the	  catabolic	  enzymes	  Cyp26a1,	  Cyp26b1	  and	  Cyp26c1	  that	  clear	  RA	  (Guris	  et	  al.,	  2006;	  Roberts	  et	  al.,	  2006).	  Lastly,	  Raldh2	  and	  Tbx1	  have	  been	  shown	  to	  interact	  epistatically	  during	  the	  formation	  of	  the	  fourth	  pouch.	  	  The	  4th	  pouch	  is	  unilaterally	   hypoplastic	   in	   mice	   heterozygous	   null	   for	   both	   Raldh2	   and	   Tbx1,	   a	  defect	   not	   observed	   in	   embryos	   lacking	   one	   allele	   of	   either	   Raldh2	   or	   Tbx1	  (Ryckebusch	  et	  al.,	  2010).	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1.3.4	  The	  Sonic	  Hedgehog	  (SHH)	  pathway	  
Sonic	   Hedgehog	   (Shh)	   is	   one	   of	   three	   Hedgehog	   (Hh)	   ligand	   homologues	   in	  expressed	   in	   mammals,	   the	   other	   two	   are	   Indian	   hedgehog	   (Ihh)	   and	   Desert	  
Hedgehog	   (Dhh)	   (Bürglin	   and	   Kuwabara,	   2006).	   Hh	   was	   first	   isolated	   from	   a	  mutagenesis	   screen	   in	   Drosophila	   melanogaster	   that	   identified	   Hh	   as	   a	   key	  regulator	  of	  the	  spatial	  organisation	  of	  the	  larva’s	  segmented	  body-­‐plan	  (Nusslein-­‐Volhard	  and	  Wieschaus,	  1980).	  HH	  signalling	  is	  now	  recognised	  as	  a	  fundamental	  to	  mammalian	  development.	  The	  absence	  of	  Shh	  in	  embryos	  homozygous	  null	  for	  this	  allele	  (Shh-­‐/-­‐	  embryos)	  	  severely	  perturbs	  development,	  resulting	  in	  defects	  of	  the	  nervous	  system	  (i.e.	  reduced	  brain	  size,	  specifically	  the	  forebrain	  and	  absence	  of	   the	   spinal	   column),	   skeleton	   (i.e.	   absence	   of	   digits,	   and	   rib	   cartilages)	   and	   of	  sensory	   organs	   (i.e.	   cyclopia	   of	   the	   eyes	   and	   the	   presence	   of	   a	   single	   nasal	   pit	  contribute	  to	  the	  holoprosencephaly	  of	  Shh-­‐/-­‐	  embryos)	  (Chiang	  et	  al.,	  1996;	  Hu	  and	  Helms,	  1999).	  As	  such,	  the	  requirement	  for	  SHH	  in	  the	  formation	  of	  the	  PA	  was	  not	  immediately	  investigated	  despite	  its	  evident	  malformation	  in	  Shh-­‐/-­‐	  embryos.	  	  	  
1.3.4.1	  SHH	  signalling	  SHH	  is	  often	  found	  in	  ‘signalling	  centres’	  (e.g.	  the	  zone	  of	  polarising	  activity	  in	  the	  limb	  buds)	  where	  its	  activity	  is	  essential	  for	  the	  patterning	  the	  surrounding	  tissues	  (Cohen,	   2010).	   There	   are	   three	   steps	   in	   SHH	   signalling	   1)	   Post-­‐translational	  
modification	   of	   the	   immature	   ligand	   which	   involves	   the	   SHH	   peptide	   being	  autocatalitically	   cleaved	   into	   two	   fragments	   (Lee	   et	   al.,	   1994).	   The	   active	   N-­‐terminal	  fragment	  is	  modified	  by	  addition	  of	  cholesterol	  and	  a	  palmitoyl	  group	  to,	  respectively,	   the	  C-­‐terminus	  and	  N-­‐terminus	  (Beachy	  et	  al.,	  1997;	  Pepinsky	  et	  al.,	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1998)	  2)	  Signal	  transduction	  involves	  the	  inhibitory	  association	  of	  Patched	  (PTCH)	  with	  a	  7-­‐pass	  G-­‐protein	  receptor,	  Smoothened	  (SMO),	  being	  relieved	  (Stone	  et	  al.,	  1996;	  Murone	  et	  al.,	  1999).	  The	  latter	   is	  achieved	  when	  PTCH1	  or	  PTCH2	  (which	  are	   12-­‐pass	   transmembrane	   receptors)	   sequester	   the	   mature,	   secreted	   SHH	  peptide	   (Marigo	   et	   al.,	   1996).	   	   3)	   Intracellular	   signalling	   is	   achieved	   by	   the	  phosphorylation	  of	  Glioma-­‐associated	  oncogene	   transcription	   factors	   (GLI1,	  GLI2	  and	   GLI3)	   by	   SMO	   recruited	   kinases	   (Ingham	   and	   McMahon,	   2001).	   GLI1	   and	  (generally)	  GLI2	  are	  transcriptional	  activators	  that	  in	  an	  un-­‐phosphorylated	  form	  are	  recruited	  to	  the	  nucleus	  to	  initiate	  transcription	  (Barnfield	  et	  al.,	  2005).	  GLI3	  in	  its	   cleaved	   form	   is	   a	   transcriptional	   repressor	   (Ding	   et	   al.,	   1999).	   	   Target	   genes	  include	   those	   in	   the	  SHH	   transduction	  pathway,	   such	  as	  Gli1	   and	  Ptch1,	   thus	   the	  SHH	  pathway	  is	  autoregulatory	  (Ingham	  and	  McMahon,	  2001).	  	  	  
1.3.4.2	  A	  requirement	  for	  SHH	  during	  pharyngeal	  pouch	  
morphogenesis	  
Shh	  is	  present	  primarily	  in	  the	  medial	  regions	  of	  pharyngeal	  endoderm	  (the	  inter-­‐pouch	   regions)	   although	   it	   has	   been	   identified	   as	   an	   early	  marker	   of	   2nd	   pouch	  formation	   in	   chick	   embryos,	   despite	   its	   absence	   from	   the	   2nd	   pouch	   later	   in	  gestation	  (Garg	  et	  al.,	  2001;	  Quinlan	  et	  al.,	  2002;	  Moore-­‐Scott	  and	  Manley,	  2005).	  In	  mouse	  embryos,	  by	  E9.5,	  Shh	  expression	  is	  generally	  restricted	  to	  the	  inter-­‐pouch	  regions	  and	   is	   absent	   from	   the	  pharyngeal	  pouches	   themselves.	   	   For	   instance,	   at	  E9.5	   Shh	   is	   visible	   in	   the	   pharyngeal	   endoderm	   caudal	   to	   the	   3rd	   pouch	   (the	  presumptive	  4th	  pouch	  domain)	  but	   is	  absent	   from	  the	  3rd	  pouch	  proper	  (Moore-­‐Scott	   and	   Manley,	   2005).	   Despite	   the	   absence	   of	   Shh	   from	   the	   majority	   of	   the	  pharyngeal	   pouch	   endoderm,	  Shh-­‐/-­‐	   embryos	   display	   pouch	   defects	   (Moore-­‐Scott	  and	  Manley,	  2005).	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  At	  E9.5	  pouches	  the	  2nd	  and	  3rd	  pouches	  of	  Shh-­‐/-­‐	  embryos	  have	  formed	  relatively	  normally	   but	   the	   1st	   pouch	   is	   severely	   hypoplastic	   (Moore-­‐Scott	   and	   Manley,	  2005).	  By	  E10.5	  all	  four	  pouches	  of	  Shh-­‐/-­‐	  embryos	  were	  hypoplastic	  (as	  were	  the	  corresponding	  arches)	  and	  abnormally	  patterned.	   	  For	  instance,	  in	  the	  absence	  of	  
Shh	  the	  expression	  of	  Fgf8	  and	  Pax1	  are	  up-­‐regulated	  in	  the	  3rd	  pouch,	  relative	  to	  the	   more	   anterior	   pouches	   (Moore-­‐Scott	   and	   Manley,	   2005).	   An	   increase	   in	  apoptosis	   is	   observed	   in	   the	   pharyngeal	  mesenchyme	   of	  Shh-­‐/-­‐	   embryos	   (Moore-­‐Scott	   and	  Manley,	   2005;	   Yamagishi	   et	   al.,	   2006).	   In	   the	   1st	   arch	   at	   the	   least,	   the	  increase	  in	  apoptosis	  is	  correlated	  to	  a	  loss	  of	  endodermal	  Shh	  that	  is	  required	  to	  drive	  the	  expression	  of	  Fgf8	   in	  the	  1st	  arch	  ectoderm	  (Haworth	  et	  al.,	  2007).	  This	  data	  indicates	  that	  if	  endodermal	  SHH	  plays	  a	  role	  in	  pouch	  development	  it	  is	  likely	  during	  the	  regulation	  of	  pouch	  patterning,	  or	  indeed	  in	  cell	  survival	  (which	  has	  not	  been	  analysed	  in	  the	  endoderm),	  because	  pharyngeal	  pouch	  formation	  commences	  in	  the	  absence	  of	  Shh.	  	  	  
1.3.4.3	  SHH	  regulates	  Tbx1	  expression	  in	  the	  endoderm	  during	  
pharyngeal	  pouch	  morphogenesis	  The	  observation	  that;	  a)	  Tbx1	  expression	  was	  absent	  from	  the	  pharyngeal	  endoderm	  of	  Shh-­‐/-­‐	  embryos	  at	  E9.5	  and	  b)	  is	  ectopically	  expressed	  in	  the	  tissue	  surrounding	  a	  SHH	  coated	  bead	  implanted	  into	  the	  PA	  of	  chick	  embryos,	  suggested	  that	  SHH	  may	  regulate	  Tbx1	  expression	  (Garg	  et	  al.,	  2001).	  It	  was	  subsequently	  found	  that	  SHH	  may	  positively	  regulate	  Tbx1	  expression	  in	  the	  endoderm	  via	  the	  transcription	  factor	  Forkhead	  box	  A2	  (Foxa2)	  (Yamagishi	  et	  al.,	  2003).	  	  SHH	  is	  required	  for	  the	  maintained	  expression	  of	  Foxa2	  and	  this	  transcription	  factor	  is	  able	  to	  activate	  a	  luciferase	  reporter	  cloned	  downstream	  of	  the	  Fox-­‐binding	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element	  (FBE)	  in	  the	  1.1-­‐kb	  Tbx1	  enhancer	  (Yamagishi	  et	  al.,	  2003).	  	  	  However,	  it	  is	  questionable	  whether	  the	  SHH	  dependent	  regulation	  of	  Tbx1	  is	  required	  for	  pouch	  formation.	  	  For,	  the	  expression	  domains	  of	  Shh	  and	  Tbx1	  do	  not	  overlap	  in	  the	  evaginating	  pouch	  endoderm.	  	  More	  significantly,	  the	  loss	  of	  Shh	  results	  in	  a	  pouch	  phenotype	  that	  is	  distinct	  from	  that	  which	  is	  generated	  by	  a	  loss	  of	  Tbx1;	  the	  rostral	  pouches	  are	  most	  significantly	  affected	  by	  the	  loss	  of	  Shh	  whereas	  the	  caudal	  pouches	  are	  most	  significantly	  affected	  by	  the	  loss	  of	  Tbx1	  (Jerome	  and	  Papaioannou,	  2001;	  Moore-­‐Scott	  and	  Manley,	  2005).	  Furthermore,	  the	  genetic	  profile	  of	  the	  caudal	  endoderm	  of	  the	  two	  mutants	  is	  also	  distinct.	  	  For	  instance,	  Fgf8	  expression	  is	  absent	  from	  the	  caudal	  endoderm	  of	  Tbx1-­‐/-­‐	  embryos	  but	  is	  maintained	  in	  Shh-­‐/-­‐	  embryos	  pharyngeal	  endoderm	  (Vitelli	  et	  al.,	  2002;	  Moore-­‐Scott	  and	  Manley,	  2005).	  Although	  parathyroid	  development	  is	  absent	  in	  both	  mutants,	  different	  mechanisms	  are	  attributed	  to	  the	  loss	  of	  this	  endocrine	  organ.	  	  The	  parathyroid	  of	  Tbx1-­‐/-­‐	  embryos	  fails	  to	  develop	  because	  the	  3rd	  pouch	  is	  aplastic	  (Liao	  et	  al.,	  2004).	  In	  contrast,	  the	  3rd	  pouch	  of	  Shh-­‐/-­‐	  embryos	  develops	  but	  the	  Gcm2	  domain	  is	  lost	  at	  the	  expense	  of	  an	  expanded	  Foxn1	  domain	  (Moore-­‐Scott	  and	  Manley,	  2005).	  	  	  	  	  	  	  	  	  
1.4	  Aim	  of	  this	  study	  
The	  research	  presented	  in	  the	  introduction	  identifies	  a	  number	  of	  genes	  expressed	  within	   the	   pharyngeal	   endoderm	   that	   when	   deleted	   affect	   pouch	   development.	  	  However,	  with	   the	  exception	  of	  Tbx1	   (which	  needs	  confirming),	   the	   requirement	  for	   these	  genes	  within	   the	  endoderm	  during	  pouch	  morphogenesis	  has	  not	  been	  directly	   examined,	   only	   inferred.	   	   The	   aim	   of	   this	   study	   was	   to	   use	   a	   new	  endodermally	   expressed	  Cre	   line,	   the	  Sox17-­‐2Ai-­‐Cre	   line,	   to	   test	   the	   requirement	  for	  Tbx1,	  Fgf8	   and	  Fgf	  receptors	  1	   and	  2	  within	   the	  endoderm	  during	  pharyngeal	  pouch	   development.	   	   It	   was	   hoped	   that	   the	   data	   collected	   would	   reveal	   the	  mechanisms	  by	  which	  Tbx1	  regulates	  pouch	  evagination.	  	  Pouch	   morphogenesis	   and	   thymi	   formation	   were	   assessed	   in	   Sox17icre/+Tbx1flox/-­‐	  (Tbx1cKOSox17)	  embryos	  to	  test	  the	  inference	  of	  Arnold	  et	  al.	  that	  Tbx1	  is	  required	  in	   the	   endoderm	  during	   pouch	   and	   endocrine	   organ	   development	   (Arnold	   et	   al.,	  2006).	   The	   formation	   of	   PA	   derivatives	   that	   originate	   from	   non-­‐endodermal	  pharyngeal	   cells	   (thoracic	   vessels	   and	   external	   ear)	   were	   also	   analysed	   in	   the	  mutants	   to	   address	   the	  non-­‐cell	   autonomous	   effect	   endodermal	  Tbx1	   has	   during	  PA	   development.	   Tbx1cKOSox17	   embryos	   recapitulated	   the	   endodermal	   defects	   of	  
Tbx1-­‐/-­‐	  and	  PE-­‐KO	  embryos.	   	  The	  next	  question	  posed	  was	  how	  does	  endodermal	  
Tbx1	   regulate	   pharyngeal	   pouch	   evagination?	   It	   was	   hypothesised	   that	   Tbx1	   is	  required	  in	  the	  endoderm	  during	  pouch	  morphogenesis	  to	  positively	  regulate	  the	  FGF	  pathway	  by	  inducing	  the	  endodermal	  expression	  of	  Fgf	  ligands.	  Subsequently,	  
in	   situ	   hybridisation	   was	   used	   to	   analyse	   the	   expression	   of	   genes	   in	   the	   FGF	  signalling	   cascade	   endoderm	   of	   Sox17icre/+Tbx1flox/-­‐	   embryos.	   	   Surprisingly,	   only	  
Fgf8	   expression	   was	   diminished	   in	   the	   pharyngeal	   endoderm	   of	   these	   mutants,	  indicative	  of	  a	  unique,	  TBX1	  dependent	  role	  for	  FGF8	  within	  the	  endoderm	  during	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pouch	   formation.	   To	   test	   the	   role	   of	   Fgf8	   within	   the	   endoderm	   during	   pouch	  formation	  Sox17icre/+Fgf8flox/-­‐	   (Fgf8cKOSox17)	  embryos	  were	  generated.	   	  An	  analysis	  of	   the	   pharyngeal	   endoderm	   and	   thymus	   formation	   in	   the	   Fgf8cKOSox17	   embryos	  revealed	  that	  pharyngeal	  endoderm	  development	  appeared	  to	  be	  unaffected	  by	  the	  loss	   of	   endodermal	   Fgf8.	   As	   FGF	   signalling	   (assessed	   by	   the	   expression	   of	   Fgf	  readouts)	   was	   unperturbed	   in	   the	   endoderm	   of	   Fgf8cKOSox17	   embryos	   it	   was	  reasoned	   that	   other	   FGF	   ligands	  within	   the	   endoderm	  may	   be	   compensating	   for	  the	  loss	  of	  Fgf8.	  	  The	  alternative	  possibility	  was	  that	  FGF	  signalling	  is	  not	  required	  in	  the	  endoderm	  during	  pouch	  formation.	  	  Thus,	   the	   second	   aim	   of	   the	   study	   was	   to	   verify	   that	   FGF	   signalling	   is	   required	  within	  the	  endoderm	  during	  pouch	  morphogenesis.	  	  Compound	  mutants	  deficient	  of	   Fgf3	   and	   Fgf8	   (Sox17icre/+;Fgf3flox/-­‐;Fgf8flox/-­‐	   embryos)	   in	   the	   endoderm	   were	  found	  to	  have	  a	  low	  frequency	  of	  rostral	  pouch	  fusion,	  detected	  by	  whole	  mount	  in	  situ	   hybridisation	   for	   Pax1.	   Deleting	   Fgfr1	   and	   Fgfr2	   from	   the	   endoderm	  recapitulated,	  with	   full	   penetrance,	   the	  bilateral	   rostral	   pouch	   fusion	  detected	   in	  some	   Sox17icre/+;Fgf3flox/-­‐;Fgf8flox/-­‐	   embryos	   and	   displayed	   severe	   3rd	   pouch	  hypoplasia.	   	  These	  pouch	  defects	  correlated	  with	  a	  greatly	  diminished	  expression	  of	  Fgf	  effectors	  within	  the	  pharyngeal	  endoderm.	  	  These	  results	  demonstrate	  that	  FGF	   signalling	   and	  TBX1	   are	   both	   required	  within	   the	   endoderm	   for	   pharyngeal	  pouch	   morphogenesis	   to	   proceed	   ‘normally’.	   	   However,	   three	   pieces	   of	   data	  indicate	   that	   FGF	   signalling	   and	   TBX1	   function	   in	   independent	   endodermal	  pathways	   to	   regulate	   pouch	   morphogenesis:	   1)	   distinct	   pouch	   phenotypes	   are	  observed	   in	   FGF-­‐deficient	   and	   Tbx1-­‐deficient	   endodermal	   mutants;	   2)	  
Sox17icre/+Fgf8flox/+;Tbx1flox/+	  mutant’s	  pouch	  morphogenesis	   is	  no	  more	  perturbed	  than	  that	  of	  Sox17icre/+;Tbx1f/+	  embryos	  indicating	  there	  is	  no	  epistatic	   interaction	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between	  FGF8	  and	  TBX1	  in	  the	  endoderm	  during	  pouch	  development;	  and	  3)	  that	  genetically	   reducing	   the	   level	   of	   FGF	   signalling	   regulators	   (Sprouty	  genes)	   in	   the	  endoderm	  of	  Tbx1cKOSox17	  embryos	  did	  not	  rescue	  caudal	  pouch	  morphogenesis.	  	  The	   third	   aim	   of	   the	   study	  was	   to	   determine	   the	  mechanism(s)	   by	  which	   TBX1	  regulates	   pouch	   outgrowth	   within	   the	   pharyngeal	   endoderm.	   	   An	   expression	  analysis	   of	   the	   RA	   signalling	   cascade	   (regulated	   by	   TBX1)	   and	   SHH	   signalling	  cascade	   (a	   regulator	   of	   Tbx1)	   revealed	   that	   genes	   in	   both	   cascades	   were	  maintained	   in	   the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos.	  Multiple	  genes	  in	   each	   cascade	   (i.e.	   Shh,	   Ptch1,	   Rarb,	   Cyp26b1)	   displayed	   an	   ‘un-­‐segmented’	  expression	  pattern	  in	  the	  pharyngeal	  endoderm	  of	  the	  Tbx1cKOSox17	  embryos.	  	  This	  led	   to	   the	   prediction	   that	   the	   expression	   changes	   were	   secondary	   to	   a	   TBX1-­‐dependent	   loss	   of	   pharyngeal	   endoderm	   architecture/structure.	   To	   test	   this	  prediction	  the	  presence	  and	  location	  of	  cytoskeletal	  proteins	  within	  TBX1-­‐deficient	  endoderm	  was	  analysed.	   	  A	   striking	   loss	   in	   the	  polarity	  of	   the	  actin	  cytoskeleton	  was	  observed	  in	  the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos.	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2.1	  General	  solutions	  and	  reagents	  
All	  solutions,	  unless	  stated	  otherwise,	  were	  prepared	  with	  deionised,	  double-­‐distilled	  water	  (ddH20)	  and	  sterilised	  by	  autoclaving.	  	  Solutions	  were	  treated	  with	  0.01%	  (v/v)	  Diethylpyrocarbonate	  (DepC)	  for	  2	  hours	  minimum,	  prior	  to	  autoclaving	  if	  RNase	  sensitive	  protocols	  were	  carried	  out.	  	  Detergents	  (tween,	  triton-­‐X	  etc.)	  were	  added	  post-­‐autoclaving.	  	  
Table	  3:	  Lists	  the	  solutions	  used	  routinely	  during	  experiments	  
Solution	   Reagents	   Storage	  conditions	  0.5M	  Ethylenediaminetetraacetic	  acid	  (EDTA),	  pH8.0	  
93.1g	  EDTA	  disodium	  salt	  (Fisher	  Bp120500),	  10g	  NaOH	  (VWR	  28244.262),	  add	  400ml	  ddH2O	  adjust	  to	  pH8.0	  with	  sodium	  hydroxide	  (fisher),	  adjust	  500ml	  with	  ddH2O.	  
Store	  at	  RToC.	  
Glycerol	  (x%)	   Glycerol	  (Fisher,	  G060017)	  diluted	  in	  PBS	  to	  required	  concentration	  (X%),	  i.e.	  80%	  	  
Store	  at	  RToC.	  
Goat	  serum	  (GS)	   Goat	  serum	  (Sigma)	  thawed	  and	  heat	  inactivated	  (HI)	  at	  56oC	  for	  30	  minutes.	  
Store	  10ml	  aliquots,	  after	  cooling,	  at	  -­‐20oC.	  
4%	  (w/v)	  Paraformaldehyde	  (PFA)	   Paraformaldehyde	  (Sigma)	  dissolved	  in	  PBS	  whilst	  heating	  to	  60oC	  and	  stirring.	  
Store	  20ml	  aliquots,	  after	  cooling,	  at	  -­‐20oC.	  Thaw	  at	  37oC	  and	  cool	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on	  ice	  before	  applying	  to	  embryos.	  	  10x	  Phosphate	  buffered	  saline	  solution	  	   10x	  Phosphate	  buffered	  saline	  tablets	  (Sigma)	  dissolved	  in	  sterile	  ddH2O	  as	  per	  manufacturers	  instructions.	  	  
Store	  at	  RToC.	  Dilute	  1:10	  with	  sterile	  ddH2O	  to	  1x	  Phosphate	  buffered	  saline	  solution,	  (PBS)	  working	  solution.	  PBT	   Tween-­‐20	  was	  added	  at	  0.1%	  (v/v)	  to	  PBS	  solutions	  (unless	  otherwise	  stated).	  	  
Store	  at	  RToC.	  
PBTX	   Triton-­‐x	  (Sigma)	  was	  added	  at	  0.1%	  (v/v)	  to	  PBS	  solutions	  (unless	  otherwise	  stated).	  	  
Store	  at	  RToC.	  
	  20%	  Sodium	  dodecyl	  sulphate	  (SDS)	  	   Sodium	  dodecyl	  sulphate	  (Sigma)	  dissolved	  in	  DepC	  H2O.	  	  
Store	  at	  RToC.	  
20x	  Sodium	  citrate	  solution	  (SSC)	  pH4.5.	   20x	  Sodium	  citrate	  solution	  (solution	  purchased	  from	   Store	  at	  RToC.	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Fisher	  BP13254)	  	  Tris-­‐HCL	  pH	  (X)	   Trizma	  base	  (Sigma,	  T1503)	  dissolve	  in	  DepC	  H2O,	  adjusted	  to	  desired	  pH	  with	  hydrochloric	  acid.	  	  	  
Store	  at	  RToC.	  
Triton	  X-­‐100	   4-­‐(1,1,3,3-­‐Tetramethylbutyl)	  phenyl-­‐polyethylene	  glycol,	  (solution	  purchased	  from	  Sigma,	  X100)	  	  
Store	  at	  RToC.	  
Tween-­‐20	   Polyethylene	  glycol	  sorbitan	  monolaurate,	  (solution	  purchased	  from	  Sigma,	  P9416)	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2.2	  Molecular	  biology	  




2.2.1.1	  Genotyping	  Solutions	  Table	  4	  lists	  the	  solutions	  routinely	  used	  during	  genotyping	  protocols.	  
	  
Table	  4:	  General	  genotyping	  solutions	  Gentle	  lysis	  buffer	   5ml	  gelatine	  (stock	  10mg/ml),	  25ml	  1M	  KCL	  (sigma),	  1ml	  1M	  MgCL2	  (fisher),	  22.5ml	  of	  10%	  IGE-­‐PAL	  (sigma)	  and	  5ml	  1M	  Tris-­‐HCL	  pH8.3	  bring	  volume	  to	  500ml	  with	  ddH2O.	  	  Autoclave,	  then	  upon	  cooling	  add	  22.5ml	  of	  Tween-­‐20,	  aliquot	  and	  store	  long	  term	  at	  -­‐20oC.	  	  	  Proteinase	  K	  (Invitrogen	  25530015)	   100mg	  Proteinase	  K	  (PK)	  added	  to	  5ml	  RNase	  free	  H2O,	  freeze	  100µl	  at	  -­‐20oC.	  	  50x	  TAE	  	   200ml	  0.5M	  EDTA	  pH8.0,	  114.2ml	  glacial	  acetic	  acid	  484g	  Tris	  base	  (Sigma),	  to	  1L	  ddH2O.	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2.2.1.2	  DNA	  isolation	  Ear	  clips	  from	  mouse	  pups	  or	  yolk	  sacs	  from	  embryos	  were	  added	  to	  300µl	  of	  gentle	  lysis	  buffer	  with	  1.5µl	  of	  proteinase	  K	  (PK,	  100µg/ml).	  Mouse	  tissue	  was	  degraded	  in	  a	  heat-­‐block	  overnight	  at	  55oC.	  	  Post-­‐incubation	  300µl	  of	  RNase	  free	  PCR	  grade	  H2O	  (molecular	  grade	  water,	  VWR	  International	  cat	  no.	  443847D)	  was	  added	  to	  the	  genotyping	  samples.	  	  Subsequently	  the	  samples	  were	  heat	  inactivated	  at	  90oC	  for	  45	  minutes	  to	  denature	  the	  PK.	  	  After	  cooling,	  the	  genotyping	  samples	  were	  spun	  in	  a	  centrifuge	  for	  5	  minutes	  to	  pellet	  cell	  debris,	  leaving	  the	  DNA	  in	  solution.	  	  
	  2.2.1.3	  PCR	  Reaction	  	  PCR	  reactions	  listed	  in	  Table	  5	  (see	  below)	  were	  set	  up	  on	  ice,	  the	  master	  mix	  used	  was	  dependent	  on	  the	  requirement	  of	  the	  oligonucleotides	  for	  additional	  GC-­‐rich	  substrate	  (see	  Appendix	  A).	  1µl	  of	  DNA	  was	  added	  to	  each	  19µl	  reaction	  aliquot.	  	  The	  PCR	  reaction	  was	  loaded	  into	  a	  thermocycler	  PCR	  machine	  (Eppendorf	  Mastercycler)	  that	  subjects	  the	  mix	  to	  a	  series	  of	  heating	  and	  cooling	  steps	  that	  result	  in	  an	  amplification	  of	  the	  genomic	  DNA.	  	  In	  brief	  the	  thermocycler	  PCR	  amplification	  steps	  are	  as	  follows,	  (for	  specifics	  of	  each	  oligonucleotides	  PCR	  see	  Appendix	  A).	  	  The	  three	  steps	  are	  repeated	  for	  between	  30-­‐40	  cycles.	  	  
Step	   Temperature	   Time	  
1)	  Denaturing	  (Disassociating	  double	  stranded	  DNA	  to	  form	  single	  stranded	  DNA)	  	  
94oC	   1	  minute	  
2)	  Annealing	  (Binding	  of	  primers	  to	  complementary	  sequence	  in	  the	  endogenous	  DNA)	  	  
54oC	   45	  seconds	  
3)	  Extension	  (The	  polymerase	  binds	  to	  the	  ends	  of	  the	  double	  stranded	  DNA	  formed	  by	  the	  primer-­‐template	  duplex	  and	  adds	  additional	  dNTPs	  to	  the	  sequence.)	  
72oC	   2	  minutes	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2.2.1.4	  Gel	  electrophoresis	  Gel	  electrophoresis	  was	  used	  to	  visualize	  the	  products	  of	  the	  PCR	  reaction.	  	  A	  1.5%	  agarose	   gel	  was	  prepared	  by	  dissolving	  6g	  of	   low	  melting	  point	   agarose	   (Fisher,	  BP160-­‐100)	   in	  400ml	  of	  1x	  TAE.	  After	  cooling	  20µl	  of	  ethidium	  bromide	   (Sigma,	  E7637)	  was	  added	  to	  the	  molten	  agarose	  and	  the	  solution	  was	  poured	  into	  a	  gel-­‐casting	   tray.	   	   The	   PCR	   samples,	   mixed	   with	   4µl	   of	   loading	   dye	   (Promega	   green	  buffer),	   and	   either	   a	   100bp	   (Fermentas,	   SM0324)	   or	   a	   1Kb	   plus	   DNA	   ladder	  (Invitrogen,	   10787018)	   were	   loaded	   onto	   the	   set	   gel.	   	   The	   samples	   were	   run	  through	   the	   gel	   in	   an	   electrophoresis	   tank	   at	   190V	   in	   1x	   TAE	   typically	   for	   40	  minutes.	   Using	   the	   DNA	   ladder	   as	   a	   reference,	   the	   size	   of	   the	   DNA	   fragments	  amplified	  in	  the	  PCR	  reaction,	  (that	  are	  intercalated	  with	  ethidium	  bromide)	  were	  determined	  after	  visualizing	  the	  gel	  in	  an	  ultraviolet	  light	  illuminator.	  	  	  
Roche	  PCR	  master	  mix,	  
19µl/sample	  total	  
Promega	  PCR	  master	  mix,	  19µl/sample	  total	  H2O	  (11.7/15.7µl)	  	   H2O	  (12.5µl)	  G-­‐C	  Rich	  buffer	  (4/0µl)	  
NB:	  Some	  PCR	  reactions	  do	  
not	  require	  G-­‐C.	  
	  
Green	  buffer	  (4µl)	  
MgCl2	  (1.2µl)	  	   MgCl2	  (2µl)	  	  Primers	  (x)	  (1µl)*	  	   Primers	  (x)	  (1µl)*	  dNTPs	  (0.15µl)	  	   dNTPs	  (0.15µl)	  Roche	  Fast	  start	  Taq	  polymerase	  	  (0.15µl)	  	   Promega	  Hot	  start	  Taq	  polymerase	  (0.15µl)	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2.2.2	  Protocol	  for	  production	  of	  an	  mRNA	  probe	  
Note:	   All	   steps	   involving	   bacterial	   cells	   were	   performed	   over	   a	   Bunsen	   burner	  flame	   under	   sterile	   conditions	   i.e.	   with	   sterilized	   consumables	   and	   ethanol	  sterilized	  surfaces.	  
	  
2.2.2.1	  Transformation	  of	  competent	  bacterial	  cells	  
N.B.	  Competent	  cells	  were	  kept	  on	  ice	  at	  all	  times	  unless	  otherwise	  stated.	  	  SOC	  media	  
and	  agar	  plates	  with	  antibiotics	  were	  warmed	  to	  37oC	  before	  use.	  Vectors	   containing	   a	   DNA	   sequence	   of	   interest	   were	   amplified	   by	   driving	   the	  plasmid	  into	  Novablue	  Escherichia	  coli	  (E.	  coli)	  competent	  cells	  (Merck	  Chemicals	  Ltd.	   Cat	   no.69825-­‐4).	   1µg	   of	   plasmid	   DNA	   was	   added	   to	   a	   10µl	   aliquot	   of	  competent	   cells,	   (thawed	   on	   ice)	   and	   incubated	   for	   a	   further	   5	   minutes	   on	   ice.	  Uptake	  of	  the	  vector	  by	  E.	  coli	  cells	  was	  achieved	  by	  heat	  shocking	  the	  cell-­‐vector	  mix	   for	   45	   seconds	   at	   42oC.	   	   The	   E.	   coli	   cells	   were	   left	   to	   recover	   on	   ice	   for	   a	  subsequent	  2	  minutes.	   	  80µl	  of	  SOC	  media	  was	  added	  to	   the	  cells	   that	  were	  then	  streaked	  onto	   agar	  plates	   (with	   the	   required	   antibiotic	   to	   select	   for	   transformed	  cells).	   The	   plates	   were	   incubated	   at	   37oC	   for	   between	   14-­‐16	   hours	   for	   optimal	  bacterial	  growth.	  	  
2.2.2.2	  Starter	  culture	  of	  transformed	  bacterial	  clones	  
N.B.	  Bacterial	  plates	  may	  be	  stored	  at	  4oC	  	  (in	  a	  bacterial	  fridge)	  for	  up	  to	  4	  weeks.	  After	   the	   overnight	   incubation	   single	   colonies	   of	   transformed	   E.	   coli	   cells	   were	  picked	   from	   the	   seeded	   bacterial	   plate	   using	   a	   pipette	   tip.	   The	   pipette	   tip	   was	  ejected	  into	  5ml	  of	  LB	  media	  (with	  appropriate	  antibiotic	  (typically	  50mg/ml)	  for	  selection	   of	   transformed	   bacteria).	   Bacterial	   cultures	   were	   incubated	   in	   a	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(300rpm)	  rotating	  shaker	  Kuhner	  Shaker	  (model	  no.isf-­‐1-­‐w)	  at	  37oC	  for	  between	  14-­‐16	  hours,	  to	  ensure	  optimal	  bacterial	  growth.	  	  
2.2.2.3	  Large	  culture	  of	  transformed	  bacterial	  clones	  and	  bacterial	  
stocks	  
N.B.	  Bacterial	   suspensions	  may	  be	   stored	  at	  4oC	   	   (in	  a	  bacterial	   fridge)	   for	  up	   to	  4	  
weeks.	  After	  overnight	  incubation	  the	  5ml	  ‘starter’	  mini	  culture	  of	  transformed	  E.	  coli	  cells	  were	   re-­‐homogenised	   by	   gently	   inverting	   the	   falcon	   tube.	   	   1ml	   of	   bacterial	   cells	  were	   removed	   from	   the	   starter	   suspension	   and	   ejected	   into	   a	   conical	   flask	  containing	  200ml	  of	  LB	  media	  (with	  400µl	  of	  the	  appropriate	  antibiotic	  (typically	  50mg/ml)	   for	   selection	   of	   transformed	   bacteria).	   Bacterial	   suspensions	   were	  incubated	   in	   a	   rotating	   shaker	   (300rpm),	   at	   37oC	   for	   between	   14-­‐16	   hours,	   to	  ensure	   optimal	   bacterial	   growth.	   A	   further	   500µl	   of	   starter	   growth	   culture	   was	  removed,	  mixed	  with	  500µl	  of	  50%	  glycerol	  or	  7%	  DMSO	  to	  make	  a	  bacterial	  stock	  and	  transferred	  to	  the	  -­‐80oC	  for	  long-­‐term	  storage.	  
	  
2.2.2.4	  Maxi-­‐preparation	  of	  plasmid	  DNA	  
N.B.	  Bacterial	  pellets	  from	  the	  centrifuged	  large	  culture	  may	  be	  stored	  at	  -­‐20oC	  for	  up	  
to	  1	  week	  once	  the	  LB	  media	  has	  been	  removed.	  After	  an	  overnight	  incubation	  the	  200ml	  ‘large’	  culture	  of	  transformed	  E.	  coli	  cells	  were	   aliquoted	   into	   four	   50ml	   falcon	   tubes	   of	   equal	   weight	   and	   spun	   at	   4oC,	  5000rpm,	   for	   30	  minutes	   in	   a	   large	   bench	   top	   centrifuge.	   	   The	   liquid	   broth	  was	  discarded	  and	  the	  bacterial	  pellet	  retained	  for	  DNA	  isolation	  by	  maxi-­‐preparation.	  The	  extraction	  of	  DNA	  was	  achieved	  by	  following	  the	  steps	  outlined	  in	  the	  Quiagen	  Maxiprep	   protocol.	   In	   brief,	   the	   DNA	   was	   re-­‐suspended	   and	   homogenized	   by	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adding	  buffer	  P1	  (containing	   lyse	  blue	  to	  visualize	  efficiency	  of	   lysis	  by	  buffer	  P2	  and100µg/ml	   of	   RNase	   A)	   to	   the	   bacterial	   pellets	   and	   combining	   to	   one	   falcon.	  Subsequently	   buffer	   P2	   was	   added	   (mixed	   by	   gentle	   inverting	   to	   avoid	   DNA	  shearing)	  to	  achieve	  bacterial	  cell	  lysis.	  	  To	  neutralize	  the	  reaction	  and	  precipitate	  genomic	  DNA	  and	  proteins,	  chilled	  buffer	  P3	  was	  added.	  	  Supernatant	  (containing	  plasmid	  DNA)	   from	   the	  P3	  mix	  was	   filtered	   through	   a	  QIAfilter	   cartidge,	   into	   an	  equilibrated	  QIAGEN-­‐tip	  500	  to	  which	  the	  DNA	  binds.	  The	  bound	  DNA	  was	  washed	  twice	   with	   buffer	   QC	   to	   remove	   any	   contaminants	   and	   then	   eluted	   into	   a	   50ml	  falcon	  with	  buffer	  QF,	  to	  which	  isopropanol	  was	  added	  to	  precipitate	  DNA	  from	  the	  solution.	  After	   incubation,	   the	  DNA	  was	   collected	  using	   the	  QIA	  precipitator	   that	  filters	  the	  isopropanol	  and	  binds	  the	  DNA.	   	  Finally,	  the	  DNA	  is	  washed	  in	  the	  QIA	  precipitator	   with	   70%	   ethanol	   and	   eluted	   with	   1.5ml	   of	   buffer	   TE	   into	   an	  eppendorf	  (repeating	  twice	  to	  maximize	  elution).	   	  The	  isolated	  DNA	  is	  stored	  at	  -­‐20oC.	  The	  optical	  density	  (OD)	  of	  the	  maxi-­‐preparation’s	  end	  product	  (1µl	  of	  prep	  diluted	  in	  199µl	  of	  H2O	  or	  TE)	  was	  measured	  in	  a	  spectrophotometer	  to	  determine	  the	  concentration	  of	  the	  isolated	  DNA.	  	  
2.2.2.5	  DNA	  digest,	  sequencing	  and	  linearization	  To	   confirm	   that	   the	   DNA	   isolated	   from	   the	   vector	   by	  maxi-­‐preparation	  was	   the	  vector	   carrying	   the	   DNA	   insert	   of	   interest,	   restriction	   digests	   were	   routinely	  performed.	  	  The	  DNA	  vector	  was	  cut	  at	  multiple	  restriction	  enzyme	  (RE)	  sites.	  The	  cutting	  of	  the	  vector	  by	  different	  REs	  cut	  the	  circular	  vector	  into	  linear	  fragments	  of	   DNA	   of	   a	   specific	   size.	   The	   size	   of	   the	   bands	   resulting	   from	   the	   digest,	  determined	  by	  gel	  electrophoresis	  (see	  2.2.1.4)	  should	  match	  those	  detailed	  on	  the	  vector	   map.	   To	   an	   eppendorf	   containing	   20µg	   of	   plasmid,	   1µl	   of	   the	   required	  restriction	  enzyme(s)	  was	  added	  with	  4µl	  of	   the	  appropriate	  RE	  buffer	  and	  0.5µl	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BSA	   (if	   required).	   	   Molecular	   biology	   grade	   H2O	   was	   added	   to	   bring	   the	   total	  volume	   to	  20µl	   and	   the	   reaction	  was	   left	   to	  proceed	  overnight	   at	  RToC,	   or,	   for	  2	  hours	   at	  37oC.	  After	   the	   incubation	  period,	  5µl	   of	   the	   reactions	   end	  product	  was	  removed	  and	  imaged	  by	  gel	  electrophoresis	  with	  the	  uncut	  plasmid	  to	  determine	  if	  the	  digest	  was	  successful	  and	  to	  determine	  the	  size	  of	  the	  cut	  DNA	  fragments.	  	  	  To	  further	  confirm	  that	  the	  vector	  isolated	  by	  maxi-­‐preparation	  contains	  the	  DNA	  insert	  of	  interest,	  an	  aliquot	  of	  the	  DNA	  was	  sent	  for	  sequencing.	  	  Typically	  10µl	  of	  DNA	   (of	   a	   concentration	   between	   10-­‐250ng/µl)	   was	   sent	   to	   DBS	   Genomics	  (Durham	  University)	   that	  was	   sequenced	  with	   their	   universal	   in-­‐house	   primers.	  	  Commonly	   either	   pBluescript	   T3	   (GCA	   ATT	   AAC	   CCT	   CAC	   TAA	   AGG	   GA),	  pBluescript/pGEM	  T7	   (GTA	  ATA	  CGA	  CTC	  ACT	  ATA	  GGG	  CG)	  or	  pGEM	  SP6	   (GCT	  ATT	  TAG	  GTG	  ACA	  CTA	  TAG)	  were	  used	  dependent	  on	  the	  vector	  map.	  
	  
2.2.2.6	  Phenol:chloroform	  extraction	  of	  digested	  DNA	  	  After	   confirming	   that	   the	   DNA	   digest	   has	   been	   successful	   (see	   2.2.2.3)	   the	  linearized	  DNA	  was	  extracted	  from	  the	  reaction	  mix,	  as	  this	  contains	  reagents	  that	  are	   inhibitory	   to	   the	   RNA	   synthesis	   reaction.	   	   To	   the	   linearized	   plasmid	   1ml	   of	  phenol:chloroform	   (25:24:1,	   volume,	   Sigma	   P3802),	   was	   added,	   vortexed	   	   and	  centrifuged	  at	  4oC	  for	  30	  minutes	  to	  extract	  the	  DNA.	   	  Subsequently,	  the	  aqueous	  phase	   (approximately	   20µl)	   containing	   high	   molecular	   weight	   DNA	   was	  transferred	   into	   a	   new	   eppendorf.	   The	   remaining	   liquid	   from	   the	  phenol:chloroform	   incubation,	   containing	   extracellular	   membranes	   and	  polysaccharides,	   were	   discarded.	   DNA	   precipitation	   was	   achieved	   by	   incubating	  the	   aqueous	   phase	   DNA	   with	   3M	   sodium	   acetate,	   NaOAc,	   (1/10	   the	   volume	   of	  aqueous	  phase	  DNA)	  and	  100%	  ethanol	  (3x	  the	  volume	  of	  aqueous	  phase	  DNA)	  for	  
	   84	  
10	   minutes	   at	   RToC.	   	   The	   DNA	   was	   vortexed	   and	   incubated	   in	   the	   100%	  ethanol:NaOAc	   mix	   at	   -­‐20oC	   for	   30	   minutes	   to	   maximise	   the	   yield	   of	   DNA	  precipitated	   from	   the	   solution.	   	   Subsequently,	   the	   mix	   was	   centrifuged	   for	   30	  minutes	   at	   4oC	   to	   form	   a	   DNA	   pellet.	   The	   100%	   ethanol	   was	   discarded	   and	   a	  further	  1ml	  of	  70%	  ethanol	  added	  to	  wash	  the	  salt	  from	  the	  pellet.	  	  After	  vortexing,	  the	  DNA	  pellet	  in	  70%	  ethanol	  was	  centrifuging	  for	  a	  final	  15	  minutes	  at	  4oC.	   	  All	  70%	  ethanol	  was	  carefully	  removed	  with	  a	  pipette	   tip,	   taking	  care	  not	   to	  disrupt	  the	  pellet.	   	  The	  DNA	  pellet	  was	  incubated	  in	  a	  heat	  block	  set	  at	  42oC	  to	  evaporate	  the	  residual	  ethanol.	  	  Once	  dry	  the	  DNA	  pellet	  was	  dissolved	  in	  20µl	  of	  RNase	  free	  (not	  DepC)	  TE	  buffer	  (10mM	  Tris-­‐HCl	  [pH	  7.4],	  1mM	  EDTA)	  or	  molecular	  biology	  grade	  H2O	  and	  stored	  at	  	  -­‐20oC.	  
	  
2.2.2.7	  Digoxigenin	  (DIG)	  labelled	  RNA	  probe	  synthesis	  
NB:	  This	  is	  an	  RNase	  sensitive	  protocol.	  To	  synthesise	  RNA	  complementary	  to	  that	  of	  the	  linear,	  genomic	  DNA	  extracted	  by	  phenol:choloroform	   the	   following	   reaction	   was	   set	   up.	   To	   an	   eppendorf	   the	  following	   reagents	  were	  added	   in	   this	  order:	   	  Molecular	  biology,	  RNase	   free	  H2O	  (DepC	  free),	  to	  give	  a	  final	  reaction	  volume	  of	  20µl;	  4µl	  of	  5x	  transcription	  buffer	  (Promega)	   containing	   salts	   and	   spermidine	   required	  by	   the	  polymerase	   enzyme;	  2µl	  of	  0.1M	  Dithiothreitol	  (DTT,	  Promega)	  to	  stabilise	  the	  RNA	  polymerase,	  2µl	  of	  DIG	  nucleotide	  mix	  (pH8.0)	  containing	  DIG-­‐11-­‐UTPs	  that	  are	  incorporated	  into	  the	  synthesised	   single-­‐stranded	   RNA	   product	   by	   in	   vitro	   RNA	   polymerase	   mediated	  transcription,	   1µl	   of	   linearized	   plasmid	   (approximately	   1µg/µl)	   to	   generate	  10µg/µl	  of	   full	   length	  DIG-­‐labelled	  RNA,	  0.5µl	  of	  RNase	   inhibitor	   (RNasin,	  Roche,	  100U/ml)	  to	  prevent	  RNase	  mediated	  degradation	  of	  RNA,	  1µl	  of	  RNA	  polymerase	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2.3	  Generation	  of	  mouse	  embryos	  
2.3.1	  Mouse	  breeding	  strategies	  
Mice	  were	  bred	  and	  housed	  in	  accordance	  with	  home	  office	  regulations.	  Conditional	  mouse	   lines	   are	  used	   throughout	   this	  project	   to	   recombine	  and	   thus	  delete	   floxed	   alleles.	   	   To	   achieve	   tissue	   specific	   deletion	   in	   endodermal	   and	  endothelial	   cells	   the	   Sox17-­‐2Ai-­‐Cre	   mouse	   line	   was	   utilised.	   	   WNT1Cre	   and	  MESP1Cre	  were	  used,	   respectively,	   to	  achieve	   tissue	   specific	  deletions	  of	   genes	   in	  the	  cranial	  neural	  crest	  cells	  and	  in	  the	  mesoderm.	  See	  Appendix	  E	  for	  mouse	  line	  references	  and	  information	  on	  the	  MGI	  ID	  number.	  	  Mouse	  breeding	  strategies	  are	  illustrated	  as	  schematics	  in	  Figures	  6	  to	  11,	  below.	  
	  
2.3.1.1	   Generation	   of	   Tbx1flox/+,	   Sox17icre/+;Tbx1flox/+,	   Sox17icre/+;Tbx1flox/-­‐,	  
Sox17icre/+;Sprouty1flox/+;Sprouty2flox/+;Tbx1flox/-­‐	   and	   Sox17icre/+;Fgf8	  
flox/+;Tbx1flox/+	  mice	  and	  embryos.	  
Fig	  5	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Fig	   5	   Illustrates	   the	   breeding	   strategy	   followed	   to	   generate	   Tbx1flox/+,	  
Sox17icre/+;Tbx1flox/+	   and	   Sox17icre/+;Tbx1flox/-­‐	   embryos.	   a.	   A	   transgenic	   stud	   male	  heterozygous	  for	  the	  Sox17tm2.1(icre)Heli	  allele	  (Sox17iCre),	  that	  drives	  expression	  of	  Cre	  from	  the	   Sox17	   promoter,	   was	   crossed	   to	   female	   transgenic	   mice	   homozygous	   for	   the	  
Tbx1tm1.1Bem	  allele,	  (exon	  5	  of	  the	  gene	  T-­‐box	  1	  flanked	  by	  lox-­‐P	  sites,	   i.e.	  Tbx1flox).	  b.	  Male	  progeny	  heterozygous	  for	  Sox17iCre	  and	  the	  Tbx1flox	  allele	  (Sox17icre/+Tbx1flox/+)	  were	  kept	  from	   this	   cross	  and	  used	   to	   impregnate	  Tbx1flox/flox	   females,	  or	   female	  mice	  homozygous	  for	  Tbx1flox	  and	  for	  the	  gene	  trap	  Rosa-­‐26	  allele,	  Gt(ROSA)26Sortm1Shoe	  (Tbx1flox/flox;R2622).	  c.	   The	   mating	   illustrated	   in	   (b)	   generated	   Tbx1flox/+	   (Cre	   negative),	   Sox17icre/+Tbx1flox/+	  (Tbx1cHetSox17)	   and	   Sox17icre/+;Tbx1flox/-­‐	   (Tbx1cKOSox17)	   embryos	   that	   are	   utilised	  within	   this	   thesis,	   all	   of	   which	   would	   also	   be	   heterozygous	   for	   R26R	   if	   derived	   from	   a	  

















Fig	   6	   Illustrates	   the	   breeding	   strategy	   followed	   to	   generate	  
Spry1flox/+;Spry2flox/+,Tbx1flox/+	   and	   	   Sox17icre/+;Spry1flox/+;Spry2flox/+;Tbx1flox/-­‐	  
embryos.	   a.	   Male	   Sox17icre/+Tbx1flox/+	   mice	   were	   used	   to	   impregnate	   female	   mice	  homozygous	  for	  the	  alleles,	  Spry1tm1Jdli	  (exon	  …	  of	  the	  gene	  Sprouty	  homolog	  1	  is	  flanked	  by	  lox-­‐P	  sites,	  i.e.	  Spry1flox),	  Spry2	  tm1.1Mrt	  (exon	  …	  of	  the	  gene	  Sprouty	  homolog	  2	  	  is	  flanked	  by	   lox-­‐P	   sites,	   i.e.	   Spry2flox,)	   and	   Tbx1flox.	   	   b.	   The	   mating	   generated	  









Fig	  7	   Illustrates	   the	  breeding	  strategy	   followed	   to	  generate	  Fgf8flox/+,Tbx1flox/+	   and	  	  
Sox17icre/+;Fgf8flox/+;Tbx1flox/-­‐	   embryos.	   a.	  Male	   Sox17icre/+Tbx1flox/+	   mice	  were	   used	   to	  impregnate	   female	   mice	   homozygous	   for	   the	   alleles,	   Fgf8tm1.3Mrt	   (exon	   …	   of	   the	   gene	  
Fibroblast	  growth	   factor	  8	   is	   flanked	  by	   lox-­‐P	  sites,	   i.e.	  Fgf8flox).	   	  b.	  The	  mating	  generated	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Fig	   8	   Illustrates	   the	   breeding	   strategy	   followed	   to	   generate	   Fgf8flox/+,	  
Sox17icre/+;Fgf8flox/+,	  Sox17icre/+;Fgf8flox/-­‐	   embryos.	  a.	  Sox17iCre/+	  males	  were	  crossed	  to	  
Fgf8flox/flox	   females.	   b.	   Male	   progeny	   heterozygous	   for	   Sox17iCre	   and	   the	   Fgf8flox	   allele	  (Sox17icre/+;Fgf8flox/+)	   were	   kept	   from	   this	   cross	   and	   used	   to	   impregnate	   Fgf8flox/flox	  female’s	   c.	   The	   mating	   illustrated	   in	   (b)	   generates	   Fgf8flox/+	   (Cre	   negative),	  
Sox17icre/+;Fgf8flox/+	   (Fgf8cHetSox17)	   and	   Sox17icre/+;Fgf8flox/-­‐	   (Fgf8cKOSox17)	   embryos	   that	  are	  utilised	  within	  this	  thesis.	  NB,	  names	  in	  parentheses	  (documented	  in	  C),	  from	  here	  on,	  identify	  the	  genotype	  of	  embryos	  used	  throughout	  the	  thesis.	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2.3.1.3	   Generation	   of	   Fgfr1;Fgfr2flox/+,	   Sox17icre/+;Fgfr1;Fgfr2flox/+,	  
Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/+,	   Sox17icre/+;Fgfr1flox/+;Fgfr2flox/-­‐	   and	  
Sox17icre/+;Fgfr1;Fgfr2flox/-­‐	  embryos	  
	  
Fig	  9	   (see	  below)	  Illustrates	   the	  breeding	  strategy	   followed	   to	  generate	  Fgfr1flox/+;	  
Fgfr2flox/+,	   Sox17icre/+;Fgfr1flox/+;Fgfr2flox/+,	   Sox17icre/+;Fgfr1flox/+;Fgfr2flox/-­‐,	  
Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/+	   and	   Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	   embryos.	   a.	  
Sox17iCre/+	   males	   were	   crossed	   to	   female	   mice	   homozygous	   for	   the	   alleles,	   Fgfr1tm3Cxd,	  (exon	  …	  of	  the	  gene	  Fibroblast	  growth	  factor	  receptor	  1	  is	  flanked	  by	  lox-­‐P	  sites,	  i.e.	  Fgfr1flox)	  and	  Fgfr2tm1.1Dor,	   (exon	  …	  of	   the	  gene	  Fibroblast	  growth	  factor	  receptor	  2	   is	   flanked	  by	   lox-­‐P	  sites,	   i.e.	  Fgfr2flox).	   b.	  Male	   progeny	   heterozygous	   for	  Sox17iCre,	   Fgfr1flox	   and	   the	  Fgfr2flox	  allele	  (Sox17icre/+;Fgfr1flox/+;Fgfr2flox/+)	  were	  kept	  from	  this	  cross	  and	  used	  to	  impregnate	  
Fgfr1;Fgfr2flox/flox	  females	  or	  Fgfr1;Fgfr2flox/flox	  	  female	  mice	  also	  homozygous	  for	  the	  allele	  
Gt(ROSA)26Sortm1.1(EYFP)Cos,	   (Rosa26	   eYFP	   Cre	   reporter	   allele,	   i.e.	   females	   are	  
Fgfr1;Fgfr2flox/flox;RYFP2).	   c.	   The	   mating	   illustrated	   in	   (b)	   generates	   Fgfr1flox/+;Fgfr2flox/+	  (Cre	   negative),	   Sox17icre/+;Fgfr1flox/+;Fgfr2flox/+	   (R1;R2cHetSox17),	  
Sox17icre/+;Fgfr1flox/+;Fgfr2flox/-­‐	   (R1cHet;R2cKOSox17),	   Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/+	  (R1cKO;R2cHetSox17)	  	  and	  Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	  (R1;R2cKOSox17)	  embryos	  that	  are	  utilised	  within	   this	   thesis,	  which	  would	  also	  be	  heterozygous	   for	  RYFP	   if	  derived	   from	  a	  
Fgfr1;Fgfr2flox/flox;RYFP2	  female	  in	  (b).	  NB:	  names	  in	  parentheses	  (documented	  in	  C),	  from	  here	  on,	  identify	  the	  genotype	  of	  embryos	  used	  throughout	  the	  thesis.	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2.3.1.4	   Generation	   of	   Fgfr1;Fgfr2flox/+,	   Mesp1cre/+;Fgfr1;Fgfr2flox/+,	  
Mesp1cre/+;Fgfr1flox/+;Fgfr2flox/-­‐	  and	  Mesp1cre/+;Fgfr1;Fgfr2flox/-­‐	  embryos	  
	  
Fig	  10	  (see	  below)	  Illustrates	  the	  breeding	  strategy	  followed	  to	  generate	  Fgfr1flox/+;	  
Fgfr2flox/+,	   Mesp1Cre/+;Fgfr1flox/+;Fgfr2flox/+,	   Mesp1Cre/+;Fgfr1flox/+;Fgfr2flox/-­‐,	  
Mesp1Cre/+;Fgfr1flox/-­‐;Fgfr2flox/+	  and	  	  Mesp1Cre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	  embryos.	  a.	   A	   transgenic	   stud	   male	   heterozygous	   for	   the	  Mesp1tm2(cre)Ysa	   allele	   (Mesp1Cre),	   that	  drives	  expression	  of	  Cre	  from	  the	  Mesoderm	  posterior	  1	  (Mesp1)	  promoter,	  was	  crossed	  to	  a	  Fgfr1;Fgfr2flox/flox	  female.	  b.	  Male	  progeny	  heterozygous	  for	  Mesp1Cre,	  Fgfr1flox	  and	  the	  
Fgfr2flox	   allele	   (Mesp1Cre/+;Fgfr1flox/+;Fgfr2flox/+)	   were	   kept	   from	   this	   cross	   and	   used	   to	  impregnate	  Fgfr1;Fgfr2flox/flox	   females	   or	  Fgfr1;Fgfr2flox/flox;RYFP2	   females.	   	   c.	   The	  mating	  illustrated	   in	   (b)	   generates	   Fgfr1flox/+;Fgfr2flox/+	   (Cre	   negative),	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2.3.1.5	  Generation	  of	  Fgfr1;Fgfr2flox/+,	  Wnt1cre/+;Fgfr1;Fgfr2flox/+	  and	  
Wnt	  1cre/+;Fgfr1;Fgfr2flox/-­‐	  embryos	  
	  
Fig	   11	   Illustrates	   the	  breeding	   strategy	   followed	   to	   generate	  Fgfr1flox/+;	   Fgfr2flox/+,	  
Wnt1Cre/+;Fgfr1flox/+;Fgfr2flox/+	  and	  	  Wnt1Cre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	  embryos.	  a.	  A	  transgenic	  stud	  male	  heterozygous	  for	  the	  Tg(Wnt1-­‐cre/Esr1*)10Rth	  allele	  (Wnt1Cre),	  that	  drives	  expression	  of	  Cre	  from	  the	  Wingless-­‐type	  MMTV	  integration	  site	  family,	  member	  
1	  (Wnt1)	  promoter,	  was	  crossed	  to	  a	  Fgfr1;Fgfr2flox/flox	  female.	  b.	  Male	  progeny	  heterozygous	  for	  Mesp1Cre,	  Fgfr1flox	  and	  the	  Fgfr2flox	  allele	  (Mesp1Cre/+;Fgfr1flox/+;Fgfr2flox/+)	  were	  kept	  from	  this	  cross	  and	  used	  to	  impregnate	  
Fgfr1;Fgfr2flox/flox	  or	  Fgfr1;Fgfr2flox/flox;RYFP2	  female’s	  c.	  The	  mating	  illustrated	  in	  (b)	  generates	  Fgfr1flox/+;Fgfr2flox/+	  (Cre	  negative),	  Wnt1Cre/+;Fgfr1flox/+;Fgfr2flox/+	  (R1;R2cHetWnt1)	  and	  Wnt1Cre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	  (R1;R2cKOWnt1)	  embryos	  that	  were	  utilised	  in	  this	  thesis,	  which	  would	  also	  be	  heterozygous	  for	  RYFP	  if	  derived	  from	  a	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2.3.2	  Embryo	  preparation	  and	  staging	  
Embryonic	   day	   of	   development	   (E)	   E0.5,	   was	   determined	   as	   noon	   on	   the	   day	   a	  vaginal	  plug	  of	  the	  mated	  female	  was	  detected.	  Embryos	  of	  stages	  E8.5	  through	  to	  E11.5	  and	  E17.5	  were	  dissected	  from	  the	  dams	  of	  pregnant	  females	  into	  DepC	  PBS	  (or	  Hanks	  solution	  if	  performing	  Lysotracker	  staining).	  The	  yolk	  sac	  was	  retained	  for	   genotyping	   (see	   2.2.1.2)	   and	   the	   remaining	   uterine	   tissues	   and	   embryonic	  membranes	   were	   discarded.	   E8.5	   to	   E11.5	   embryos	   were	   staged	   with	   more	  accuracy	   by	   counting	   the	   number	   somites	   that	   had	   developed.	   	   E17.5	   embryos	  were	  staged	  further	  by	  a	  comparison	  of	  their	  morphology	  with	  the	  atlas	  of	  mouse	  development	  (Kaufman,	  1992).	  All	  embryos	  were	  fixed	  for	  a	  minimum	  of	  2	  hours	  at	  RToC	  or	   overnight	  4oC	   in	  4%PFA	   (unless	   the	  protocol	   states	   otherwise.	   	   Post-­‐fixation	   embryos	   were	   washed	   at	   least	   twice	   for	   a	  minimum	   of	   5	  minutes	   with	  DepC	  PBS	  to	  remove	  any	  PFA.	   	  Embryos	  were	  stored	  short	  term	  in	  4oC	  DepC	  PBS	  and	  long	  term	  in	  either	  70%	  ethanol	  at	  4oC,	  or,	  in	  100%	  methanol	  at	  -­‐20oC	  after	  a	  series	  of	  Methanol:PBT	  dehydration	  steps	  (see	  2.4.4.1.a).	  	  
	  
2.3.3	  Embedding	  of	  embryos	  
2.3.3.1	  Embedding	  embryos	  for	  paraffin	  wax	  sectioning	  Dissected	   embryos	   were	   dehydrated	   from	   DepC	   PBS,	   to	   30%	   and	   then	   70%	  ethanol:DepC	   PBS	   (5min	   washes	   or	   until	   embryo	   equilibrates)	   and	   placed	   in	  embedding	  cassettes.	  The	  Leica	  series-­‐300	  was	  used	  to	  process	  embryos	   for	  wax	  embedding.	   	   The	   machine	   automatically	   fills	   and	   drains	   a	   retort	   (holding	   the	  embryos	   within	   their	   embedding	   cassettes)	   with	   a	   series	   of	   ethanol	   solutions	  (70%,	  80%,	  95%	  and	  100%	  each	  applied	  twice)	  followed	  by	  three	  xylene	  changes	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and	  a	  final	  incubation	  in	  paraffin.	  	  Embryos	  up	  to	  stage	  E11.5	  were	  subjected	  to	  1-­‐hour	   incubation	   periods	   in	   the	   each	   solution.	   Subsequently	   the	   cassettes	   were	  transferred	  to	  fresh	  paraffin	  for	  embedding	  either	  frontally	  or	  sagittally.	  	  	  	  A	  Leica	  microtome	  was	  used	  to	  cut	  7um	  thick	  sections	  of	  paraffin	  wax	  embedded	  mouse	  tissue.	  Typically	  alternate	  sections	  were	  cut	  and	  floated	  onto	  a	  water	  bath	  set	  at	  40oC	  (RNase	  free	  H2O).	  	  Tissue	  sections	  were	  mounted	  onto	  Superfrost	  plus	  slides,	   (Thermo	   scientific),	   dried	  briefly	  on	  a	  heat	  block	   and	   incubated	   in	   a	  42oC	  oven	  overnight	  so	  the	  sections	  bond	  to	  the	  slides.	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2.4	  Staining	  of	  embryonic	  tissues	  
2.4.1	  Staining	  solutions	  	  
See	  Appendix	  B	  for	  a	  list	  of	  specific	  solutions	  used	  in	  each	  staining	  protocol.	  
	  
2.4.2	  Whole	  mount	  X-­‐gal	  staining	  to	  detect	  the	  Rosa26	  
Reporter	  
NB:	  all	  reagents	  are	  light	  sensitive	  and	  should	  be	  kept	  in	  foil.	  X-­‐gal	   (5-­‐Bromo-­‐4-­‐chloro-­‐3-­‐indolyl-­‐β-­‐D-­‐galactopyranoside)	   staining	   is	   a	  colorimetric	  reaction	  used	  to	  detect	  the	  activity	  of	  B-­‐galactosidase	  expressed	  from	  the	  R26R	  allele.	  	  	  Pre-­‐prepared	   X-­‐gal	   base	   solution	  was	  warmed	   to	   37oC.	   Embryos	   dissected	   from	  the	  uterus	  at	  stage	  E9.5	  were	  fixed	  for	  10	  minutes	  on	  ice	  and	  immediately	  washed	  into	  PBS	   (2	   x	  5	  minute	  washes).	   	   Fixed	  embryos	  were	  equilibrated	   in	  X-­‐gal	  base	  solution	   for	   30	   minutes	   at	   37oC.	   	   Subsequently,	   X-­‐gal	   enzyme	   (stock	   40mg/ml,	  Fermentas	   R0941),	   was	   diluted	   1:40	   into	   the	   pre-­‐warmed	   base	   solution	   and	   a	  minimum	  of	   250µl	  was	   added	   to	   each	   embryo	   in	   a	   24	  well	   plate.	   	   The	   embryos	  were	  incubated	  in	  foil	  at	  either	  RToC	  (or	  37oC),	  typically	  for	  an	  hour,	  or	  until	  blue	  stain	   was	   evident	   in	   the	   embryos.	   	   Alternatively	   the	   colour	   reaction	   was	   left	   to	  proceed	   slowly	   overnight	   at	   4oC.	   	   Once	   appropriate	   staining	   had	   developed	   the	  reaction	  was	  stopped	  by	  washing	  the	  embryos	  in	  PBS	  and	  post	  fixing	  with	  4%	  PFA	  overnight	  at	  4oC	  before	  imaging.	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2.4.3.	  Whole	  mount	  LysoTracker	  staining	  
LysoTracker	  red	  (Invitrogen,L7528)	  probes	  (a	  fluorophore	  linked	  to	  a	  weak	  base),	  were	   used	   to	   stain	   acidic	   organelles,	   such	   as	   lysosomes,	   as	   an	   indicator	   of	   cell	  death.	   	  The	  probe	  will	  only	  accumulate	   in	   the	  acidic	  organelles	  of	   live	  cells,	   thus,	  embryos	  must	  be	  kept	  alive	  on	  removal	  from	  their	  mother’s	  dam.	  	  Uteri	  containing	  embryos	  to	  be	  Lysotracker	  stained	  are	  collected	  and	  dissected	   in	  Hanks	  buffered	  saline	  solution	  (Hanks,	  Sigma	  H6684-­‐1L),	  pre-­‐warmed	  to	  37oC.	   	  Once	  all	  embryos	  have	  been	  collected	  they	  were	  incubated	  in	  Lysotracker	  red	  probe	  diluted	  1/50	  in	  Hanks	   for	   15	  minutes	   in	   the	  dark	   at	   37oC.	   	   After	   the	   incubation	  period	   embryos	  were	   fixed	   in	   4%	   PFA	   for	   30	   minutes	   and	   dehydrated	   into	   100%	   methanol	   to	  reduce	  background	  staining	  before	  being	  imaged.	  
	  
2.4.5	  Non-­‐radioactive	  in	  situ	  hybridisation	  
Gene	  expression	  in	  fixed	  tissue	  can	  be	  qualitatively	  assessed	  by	  a	  technique	  called	  
in	  situ	  hybridisation	  (ISH).	  	  The	  principle	  of	  ISH	  is	  to	  label	  endogenous	  mRNA,	  at	  a	  cellular	   level,	   with	   complementary	   antisense	   mRNA	   probes	   (see	   2.2.2).	   	   The	  antisense	  mRNA	  probe	  contains	  labelled	  nucleic	  acids,	  (in	  this	  thesis	  all	  probes	  are	  labelled	  with	  DIG,	  see	  2.2.28),	  which,	  after	  being	  bound	  by	  a	  specific	  antibody,	  can	  be	   visualised	   with	   specific	   chromogenic	   substrates.	   	   Thus,	   the	   greater	   the	   gene	  expression,	   the	  more	   endogenous	  mRNA:antisense	  mRNA	   probe	   complexes	   that	  will	   form,	  enabling	  greater	  antibody	  binding	   to	   the	  mRNA	  probe,	   thus	   increasing	  the	  signal	  from	  the	  chromogenic	  substrate.	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2.4.5.1	  Whole	  mount	  in	  situ	  hybridisation	  To	   prevent	   trapping	   of	   staining	   substrates,	   embryos	   of	   a	   developmental	   stage	  E10.0	  or	  older	  were	  perforated	  in	  the	  otic	  vesicle,	  hindbrain	  and	  nasal	  pit.	  All	  high	  temperature	  incubations	  were	  performed	  in	  a	  water	  bath.	  
	  
2.4.5.1.a.	  WMISH,	  hybridisation	  steps	  
N.B.	  These	  steps	  are	  RNase	  sensitive.	  Embryos	   were	   dehydrated	   by	   a	   series	   of	   methanol:PBT	   (25%,	   50%,	   75%	   and	  100%)	  washes	  until	  equilibrated.	   	  Blood	  was	  bleached	  from	  the	  embryos	  by	  a	  15	  minute	   minimum	   incubation	   (embryo	   stage	   dependent)	   in	   6%	   H2O2:methanol	  (stock	  H2O2	  30%	  v/v	   solution,	   Sigma)	  at	  RToC.	   	  Embryos	  were	   rehydrated	   into	  a	  final	   solution	   of	   PBT	   through	   a	   series	   of	   methanol:PBT	   washes,	   (reverse	   of	  dehydration).	   Subsequently	   embryos	   were	   incubated	   in	   detergent	   mix	   for	   a	  minimum	  of	  two	  20	  minute	  periods	  and	  re-­‐fixed	  by	  a	  20	  minute	  incubation	  in	  4%	  PFA	   (all	   incubations	   at	   RToC).	   	   These	   steps	   ensure	   that	   the	   embryonic	   tissue	   is	  permeable	   to	   the	   uptake	   of	  mRNA	  probes	   and	   anti-­‐DIG.	   After	   removing	   the	   PFA	  and	  washing	  the	  embryos	   in	  PBT,	  embryos	  were	  rinsed	   in	  1:1	  PBT:Hybridisation	  mix	  for	  10	  minutes	  at	  65oC.	  A	  1hour	  incubation	  period	  at	  65oC	  in	  Hybridisation	  mix	  equilibrated	   the	   embryos	   for	   a	   subsequent	   incubation	   of	   16hours	   minimum	   at	  65oC	   in	   the	   mRNA	   probe	   (typically	   2µl/ml	   of	   mRNA	   probe	   was	   added	   to	  hybridisation	  mix),	  see	  2.2.2	  for	  probe	  synthesis	  details.	  
	  
2.4.5.1.b.	  WMISH,	  Immunohistochemistry	  steps	  The	  probe-­‐hybridisation	  mix	  was	  removed	  and	  stored	  at	  -­‐20oC	  for	  re-­‐use.	  	  Residual	  mRNA	  probe	  was	  removed	  by	  rinsing	  embryos	  in	  pre-­‐warmed	  Solution	  X	  followed	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by	   a	   series	   of	   four,	   30-­‐minute	   incubations	   in	   Solution	   X	   at	   65oC.	   Subsequently	  embryos	  were	  rinsed	  in	  MABT	  and	  incubated	  in	  MABT	  for	  two	  30-­‐minute	  periods	  at	  RToC.	  	  The	  MABT	  incubations	  ensure	  that	  the	  embryonic	  tissue	  is	  at	  pH	  optimal	  for	   the	  binding	  of	   the	  anti-­‐DIG	  antibody	   to	   the	  endogenously	  bound	  DIG	   labelled	  RNA	   probe.	   	   Prior	   to	   the	   application	   of	   the	   antibody,	   non-­‐specific	   binding	   was	  minimised	  by	  incubating	  the	  embryos	  in	  block	  1	  for	  1	  hour	  and	  then	  in	  block	  2	  for	  1-­‐3	  hours	  (both	  incubation	  periods	  at	  RToC).	  Post-­‐blocking	  the	  anti-­‐DIG-­‐antibody,	  coupled	   to	   alkaline	  phosphatase	   (Roche),	  was	  diluted	  1:2000	   into	  block	  buffer	  2	  and	  applied	  to	  the	  embryos	  for	  a	  minimum	  of	  16	  hours	  at	  4oC.	  To	  remove	  excess	  anti-­‐DIG,	  after	   the	   incubation	  period,	  embryos	  were	  rinsed	   in	  MABT	  and	  washed	  hourly	  into	  fresh	  MABT	  for	  a	  further	  8	  hours	  before	  a	  final	  overnight	  incubation	  in	  fresh	  MABT.	  
	  
2.4.5.1.c.	  WMISH	  signal	  detection	  steps	  Alkaline	  phosphatase	  (AP)	  coupled	  to	  the	  endogenously	  bound	  anti-­‐DIG	  antibody	  is	   detected	   by	   the	   addition	   of	   a	   chromogen	   substrate	   that	   reacts	   with	   AP	   will	  produce	   a	   visible	   colour	   precipitate.	   Subsequent	   to	   an	   overnight	   incubation	   in	  MABT	  the	  embryos	  are	  incubated	  in	  NTMT	  for	  four	  10-­‐minute	  periods,	  this	  buffer	  is	  optimal	  for	  the	  enzymatic	  activity	  of	  the	  alkaline	  phosphatase	  on	  the	  chromogen	  substrate.	   	   The	   enzymatic	   colour	   reaction	   was	   typically	   carried	   out	   using	   BM	  purple	   (Roche	   #11442074001)	   as	   the	   chromogen	   substrate.	   Embryos	   incubated	  with	  BM	  purple	  were	  kept	  in	  the	  dark	  at	  RToC,	  or,	  at	  4oC	  to	  slow	  the	  reaction.	  	  The	  progress	   of	   the	   colour	   reaction	  was	   checked	   every	   30	  minutes	   until	   the	   desired	  stain	   intensity	   was	   achieved.	   The	   colour	   reaction	   was	   stopped	   by	   washing	   the	  embryos	  out	  of	  BM	  purple	  and	  through	  a	  series	  of	  NTMT,	  PBT	  washes	  before	  fixing	  in	  4%	  PFA	  and	  imaging	  the	  samples.	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2.4.5.2	  Section	  in	  situ	  hybridisation	  (ISH)	  
NB:	   All	   steps	   are	   carried	   out	   in	   autoclaved	   coplin	   jars	   at	   RToC	   unless	   stated	  
otherwise.	   	   The	   overnight	   incubation	   in	   RNA	   probe	   is	   carried	   out	   in	   a	   humid	  
(H2O:Formamide),	  floating	  chamber	  in	  a	  65oC	  water	  bath.	  
	  
2.4.5.2.a.	  ISH,	  hybridisation	  steps	  
N.B.	  These	  steps	  are	  RNase	  sensitive.	  Wax	  was	   removed	   from	   tissue	   sections	   by	   incubating	   the	   slides	   in	   xylene,	   three	  times	   for	  3minutes,	  before	  re-­‐hydrating	   the	   tissue	   through	  a	  series	  ethanol:DepC	  H2O,	   (100%,	   95%,	   70%)	   for	   two	   2minute	   incubations.	   	   A	   subsequent	   10minute	  incubation	   in	  4%PFA	  ensured	  the	   tissue	  was	  bonded	  to	   the	  slides.	  After	  washing	  the	  slides	  twice	   in	  DepC	  PBS	  to	  remove	  the	  fixative	  the	  tissue	  was	  permeabilized	  by	   incubating	   it	   for	   8minutes	   in	   8µg/ml	   Proteinase	  K	   (PK,	   Dako	   S3020).	   After	   a	  5minute	   incubation	   in	   DepC	   PBS	   the	   tissue	   was	   cross-­‐linked	   in	   its	   ‘permeable’	  state	  by	  a	  further	  5	  minute	  incubation	  in	  4%	  PFA.	  Residual	  fix	  was	  washed	  away	  by	  another	   5-­‐minute	   incubation	   in	   DepC	   PBS.	   As	   the	   mRNA	   probe	   is	   negatively	  charged	   it	   may	   bind	   non-­‐specifically	   to	   positively	   charged	   amino	   groups	   in	   the	  tissue,	  resulting	  in	  background	  staining.	  To	  reduce	  background	  staining,	  positively	  charged	  amino	  groups	  in	  the	  tissue	  are	  acetylated	  by	  incubation	  for	  10minutes	  in	  the	  acetylation	  mix.	  	  The	  sections	  were	  washed	  a	  further	  three	  times	  in	  DepC	  PBS	  whilst	  diluting	   the	  mRNA	  probes	   to	  2µl/ml	  of	  hybridization	  mix.	   	  The	   tissue	  was	  dehydrated	   from	   70%	   to	   95%	   ethanol	   ready	   for	   incubation	   with	   the	   probe-­‐hybridisation	  mix.	  Probes	  were	   incubated	  at	  80oC	   for	  2	  minutes	   to	  prevent	  non-­‐specific	  binding	  before	  applying	  300µl	  to	  each	  slide,	  covering	  with	  parafilm	  (Alcan	  PARAPM996)	  and	  incubating	  at	  65oC	  for	  at	  least	  16	  hours.	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2.4.5.2.b.	  ISH,	  immunohistochemistry	  steps	  Coverslips	   were	   gently	   floated	   off	   from	   the	   slides	   in	   pre-­‐warmed	   5xSSC	   before	  being	   incubated	   in	  HIS	   for	   20	  minutes	   at	   65oC.	   	   After	   equilibrating	   the	   tissue	   in	  RNase	   buffer	   for	   three	   10	   minutes	   washes	   at	   37oC,	   unbound	   mRNA	   probe	   was	  removed	   from	   the	   sections	   by	   incubation	   with	   100µg/ml	   of	   RNaseA	   (diluted	   in	  RNase	   buffer).	   A	  wash	   for	   15	  minutes	   at	   37oC	   in	   RNase	   buffer	   followed	   by	   two	  20minute	  washes	  in	  HIS	  were	  carried	  out	  to	  remove	  residual	  RNase	  enzyme.	  High	  stringency	   washes	   (15	   minutes	   each	   at	   37oC)	   in	   2xSSC,	   and	   0.1xSSC	   ensure	  removal	  of	  any	  mRNA	  probe	  not	  tightly	  bound	  to	  the	  endogenous	  mRNA	  sequence.	  After	  a	  final	  wash	  in	  PBT	  the	  slides	  are	  blocked	  in	  10%	  HI	  GS	  in	  PBT	  for	  1hour	  to	  prevent	  non-­‐specific	   binding	  of	   the	   anti-­‐DIG	   antibody.	   Subsequently	   the	   sections	  are	   incubated	   with	   anti-­‐DIG-­‐antibody	   diluted	   1:5000	   in	   0.1%	   HI	   GS:PBT	   for	   a	  minimum	  of	  16	  hours	  at	  4oC.	  	  Alternatively,	  the	  binding	  of	  the	  anti-­‐DIG	  antibody	  to	  the	  endogenously	  bound	  DIG	  labelled	  RNA	  probe	  can	  be	  left	  to	  proceed	  for	  3hours	  at	  RToC	  before	  proceeding	  straight	  onto	  the	  signal	  detection	  steps.	  
	  
2.4.5.2.c.	  ISH,	  signal	  detection	  steps	  Residual,	  unbound	  anti-­‐DIG	  antibody	  is	  removed	  by	  four	  15-­‐minute	  washes	  in	  PBT.	  Subsequently	   the	   tissue	  was	   incubated	   in	  NTMT	   for	   two	  10-­‐minute	  periods,	   this	  buffer	   is	   optimal	   for	   the	   enzymatic	   activity	   of	   alkaline	   phosphatase	   on	   the	  chromogen	   substrate.	   	   The	   enzymatic	   colour	   reaction	   was	   typically	   carried	   out	  using	   BM	   purple	   (Roche	   #11442074001)	   as	   the	   chromogen	   substrate.	   Embryos	  incubated	  with	   BM	  purple	  were	   kept	   in	   the	   dark	   at	   RToC,	   or,	   at	   4oC	   to	   slow	   the	  reaction.	  	  The	  progress	  of	  the	  colour	  reaction	  was	  checked	  at	  regular	  intervals	  until	  the	  desired	  stain	  intensity	  was	  achieved.	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2.4.5.2d	  ISH,	  counterstaining	  and	  mounting	  When	  the	  desired	  staining	  of	  the	  tissues	  was	  achieved	  the	  BM	  purple	  was	  removed	  and	  residual	  chromogen	  substrate	  removed	  by	  two	  5minutes	  PBS	  washes.	  Tissue	  was	   counterstained	   with	   nuclear	   fast	   red	   (N3020)	   and	   diluted	   1/50	   in	   PBS	   for	  between	  2-­‐5	  minutes.	   	  After	  dehydrating	   the	   tissue	   through	  a	   series	  ethanol:PBS	  (70%,	   95%,	   100%)	   washes,	   residual	   H2O	   was	   removed	   by	   incubation	   in	   xylene	  before	   applying	   DPX	   mounting	   medium	   (a	   mix	   of	   distyrene,	   a	   plasticizer,	   and	  xylene,	  VWR)	  to	  the	  slides	  and	  mounting	  them	  with	  glass	  coverslips	  (VWR).	  
	  
	  
2.4.6	  Immunohistochemistry	  (IHC)	  
This	   technique	   is	   used	   to	   detect	   the	   abundance	   of	   proteins	   by	   the	   detection	   of	  antigens	   unique	   to	   specific	   proteins.	   All	   steps	   are	   carried	   out	   at	   RToC	   in	   slide	  holders	  (Tissue-­‐Tek	  62540-­‐01),	  unless	  otherwise	  stated.	  In	  all	  IHC	  protocols,	  after	  the	  blocking	  step	  excess	  solution	  was	  removed	  from	  the	  edges	  of	  the	  slides	  and	  a	  hydrophobic	   barrier	   was	   applied	   around	   the	   tissue	   sections	   with	   a	   PAP	   pen	  (Abcam	  ab2601).	   	   Subsequent	   solutions	  were	  drained	   from	   the	   slide	  onto	  paper	  towels	   and	   pipetting	   the	   next	   solution	   inside	   the	   hydrophobic	   barrier,	   onto	   the	  tissue.	  	  Antibodies	  used	  in	  the	  thesis	  are	  detailed	  in	  Appendix	  C.	  	  
2.4.6.1	  HRP/Fluorescently	  conjugated	  immunohistochemistry	  on	  
wax	  paraffin	  sections	  
2.4.6.1a	  Antigen	  blocking	  and	  primary	  antibody	  binding	  Tissue	   sections	  were	   cleared	  of	  wax	  by	   two	  10minute	   incubations	   in	  Xylene	  and	  rehydrated	  through	  a	  series	  of	  ethanol:PBS	  (100%,	  95%,	  90%,	  70%)	  washes	  into	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PBS,	   each	   gradient	   is	   performed	   twice	   for	   5	   minutes.	   Endogenous	   hydrogen	  peroxidase	  activity	   in	   the	   tissue	  will	  non-­‐specifically	  oxidise	   the	  chromogen	  3,3’-­‐Diaminobenzidine	   tetra-­‐hydrochloride	   (DAB	   Sigma,	   D5905),	   resulting	   in	  background	  staining.	   	  To	  minimise	  non-­‐specific	  background	  staining,	  endogenous	  hydrogen	   peroxidase	   was	   blocked	   with	   3%	   H2O2:PBS	   for	   15	   minutes.	   	   After	  washing	   in	   PBS,	   antigen	   retrieval	   was	   achieved	   by	   heating	   the	   slides	   in	   10mM	  sodium	  citrate	  solution	  in	  the	  microwave	  on	  full	  power	  for	  four,	  4minute	  intervals	  (topping	  up	  with	  H2O	  after	  each	  heating	  period).	  	  Once	  the	  sections	  had	  cooled	  to	  RToC	  they	  were	  washed	  in	  with	  PBT2	  (0.2%	  Tween-­‐20	  in	  PBS)	  to	  permeabilize	  the	  tissue.	  Binding	  of	  the	  primary	  antibody	  to	  non-­‐specific	  antigens	  in	  the	  tissue	  was	  minimised	  by	  applying	  wax-­‐blocking	  solution	  (see	  Appendix	  B)	  to	  the	  sections	  for	  a	   minimum	   of	   1	   hour	   in	   a	   humid	   chamber.	   Subsequently,	   100µl	   of	   primary	  antibody	  diluted	  in	  wax	  primary/secondary	  diluent	  (see	  Appendix	  B)	  was	  pipetted	  onto	  sections	  and	  incubated	  at	  4oC	  overnight	  in	  a	  humid	  chamber.	  
	  
2.4.6.1b	  Secondary	  antibody	  binding,	  signal	  amplification	  and	  
chromogen	  substrate	  detection	  After	  an	  overnight	   incubation,	   the	  primary	  antibody	  was	  removed	  and	   the	  slides	  washed	   in	   PBT	   three	   times,	   each	   for	   10	   minutes.	   	   Subsequently	   250µl	   of	  horseradish-­‐peroxidase	   (HRP)	   conjugated	   secondary	   antibody,	   diluted	   1:250	   in	  wax	   primary/secondary	   diluent,	   was	   pipetted	   onto	   the	   sections	   that	   were	  incubated	   in	   a	   humid	   chamber	   for	   1	  hour.	   The	   secondary	   antibody	   solution	  was	  removed	   and	   the	   slides	   washed	   in	   PBT	   three	   times,	   each	   for	   10	   minutes.	   	   To	  amplify	  the	  amount	  of	  chromogen	  substrate	  signal	  A	  and	  B	  reagents	  (diluted	  1:200	  in	   wax	   primary/secondary	   diluent)	   were	   mixed	   and	   250µl	   was	   applied	   to	   the	  sections	  for	  an	  hour	  in	  a	  humid	  chamber.	  The	  A	  and	  B	  reagents	  were	  removed	  by	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2.4.6.2	  Fluorescently	  labelled	  immunohistochemistry	  on	  
cryosections.	  
2.4.6.2a	  Antigen	  blocking	  and	  primary	  antibody	  binding	  OCT	   was	   removed	   by	   two	   5	   minute	   incubations	   in	   PBS	   and	   the	   tissue	   was	  permeabilized	  by	  a	  subsequent	  incubation	  in	  0.5%	  Tween-­‐20	  in	  PBS	  before	  a	  final	  wash	  in	  PBS.	  	  Tissues	  were	  blocked	  for	  1	  hour	  with	  ‘cryosection	  blocking	  solution’	  to	   minimise	   binding	   of	   the	   primary	   antibody	   to	   non-­‐specific	   antigens.	   	   Finally	  100µl	  of	  primary	  antibody	  diluted	  in	  ‘cryosection	  primary/secondary	  diluent’	  was	  pipetted	  onto	  the	  sections	  and	  incubated	  at	  4oC	  overnight	  in	  a	  humid	  chamber.	  	  	  	  
2.4.6.2b	  Binding	  of	  fluorescently	  tagged	  secondary	  antibodies	  After	  the	  overnight	  incubation,	  primary	  antibody	  was	  removed	  and	  the	  slides	  were	  washed	   in	   PBT	   three	   times,	   each	   for	   10	   minutes.	   	   Subsequently,	   250µl	   of	  fluorescently	   labelled	   secondary	   antibody,	   diluted	   1:250	   in	   ‘cryosection	  primary/secondary	  diluent’,	  was	  pipetted	  onto	  the	  cryosections	  and	  incubated	  for	  1	  hour	   in	   a	   dark,	   humid	   chamber.	  After	   the	  hour-­‐long	   incubation,	   the	   secondary	  antibody	  was	  removed	  and	  the	  slides	  were	  washed,	  in	  the	  dark,	  in	  PBT	  three	  times,	  each	   for	   10	  minutes.	   	   In	   the	   last	  minute	   of	   a	   final	   5-­‐minute	   PBS	  wash,	   Hoechst	  diluted	  1:50,000	  was	  added	  to	  mark	  the	  minor	  groove	  of	  AT-­‐rich	  regions	  of	  DNA	  in	  the	  nucleus.	  	  Excess	  PBS	  was	  drained	  from	  the	  slides	  and	  the	  tissues	  were	  mounted	  in	  AF1	  mountant	  solution	  (a	  glycerol:PBS	  based	  anti-­‐fadent,	  Citifluor)	  and	  covered	  with	  glass	  coverslips.	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2.7	  Photo-­‐microscopy	  
All	  photo	  microscopy	  images	  were	  processed	  and	  compiled	  in	  Photoshop	  CS2.	  	  
2.7.1	  Whole	  mount	  fluorescent	  images	  
Embryos	   in	   PBS,	   detecting	   fluorescence	   from	   an	   RYFP	   reporter	   or	   from	   a	  Lysotracker	   probe,	   were	   captured	   as	   Z-­‐stacks	   with	   a	   Zeiss	   Axioscope2.	  	  Fluorescence	  was	  detected	  under	   filtered	  UV	   light	   that	  masks	   all	  wavelengths	  of	  light	  but	  that	  emitted	  from	  the	  fluorophore	  of	  interest.	  Z-­‐stacks	  were	  flattened	  into	  a	  compressed	  image	  using	  and	  the	  accompanying	  Axiovision	  software.	  	  	  
2.7.2	  Whole	  mount	  images	  captured	  using	  white	  light	  
WMISH	  stained	  embryos	  were	   imaged	  using	  a	  Nikon	  Axiovision	  microscope	  with	  the	  accompanying	  Zeiss	  software.	  	  	  
	  
2.7.3	  White	  light	  and	  fluorescent	  images	  of	  sectioned	  
tissue	  (not	  requiring	  Z-­‐stacks)	  
White	  light	  was	  used	  to	  visualize	  BM	  purple	  or	  DAB	  precipitates	  in	  sectioned	  tissue	  on	  a	  Nikon	  SMZ1500	  camera,	  attached	  to	  a	  Nikon	  driver,	  with	   the	  accompanying	  NIS	  Elements	  software.	  	  Fluorescently	  labelled	  tissue	  sections	  were	  visualized	  on	  a	  Nikon	   camera,	   attached	   to	   a	   Hamamatsu	   driver,	   with	   the	   accompanying	   NIS	  Elements	  software.	  UV	  light,	  with	  filters	  to	  mask	  all	  but	  the	  required	  wavelength	  of	  light,	   was	   used	   to	   excite	   emissions	   from	   the	   fluorophore	   conjugated	   to	   the	  secondary	  antibody.	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2.7.4	  Fluorescent	  images	  of	  sectioned	  tissue	  (requiring	  Z-­‐
stacks)	  processed	  on	  the	  confocal	  
Fluorescent	   images	   of	   cryosectioned	   tissue	   stained	   by	   IHC	   were	   captured	   as	   Z-­‐stacks	  on	  a	   confocal	  microscope.	   	   Confocal	  microscopy	  uses	   lasers	   that	   emit	   and	  excite	   fluorophores	  with	  a	  specific	  wavelength	  of	   light.	   	  The	  Z-­‐stack	   images	  were	  compressed	  in	  image	  J.	  	  	  
	  
2.7.5	  Quantitative	  analysis	  and	  Statistics	  
	  
2.7.5.1	  Proliferation	  assay	  To	  determine	  the	  level	  of	  proliferation	  in	  the	  pharyngeal	  epithelia,	  fluorescently	  labelled	  tissue	  sections	  were	  visualized	  on	  a	  Nikon	  camera,	  attached	  to	  a	  Hamamatsu	  driver	  (see	  section	  2.7.3)	  to	  visualise	  PH3	  (identifies	  cells	  in	  S-­‐phase	  i.e.	  proliferating)	  and	  E-­‐cad	  (identifies	  epithelial	  cells)	  labelled	  cells.	  More	  than	  2000	  E-­‐cad	  labelled	  cells	  were	  counted	  in	  both	  the	  endoderm	  and	  the	  ectoderm	  using	  Image	  J	  software,	  (ectoderm	  is	  used	  as	  a	  control	  because	  there	  should	  be	  no	  difference	  in	  proliferation	  between	  control	  and	  Tbx1cKOSox17	  ectoderm,	  as	  both	  are	  Tbx1	  positive).	  	  From	  the	  2000	  E-­‐cad	  positive	  cells,	  the	  number	  of	  E-­‐cad;PH3	  positive	  (doubly	  labelled),	  cells	  were	  counted	  using	  Image	  J	  and	  a	  mitotic	  index	  (MI)	  was	  calculated	  as	  described	  Xu.et.al.,2005):	  	  MI	  =	  Number	  of	  proliferating	  cells	  (PH3	  positive)	  	  	  	  	  	  	  	  	  Total	  cell	  number	  (E-­‐cad;PH3	  positive)	  	  
	  
	   111	  
2.7.5.2	  Calculating	  thymi	  circumference	  E17.5	  embryos	  were	  dissected	  from	  the	  uterus	  (see	  section	  2.3.2),	  the	  chest	  cavity	  of	  each	  embryo	  was	  opened	  up	  and	  the	  overlying	  tissue	  e.g.	  skin,	  rib	  cartilage	  was	  carefully	  removed	  to	  reveal	  the	  position	  in	  which	  the	  thymus	  glands	  should	  lie.	  	  After	  imaging	  any	  thymi	  present,	  in	  situ,	  the	  glands	  were	  carefully	  removed	  to	  reveal	  and	  image	  the	  underlying	  thoracic	  vessels	  of	  the	  heart,	  (see	  section	  2.7.3).	  	  Subsequently,	  the	  circumference	  of	  each	  thymi	  lobe	  was	  outlined	  and	  measured	  in	  Image	  J	  using	  the	  ‘measure	  and	  label’	  tool.	  	  Arbitrary	  values	  corresponding	  to	  the	  circumference	  of	  each	  thymi,	  generated	  by	  the	  ‘measure	  and	  label’	  tool	  in	  Image	  J,	  were	  converted	  to	  mm	  using	  the	  scale	  bar	  imaged	  at	  the	  same	  magnification	  as	  the	  thymi	  lobes.	  	  	  2.7.5.3	  Statistical	  analyses	  Bar	  graphs,	  scatter	  plots	  and	  p-­‐values	  (calculated	  using	  the	  Student’s	  t-­‐test)	  were	  produced	  with	  Graph	  Pad	  software.	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3.1	  Tbx1	  is	  required	  in	  the	  endoderm	  for	  the	  formation	  of	  
the	  pharyngeal	  pouches	  
T-­‐box	   transcription	   factor	   1	   (Tbx1)	   is	   required	   for	   the	   outgrowth	   of	   the	   caudal	  pharyngeal	  pouches	  (pp	  2-­‐4)	  (Lindsay	  et	  al.,	  2001).	  The	  absence	  of	  caudal	  pouches	  and	   arches	   in	  Tbx1-­‐/-­‐	   embryos	   results	   in	   an	   un-­‐segmented	  pharyngeal	   apparatus	  (PA)	  (Jerome	  and	  Papaioannou,	  2001).	  Structures	  derived	  from	  every	  pharyngeal	  cell	  type	  are	  affected	  by	  the	  aberrant	  formation	  of	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos,	  (see	  sections	   1.1.1-­‐1.1.4).	   For	   instance,	   the	   pinna	   of	   the	   external	   ear	   is	   aplastic	   in	  	  	  	  
Tbx1-­‐/-­‐	   embryos	   (Jerome	   and	   Papaioannou,	   2001).	   The	   pharyngeal	   arch	   arteries	  (PAA)	  3-­‐6	  do	  not	  form	  if	  Tbx1	  is	  absent	  during	  PA	  development	  and	  so	  the	  thoracic	  vessels	  of	  the	  heart	  are	  absent,	  or,	  re-­‐arranged	  (Lindsay	  et	  al.,	  2001;	  Zhang	  et	  al.,	  2005;	   Calmont	   et	   al.,	   2009).	   The	   loss	   of	   Tbx1	   from	   the	   mesoderm	   also	   affects	  outflow	  tract	  (OFT)	  development	  and	  so	  the	  formation	  of	  the	  aorta	  (Lindsay	  et	  al.,	  2001;	  Kirby	  et	  al.,	  2008;	  Theveniau-­‐Ruissy	  et	  al.,	  2008).	  	  The	  3rd	  pouch	  is	  unable	  to	  form	   in	   the	   absence	   of	  Tbx1	   and	   so	   its	   derivatives,	   such	   as	   the	   thymi	   lobes,	   are	  aplastic	  (Jerome	  and	  Papaioannou.,	  2001;	  Liao	  et	  al.,	  2004).	  	  	  	  The	   role	   of	   TBX1	   in	   the	   development	   of	   specific	   PA	   structures	   is	   defined	   by	   the	  time,	   level	   and	   place	   of	   Tbx1	   expression.	   Over-­‐expression	   of	   Tbx1	   recapitulates	  many	  of	  the	  PA	  defects	  observed	  in	  Tbx1-­‐/-­‐	  embryos,	  including	  thymus	  aplasia	  and	  ventricular	  septal	  defect,	  (Liao	  et	  al.,	  2004).	  	  However,	  the	  ‘gain	  of	  function’	  Tbx1-­‐mutants	  do	  not	  appear	  to	  display	  defects	  in	  pharyngeal	  pouch	  evagination.	  Caudal	  pouch	  aplasia	  manifests	  when	  the	  level	  of	  Tbx1	  mRNA	  in	  development	  is	  less	  than	  25%	  the	  level	  synthesised	  in	  wild	  type	  embryos	  (Hu	  et	  al.,	  2004).	  In	  contrast,	  the	  deletion	  of	  one	  allele	  of	  Tbx1	  does	  not	  appear	   to	  affect	  caudal	  pouch	  evagination	  (Vitelli	   et	   al.,	   2002).	   By	   carrying	   out	   a	   timed	   deletion	   of	  Tbx1	   with	   a	   tamoxifen	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inducible	   CRE	   mouse	   line,	   Xu	   et	   al.	   have	   identified	   a	   temporal	   requirement	   for	  
Tbx1	  expression	  in	  pouch	  morphogenesis	  to	  be	  between	  E8.5	  and	  E10.5	  (Xu	  et	  al.,	  2005).	  As	   such,	  analyses	  of	   the	   role	  endodermal	  Tbx1	  plays	   in	  pharyngeal	  pouch	  morphogenesis	  in	  this	  have	  been	  conducted	  within	  this	  developmental	  period.	  
	  The	   deletion	   of	   Tbx1	   from	   specific	   cell	   types	   during	   development	   has	   begun	   to	  address	   the	   tissue	   specific	   requirements	   for	  Tbx1	   during	   pouch	  morphogenesis.	  Cranial	   neural	   crest	   cells	   (CNCCs)	   do	   not	   express	   Tbx1	   thus,	   accordingly,	   NCC	  specific	   deletions	   of	   Tbx1	   are	   not	   sufficient	   to	   cause	   pharyngeal	   pouch	   defects	  (Garg	  et	  al.,	  2001;	  Kochilas	  et	  al.,	  2002;	  Aggarwal	  et	  al.,	  2010).	  Embryos	  deficient	  in	  ectodermal	  Tbx1	  display	  hypoplastic	  thymi,	  however,	  no	  pharyngeal	  pouch	  defects	  have	   been	   reported	   in	   these	   mutants	   (Randall	   et	   al.,	   2009).	   In	   contrast,	  surprisingly,	   the	   expression	   of	   Tbx1	   from	   the	  mesoderm	   has	   been	   shown	   to	   be	  required	   for	  and	   is	  partially	  sufficient	   to	  drive	  pouch	  evagination,	  predominantly	  that	  of	  the	  2nd	  pouch	  (Zhang	  et	  al.,	  2006).	  	  Despite	  the	  wealth	  of	  tissue-­‐specific	  CRE	  drivers	  available,	  a	  requirement	  for	  Tbx1	  in	   the	   endoderm	  during	   pouch	  morphogenesis	   has	   not	   been	   definitively	   proven.	  	  The	   NKX2.5Cre	   driven	   deletion	   of	   Tbx1	   from	   domains	   within	   the	   3rd	   and	   4th	  pharyngeal	  pouches	  has	  been	  reported	   to	  cause	  a	  reduction	   in	   the	  size	  of	   the	  4th	  arch	  and	  thymus	  hypoplasia,	  (Xu	  et	  al.,	  2004).	  Severe	  endodermal	  defects	  were	  not	  observed	   in	   these	  mutants	  because	   the	  endodermal	  domains	  of	  Nkx2.5	  and	  Tbx1	  only	   partially	   overlap	   in	   the	   caudal	   pouches,	   (Xu	   et	   al.,	   2004).	   Caudal	   pouch	  formation	   is	   absent	   in	   Foxg1Cre/+;Tbx1flox/-­‐	   embryos	   (PE-­‐KO	   embryos)	   bred	   on	   a	  Swiss-­‐Webster	   (S-­‐W)	   background,	   (Arnold	   et	   al.,	   2006).	   This	   is	   likely	   because	  
Foxg1	  is	  expressed	  extensively	  throughout	  the	  pharyngeal	  endoderm.	  However,	  on	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genetic	   backgrounds	   other	   than	   S-­‐W,	   FOXG1Cre	   is	   active	   in	   non-­‐endodermal	   PA	  tissue	  (Zhang	  et	  al.,	  2005).	  Thus,	  taken	  together	  with	  the	  finding	  that	  mesodermal	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3.1.1	  SOX17icre	  deletes	  Tbx1	  specifically	  within	  the	  
pharyngeal	  endoderm	  
Tbx1	   is	   expressed	   in	   the	  ectoderm,	  mesoderm	  and	  endoderm	  of	   the	  PA	  between	  E8.5	  and	  E11.5	  when	  the	  pharyngeal	  pouches	  are	  evaginating	  (Vitelli	  et	  al.,	  2002).	  It	   is	   hypothesized	   that	   Tbx1	   is	   required	   specifically	   in	   the	   endoderm	   for	  pharyngeal	  pouch	  morphogenesis	  to	  occur	  (Arnold	  et	  al.,	  2006).	  Until	  recently	  this	  hypothesis	  was	  unable	   to	  be	   tested	  directly	  because	   the	  Cre	   lines	  available	  were	  expressed	   in	   non-­‐endodermal	   tissues	   that	   have	   been	   shown	   to	   affect	   pouch	   or	  endocrine	   organ	   development.	   Recently	   a	   new	   mouse	   line	   that	   expresses	   Cre	  
recombinase	   under	   the	   Sox17	   promoter	   has	   been	   generated	   (Engert	   et	   al.,	   2009;	  Liao	  et	  al.,	  2009).	   	  The	  activity	  of	  SOX17iCre	  determined	  by	  LacZ	   expression	   from	  
ROSA26	   conditional	   reporter	   (R26R),	   recapitulates	   the	   endogenous	   expression	  pattern	   of	   Sox17	   in	   endodermal	   and	   endothelial	   cells	   (Engert	   et	   al.,	   2009).	   To	  determine	   the	   requirement	   for	   Tbx1	   in	   the	   endoderm	   during	   pouch	  morphogenesis	   the	  Sox17-­‐2Ai-­‐Cre	  mouse	   line	  was	  used	   to	  generate	  Tbx1flox/+	   and	  
Tbx1flox/-­‐	   (Cre	   negative),	   Sox17icre/+Tbx1flox/+	   (Tbx1cHetSox17)	   and	   Sox17icre/+Tbx1flox/-­‐	  (Tbx1cKOSox17)	  embryos,	  see	  2.3.1	  for	  details	  of	  breeding	  strategies.	  The	  deletion	  of	  
Tbx1	  from	  endothelial	  cells	  using	  TIE2Cre	  (the	  activity	  of	  this	  CRE	  protein	  is	  specific	  to	   endothelial	   tissue	   expressing	   Tie2),	   has	   not	   been	   reported	   to	   cause	   pouch	  defects	   (Xu	  et	   al.,	   2004;	  Chen	  et	   al.,	   2010).	  Thus,	   any	  perturbations	   in	   the	  pouch	  morphogenesis	   of	   Tbx1cHetSox17	   and	   Tbx1cKOSox17	   embryos	   will	   be	   a	   direct	  consequence	  of	  Tbx1	  being	  deleted	  from	  the	  pharyngeal	  endoderm.	  	  	  The	   tissue-­‐specific	   activity	   of	   SOX17iCre	   in	   endoderm	   and	   endothelial	   cells,	   on	   a	  C57BL/6	   genetic	   background,	   has	   been	   documented	   previously	   by	   Engert	   et	   al,	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(Engert	  et	  al.,	  2009).	  To	  confirm	  that	  SOX17iCre	  has	  the	  same	  specificity	  in	  a	  mixed	  genetic	   background,	   embryos	   were	   collected	   from	   crosses	   between	  
Sox17icre/+Tbx1flox/+	  males	   and	  Tbx1f/f;R26R2	   females	   (see	  2.3.1)	   and	  processed	   for	  X-­‐gal	  staining.	  By	  E9.5	  Cre	  negative	  embryos	  have	  formed	  their	  1st	  and	  2nd	  pouches	  and	  the	  3rd	  pouch	  is	  just	  beginning	  to	  evaginate.	  No	  X-­‐gal	  staining	  is	  evident	  in	  Cre	  negative	  embryos,	  (Fig	  12a).	  Despite	  the	  X-­‐gal	  marked	  SOX17iCre	  activity	  present	  in	  the	   pharyngeal	   endoderm	   of	   Tbx1cHetSox17	   embryos,	   pharyngeal	   morphogenesis	  appears	   equivalent	   to	   that	   of	   Cre	   negative	   embryos	   (Fig	   12:	   compare	   pouches	  indicated	   by	   arrows	   in	   panels	   a	   and	   b).	   	   In	   contrast,	   the	   endoderm	   of	   the	  
Tbx1cKOSox17	  embryo	  is	  clearly	  un-­‐segmented	  at	  E9.5	  and	  only	  the	  1st	  pouch	  can	  be	  detected	   (Fig	   12	   panel	   c,	   solid	   arrow).	   X-­‐gal	   staining	   is	   only	   evident	   in	   the	   un-­‐segmented	  endoderm	  and	  in	  the	  endothelial	  cells	  of	  the	  Tbx1cKOSox17	  embryos	  (Fig	  12c).	   Some	   variation	   in	   the	   pattern	   of	   X-­‐gal	   staining	   is	   evident	   between	   the	  
Tbx1cKOSox17	   and	   Tbx1cHetSox17	   embryos	   (Fig	   12	   b	   vs	   c).	   The	   difference	   in	   stain	  appears	   specific	   to	   X-­‐gal	   staining	   of	   endothelial	   cells.	   	   This	   inconsistency	   is	   not	  present	  when	  the	  Rosa26-­‐eYFP	  (RYFP)	  reporter	  line	  is	  used	  to	  identify	  SOX17iCre	  activity,	   as	   fluorescence	   is	   always	   detected	   in	   endothelial	   and	   endodermal	   cells	  (see	  Fig	  30).	  	  The	  efficiency	  and	  specificity	  of	  the	  deletion	  of	  Tbx1	  by	  SOX17icre,	  within	  the	  PA,	  was	   assessed	   by	   immunohistochemistry	   using	   an	   anti-­‐TBX1	   antibody.	   	   TBX1	  protein	   was	   detected	   in	   the	   caudal	   pharyngeal	   endoderm	   and	   in	   the	   core	  mesoderm	  of	  Cre	  negative	  and	  Tbx1cHetSox17	   embryos	  at	  E9.5	  (Fig	  12	  g,	  h	  and	  e).	  	  These	   TBX1	   positive	   domains	   in	   the	   PA	   corroborate	   with	   the	   domains	   of	   Tbx1	  expression	  in	  the	  PA	  (Fig	  12	  d).	  In	  contrast,	  TBX1	  was	  absent	  from	  the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos	  but	  was	  detected	  in	  the	  core	  mesoderm	  of	  the	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pharyngeal	  arches,	   (Fig	  12	   f	  and	   i).	  The	   lack	  of	  TBX1	  protein	   in	   the	  endoderm	  of	  




Fig	  12:	  Caudal	  pouches	  do	  not	   form	  when	  SOX17-­‐2A-­‐icre	  ablates	  Tbx1	   from	  endoderm	  and	  







	  Fig	  	  12	   	  
	  
	   120	  
3.1.2	   Tbx1cKOSox17	   embryos	   are	   unable	   to	   form	   caudal	  
pharyngeal	   pouches	   or	   endodermally	   derived	   thymi	  
glands.	  
From	  Figure	  12	   it	   is	   evident	   that	   the	  pharyngeal	   endoderm	  of	   E9.5	  Tbx1cKOSox17	  embryos	   is	   un-­‐segmented.	   It	   is	   possible	   that	   the	   absence	   of	   endodermal	   Tbx1	  delays	  pouch	  formation,	  rather	  than	  preventing	  it.	  The	  Paired	  box	  protein	  1	  (Pax1)	  is	   expressed	   in	   the	  pharyngeal	  pouches	   from	  E8.5,	   as	   such	   it	   is	   a	   good	  maker	  of	  pouch	  morphology	  (Wallin	  et	  al.,	  1996).	  To	  assess	  whether	  caudal	  pouch	  formation	  is	  delayed	  in	  Tbx1cKOSox17	  embryos,	  mutant	  and	  control	  embryos	  were	  collected	  at	  E10.5	  and	  Pax1	  expression	  was	  analysed.	  	  	  At	  E10.5	  Pax1	   expression	   is	  visible	   in	  pharyngeal	  pouches	  1	   to	  3	  of	  Cre	  negative	  embryos,	   all	   of	   which	   have	   a	   slit-­‐like	   morphology,	   (Fig	   13,	   panel	   a:	   solid	  arrowheads	  mark	  Pax1	  expression	  in	  the	  pouches).	  The	  pattern	  of	  Pax1	  expression	  within	   the	  pouches	   of	  Tbx1cHetSox17	  embryos	   remained	  unchanged,	   however,	   the	  level	   of	  Pax1	   expression	   appears	   reduced	   (Fig	   13b).	   	   In	   contrast,	   the	   absence	   of	  
Pax1	   expression	   observed	   in	   Tbx1cKOSox17	   embryos	   caudal	   endoderm	   indicates	  that,	   caudal	   to	   the	   1st	   pouch,	   no	   endodermal	   evagination	   has	   occurred	   between	  E9.5	  and	  E10.5,	  (Fig	  13,	  panel	  c).	  Overall	  these	  observations	  indicate	  that	  Tbx1	   is	  essential	  within	  the	  endoderm	  for	  caudal	  pharyngeal	  pouch	  formation.	  	  The	   absence	   of	   3rd	   pouch	   in	   Tbx1-­‐/-­‐	   embryos	   prevents	   the	   development	   of	   the	  thymi	  in	  these	  mutant	  embryos	  (Jerome	  and	  Papaioannou,	  2001).	  	  As	  the	  3rd	  pouch	  is	  unable	  to	  form	  in	  Tbx1cKOSox17	  embryos	  it	  was	  predicted	  that	  the	  thymus	  would	  be	   unable	   to	   develop.	   	   To	   investigate	   the	   latter	   hypothesis,	   E17.5	   Tbx1cKOSox17	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Fig	  13:	  Pax1,	  which	  demarcates	  the	  endoderm	  of	  the	  pharyngeal	  pouches,	  identifies	  a	  lack	  of	  
caudal	  pouches	  in	  Tbx1cKOSox17	  embryos.	  a-­‐c:	   low	  magnification	  (4x)	  side	  views	  of	  Pax1	   expression	   in	  E10.5	  embryos.	  a’-­‐c’;	   the	  pharyngeal	  apparatus	  of	  embryos	  a-­‐c	  viewed	  at	  high	  (8x)	  magnification.	  	  Note	  that	  in	  Tbx1cKOSox17	  embryos	  (c	  and	  c’	  n=6)	  Pax1	  expression	  is	  reduced	  in	  the	  1st	  pharyngeal	  pouch	  (pp),	  as	  indicated	  by	  the	  unfilled	  arrowhead,	  but	  is	  completely	  absent	  from	  the	  endoderm	  where	  pp	  2	  and	  3	  should	  have	  formed	  (*	  indicate	  absence	  of	  caudal	  pouches	  and	  a	  lack	  of	  Pax1	  expression).	  N=6	  Annotations:	  Arrows	  to	  the	  left	  of	  the	  figure	  identify	  the	  orientation	  of	  the	  embryos:	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  	  Outlined	  area	  in	  panel’s	  a-­‐c	  indicate	  the	  area	  magnified	   in	  panels	  a’-­‐b’.	   	   L=Limb	  bud,	   S	  =	   somite,	  pp	  =	  pharyngeal	  pouch,	   ?	  =	  presumptive	  pouch,	   solid	   arrowheads	   identify	   areas	   of	   Pax1	   expression	   in	   each	   pouch,	   unfilled	   	   arrowheads	  identify	  areas	  of	  reduced	  Pax1	  expression	  in	  each	  pouch.	  
	  
	  
Fig	  14:	  Thymus	  aplasia	  manifests	  in	  Tbx1cKOSox17	  embryos.	  	  a-­‐c:	  Open	  chest	  cavities	  of	  E17.5	  embryos	  photographed	   frontally	   to	  display	   the	   two	   lobes	  of	   the	  thymus	  in	  Cre	  negative	  and	  Tbx1cHetSox17	  embryos	  (a	  and	  b,	  respectively),	  *	  denotes	  the	  absence	  of	  thymus	   glands	   in	   Tbx1cKOSox17	   embryos	   (c)	   (n=7).	   	   d:	   The	   circumference	   measurements	   were	  plotted	   in	  graph	  (d)	  using	  Graphpad	  software,	   (each	  symbol	  corresponds	   to	  an	   individual	  gland).	  	  Note	   there	   is	  no	  statistically	  significant	  size	  difference	  between	  the	  mean	  circumference	  between	  the	   circumference	  of	  Cre	  negative	   (n=7)	   and	  Tbx1cHetSox17	   (n=3)	   thymi	   glands	   (n=7),	   (p=0.565.and.
p=0.742).respectively,	   by	   students	   T-­‐test.	   Error	   bars	   display	   standard	   error	   of	   the	  mean.	   The	  mean	   thymi	  circumference	  for	  each	  genotype	  of	  embryo	  with	  the	  corresponding	  standard	  error	  of	  the	  mean	  and	  P-­‐value	  (generated	  using	  the	  Student’s	  T-­‐test	  in	  GraphPad)	  are	  listed	  below.	  	  
Genotype	   Right	   lobe	   Mean	   ±	  SEM	  (replicates)	   Difference	  between	  means	  of	  mutants	  and	  Cre	  negatuve	  (P-­‐value)	  
Left	  lobe	  Mean	  ±	  SEM	  (replicates)	   Difference	  between	  means	  of	  mutants	  and	  Cre	  negative	  (P-­‐value)	  Cre	  negative	   4.958	  ±	  0.2954	  (N=8)	  	   	   5.029	  ±	  0.1944	  (N=8)	  	   	  
Tbx1cHetSox17	   5.274	  ±	  0.3147	  (N=3)	   -­‐0.3160	  ±	  0.5283	   4.907	  ±	  0.2708	  (N=3)	  	   0.1223	  ±	  0.3608	  	  
Tbx1cKOSox17	   0.0 ±	  0.0	  (N=7)	  	   -­‐4.958	  ±	  0.317	   0.0	  ±	  0.0	  (N=7)	   -­‐5.029	  ±	  0.2088	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3.2	   The	   loss	   of	   Tbx1	   from	   the	   endoderm	   affects	   the	  
development	  of	  PA	  structures	  derived	  from	  tissues	  other	  
than	  the	  pharyngeal	  endoderm	  
In	   addition	   to	   a	   lack	   of	   segmented	  pharyngeal	   endoderm,	   the	   caudal	   pharyngeal	  arches	   (2-­‐6)	  do	  not	   form	   in	  Tbx1cKOSox17	  embryos.	   	  Thus,	   the	  PA	  of	  Tbx1cKOSox17	  embryos,	   as	   a	   whole,	   appears	   as	   an	   un-­‐segmented	   structure	   (Fig	   13	   panel	   c),	   a	  morphology	  that	  is	  reminiscent	  of	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos.	  	  It	  is	  possible	  that	  the	  perturbed	  morphology	  of	  the	  Tbx1cKOSox17	  embryos	  pharyngeal	  endoderm,	  and/or,	  a	  loss	  of	  Tbx1-­‐dependent	  signals	  from	  the	  endoderm	  will	  affect	  the	  development	  of	  adjacent	  PA	  tissues	  and	  their	  derivatives.	  	  
	  
3.2.1	   Cranial	   neural	   crest	   migration	   is	   reduced	   in	  
Tbx1cKOSox17	  embryos	  
The	  pharyngeal	  arches	  are	  populated	  by	  mesenchyme	  that	  is,	  in	  part,	  derived	  from	  CNCC	  that	  migrate	  into	  the	  PA	  from	  the	  hindbrain	  (Graham	  et	  al.,	  2004)	  Reduced	  and/or	   ectopic	   CNCC	   migration	   into	   the	   PA	   can	   negatively	   impact	   upon	   arch	  formation.	  The	  latter	  is	  observed	  in	  Tbx1-­‐/-­‐	  embryos	  that	  do	  not	  form	  caudal	  arches	  (Vitelli	  et	  al.,	  2002).	  CNCC	  do	  not	  express	  Tbx1,	  hence,	  their	  migratory	  trajectories	  are	  disrupted	  in	  Tbx1-­‐/-­‐	  embryos	  because	  of	  the	  loss	  of	  Tbx1	  from	  the	  CNCC	  niche	  (Vitelli	   et	  al.,	  2002).	  As	  evaginating	  pharyngeal	  pouches	  normally	   segregate	  each	  arch	   it	   is	   possible	   that	   Tbx1	   dependent	   signals	   from	   the	   endoderm	   may	   act	   as	  CNCC	   guidance	   factors.	   To	   investigate	   this	   hypothesis	   Tbx1cKOSox17	   and	   Cre	  negative	   embryos	   were	   examined	   for	   Dlx2	   expression	   by	   whole	   mount	   in	   situ	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hybridization.	  	  Dlx2	  is	  a	  gene	  normally	  expressed	  by	  migratory	  and	  post-­‐migratory	  CNCC	  (Qiu	  et	  al.,	  1997).	  At	  E9.5	  Dlx2	  expressing	  CNCC	  are	  visible	   in	  the	  proximal	  and	   distal	   halves	   of	   Cre	   negative	   embryos	   1st	   and	   2nd	   arches.	   The	   pharyngeal	  pouches	  segregate	  each	  domain	  of	  Dlx2	  positive	  CNNC	  in	  the	  PA	  (Fig	  15,	  panel	  a:	  three	  arrowheads	  demarcate	  the	  segregation).	  	  Even	  in	  the	  caudal	  PA,	  that	  is	  yet	  to	  form	  a	  defined	  arch,	   the	   just	   forming	  3rd	  pouch	  can	  be	  seen	  to	  divide	   the	  bulk	  of	  CNCC	  migrating	   into	   this	   region	   (Fig	   15	   panel	   a,	   area	   indicated	   by	   the	   posterior	  arrow).	   	   In	   the	  Tbx1cKOSox17	   embryos	  a	   reduction	   in	  Dlx2	  expression	  can	  be	  seen	  throughout	  the	  PA	  but	   in	  particular	  caudal	   in	  the	  1st	  arch.	   	  The	  reduction	   in	  Dlx2	  expression	   is	   indicative	   of	   reduced	   CNCC	   migration	   into	   the	   PA	   (compare	   solid	  arrowheads	   in	   Fig	   15	   a	   to	   the	   unfilled	   arrowheads	   in	   15	   b	   and	   c).	   	   In	   addition,	  patches	   of	   ectopic	  migrating	   CNCC	  were	   observed	   rostral	   to	   the	   1st	   arch	   in	   one	  
Tbx1cKOSox17	   embryo	  (Fig	  15	  panel	   c,	  observe	  areas	  highlighted	  by	  solid	  arrows).	  	  The	   reduced	   and	   disorganized	   pattern	   of	   Dlx2	   expression	   observed	   in	   the	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3.2.2	   Hypoplasia	   of	   the	   external	   ear	   manifests	   in	  
Tbx1cKOSox17	  embryos	  	  
The	   three	   structures	   that	   define	   the	   external	   ear,	   the	   pinna	   (external	   flap),	   the	  external	   acoustic	  meatus	   (EAM,	   the	   ear	   canal)	   and	   the	   tympanic	  membrane	   (ear	  drum),	   are	   derived	   from	   the	   rostral	   PA	   (Mallo	   and	   Gridley,	   1996).	   The	   EAM	   is	  derived	  from	  the	  ectodermal	  cleft	  of	  the	  first	  arch	  and	  the	  endodermal	  epithelium	  of	   the	   tubotympanic	   recess,	   which	   contributes	   to	   the	   tympanic	   membrane,	   is	  formed	  from	  the	  first	  pouch	  (Mallo	  and	  Gridley,	  1996).	  Furthermore	  the	  pinna	  are	  derived	  from	  six	  hillocks,	  mesenchymal/ectodermal	  thickenings,	  on	  the	  surface	  of	  the	  1st	  arch	  (Alasti	  and	  Van	  Camp,	  2009).	  External	  ear	  defects	  are	  exhibited	  in	  most	  DiGeorge	  syndrome	  patients,	   indicating	  that	  the	  loss	  of	  Tbx1	  may	  be	  required	  for	  the	  formation	  of	  this	  structure	  (Greenberg,	  1989).	  Absence	  of	  the	  hyoid	  crest	  from	  the	  2nd	  arch	  and	  its	  misrouting	  into	  the	  1st	  arch	  were	  the	  defects	  proposed	  to	  cause	  absence	  of	   the	  external	  ear	   in	  Tbx1-­‐/-­‐	  embryos	  (Moraes	  et	  al.,	  2005).	  However,	  as	  already	  noted	  above,	  CNCC	  do	  not	  express	  Tbx1.	  Thus,	  any	  CNCC	  migration	  defects	  that	  result	   in	  pinna	  aplasia	  occur	  because	  Tbx1	   is	  absent	  from	  adjacent	  tissues	  in	  the	  PA.	  Tbx1cKOSox17	  embryo’s	  pinna	  were	  analysed	  at	  E17.5	  to	  assess	  whether	  the	  observed	  defects	  in	  Dlx2	  marked	  CNCC	  perturb	  the	  formation	  of	  this	  external	  ear	  structure.	   	   All	  Tbx1cKOSox17	  mutants	   (Fig	   16	  b)	   (n=3/3)	   have	   slightly	   hypoplastic	  pinna	   (relative	   to	   Cre	   negative	   embryos,	   Fig	   16	   a)	   that	   are	   otherwise	   normal	   in	  morphology	  and	  position	  on	  the	  embryo’s	  head	  (compare	  T-­‐bars	  in	  Fig	  16	  a-­‐c,	  the	  arrow	  in	  panels	  a-­‐c	  indicates	  the	  position	  of	  the	  ear	  relative	  to	  the	  eye).	  	  The	  subtle	  hypoplasia	  observed	   in	   the	  pinna	  of	  Tbx1cKOSox17	   embryos	   is	  a	  major	   contrast	   to	  the	  aplasia	  presenting	  in	  PE-­‐KO	  pinna	  (Arnold	  et	  al.,	  2006).	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Fig	  16:	  The	  formation	  of	  the	  pinna	  and	  the	  thoracic	  vessels,	  derived	  from	  the	  PA,	  are	  affected	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3.2.3	  Thoracic	  vessel	   formation	  may	  require	  Tbx1	   in	   the	  
pharyngeal	  endoderm	  	  
The	  thoracic	  vessels	  of	  the	  heart	  and	  the	  aorta	  are,	  respectively,	  contributed	  to	  by	  the	  pharyngeal	  arch	  arteries	  (PAAs)	  and	  the	  OFT	  of	  the	  heart.	  Five	  bilateral	  PAAs	  (1-­‐4	  and	  6)	  develop	  in	  the	  centre	  of	  each	  pharyngeal	  arch	  (Moffat,	  1959;	  Hiruma	  et	  al.,	  2002).	  CNCC	  migrate	  to	  the	  PAAs	  where	  they	  differentiate	  into	  smooth	  muscle	  cells	  that	  ‘reinforce’	  the	  vessels	  (Ryckebusch	  et	  al.,	  2010).	  If	  the	  PAAs	  do	  not	  form	  or	   remodel	   appropriately	   then	   thoracic	   vessel	   defects	   such	   as	   interrupted	   aortic	  arch	   type	   (IAA,	   discontinuity	   between	   the	   ascending	   and	  descending	  portions	   of	  the	   aorta)	   and	   aberrant	   branching	   of	   the	   right	   subclavian	   artery	   (A-­‐RSA)	   occur;	  these	   defects	   manifest	   in	   DGS	   and	   Tbx1	   mutant	   mouse	   embryos	   (Mulay	   and	  Watterson,	   1997;	   Scambler,	   2010).	   The	   OFT	   is	   contributed	   to	   by	   the	   splanchic	  mesoderm,	  located	  caudal	  to	  the	  pharynx,	  and	  by	  CNCC	  migrating	  through	  the	  PA	  (Xu	  et	  al.,	  2004).	  The	  formation	  of	  this	  primitive	  vessel	  is	  required	  to	  connect	  the	  right	  ventricle	  to	  the	  PAAs	  (and	  thus	  the	  dorsal	  aorta)	  via	  the	  aortic	  sac.	  	  Division	  of	   the	  OFT	   later	   in	  gestation	  separates	   the	  pulmonary	   from	  the	  aortic	   (systemic)	  circulatory	  system	  (Xu	  et	  al.,	  2004).	   	  Cardiac	  defects	   incompatible	  with	  postnatal	  life,	   such	   as	   persistent	   truncus	   aterious	   (PTA),	  manifest	  when	   the	  OFT	   does	   not	  grow	  or	  divide	  properly	  (Finley	  et	  al.,	  1977;	  Xu	  et	  al.,	  2004).	  PTA	  can	  be	  identified	  as	  a	   single	  vessel	  arising	   from	  both	  ventricles	  of	   the	  heart,	   rather	   than	   the	  aorta	  and	  pulmonary	  trunk	  (Kirby	  et	  al.,	  2008).	  	  Again,	  these	  defects	  are	  present	  in	  Tbx1-­‐
/-­‐	  embryos	  and	  contribute	  to	  the	  postnatal	  morbidity	  of	  these	  mutants	  (Theveniau-­‐Ruissy	  et	  al.,	  2008).	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The	  structure	  of	   the	  heart	  and	   its	  associated	  vessels	  were	  examined,	   in	   situ	   after	  removal	   of	   the	   thymi,	   to	   determine	  whether	   pharyngeal	   arch	   artery	   and	   cardiac	  defects	  arise	  in	  these	  mutants,	  (Fig	  16	  c	  and	  16	  d).	  	  No	  evidence	  of	  cardiac	  defects	  such	  as	  PTA	  were	  detected	  in	  the	  Tbx1cKOSox17	  or	  Cre	  negative	  embryos	  analysed	  (n=7).	  At	   E17.5	   one	  Tbx1cKOSox17	   embryo	  presented	  with	   interrupted	   aortic	   arch	  type	   (IAA-­‐B)	   (Fig	   16	   d)	   and	   two	  Tbx1cKOSox17	   embryos	   presented	  with	   aberrant	  branching	   of	   the	   right	   subclavian	   artery	   (Fig	   16	   d).	   An	   analysis	   of	   the	   heart’s	  septum,	  (by	  haematoxylin	  and	  eosin	  staining,	   for	  example),	  would	  be	  required	  to	  confirm	  that	  ventral	  septal	  defects	  (that	  often	  occur	  in	  tandem	  with	  IAA-­‐B)	  do	  not	  manifest	  in	  the	  conditional	  Tbx1	  mutants.	  The	  thoracic	  vessel	  defects	  are	  indicative	  of	   the	   PAA	   being	   unable	   to	   form	   or	   align	   properly	   during	   PA	   development.	   To	  verify	   the	  manifestation	  of	   IIA-­‐B	   in	  Tbx1cKOSox17	   embryos	   an	   analysis	   of	   a	   larger	  sample	   of	  mutants	   at	   E17.5	   is	   required,	   in	   combination	  with	   an	   analysis	   of	   PAA	  development	   in	   Tbx1cKOSox17	   embryos	   at	   E10.5.	   	   Time	   constrains	   and	   mutant	  numbers	   prevented	   such	   an	   extensive	   analysis	   of	   thoracic	   vessel	   formation	   in	  
Tbx1-­‐deficient	  embryos.	  	  In	   summary,	   the	   data	   presented	   demonstrates	   that	   Tbx1	   is	   required	   in	   the	  endoderm	  for	  the	  formation	  of	  a	  segmented	  PA	  and	  the	  development	  of	  a	  number	  of	   its	  derivatives.	   	  The	  deletion	  of	   Tbx1	   from	   the	  pharyngeal	   endoderm	  perturbs	  CNCC	   migration,	   which	   may	   be	   responsible	   for	   the	   observed	   defects	   in	   the	  development	  of	  Tbx1cKOSox17	  embryos	  pinna	  and	  thoracic	  vessels	  later	  in	  gestation.	  The	   data	   has	   proven	   Tbx1	   is	   required	   within	   the	   endoderm	   for	   caudal	   pouch	  formation	   and	   the	   development	   of	   the	   endodermally	   derived	   thymus	   gland.	   The	  next	   question	   to	   address	  was	  which	   factors	   act	   downstream	   of	  Tbx1,	   within	   the	  endoderm,	  to	  enable	  pharyngeal	  pouch	  morphogenesis.	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3.3	  Expression	  of	  Fgf8	  within	  the	  pharyngeal	  endoderm	  is	  
dependent	  on	  endodermal	  Tbx1	  	  
Fgf8	   and	  Tbx1	   interact	   epistatically	   during	   the	   development	   of	   cardiac	   elements	  and	  endocrine	  glands	  derived	  from	  the	  PA	  (Vitelli	  et	  al.,	  2002b;	  Lania	  et	  al.,	  2009).	  	  
In	  vitro	  data	  has	  shown	  that	  TBX1	   is	  able	   to	   induce	   luciferase	  expression,	  driven	  from	   an	   Fgf8	   promoter	   (Hu	   et	   al.,	   2004).	   In	   vivo	   data	   has	   suggested	   that	   this	  positive	   regulation	   of	   Fgf8	   by	   TBX1	   may	   be	   relevant	   to	   pouch	   development	  because	   Fgf8	   expression	   is	   absent	   from	   the	   pharyngeal	   endoderm	   of	   Tbx1-­‐/-­‐	  embryos	  (Vitelli	  et	  al.,	  2002b).	  To	  test	  whether	  Tbx1	   in	  the	  endoderm	  is	  required	  for	  the	  expression	  of	  Fgf8	  in	  the	  pharyngeal,	  the	  expression	  of	  this	  FGF	  ligand	  was	  assessed	  in	  Tbx1cKOSox17	  embryos	  by	  in	  situ	  hybridization.	  	  	  	  At	  E9.5	   Fgf8	   expression	   is	  detected	   robustly	   in	   the	   caudal	  pharyngeal	   endoderm	  with	  expression	  visible	  in	  the	  majority	  of	  the	  evaginating	  3rd	  pouch.	  Rostral	  to	  the	  3rd	  pouch	  the	  expression	  of	  Fgf8	  in	  the	  endoderm	  is	  restricted	  to	  the	  distal	  aspects	  of	   the	   1st	   and	   2nd	   pouch	   (Fig	   17	   panel	   a,	   black	   solid	   arrowhead	   show	   Fgf8	  expression	   in	   each	   pouch).	   In	   contrast	   Fgf8	   expression	   extends	   throughout	   the	  pharyngeal	  ectoderm	  (Fig	  17	  panel	  a,	  blue	  solid	  arrowhead).	  Fgf8	  expression	  in	  the	  endoderm	  of	  Tbx1cHetSox17	  embryos	  appears	  indistinguishable	  in	  pattern	  and	  level	  from	   that	   observed	   in	   Cre	   negative	   embryos.	   	   Unsurprisingly,	   the	   expression	   of	  ectodermal	  Fgf8	  is	  also	  unchanged	  in	  the	  Tbx1-­‐positive	  endoderm	  of	  Tbx1cHetSox17	  embryos	   (Fig	   17:	   compare	   endodermal	  Fgf8	   [black	   arrowheads]	  and	   ectodermal	  
Fgf8	   [blue	   arrowhead]	   in	   panels	   a	   and	   b).	   In	   contrast,	   in	   the	   majority	   of	  
Tbx1cKOSox17	  embryos	  analysed	  (n=2/3)	  Fgf8	  was	  absent	  from	  all	  but	  a	  small	  area	  of	  caudal	  endoderm	  where	  expression	  was	  extremely	  diminished,	  (Fig	  17,	  panel	  c:	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Fig	  17:	  Fgf8	  expression	  is	  greatly	  diminished	  in,	  or	  absent	  from,	  the	  pharyngeal	  endoderm	  of	  
Tbx1cK0Sox17	  embryos.	  Fgf8	  expression	  was	  assessed	  by	  in	  situ	  hybridisation	  on	  frontal	  sections	  of	  E9.5	   embryo’s	   pharyngeal	   apparatus.	   (a,	   b	   and	   e)	   Cre	   negative	   and	  Tbx1cHetSox17	   embryos	   show	  robust	  expression	  in	  the	  ectoderm	  (blue	  arrowhead)	  and	  endoderm	  (black	  arrowheads)	  at	  E8.5	  and	  E9.5.	  In	  contrast,	  Fgf8	  is	  only	  weakly	  expressed	  in	  a	  small	  area	  of	  Tbx1cKOSox17	  embryos	  endoderm	  (panel	  c,	  red	  arrowhead)	  where	  the	  3rd	  pp	  should	  have	  formed,	  (in	  one	  Tbx1cKOSox17	  no	  endodermal	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3.4	  The	  expression	  of	  genes	  in	  the	  FGF	  signalling	  cascade	  
are	  maintained	   independently	  of	  Tbx1	   in	   the	  pharyngeal	  
endoderm.	  
A	   number	   of	   FGF	   ligands	   are	   expressed	   in	   the	   pharyngeal	   endoderm	   at	   E9.5,	   in	  addition	  to	  Fgf8,	  including	  Fgf3,	  Fgf10	  and	  Fgf15	  (Kelly	  et	  al.,	  2001;	  Vincentz	  et	  al.,	  2005;	   Aggarwal	   et	   al.,	   2006).	   In	   vitro,	   TBX1	   is	   sufficient	   to	   activate	   a	   luciferase	  expression	   construct	   driven	   by	   the	   Fgf10	   promoter,	   indicating	   that	   TBX1	   may	  positively	  regulate	  the	  expression	  of	  multiple	  FGF	  ligands	  (Xu	  et	  al.,	  2004).	  The	  loss	  of	   Fgf3	   and	   Fgf10	   expression	   in	   Tbx1-­‐/-­‐	   embryos	   suggests	   that	   TBX1	   is	   also	  required	  for	  the	  transcription	  of	  these	  ligands,	  in	  vivo,	  within	  the	  PA	  (Vitelli	  et	  al.,	  2002b;	   Aggarwal	   et	   al.,	   2006).	   To	   address	   whether	   TBX1	   is	   required	   in	   the	  endoderm	   for	   the	   expression	   of	   Fgf3,	   Fgf10	   and	   Fgf15,	   these	   FGF	   ligands	   were	  analysed	  by	  in	  situ	  hybridisation	  in	  frontal	  sections	  of	  Tbx1cKOSox17	  embryos	  PA.	  	  	  	  In	  Cre	  negative	  embryos	  the	  expression	  of	  Fgf3	  is	  confined	  to	  the	  posterior	  half	  of	  each	  pouch.	  Moreover,	  the	  domain	  of	  Fgf3	  expression	  in	  the	  3rd	  pouch	  appears	  to	  be	  complimentary	   to	   the	  more	  anterior	  domain	  of	  Fgf8	   expression	   (compare	   the	  expression	  domain	  of	  Fgf8	   in	   the	  3rd	  pouch	   [Fig	  17,	  panel	  a]	  with	   the	  expression	  domain	   of	   Fgf3	   in	   the	   3rd	   pouch	   [Fig	   18,	   panel	   a]).	   The	   absence	   of	   endodermal	  TBX1	   correlates	  with	   an	   extension	   of	  Fgf3	   expression.	   	   In	  Tbx1cKOSox17	   embryos	  
Fgf3	  is	  expressed	  throughout	  the	  pharyngeal	  endoderm,	  in	  a	  largely	  un-­‐segmented	  pattern,	  consistent	  with	  the	  morphology	  of	  this	  epithelium	  (Fig	  18,	  panel	  a	  versus	  panel	   b).	   A	   similar	   change	   in	   the	   expression	   pattern	   of	   Fgf15	   is	   observed	   in	  
Tbx1cKOSox17	  embryos	  when	  compared	  to	  controls	  (Fig	  18,	  panel	  c	  versus	  panel	  d).	  
Fgf15	  is	  expanded	  through	  rostral	  areas	  of	  pharyngeal	  endoderm	  in	  the	  absence	  of	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endodermal	   TBX1.	   	   However,	   the	   extent	   of	   Fgf15	   expansion	   in	   Tbx1cKOSox17	  endoderm	   is	   less	   severe	   than	   that	   observed	   with	   Fgf3.	   	   There	   was	   no	   loss	   or	  change	  to	  the	  expression	  pattern	  of	  Fgf10	  in	  Tbx1cKOSox17	  embryos	  at	  E9.5	  (Figure	  	  18e	  and	  f).	  	  	  	  In	   summary,	   it	   appears	   that	   within	   the	   endoderm	   only	   Fgf8	   expression	   is	  dependent	   on	   TBX1	   as	   all	   the	   mRNA	   of	   all	   other	   FGF	   ligands	   analysed	   was	  maintained	  within	  TBX1-­‐deficient	  endoderm.	  Thus,	  it	  was	  questioned	  whether	  the	  loss	   of	   Fgf8	   expression	   in	   Tbx1cKOSox17	   embryos	   would	   alter	   the	   level	   of	   FGF	  signalling	  within	  the	  pharyngeal	  endoderm.	  To	  address	  this,	  Etv4	  (Pea3)	  and	  Etv5	  
(Erm),	  Sprouty	   1	  and	   Sprouty	   2	  were	   utilised	   as	   ‘readouts’	   of	   FGF	   signalling	   and	  their	  expression	  was	  analysed	  in	  Tbx1cKOSox17	  and	  control	  embryos	  at	  E9.5.	  	  	  
Pea3	  and	  Fgf8	  appear	  to	  have	  similar	  patterns	  of	  expression	  within	  the	  pharyngeal	  endoderm	  at	  E9.5,	  (compare	  Fig	  17	  panel	  a	  and	  Fig	  19	  panel	  a).	   	  Pea3	  transcripts	  are	   present	   in	   the	   very	   distal	   tips	   of	   pharyngeal	   pouches	   1	   and	   2,	   where	   the	  evaginating	  endoderm	  and	  invaginating	  ectoderm	  meet.	  	  In	  the	  3rd	  pouch	  Pea3	  has	  a	   wide	   expression	   domain,	   (in	   comparison	   to	   the	   more	   rostral	   pouches),	  corresponding	  to	   the	  morphology	  of	   the	  outgrowing	  pouch.	  However,	   in	  contrast	  to	   Fgf8,	   the	   expression	   of	   Pea3	   was	  maintained	   in	   the	   pharyngeal	   endoderm	   of	  
Tbx1cKOSox17	  embryos,	  significantly	  so	  within	  the	  presumptive	  3rd	  pouch	  regions	  of	  the	  caudal	  endoderm,	  (compare	  magnified	  areas	  of	  caudal	  endoderm,	  Fig	  19	  panels	  a	   and	   b).	   	   Similarly,	   Erm	   expression	   is	   maintained	   in	   Tbx1cKOSox17	   embryos,	  indicating	   that	   the	   loss	   of	   Fgf8	   does	   not	   cause	   a	   loss	   of	   FGF	   signalling	   in	   the	  pharyngeal	  endoderm	  (Fig	  19	  panel	  d).	  	  Erm	  is	  expressed	  diffusely	  through	  most	  of	  the	   pharyngeal	   endoderm,	   except	   in	   the	   most	   medial	   areas	   of	   inter-­‐pouch	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endoderm	   (Fig	   19,	   panel	   c	   solid	   arrowheads	   indicate	   Erm	   expression	   in	   the	  pharyngeal	   pouches).	   Robust	  Erm	  expression	   overlaps	  with	   the	   domains	   of	  Fgf3	  and	  Fgf15	  expression	  in	  the	  posterior	  halves	  of	  the	  rostral	  pouches	  and	  throughout	  the	  evaginating	  3rd	  pouch	  (compare	  Fig	  18,	  panels	  a	  and	  c	  with	  Fig	  19,	  panel	  c).	  Akin	  to	  Fgf3	  and	  Fgf15,	  the	  expression	  domain	  of	  Erm	  expands	  along	  the	  A-­‐P	  axis	  of	  Tbx1cKOSox17	  embryos	  pharyngeal	   endoderm,	   in	   contrast	   to	   the	  more	  dynamic	  expression	  pattern	  visible	  in	  Cre	  negative	  embryos	  (compare	  Fig	  19	  panels	  c	  and	  d).	  	  	  Similarly,	  there	  was	  a	  loss	  of	  the	  segmented	  pattern	  of	  Sprouty	  1	  (Fig	  20,	  panels	  a	  and	  b)	  and	  Sprouty	  2	  (Fig	  20,	  panels	  c	  and	  d)	  expression	  observed	  in	  Cre	  negative	  embryos	   pharyngeal	   endoderm	   in	   Tbx1cKOSox17	   embryos.	   Sprouty	   genes	   are	  expressed	  in	  a	  continuous	  manner	  throughout	  TBX1-­‐deficient	  endoderm,	  whereas,	  in	   TBX1-­‐positive	   endoderm	   a	   segmented	   expression	   pattern	   is	   observed,	   with	  expression	  appearing	  more	  robust	  in	  the	  posterior	  half	  of	  the	  pharyngeal	  pouches	  than	  in	  the	  anterior	  (Fig	  20,	  panels	  a	  and	  c	  vs	  d	  and	  e).	  	  	  Overall,	   the	   analysis	   of	   FGF	   signalling	   readouts	  by	   in	   situ	   hybridisation	   indicates	  that	  FGF	  signalling	   is	  maintained	  in	  TBX1	  deficient	  endoderm,	  despite	  the	   loss	  of	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Fig	  18:	   	  TBX1	   is	  not	   required	   for	   the	   expression	  of	  Fgf3,	   Fgf10	   or	  Fgf15	   in	   the	  pharyngeal	  
endoderm.	  Frontal	  sections	  of	  E9.5	  Cre	  negative	  (a,	  a’,	  c,	  c’	  and	  e),	  and	  Tbx1cKOSox17	  (b,	  b’,	  d,	  d’	  and	  f)	  embryo’s	  PA	  reveal	  that	  the	  expression	  of	  Fgf3	  (a	  –	  b’,	  n=2),	  Fgf15	  (c	  –	  d’,	  n=1),	  and	  Fgf10	  (e	  and	  f	  n=1),	   is	  maintained	   in	   the	  endoderm	  independently	  of	  TBX1.	   	  Note	   the	   ‘unsegmented’	  expression	  pattern	   of	   Fgf3	   and	   Fgf15	   in	   the	   pharyngeal	   endoderm	   of	   Tbx1cKOSox17	   embryos.	   a’-­‐	   d’	   are	   high	  magnification	  images	  of	  panels	  a-­‐d.	  	  Annotations:	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  unfilled	  arrowhead	  =	  endodermal	  pouch	   (no/little	   expression	   visible),	   pp	   =	   pharyngeal	   pouch,	   ?	   =	   presumptive	   pouch	   regions	   in	  TBX1-­‐deficient	  endoderm,	  outlined	  areas	  in	  panels	  a-­‐d	  indicate	  the	  area	  magnified	  in	  panels	  a’-­‐d’.	  Meso	  labelled	  arrow	  =	  Mesodermal	  expression	  of	  Fgf10.	  Arrows	  to	  the	  right	  of	  figure	  illustrate	  the	  orientation	  of	  the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  
	  
Fig	  19:	  Expression	  of	  Fgf	  signalling	  ‘readouts’	  is	  maintained	  in	  the	  endoderm	  independently	  
of	  cell-­‐autonomous	  Tbx1	  expression.	  In	  situ	  hybridization	  on	  frontal	  sections	  of	  E9.5	  Cre	  negative	  (a,c)	  and	  Tbx1cKOSox17	  (b,d)	  pharyngeal	  pouches	  with	  an	  antisense	  Pea3	  (a-­‐b	  and	  high	  power	  a’-­‐b’)	  or	  Erm	  (c-­‐d	  and	  high	  power	  c’-­‐d’)	  mRNA	  probe.	   	   The	   in	   situ	   hybridisation	   reveals	   that	   FGF	   signalling	   is	   maintained	   in	   Tbx1-­‐deficicent	  endoderm.	   In	   addition,	   Erm	   is	   expressed	   in	   an	   un-­‐segmented	   pattern	   in	   the	   endoderm	   of	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Fig	  20:	  	  Sprouty	  genes	  are	  expressed	  in	  a	  de-­‐regulated	  manner	  throughout	  the	  pharyngeal	  
endoderm	  and	  mesenchyme	  when	  Tbx1	  is	  deleted	  from	  the	  endoderm.	  In	  situ	  hybridization	  for	  Sprouty	  1	  (a	  and	  b)	  and	  Sprouty	  2	  (c	  and	  d)	  showed	  that	  the	  segmented	  pattern	  of	  expression	  in	  Cre	  negative	  embryos	  (a	  and	  c)	  is	  absent	  from	  Tbx1cKOSox17	  embryos	  (b	  and	  d).	  	  Sprouty	  1	  expression	  is	  expressed	  throughout	  the	  pharyngeal	  endoderm	  (black	  arrowheads)	  and	  mesenchyme	  (green	  arrowheads).	  An	  in	  situ	  hybridization	  for	  Sprouty	  2	  also	  showed	  de-­‐regulated	  expression	  in	  mutant’s	  rostral,	  unsegmented	  endoderm	  (panel	  d,	  black	  arrowheads),	  but	  unlike	  
Sprouty	  1,	  the	  expression	  of	  Sprouty	  2	  in	  the	  mesenchyme	  appears	  to	  be	  similar	  to	  that	  of	  the	  mesenchyme	  of	  the	  Cre	  negative	  embryos	  (green	  arrows	  in	  panels	  c	  and	  d).	  N	  =	  3	  for	  each	  gene.	  Annotations:	   Black	   arrowhead	   =	   endodermal	   pouch	   expression,	   pp	   =	   pharyngeal	   pouch,	   ?	   =	  presumptive	   pouch	   regions	   in	   TBX1-­‐deficient	   endoderm,	   Green	   arrowhead	   =	   pharyngeal	  mesenchyme.	  Arrows	   to	   the	  right	  of	  Fig	  20	   illustrate	   the	  orientation	  of	   the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	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3.5	  Discussion	  
A	  new	   transgenic	  mouse	   line	  with	   Cre	   activity	   specifically	   in	   the	   endoderm	  was	  required	   to	   determine	  whether	  Tbx1	   is	   required	   in	   the	   endoderm	   during	   pouch	  formation.	   Foxg1Cre	   on	   a	   S-­‐W	   genetic	   background	  was	   found	   to	   recombine	  Tbx1	  specifically	  in	  the	  endoderm	  (Arnold	  et	  al.,	  2006).	  	  However,	  this	  mouse	  line	  is	  not	  an	   ideal	   tool	   to	   study	   the	   role	  of	   specific	  genes	  within	   the	  endoderm	  because	  on	  genetic	   backgrounds	   other	   than	   S-­‐W,	   Foxg1Cre	   expression	   is	   not	   specific	   to	   the	  endoderm	  (Zhang	  et	  al.,	  2005).	  Conditional	  Cre	  lines	  that	  are	  expressed	  in	  multiple	  tissues,	   including	   the	   endoderm,	   (e.g.	   Hoxa2Cre	   and	   Nkx2.5Cre)	  may	   be	   utilised	   if	  recombination	   in	   the	   non-­‐endodermal	   tissue	   alone	   does	   not	   cause	   pharyngeal	  pouch	  defects	  (Xu	  et	  al.,	  2004;	  Zhang	  et	  al.,	  2005).	  For	  instance,	  Hoxa2	  is	  expressed	  in	   the	  endoderm	  and	  ectoderm	  caudal	   to	   the	  2nd	  pharyngeal	  pouch.	   	  Yet,	   thymus	  hypoplasia	   generated	   by	   the	   recombination	   of	   Fgf8	   by	   Hoxa2Cre	   has	   been	  attributed	  to	   loss	  of	  Fgf8	   form	  the	  endoderm	  (Zhang	  et	  al.,	  2005).	  The	   latter	  was	  inferred	  because	  deletion	  of	  Fgf8	  by	   the	  Ap2alphaCre	   (expressed	   in	  ectoderm	  and	  CNCC)	  does	  not	   generate	   the	   same	   thymus	  defect	   (Zhang	  et	   al.,	   2005).	  However,	  the	   restricted	   temporal-­‐spatial	   expression	   of	   the	   Hoxa2Cre	   and	   Nkx2.5Cre	   in	   the	  pharyngeal	   endoderm	   limits	   their	   use	   in	   studying	   pharyngeal	   pouch	  morphogenesis.	  For	  example,	  Hoxa2Cre	  expression	  is	  only	  initiated	  after	  E9.0	  in	  the	  PA	  where	  its	  expression	  is	  restricted	  to	  the	  caudal	  endoderm	  (Zhang	  et	  al.,	  2005).	  	  	  In	  this	  thesis	  a	  new	  Cre	  line,	  Sox17-­‐2Ai-­‐Cre,	  has	  been	  utilised	  to	  delete	  Tbx1	  within	  the	  endoderm.	  Sox17	  (which	  drives	  the	  transcription	  of	  the	  Cre)	  is	  active	  before	  the	  pharyngeal	   endoderm	   forms	   (E7.0)	   and	   is	   expressed	   within	   all	   the	   cells	   of	   the	  pharyngeal	   endoderm.	   Thus,	   Sox17-­‐2Ai-­‐Cre	   is	   as	   ideal	   tool	   to	   study	   the	   role	   of	  genes	  expressed	  in	  the	  endoderm	  during	  pouch	  morphogenesis.	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3.5.1	   Variable	   X-­‐gal	   staining	   in	   endothelial	   cells	   is	   a	  
reporter	  specific	  discrepancy	  
There	   is	   some	   discrepancy	   between	   SOX17iCre	   positive	   embryos	   in	   the	   level	   and	  pattern	   of	   R26R	   expression	   detected	   by	   X-­‐gal	   staining.	   The	   difference	   in	   stain	  appears	   specific	   to	   the	   X-­‐gal	   staining	   of	   endothelial	   cells,	   where	   Sox17	   is	   also	  expressed.	  Differences	  in	  reporter	  expression	  pattern,	  identifying	  Cre	  activity,	  have	  been	   documented	   for	   other	   tissue	   specific	   Cre	   lines	   (Hébert	   et	   al.,	   2000).	   For	  instance,	  the	  pattern	  of	  human-­‐placental-­‐alkaline-­‐phosphatase	  staining	  (detecting	  
Z/AP	   recombination)	   varied	   from	   the	   pattern	   of	   X-­‐gal	   staining	   (detecting	   R26R	  recombination)	  when	  both	  were	  mediated	  by	  FOXG1Cre	  (Hébert	  et	  al.,	  2000).	  One	  theory	   is	   that	   the	  Z/AP	  allele	   is	  more	  susceptible	   to	  recombination	  and	  occurs	   in	  the	  presence	  of	  very	   low	   levels	  of	  FOXG1Cre.	   If	   this	  hypothesis	   is	  applicable	   to	  all	  conditional	   Cre	   lines	   it	   is	   possible	   that	   the	   R26R	   allele	   is	   less	   susceptible	   to	  recombination	   than	   the	   RYFP	   allele	   and	   so	   endothelial	   cell	   recombination	   is	   not	  always	   apparent.	   	   However,	   this	   also	   implies	   that	   endothelial	   cells	   have	   a	   lower	  level	   of	   Sox17	   expression	   than	   endodermal	   cells,	  which	  was	   not	   reported	   in	   the	  original	  report	  paper	  (Engert	  et	  al.,	  2009).	  
	  Although	   differences	   in	   SOX17icre	   mediated	   endothelial	   cell	   recombination	   are	  important	   to	   document,	   the	   functional	   consequences	   of	   this	   discrepancy	   are	   not	  relevant	  for	  pharyngeal	  pouch	  morphogenesis,	  (i.e.	  the	  loss	  of	  Tbx1	  expression	  in	  endothelial	  cells).	  Tie2	   is	  expressed	  specifically	  within	  endothelial	  cells.	  Embryos	  deficient	  in	  endothelial	  Tbx1	  (Tie2Cre/+;Tbx1flox/-­‐)	  do	  not	  display	  any	  cardiovascular	  defects	   and	   no	   pouch	   or	   endocrine	   defects	   were	   documented	   either	   (Xu	   et	   al.,	  2004;	  Chen	  et	  al.,	  2010).	  Furthermore	  the	  activity	  of	  SOX17iCre	  at	  E9.5	  is	  sufficient	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to	  delete	  Tbx1	  and	  thus	  prevent	  the	  translation	  of	  TBX1	  protein	  in	  the	  pharyngeal	  endoderm,	  the	  focus	  of	  this	  thesis	  analysis	  of	  pharyngeal	  pouch	  morphogenesis.	  	  	  
3.5.2	   Caudal	   pouch	   formation	   is	   prevented	   by	   the	  
efficient,	   SOX17icre-­‐mediated,	   deletion	   of	   Tbx1	   from	   the	  
endoderm	  	  
The	  deletion	  of	  Tbx1	   in	   the	  endoderm	  by	  SOX17icre	   is	  efficient	  and	  specific,	  as	  PA	  tissue,	   other	   than	   the	   pharyngeal	   endoderm,	   is	   positive	   for	   TBX1	   protein	   when	  
Sox17iCre	   is	   expressed.	   This	   indicates	   that	   the	   pharyngeal	   defects	   of	   the	   Tbx1-­‐deficient	   embryos	   are	   a	   direct	   result	   of	   the	   loss	   of	   Tbx1	   from	   the	   pharyngeal	  endoderm.	   Tbx1+/-­‐	   embryos	   do	   not	   have	   any	   documented	   defects	   in	   pharyngeal	  pouch	  evagination	  (Vitelli	  et	  al.,	  2002b;	  Liao	  et	  al.,	  2004).	  In	  agreement,	  pharyngeal	  pouch	   outgrowth	   was	   not	   affected	   by	   the	   deletion	   of	   one	   Tbx1	   allele	   from	   the	  endoderm.	   Thymus	   development	   also	   appears	   unaffected	   in	   the	   Tbx1cHetSox17	  embryos,	  with	  no	   apparent	   size	   or	  migration	  defects	   observed	   in	   these	  mutants.	  This	  data	  complements	  the	  findings	  of	  Arnold	  et	  al.	  who	  used	  the	  Foxg1Cre	  mouse	  line	  on	  a	  S-­‐W	  background	  to	  delete	  Tbx1	  from	  the	  endoderm	  (Arnold	  et	  al.,	  2006).	  It	   also	   suggests	   that	   thymus	   organogenesis	   is	   affected	   by	   the	   loss	   of	  Tbx1	   from	  multiple	  tissues	  as	  Tbx1+/-­‐	  embryos	  display	  a	   low	  incidence	  of	  thymus	  hypoplasia	  (Vitelli	   et	   al.,	   2002b).	   The	   thymus	   develops	   from	  Foxn1	   positive	   cells	   of	   the	   3rd	  pouch,	   however	   CNCC	   also	   contribute	   to	   thymus	   organogenesis	   (Gordon	   et	   al.,	  2001;	  Blackburn	   and	  Manley,	   2004).	   It	   is	   possible	   that	   loss	   of	   one	   allele	   of	  Tbx1	  from	  the	  ectoderm	  causes	  the	  perturbed	  migration	  of	  CNCC	  into	  the	  caudal	  PA	  of	  
Tbx1+/-­‐	   embryos	   that	   subsequently	   perturbs	   thymi	   development	   (Calmont	   et	   al.,	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2009).	   Certainly	  PSE-­‐KO	   embryos	  display	  defects	   in	  CNCC	  migration	  and	   thymus	  hypoplasia	  (Randall	  et	  al.,	  2009).	  The	  cumulative	  affect	  of	  reduced	  Tbx1	  expression	  in	   the	  endoderm	  and	  mild	  CNCC	  defects	  may	  cause	   thymus	  hypoplasia	   in	  Tbx1+/-­‐	  embryos.	   To	   validate	   this	   hypothesis	   a	   simultaneous	   analysis	   of	   CNCC	  migration	  and	   thymus	   defects	   in	   Cre	   negative	   embryos,	   Tbx1+/-­‐	   embryos,	   Tbx1cHetSox17	  embryos	  and	   embryos	   lacking	   one	   allele	   of	  Tbx1	   in	   ectodermal	   cells	   is	   required.	  
Tbx1cKOSox17	  embryos	  recapitulate	  the	  caudal	  pouch	  and	  thymus	  aplasia	  observed	  when	  Tbx1	  is	  deleted	  from	  all	  tissues	  (Tbx1-­‐/-­‐	  embryos).	  The	  lack	  of	  caudal	  pouch	  evagination	   in	   Tbx1cKOSox17	   embryos	   proves	   that	   Tbx1	   is	   required	   within	   the	  endoderm	  for	  caudal	  pharyngeal	  pouch	  morphogenesis,	  corroborating	  the	  findings	  of	  Arnold	  et	  al.,	  (Arnold	  et	  al.,	  2006).	  It	  is	  becoming	  apparent	  that	  the	  1st	  pouch	  has	  an	  autonomous	  developmental	  programme.	  The	  major	  distinction	  between	  the	  1st	  pouch	   and	   the	   caudal	   endoderm	   of	  Tbx1cKOSox17,	   Tbx1-­‐/-­‐	   and	  Tbx1	   hypomorphic	  embryos	  is	  that	  the	  1st	  pouch	  is	  able	  to	  evaginate,	  enabling	  the	  1st	  arch	  to	  form	  (Hu	  et	  al.,	  2004).	  	  Caudal	  pouch	  evagination	  is	  unable	  to	  proceed	  in	  Tbx1cKOSox17	  embryos	  despite	  the	  presence	  of	   a	   source	  of	  mesodermal	  Tbx1.	   Zhang	  et	   al.,	   propose	   that	  Tbx1	   in	   the	  pharyngeal	   mesoderm	   was	   sufficient	   to	   partially	   drive	   pharyngeal	   pouch	  morphogenesis	  (Zhang	  et	  al.,	  2006).	  Re-­‐activation	  of	  mesodermal	  Tbx1	  expression	  in	  Tbx1	  hypomorphic	  embryos	  normalized	  the	  2nd	  pouch	  and	  partially	  normalized	  4th	  pouch	  outgrowth.	   	  Residual	  Tbx1	  expression	  from	  the	  hypomorphic	  allele	  was	  deemed	  insufficient	  to	  support	  pouch	  outgrowth	  (Zhang	  et	  al.,	  2006).	  However,	  the	  residual	   amount	   of	   Tbx1	   may	   have	   enabled	   the	   endoderm	   to	   ‘respond’	   to	  evagination	   signals	   from	   the	   mesoderm.	   Vitelli	   et	   al.,	   propose	   that	   a	   minimal	  amount	   of	  Tbx1	   is	   required	   for	   cells	   to	  be	   able	   to	   respond	   to	   adjacent	   signalling	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molecules,	   such	  as	  FGF8	   (Vitelli	   et	   al.,	   2010).	  Mesenchymal	   embryonic	   fibroblast	  cells	  (MEFs)	  were	  harvested	  from	  Tbx1neo/-­‐	  embryos	  (which	  express	  residual	  Tbx1)	  and	   from	   Tbx1-­‐/-­‐	   embryos.	   Only	   the	   Tbx1neo/-­‐	   MEFs	   were	   able	   to	   respond	   to	  exogenous	   FGF8	   as	   assayed	   by	   amount	   of	   phospho-­‐RSK	   produced	   by	   the	  hypomorphic	   cells,	   relative	   to	   Tbx1+/+	   MEFs	   (Vitelli	   et	   al.,	   2010).	   Thus,	   Tbx1	  expression	   in	   the	  mesoderm	   of	  Tbx1cKOSox17	   embryos	  may	   be	   unable	   to	   support	  caudal	  pouch	  morphogenesis	  because	  the	  pharyngeal	  endoderm	  of	  these	  mutants	  is	  completely	  devoid	  of	  Tbx1.	  
	  
3.5.3	   Loss	   of	   Tbx1	   from	   the	   endoderm	   affects	   CNCC	  
migration	   and	   the	   formation	   of	   the	   thoracic	   vessels	   and	  
pinna	  
The	  amount	  of	  CNNC,	  indicated	  by	  the	  level	  of	  Dlx2	  expression,	  in	  the	  caudal	  PA	  of	  
Tbx1-­‐/-­‐	  embryos	  is	  severely	  reduced	  (Vitelli	  et	  al.,	  2002).	  CNCC	  do	  not	  express	  Tbx1	  thus	  the	  defects	  observed	  in	  Tbx1-­‐/-­‐	  embryos	  are	  consequence	  of	  the	  loss	  of	  Tbx1	  in	  the	  pharyngeal	  epithelia	  and/or	  mesoderm	  (Garg	  et	  al.,	  2001;	  Vitelli	  et	  al.,	  2002).	  However,	   by	   collating	   data	   from	   embryos	   harbouring	   tissue-­‐specific	   deletions	   of	  
Tbx1	  it	  is	  becoming	  apparent	  that	  CNCC	  migration	  toward	  and	  infiltration	  of	  the	  PA	  requires	  Tbx1	  expression	  in	  every	  tissue	  of	  the	  PA.	  Deleting	  Tbx1	  in	  the	  pharyngeal	  ectoderm	   (PSE-­‐KO	   embryos)	   causes	  migratory	   defects	   in	   Sox10-­‐expressing	  CNCC	  (Calmont	   et	   al.,	   2009).	   The	   circumpharyngeal	   crest	   of	   the	  PSE-­‐KO	   embryos	  were	  absent	  distally	  and	  often	  merged	  with	  the	  post	  otic	  crest	  proximally	  (Calmont	  et	  al.,	  2009).	  The	  tissue-­‐specific	  deletion	  of	  Tbx1	  from	  mesodermal	  cells	  (M-­‐KO	  embryos)	  also	   perturbs	   Crabp1	  marked	   CNCC	   migration	   into	   the	   caudal	   PA	   (Zhang	   et	   al.,	  2006).	   Finally,	   a	   reduction	   in	   Dlx2	   expressing	   CNCC	   was	   also	   observed	   in	   the	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caudal	   PA	   of	   Tbx1cKOSox17	   embryos	   suggesting	   that	   the	   TBX1	   dependent	   signals	  from,	   and/or	   the	  morphology	   of,	   the	   pharyngeal	   endoderm	   also	   influence	   CNCC	  development.	   A	   detailed	   analysis	   of	   CNCC	  markers	   such	   a	   Sox10	   and	   Crabp1	   in	  
Tbx1cKOSox17	  embryos	  is	  required	  to	  determine	  ‘stream’-­‐specific	  migratory	  defects	  caused	  by	  the	  loss	  of	  Tbx1	  in	  the	  endoderm.	  	  
	  
Tbx1-­‐/-­‐	  embryos	  display	  defects	  in	  multiple	  PA	  derivatives	  that	  are	  contributed	  to	  by	   CNCC,	   including,	   the	   external	   ear,	   OFT	   and	   thoracic	   vessels	   of	   the	   heart	  (Scambler,	  2010).	  The	  pinna,	  one	  of	  the	  structures	  of	  the	  external	  ear,	  are	  derived	  from	  six	  hillocks,	  (mesenchymal/ectodermal	  thickenings),	  on	  the	  surface	  of	  the	  1st	  arch	  (Alasti	  and	  Van	  Camp,	  2009).	  Despite	  the	  mesenchymal/ectodermal	  origin	  of	  this	  structure,	  the	  deletion	  of	  Tbx1	  from	  the	  endoderm	  (by	  the	  FOXG1Cre	  on	  a	  S-­‐W	  background)	  recapitulates	  the	  pinna	  aplasia	  observed	  in	  Tbx1-­‐/-­‐	  embryos	  (Jerome	  and	  Papaioannou,	  2001;	  Arnold	  et	  al.,	  2006).	  A	  mesodermal	  source	  of	  Tbx1	  has	  also	  been	  shown	  to	  be	  both	  necessary	  for	  the	  formation	  of	  the	  pinna.	  	  Hypoplastic	  pinna	  form	  when	   Tbx1	   is	   absent	   from	   the	  mesoderm	   (Zhang	   et	   al.,	   2006).	   Conversely	  reactivation	   of	   Tbx1	   in	   mesodermal	   cells	   (in	   a	   Tbx1	   hypomorphic	   background)	  rescues	   the	  external	  ear	  hypoplasia	  displayed	   in	  Tbx1	   hypomorphs	   (Zhang	  et	  al.,	  2006).	   Surprisingly,	   it	   was	   noticed	   that	   pinna	   are	   able	   to	   form,	   albeit	  hypoplastically,	   in	   Tbx1cKOSox17	   embryos.	   	   The	   pinna	   defects	   of	   Tbx1cKOSox17	  mutants	   appear	   akin	   to	   those	   of	  M-­‐KO	  mutants,	   rather	   than	   the	  PE-­‐KO	  mutants.	  The	   discrepancy	   between	   the	   Tbx1cKOSox17	   and	   PE-­‐KO	   mutants	   is	   unusual	  considering	  the	  1st	  arch	  forms	  in	  both	  mutants	  and	  the	  only	  loss	  of	  Tbx1	  is	  from	  the	  endoderm	   (Arnold	   et	   al.,	   2006).	   It	   is	   possible	   that	   the	   deletion	   of	  Tbx1	   from	   the	  endoderm	  on	  different	  genetic	  backgrounds	  affects	  pinna	  development	  to	  different	  extents.	   Alternatively,	   it	  may	   be	   that	   the	   contribution	   of	   CNCC	   to	   the	   1st	   arch	   is	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more	   severely	   disrupted	   in	   PE-­‐KO	   mutants.	   	   But	   as	   CNCC	   migration	   was	   not	  analysed	   in	  PE-­‐KO	  embryos	   a	   comparison	   cannot	  be	  made	  with	   the	  migration	  of	  CNCC	   in	   Tbx1cKOSox17	   and	   M-­‐KO	   embryos,	   both	   of	   which	   retain	   some	   CNCC	  migration	  into	  their	  1st	  arch	  (Zhang	  et	  al.,	  2006).	  	  Alternatively,	  the	  discrepancy	  in	  the	  expression	  of	  Fgf3	  between	  PE-­‐KO	  and	  Tbx1cKOSox17	  embryos	  may	  explain	  the	  different	   severities	   of	   pinna	   defects	   observed	   in	   these	   endodermally	   deficient	  mutants	   (Arnold	   et	   al.,	   2006).	   For,	   pinna	   defects	   are	   associated	   with	   Fgf3	  homozygous	   loss	   of	   function	   mutations	   in	   human	   patients	   with	   syndromic	  deafness	  (Tekin	  et	  al.,	  2008).	  
	  The	  lack	  of	  caudal	  pouch	  outgrowth	  in	  Tbx1cKOSox17	  embryos	  corroborates	  the	  data	  of	   Arnold	   et	   al.	   demonstrating	   that	   Tbx1	   is	   required	   within	   the	   endoderm	   for	  pharyngeal	  pouch	  morphogenesis.	  	  However,	  the	  Tbx1cKOSox17	  phenotype	  does	  not	  support	   the	   authors	   conclusions	   that;	   ‘complete	   inactivation	   of	   Tbx1	   in	   the	  endoderm	  results	  in	  a	  phenotype	  identical	  to	  the	  Tbx1	  homozygous	  null	  mutants’	  (Arnold	  et	   al.,	   2006).	   In	  addition	   to	   the	  pinna,	   another	  example	  provided	  by	   this	  thesis	   to	   suggest	   that	   the	   endoderm	   deletion	   of	   Tbx1	   is	   not	   sufficient	   to	  recapitulate	   the	   Tbx1-­‐/-­‐	   phenotype	   is	   that	   Tbx1cKOSox17	   do	   not	   present	   with	   any	  outflow	  tract	  (OFT)	  defects	  that	  manifest	  in	  PE-­‐KO	  and	  Tbx1-­‐/-­‐	  embryos.	  	  The	  division	  of	  the	  pulmonary	  and	  aortic	  (systemic)	  circulation	  is	  enabled	  by	  the	  division	  of	  the	  OFT	  into	  two	  channels	  which	  are	  separated	  by	  the	  formation	  of	  an	  aorto-­‐pulmonary	   septum	   (Xu	  et	   al.,	   2004).	  Current	   literature	  proposes	   that	  Tbx1	  within	   the	   mesoderm	   is	   critical	   for	   OFT	   development	   whereas	   the	   role	   of	  expression	   from	   the	   endoderm	   is	   marginal	   (Zhang	   et	   al.,	   2006).	   	   However,	   OFT	  septation	  and	  alignment	  defects	  such	  as	  ventral	  septal	  defects	  (VSD)	  and	  persistent	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truncus	  arteriosus	  (PTA)	  were	  detected	  in	  PE-­‐KO	  embryos	  indicating	  that	  Tbx1	  in	  the	   endoderm	   is	   also	   required	   for	   the	  OFT	   to	   develop	   (Arnold	   et	   al.,	   2006).	   The	  deletion	  of	  Tbx1	  from	  mesodermal	  OFT	  precursor	  cells	  with	  the	  Nkx2.5Cre	  line	  also	  caused	  OFT	  septation	  defects	  but	  Nkx2.5	  is	  expressed	  within	  the	  endoderm	  of	  the	  3rd	  and	  4th	  pouch	  (Xu	  et	  al.,	  2004).	  OFT	  defects	  were	  present	  in	  all	  M-­‐KO	  mutants	  and	   this	   defect	   was	   fully	   rescued	   by	   the	   reactivation	   of	   Tbx1	   in	   a	   Tbx1	  hypomorphic	   background	   (Zhang	   et	   al.,	   2006).	   This	   indicated	   that	   Tbx1	   in	   the	  mesoderm	   was	   crucial	   to	   the	   septation	   of	   the	   OFT	   but	   did	   not	   disprove	   any	  marginal	   role	   a	  basal	   level	   of	   endoderm	  expression	  may	  be	  playing.	   	   Even	  a	   low	  level	   of	  Tbx1	   in	  Tbx1	   hypomorphs	   can	   ameliorate	   the	   severity	   of	   OFT	   septation	  defects	   seen	   in	  Tbx1-­‐/-­‐	   embryos	   (Vitelli	   et	   al.,	   2010).	   The	   lack	   of	   OFT	   defects	   in	  
Tbx1cKOSox17	  supports	  the	  current	  view	  of	  Zhang	  et	  al.,	  that	  Tbx1	  in	  the	  endoderm	  is	  not	  required	  for	  OFT	  development.	  	  In	  contrast,	   the	  presence	  of	  aortic	  arch	  defects	   in	  Tbx1cKOSox17	  embryos	  supports	  the	   hypothesis	   that	   Tbx1	   is	   required	   in	   the	   pharyngeal	   epithelia	   for	   4th	   PAA	  development.	   	   The	   deletion	   of	   one	   allele	   of	   Tbx1	   in	   the	   pharyngeal	   epithelia,	  mediated	   by	   FGF15Cre	   (which	   has	   endoderm	   and	   ectoderm	   activity),	   HOXA3Cre	  (which	  has	  endoderm,	  ectoderm	  and	  mesoderm	  activity)	  and	  Ap2alphaCre	   (which	  has	   ectoderm	   activity)	   all	   generate	   4th	   PAA	   aplasia	   that	   leads	   to	   defects	   such	   as	  IAA-­‐B	  (Zhang	  et	  al.,	  2005).	  	  Whilst	  the	  data	  presented	  here	  establishes	  that	  Tbx1	  is	  required	  for	  aortic	  arch	  development	  it	  is	  unclear	  whether	  this	  is	  due	  to	  a	  loss	  of	  arch	   formation,	   or,	   because	   TBX1-­‐dependent	   signals	   from	   the	   endoderm	   are	  directly	  required	  for	  PAA	  formation.	  To	  determine	  the	   latter	  requires	  an	  analysis	  of	   thoracic	   vessel	   development	   in	   Tbx1cHetSox17	   embryos.	   	   If	   IAA-­‐B	   and	   a-­‐RSA	  manifest	   in	   Tbx1cHetSox17	   embryos	   this	   would	   confirm	   that	   TBX1-­‐dependent	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signals	   from	   the	   endoderm	   are	   directly	   required	   for	   PAA	   formation	   because	   the	  formation	  of	   the	  pharyngeal	  pouches	  and	   thus	  arches	  are	  not	  perturbed	   in	   these	  mutants.	  
	  
3.5.4	   Fgf8	   expression	   but	   not	   FGF	   signalling	   within	   the	  
endoderm	  is	  dependent	  on	  Tbx1	  	  	  	  	  	  
After	   establishing	   that	   Tbx1	   is	   required	   in	   the	   endoderm	   for	   pharyngeal	   pouch	  formation,	   it	   was	   necessary	   to	   identify	   candidates	   that	   may	   act	   downstream	   of	  
Tbx1	   to	   control	   pouch	   formation.	   	   Expression	   of	   Fgf3	   and	   Fgf8	   are	   both	   absent	  from	  the	  pharyngeal	  endoderm	  of	  Tbx1-­‐/-­‐	  and	  PE-­‐KO	  embryos,	  mesodermal	  Fgf10	  expression	  domains	  are	  also	  absent	   from	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos	  (Vitelli	  et	  al.,	  2002b;	  Aggarwal	  et	  al.,	  2006;	  Arnold	  et	  al.,	  2006).	  TBX1	  has	  been	  shown	  to	  directly	  activate	   Fgf8	   and	   Fgf10-­‐luciferase	   constructs	   in	   vitro	   via	   T-­‐box	   consensus	   sites	  within	  the	  promoters	  of	  these	  genes	  (Hu	  et	  al.,	  2004;	  Xu	  et	  al.,	  2004).	  The	  loss	  of	  
Fgf8	   specifically	   from	   the	   endoderm	   of	   Tbx1cKOSox17	   embryos	   at	   E8.5	   and	   E9.5	  corroborates	   that	   TBX1	   is	   required	   for	   the	   expression	   of	   this	   ligand	   in	   the	  pharyngeal	   endoderm.	   The	   loss	   of	   Fgf8	   from	   the	   un-­‐segmented	   endoderm	   is	  unlikely	  to	  be	  caused	  by	  the	  change	  in	  tissue	  morphology	  as	  Fgf8	  is	  maintained	  in	  the	  ectoderm	  despite	  the	  loss	  of	  segmentation	  in	  this	  tissue.	  	  	  	  In	  contrast,	  however,	  the	  expression	  of	  Fgf3,	  Fgf10	  and	  Fgf15	  are	  maintained	  in	  the	  endoderm	   of	   Tbx1cKOSox17	   embryos,	   indicating	   that	   expression	   of	   Tbx1	   in	   the	  endoderm	   is	   not	   required	   for	   the	   expression	  of	   these	   ligands.	  The	   change	   in	   the	  expression	   patterns	   of	   Fgf3	   and	   Fgf15	   in	   Tbx1cKOSox17	   embryos	   could	   be	   an	  indication	  of	  FGF	  ligand	  redundancy,	  particularly	  with	  regards	  to	  Fgf3.	   	  Normally	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Fgf3	  is	  restricted	  to	  the	  posterior	  portion	  of	  the	  forming	  3rd	  pouch,	  complimentary	  to	  the	  anterior	  expression	  domain	  of	  Fgf8.	  	  In	  Tbx1cKOSox17	  embryos,	  however,	  the	  expression	   of	   Fgf3	   in	   the	   caudal	   endoderm	   extends	   into	   the	   Fgf8	   expression	  domain.	  Alternatively,	  the	  change	  in	  the	  expression	  pattern	  of	  these	  ligands	  may	  be	  secondary	  to	  the	  change	  in	  Tbx1cKOSox17	  embryos	  endodermal	  tissue	  morphology.	  	  	  The	   ETS	   transcription	   factors	   Pea3	   and	   Erm	   have	   been	   shown	   to	   be	   expressed	  downstream	   of	   Fgf8	   (Roehl	   and	   Nusslein-­‐Volhard,	   2001).	   For	   instance,	   the	  ISLET1Cre	  mediated	  deletion	  of	  Fgf8	   from	  the	  pharyngeal	  endoderm	  and	  anterior	  heart	  field	  severely	  reduces	  the	  expression	  of	  Erm	  in	  these	  cells	  (Park	  et	  al.,	  2006).	  
Sprouty	  genes	  are	  also	  expressed	  in	  response	  to	  FGF8	  signalling	  and	  are	  lost	  in	  the	  absence	   of	   Fgf8,	   indicating	   they	   mediate	   the	   regulation	   of	   an	   FGF8	   induced	  signalling	   cascade	   (Minowada	   et	   al.,	   1999).	   However,	   despite	   the	   severely	  diminished	   expression	   of	   Fgf8	   in	   the	   pharyngeal	   endoderm	   of	   Tbx1cKOSox17	  embryos,	   the	   endodermal	   expression	   of	   Erm,	   Pea3,	   Sprouty	   1	   and	   Sprouty	   2	   is	  maintained.	   This	   expression	   data	   contrasts	   with	   the	   loss	   of	   expression	   of	   Fgf	  signalling	   readouts	   in	   the	   PA	   of	  Tbx1-­‐/-­‐	   and	  Tbx1+/-­‐	  mutants.	   	   The	   expression	   of	  
Erm,	  Sprouty1	  and	  Sprouty2	  appear	  reduced	  in	  the	  PA	  of	  Tbx1+/-­‐	  embryos	  and	  the	  expression	   of	  Sprouty1	   and	  Sprouty2	  are	   severely	   diminished	   in	  Tbx1-­‐/-­‐	   embryos	  (Simrick	  et	  al.,	  2012).	  This	  same	  trend	  is	  observed	  in	  the	  expression	  of	  Fgf	  receptor	  
1	  (Fgfr1)	  in	  the	  PA	  of	  Tbx1+/-­‐	  and	  Tbx1-­‐/-­‐	  embryos	  (Park	  et	  al.,	  2006).	  	  	  It	   is	   likely	   that	   the	   maintained	   expression	   of	   FGF	   signalling	   readouts	   in	  
Tbx1cKOSox17	   embryos	   is	   due	   to	   the	   maintenance	   of	   Fgf3,	   Fgf10	   and	   Fgf15	  expression	  in	  the	  pharyngeal	  endoderm	  of	  these	  mutants.	  However,	  Fgf	  expression	  in	   adjacent	   pharyngeal	   tissues,	   such	   as	   Fgf10	   in	   the	   mesoderm	   and	   Fgf8	   in	   the	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4.1	   The	   expression	   of	   Fgf8	   within	   the	   endoderm	   is	   not	  
essential	  for	  pharyngeal	  pouch	  formation	  
The	  requirement	  for	  Fgf8	  during	  the	  development	  of	  the	  pharyngeal	  pouches	  has	  been	  demonstrated	  in	  mouse	  lines	  that	  have	  a	  reduced	  level	  of	  transcription	  from	  the	  Fgf8	   allele	   (hypomorphs).	   Severe	  Fgf8	   hypomorphs	  have	  disorganised	  pouch	  formation;	   the	   two	   rostral	   pouches	   are	   present	   but	   fused	   and	   the	   two	   caudal	  pouches	  are	  hypoplastic	  or	  absent	   (Abu-­‐Issa	  et	  al.,	  2002).	  Fgf8	  mild	  hypomorphs	  are	  unable	   to	   form	  their	  3rd	  pouch,	   resulting	   in	  a	   fusion	  of	   the	  3rd	  and	  4th	  arches	  (Frank	   et	   al.,	   2002).	   The	   less	   extensive	   pouch	   defect	   of	   Fgf8	  mild	   hypomorphs	  indicates	   that	   caudal	   pouches	   are	  more	   sensitive	   to	   the	   loss	   of	  Fgf8	   than	   rostral	  pouches.	   The	   caudal	   pouch	   defects	   of	   both	   Fgf8	   mutant’s	   correlates	   with	   the	  thymus	   hypoplasia	   and	   aplasia	   that	  manifests	   later	   in	   gestation	   (Abu-­‐Issa	   et	   al.,	  2002;	  Frank	  et	  al.,	  2002)	  
	  
Fgf8	  is	  expressed	  in	  multiple	  tissues	  within	  the	  PA,	  thus	  the	  loss	  of	  Fgf8	  from	  each	  tissue	  could	  affect	  pharyngeal	  pouch	  morphogenesis	  (Crossley	  and	  Martin,	  1995).	  Tissue	  specific	  deletions	  of	  Fgf8	  have	  not	  yet	  revealed	  a	  requirement	  for	  Fgf8	  in	  a	  defined	   population	   of	   cells	   during	   pouch	   formation.	   CNCC	   do	   not	   express	   Fgf8,	  accordingly,	  recombination	  of	  Fgf8	  by	  a	  Cre	  line	  only	  expressed	  in	  CNCC	  does	  not	  cause	   pharyngeal	   pouch	   defects	   (Frank	   et	   al.,	   2002).	   Fgf8	   is	   expressed	   widely	  throughout	   the	   pharyngeal	   ectoderm	   during	   PA	   development.	   Although	   the	  deletion	   of	   Fgf8	   from	   the	   ectoderm,	   (Ap2alphaIRESCre/+;Fgf8flox/-­‐	   embryos),	  generates	  ‘fused’	  pharyngeal	  arches,	  no	  pouch	  phenotypes	  have	  been	  described	  in	  these	  mutants.	   	  Moreover,	   endocrine	  organs	  derived	   from	   the	   caudal	  pharyngeal	  pouches	   form	   normally	   (Macatee	   et	   al.,	   2003).	  Loss	   of	  Fgf8	   from	   the	  mesoderm	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prevents	   4th	   PAA	   formation	   but	   consequences	   for	   pouch	   formation	   were	   not	  assessed	  (Park	  et	  al.,	  2006).	  	  In	  summary,	   this	  data	   indicates	  that	  pharyngeal	  pouch	  development	  may	  require	  expression	  of	  Fgf8	  specifically	  within	  the	  endoderm.	  The	  deletion	  of	  Fgf8	  with	  the	  Hoxa2Cre	   supports	   the	   latter	   hypothesis	   as	   the	   incidence	   of	   thymus	   and	  parathyroid	  defects	  are	  comparable	  to	  that	  of	  severe	  Fgf8	  hypomorphs	  (Macatee	  et	  al.,	  2003).	  Hoxa2	  is	  expressed	  in	  the	  pharyngeal	  epithelia	  and	  mesenchyme	  caudal	  to	  the	  2nd	  arch	  (Macatee	  et	  al.,	  2003).	  As	  neither	  ectodermal,	  mesodermal	  or	  CNCC	  deletions	  of	  Fgf8	  are	  reported	  to	  cause	  thymus	  or	  parathyroid	  defects,	   it	   is	   likely	  that	  a	   loss	  of	  Fgf8	   from	  the	  endoderm	  disrupts	  organogenesis	  of	   these	  endocrine	  glands.	   The	   conditional	   Cre	   lines	   available,	   until	   now,	   have	   not	   been	   suitable	   to	  directly	  test	  the	  role	  of	  Fgf8	  in	  the	  endoderm	  during	  pouch	  formation.	  The	  aim	  of	  the	  experiments	  presented	  in	  Chapter	  3	  was	  to	  determine	  whether	  the	  expression	  of	  Fgf8	   in	   the	  endoderm	  is	  required	  for	  the	   formation	  of	   the	  pharyngeal	  pouches	  and	  the	  thymus	  gland.	  	  
4.1.1	   SOX17icre	   deletes	   Fgf8	   specifically	   within	   the	  
pharyngeal	  endoderm	  
Conditional	  Cre	  lines	  that	  have	  been	  used	  to	  delete	  Fgf8	   in	  the	  endoderm	  are	  not	  suitable	  to	  analyse	  the	  role	  of	  endodermal	  Fgf8	   in	  pouch	  morphogenesis	  because	  often	   the	   promoter	   driving	   the	   expression	   of	   Cre	   may	   be	   temporally-­‐spatially	  restricted	  in	  the	  pharyngeal	  endoderm	  (these	  Cre	  lines	  were	  outlined	  in	  Chapter	  3	  with	  reference	  to	  the	  recombination	  of	  Tbx1).	  Alternatively,	  endoderm	  specific	  Cre	  lines	   may	   have	   weak	   activity	   within	   the	   pharyngeal	   endoderm	   as	   has	   been	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observed	   with	   Foxa3-­‐Cre	   line	   (Dominguez-­‐Frutos	   et	   al.,	   2009).	   To	   address	   the	  requirement	   for	   Fgf8	   in	   the	   endoderm	   during	   pouch	   formation	   the	   SOX17iCre	  mouse	   line	   was	   utilised	   (Engert	   et	   al.,	   2009).	   In	   Chapter	   3	   the	   efficiency	   and	  specificity	  of	  SOX17iCre	  activity	  was	  demonstrated	  in	  Tbx1cKOSox17	  embryos.	  	  It	  was	  hoped	   that	   the	   same	   qualities	   would	   be	   observed	   when	   SOX17iCre	   was	   used	   to	  drive	  recombination	  of	  the	  floxed	  exons	  (2	  and	  3)	  of	  the	  Fgf8	  allele	  (Meyers	  et	  al.,	  1998).	  	  To	   determine	   the	   requirement	   for	   Fgf8	   in	   the	   endoderm	   during	   pouch	  morphogenesis	  the	  SOX17iCre	  mouse	  line	  was	  used	  to	  generate	  and	  Fgf8flox/flox	  (Cre	  negative),	  Sox17iCre/+;Fgf8flox/+	  (Fgf8cHetSox17)	  and	  Sox17iCre/+;Fgf8flox/-­‐	  (Fgf8cKOSox17)	  embryos	  (see	  2.3.1	  for	  details	  of	  breeding	  strategies).	  In	  situ	  hybridisation	  with	  an	  
Fgf8-­‐exon2/3	   antisense	  probe	  was	  used	   to	   test	   the	  efficiency	  and	  specificity	  of	   the	  SOX17iCre	  recombination	  in	  Fgf8cKOSox17	  embryos.	  	  Fgf8	  exons	  2	  and	  3	  are	  flanked	  by	  loxP	  sites	  (floxed)	  and	  so	  should	  be	  excised	  in	  tissue	  with	  SOX17iCre	  activity,	  to	  produce	  an	  Fgf8	  null	  allele	  (Meyers	  et	  al.,	  1998).	  In	  frontal	  sections	  of	  Cre	  negative	  embryos	  the	  expression	  of	  Fgf8ex2/3	  is	  identical	  to	  the	  expression	  pattern	  of	  the	  full-­‐length	   probe	   (compare	   black	   arrowheads	  marking	   Fgf8	   positive	   domains	   in	   the	  pharyngeal	   pouches	   in	   panels	   a	   of	   Fig	   17	   and	   21).	   	   Of	   significance	   is	   the	   robust	  endodermal	  expression	  of	  Fgf8ex2/3	  visible	   in	  the	  distal	  domains	  of	  the	  1st	  and	  2nd	  pouch	  and	   throughout	   the	  entire	  evaginating	  3rd	  pouch.	  Whilst	   the	  expression	  of	  
Fgf8ex2/3	   in	   the	   ectoderm	   is	   maintained	   in	   Fgf8cKOSox17	   embryos,	   (light-­‐blue	  arrowhead	   Fig	   21,	   panel	   b),	   the	   endodermal	   expression	   domain	   of	   Fgf8ex2/3	   is	  completely	  ablated	  (unfilled	  arrowheads	  in	  Fig	  21	  panel	  b).	  	  In	  summary,	  the	  data	  shows	  that	  SOX17iCre	  mediated	  deletion	  of	  Fgf8	  is	  specific	  to	  the	  endoderm.	  	  
	  
160  
 Fig  21 
	   161	  
Fig	  21:	  Fgf8	  expression	  is	  absent	  in	  the	  endoderm	  of	  Fgf8cKOSox17	  embryos	  In	  situ	  hybridization	  for	  Fgf8	  expression	  on	  frontal	  sections	  of	  Cre	  negative	  (a),	  and	  Fgf8cKOSox17	  (b)	  embryos	  PA	  using	  an	  antisense	  mRNA	  probe	  designed	  to	  hybridise	  to	  nascent	  sense	  transcripts	  of	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4.1.2	   Fgf8cKOSox17	   embryos	   do	   not	   display	   defects	   in	  
pouch	   morphogenesis	   or	   patterning	   at	   stage	   E9.5	   of	  
development	  	  
Surprisingly,	   no	   overt	   defects	   in	   the	   formation	  or	  morphology	  of	   the	  pharyngeal	  pouches	  or	   arches	   are	  visible	   in	   the	   frontal	   sections	  of	  Fgf8cKOSox17	  presented	   in	  Fig	  21,	  panel	  c.	  One	  way	   to	  assess	   the	  normality	  and	  extent	  of	  pharyngeal	  pouch	  and	   arch	   formation	   within	   the	   PA	   is	   to	   use	   genetic	   markers	   to	   identify	   specific	  regions	  within	   these	   structures.	   Homeobox	   (Hox)	   genes	   have	   specific	   expression	  domains	  within	  the	  PA	  and	  as	  such	  are	  good	  markers	  of	  arch	  and	  pouch	   identity	  (Hunt	  et	  al.,	  1991;	  Hunt	  et	  al.,	  1991b;	  Wendling	  et	  al.,	  2000).	  To	  determine	  whether	  the	  PA	  is	  regionalised	  in	  the	  absence	  of	  endodermal	  Fgf8	  the	  expression	  of	  Hoxa2,	  
Hoxa3	  and	  Hoxb1	  were	  analysed	  in	  controls	  and	  embryos	  deficient	  in	  endodermal	  
Fgf8	  by	  in	  situ	  hybridisation.	  	  	  In	   frontal	   sections	   through	   the	   PA	   of	   Cre	   negative	   embryo’s	  Hoxa2	   is	   expressed	  throughout	  the	  pharyngeal	  mesenchyme	  and	  is	  most	  robustly	  expressed	  in	  the	  2nd	  pharyngeal	   arch,	   (green	   arrowhead,	   Fig	   22,	   panel	   a).	   	   Endodermal	   expression	   of	  
Hoxa2	  is	  present	  in	  a	  very	  small	  area	  of	  ‘inter-­‐pouch’	  endoderm	  that	  lines	  the	  third	  arch,	  (grey	  arrowhead,	  Fig	  22,	  panel	  a).	  All	  the	  Hoxa2	  expression	  domains	  visible	  in	  Cre	  negative	  embryos	  are	  present	  in	  Fgf8cHetSox17	  and	  Fgf8cKOSox17	  at	  the	  same	  level	  and	  pattern	  of	  expression,	  (compare	  green	  and	  grey	  arrows	  in	  Fig	  22	  a,	  b	  and	  c).	  	  Similarly,	   no	   variation	   in	   Hoxa3	   expression	   is	   visible	   between	   Cre	   negative,	  
Fgf8cHetSox17	   and	   Fgf8cKOSox17	   embryos,	   (compare	   Fig	   22	   c	   to	   e).	   Irrespective	   of	  genotype	   Hoxa3	   expression	   is	   maintained	   in	   the	   PA	   rostral	   to	   the	   3rd	   arch.	   	   In	  particular,	   note	   the	   presence	   of	   Hoxa3	   expression	   in	   the	   caudal	   Fgf8-­‐deficient	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endoderm,	   posterior	   to	   the	   3rd	   arch,	   (compare	   the	   two	   most	   posterior	   black	  arrowhead	  in	  Fig	  22	  d	  to	  e).	  	  Hoxb1	  expression	  is	  robust	  in	  the	  caudal	  pharyngeal	  epithelia,	   in	   the	   caudal	   endoderm	  Hoxb1	   appears	   to	  mark	   the	   out-­‐pocketing	   3rd	  pouch	  at	  E9.5	   (black	  arrowhead	  Fig	  22,	  panels	  g-­‐i).	   In	  RA-­‐deficient	  embryos	   that	  display	   caudal	   pouch	   aplasia,	   Hoxb1	   expression	   is	   absent	   from	   the	   caudal	  pharyngeal	  endoderm	  (Wendling	  et	  al.,	  2000).	  However,	  as	  with	  all	  the	  Hox	  genes	  analysed	  in	  the	  Fgf8	  conditional	  mutants	  there	  is	  no	  apparent	  change	  to	  the	  level	  or	  pattern	  of	  Hoxb1	  expression	  in	  any	  expression	  domain.	  	  	  It	   is	   possible	   that	   pharyngeal	   pouch	   outgrowth	   and	  patterning	   at	   E9.5	   is	   able	   to	  occur	   in	   Fgf8cKOSox17	   embryos	   because	   other	   Fgf	   ligands	   expressed	   in	   the	  endoderm	  can	  compensate	  for	  the	  loss	  of	  Fgf8.	  For	  instance,	  FGF3	  has	  been	  shown	  to	   act	   redundantly	   with	   FGF8	   in	   many	   developmental	   contexts	   (Maroon	   et	   al.,	  2002;	   Walshe	   et	   al.,	   2002).	   	   Fgf3	   is	   expressed	   within	   the	   endoderm	   at	   E9.5	   in	  domains	   that	  overlap	  with	   the	  expression	  domain	  of	  Fgf8,	   (Vincentz	  et	   al.,	   2005;	  Aggarwal	  et	  al.,	  2006).	  However,	  at	  E9.5	  Fgf3	   is	  not	  up-­‐regulated	  or	  expanded	   in	  the	   pharyngeal	   endoderm	   of	   Fgf8cKOSox17	   embryos	   relative	   to	   controls	   (Fig	   23,	  panels	  i	  and	  j	  respectively),	  (Vitelli	  et	  al.,	  2002b;	  Vincentz	  et	  al.,	  2005;	  Aggarwal	  et	  al.,	   2006).	   Fgf3	   expression	   does	   not	   extend	   into	   the	   3rd	   pouch	   domain	   that	  normally	  expresses	  Fgf8,	  as	  was	  observed	  in	  Tbx1cKOSox17	  embryos	  (Fig	  23	  j	  vs	  Fig	  17	   c).	   	   	   The	  maintenance	  of	   FGF	   signalling	   effectors	   in	  Fgf8-­‐deficient	  pharyngeal	  endoderm	  (Fig	  23	  b,	  d,	  f,	  and	  h)	  shows	  that	  FGF	  signalling	  is	  maintained	  despite	  the	  loss	  of	  this	  ligand.	  The	  diffuse	  expression	  of	  Erm,	  Pea3,	  Sprouty	  1	  and	  Sprouty	  2	  in	  the	   mesenchyme	   and	   ectoderm	   is	   maintained	   in	   the	   PA	   of	   Cre	   negative	   and	  
Fgf8cKOSox17	   embryos.	   In	   the	   rostral	   pouches	   the	   FGF	   readouts	   are	   expressed	  robustly	   in	   the	   posterior	   half	   of	   each	   pouch,	   generating	   a	   segmented	   expression	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pattern	  that	  is	  evident	  in	  all	  embryos	  irrespective	  of	  genotype	  (black	  arrowheads	  in	   Fig	   23	   mark	   the	   robust	   expression	   in	   the	   pharyngeal	   pouches).	   Most	  significantly	  all	   the	  FGF	  readouts	  analysed	  are	  present	  and	  expressed	  robustly	   in	  the	   caudal	   evaginating	   endoderm	   (most	  posterior	   arrowhead	   in	   all	   panels	   of	   Fig	  23).	  The	  maintenance	  of	  a	  segmented	  expression	  pattern	  of	  Erm	  (Fig	  23,	  panels	  a	  and	  b),	  Pea3	  (Fig	  23,	  panels	  c	  and	  d),	  Sprouty	  2	  (Fig	  23	  e	  and	  f)	  and	  Sprouty	  1	  (Fig	  16	   g	   and	   h)	   in	   the	   endoderm	   of	   Fgf8cKOSox17	   embryo’s	   contrasts	   with	   the	   un-­‐segmented	   expression	   pattern	   observed	   in	   the	   Fgf8-­‐deficient	   endoderm	   of	  
Tbx1cKOSox17	  embryos	  (Fig	  19	  and	  20).	  	  	  	  In	   summary,	   the	   expression	   data	   suggests	   that	   pharyngeal	   pouch	   formation	   in	  
Fgf8-­‐deficient	   endoderm,	   at	   E9.5,	   appears	   indistinguishable	   from	   that	   of	   Cre	  negative	  embryos	  in	  morphology	  and	  expression.	  To	  assess	  whether	  caudal	  pouch	  formation	   is	   maintained	   in	   the	   absence	   of	   endodermal	   Fgf8	   expression,	   pouch	  morphology	  was	  assessed	  a	  day	  later	  in	  embryonic	  development.	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Fig	   22:	   Pharyngeal	   pouches	   form	   and	   Hox	   gene	   expression	   domains	   are	   maintained	   in	  
endoderm	  that	  does	  not	  express	  Fgf8.	  Frontal	   sections	  of	  E9.5	  embryo’s	  pharyngeal	  apparatus	  show	  Hoxa2	   (a-­‐c),	  Hoxa3	   (d-­‐f)	  and	  Hoxb1	   (h-­‐j)	  expression	  detected	  by	   in	   situ	  hybridisation	   is	  not	  changed	   in	  Fgf8cKOSox17	   embryos.	   Note	   the	   endodermal	   expression	   of	  Hoxa2	   detected	   in	   the	   Cre	  negative	  embryo	  (marked	  by	  an	  asterix)	  was	  also	  detected	   in	  ventral	  sections	  of	  Fgf8	  conditional	  mutants.	  N=	  2	  for	  Hoxb1	  and	  Hoxa2,	  N	  =	  3	  for	  Hoxa3.	  Annotations:	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  light	  blue	  arrowhead	  =	  ectodermal	  PA	  expression,	  unfilled	  arrowhead	  =	  endodermal	  pouch	  with	  no/little	  expression,	  green	  arrowhead	  =	  mesenchyme,	  pp	  =	  pharyngeal	  pouch,	  ecto	  =	  ectoderm,	  mesen	  =	  mesenchyme.	  	  Arrows	  to	  the	  left	  of	  Fig	  22	  illustrate	  the	  orientation	  of	  the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  
	  
	  
Fig	  23:	  Expression	  of	  genes	  in	  the	  FGF	  signalling	  pathway	  are	  not	  altered	  in	  the	  pharyngeal	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4.1.3	  Fgf8cKOSox17	  embryos	  display	  a	   slight	  hypoplasia	  of	  
the	  3rd	  pharyngeal	  pouch	  at	  stage	  E10.5	  	  
The	   initiation	  of	   caudal	  pouch	  outgrowth	  at	  E9.5	  does	  not	   guarantee	   that	   caudal	  pouch	  morphogenesis	  will	  proceed	  normally	   throughout	  PA	  development.	   In	  Shh	  null	   embryos,	   for	   instance,	   pharyngeal	   pouches	   form	   at	   E9.5	   but	   by	   E10.5	   the	  pouches	   have	   atrophied,	   particularly	   the	   1st	   pouch	   (Moore-­‐Scott	   and	   Manley,	  2005).	  The	  caudal	  pouches	  are	  most	  severely	  perturbed	  by	  the	  loss	  of	  Fgf8	  (Abu-­‐Issa	  et	  al.,	  2002;	  Frank	  et	  al.,	  2002).	  	  Thus,	  it	  was	  necessary	  to	  determine	  whether	  caudal	   pouches	   continue	   to	   develop	   successfully	   in	   the	   absence	   of	   endodermal	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Fig	  24:	  The	   expression	  of	  Pax1,	  which	  demarcates	  pouch	  morphology,	   appears	   reduced	   in	  
the	  hypoplastic	  3rd	  pouch	  of	  Fgf8cKOSox17	   embryos.	   (a-­‐c)	   	  Pax1	  expression,	   detected	  by	  whole	  mount	   in	   situ	   hybridization,	   in	   E10.5	   embryos	   at	   low	  magnification	   (4x).	   (a’-­‐c’)	   The	   pharyngeal	  apparatus	   of	   embryos	   a-­‐c	   viewed	   at	   high	   magnification	   (8x).	   Solid	   arrowheads	   identify	   normal	  pouch	  morphology	  as	  demarcated	  by	  Pax1	  expression.	  Unfilled	  arrowheads	  identify	  the	  hypoplastic	  3rd	  pouch	  of	  Fgf8cKOSox17	  that	  have	  reduced	  Pax1	  expression.	  N=3.	  Annotations:	   Outlined	   area	   in	   panels	   a-­‐d	   indicate	   the	   area	   magnified	   in	   panels	   a’-­‐d’.	   Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  unfilled	  arrowhead	  =	  endodermal	  pouch	  with	  reduced	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4.2	   Fgf8	   is	   required	   in	   the	   endoderm	   during	   thymus	  
organogenesis	  
Although	   the	   initial	   evagination	   of	   the	   3rd	   pouch	   appears	   to	   be	   normal	   in	   Fgf8-­‐deficient	   pharyngeal	   endoderm,	   the	   3rd	   pouch	   at	   E10.5	   appears	   slightly	  hypoplastic.	   This	   indicates	   that	   Fgf8	   in	   the	   endoderm	   may	   be	   required	   for	   the	  development	  of	  the	  thymus	  from	  the	  3rd	  pouch,	  rather	  than	  for	  3rd	  pouch	  formation	  itself.	   The	   thymus	   and	   parathyroid	   organs	   are	   derived,	   respectively,	   from	  Foxn1	  and	  Gcm2	  positive	  cells	  within	   the	  3rd	  pharyngeal	  pouch	   (Gordon	  et	  al.,	  2001).	   If	  the	  3rd	  pharyngeal	  pouch	  forms	  but	  the	  establishment	  of	  these	  presumptive	  organ	  domains	   are	   disrupted,	   thymus	   and	   parathyroid	   defects	   will	   manifest	   in	   the	  embryo,	   as	   observed	   in	   Hoxa3-­‐/-­‐	   embryos,	   Sprouty1;2-­‐/-­‐	   embryos	   and	   Pbx1-­‐/-­‐	  embryos	  (Manley	  and	  Capecchi,	  1995;	  Manley	  et	  al.,	  2004;	  Gardiner	  et	  al.,	  2012).	  To	   assess	   the	   patterning	   of	   the	   3rd	   pouch	   into	   presumptive	   thymus	   and	  parathyroid	  domains,	  in	  the	  absence	  of	  endodermal	  Fgf8,	  stage	  E11.5	  Fgf8cKOSox17	  embryos	  were	  collected	  and	  evaluated	  for	  the	  expression	  of	  Foxn1	  and	  Gcm2.	  	  Analysis	   of	   Fgf8cKOSox17	   embryos	   3rd	   pouch	   at	   E11.5	   demonstrated	   that	   the	  presumptive	   thymus	   and	   parathyroid	   domains	   are	   able	   to	   form	   despite	   the	  absence	   of	   endodermal	   Fgf8	   (Fig	   25).	   In	   both	   Cre	   negative	   and	   Fgf8cKOSox17	  embryos,	  Foxn1	  expression	  at	  E11.5	   is	   limited	  to	   the	  posterior	  ventral	  domain	  of	  the	  3rd	  pouch,	  (Fig	  25c	  and	  d)	  and	  Gcm2	  expression	  is	  present	  in	  a	  complimentary	  anterior	  dorsal	  domain	  (Fig	  25	  c	  and	  d).	  	  The	  Foxn1	  and	  Gcm2	  expression	  domains	  of	   Fgf8cKOSox17	   do	   not	   appear	   to	   be	   distinguishable	   in	   terms	   of	   size	   or	   position	  within	  the	  3rd	  pouch	  from	  Cre	  negative	  embryos.	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Fig	  25:	  The	  3rd	  pouch	  at	  E11.5	  is	  patterned	  into	  Foxn1	  and	  Gcm2	  domains	  when	  Fgf8	  is	  absent	  
from	   the	   endoderm.	   In	   situ	   hybridization	   on	   sagittal	   sections	   of	   E11.5	   embryos	   identifies	   the	  expression	   of	  Gcm2	   in	   the	   correct	   anterior,	   dorsal	   domain	   of	   the	   3rd	   pouch	   that	   should	   form	   the	  parathyroid	   later	   in	   gestation.	   	   The	   expression	   of	   Foxn1	   is	   also	   in	   the	   correct	   posterior,	   ventral	  domain	  of	  the	  3rd	  pouch	  that	  should	  form	  the	  thymus	  later	  in	  gestation	  (c	  and	  d).	  (N=2).	  Annotations:	  Dashes	  outline	  the	  3rd	  pouch	  to	  aid	  visualization	  of	  the	  structure.	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  pp	  =	  pharyngeal	  pouch,	  Mesen	  =	  Mesenchyme.	  	  Arrows	  to	  the	  right	  of	  Fig	  25	  illustrate	  the	  orientation	  of	  the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  
	  
Fig	  26:	  Thymus	  hypoplasia	  manifests	  in	  the	  right	  thymus	  lobe	  of	  Fgf8cKOSox17	  embryos.	  Open	  chest	  cavities	  of	  E17.5	  embryos	  photographed	  to	  display	  the	  two	  thymus	  lobes	  present	  in	  Cre	  negative	   (a)	   and	   Fgf8cKOSox17	   (b)	   embryos.	   	   Circumference	   of	   individual	   thymus	   lobes	   were	  measured	   in	   image	   J	   and	   converted	   to	  micrometres	  using	   imaged	   scale	   bars.	   	   The	   circumference	  measurements	  were	  plotted	  in	  graph	  (c)	  using	  Graphpad	  software,	  (each	  symbol	  corresponds	  to	  an	  individual	   gland).	   	   Note	   there	   is	   no	   statistically	   significant	   size	   difference	   between	   the	   mean	  circumference	  of	  the	  left	  or	  right	  thymus	  lobe	  of	  Cre	  negative	  (n=7)	  and	  Fgf8cKOSox17	  (n=5)	  samples	  (p=0.520	   and	  p=0.592	   respectively,	   by	   students	   T-­‐test).	   Error	   bars	   display	   standard	   error	   of	   the	  mean.	   The	   mean	   thymi	   circumference	   for	   each	   genotype	   of	   embryo	   with	   the	   corresponding	  standard	   error	   of	   the	  mean	   and	   P-­‐value	   (generated	   using	   the	   Student’s	   T-­‐test	   in	   GraphPad)	   are	  listed	  below.	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4.3	  Fgf8	  and	  Tbx1	  do	  not	  interact	  epistatically	  within	  the	  
pharyngeal	  endoderm	  during	  pouch	  formation	  
The	   caudal	   pouch	   defects	   observed	   in	   Fgf8-­‐hypomorphs,	   Tbx1-­‐hypomorphs	   and	  
Tbx1-­‐/-­‐	  embryos	  indicate	  that	  FGF8	  and	  TBX1	  may	  act	  in	  the	  same	  pathway	  during	  pouch	   morphogenesis	   (Abu-­‐Issa	   et	   al.,	   2002;	   Frank	   et	   al.,	   2002).	   This	   was	  supported	  by	  data	  in	  Chapter	  3	  that	  showed	  Fgf8	  expression	  was	  tissue	  specifically	  diminished	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	   	  However,	  a	  comparison	  of	  pouch	   formation	   in	  Fgf8KOSOX17	   and	  Tbx1cKOSox17	   embryos	   illustrates	   that	  whilst	  endodermal-­‐Tbx1	   is	   essential	   for	   pouch	   formation,	   endodermal-­‐Fgf8	   is	  dispensable.	   	   If	  FGF8	  and	  TBX1	   function	   in	   the	  same	  pathway	  during	  pharyngeal	  pouch	  morphogenesis	  this	  would	  be	  revealed	  by	  an	  experiment	  to	  test	  for	  genetic	  epistasis.	   	   The	   compound	   deletion	   of	   one	   allele	   of	   Fgf8	   and	   Tbx1	   from	   the	  endoderm	  during	  development	  should	  have	  an	  additive	  effect	  on	  pouch	  formation	  if	   both	   genes	   act	   in	   the	   same	   pathway	   during	   this	   process.	   To	   test	   this,	  
SOX17icre/+;Tbx1flox/+;Fgf8flox/+	   (Fgf8;Tbx1cHetSox17)	   embryos	   were	   generated	   (see	  section	   2.3.1	   for	   details	   of	   the	   breeding	   strategy).	   Pouch	   formation	   and	  morphology	   (delineated	   by	   Pax1	   expression)	   of	   Fgf8cHetSox17,	   Tbx1cHetSox17	   and	  
Fgf8;Tbx1cHetSox17	  embryos	  were	  assessed,	  relative	  to	  Cre	  negative	  embryos.	  Stage	  matched	   Tbx1cHetSox17	   embryos	   were	   generated	   from	   a	   separate	  
Sox17icre/+;Tbx1flox/+	  by	  Tbx1flox/flox	  cross.	  	  
	  In	  both	  single	  and	  compound	  heterozygotes,	  pouches	  1	  to	  3	  have	  formed	  in	  their	  correct	  location	  along	  the	  anterior	  to	  posterior	  axis	  of	  the	  PA	  and	  have	  a	  narrow,	  slit	   like	   morphology.	   Pouch	   morphogenesis	   and	   Pax1	   expression	   was	  indistinguishable	  between	  Cre	  negative	  and	  Fgf8cHetSox17	  embryos	  (compare	  black	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arrowheads	   in	  panels	  a	  and	  b	  of	  Fig	  27).	   	  As	  was	  observed	   in	  Chapter	  1	   (Fig	  20,	  panel	   b),	  Pax1	   expression	   is	   reduced	   in	   the	   pharyngeal	   pouches	  of	  Tbx1cHetSox17	  embryos,	  relative	  to	  Cre	  negative	  embryos	  (compare	  solid	  arrowheads	  in	  panel	  a	  of	  Fig	  27	  to	  unfilled	  arrowheads	  in	  panel	  c	  of	  Fig	  27).	  	  The	  morphology	  and	  level	  of	  
Pax1	  expression	  in	  the	  pouches	  of	  Fgf8;Tbx1cHetSox17	  embryos	  is	  equivalent	  to	  that	  of	  Tbx1cHetSox17	  embryos	  (compare	  unfilled	  arrowheads	  in	  Fig	  27,	  panels	  c	  and	  d).	  	  This	   data	   demonstrates	   that	   there	   is	   no	   epistatic	   interaction	   between	   Fgf8	   and	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Fig	   27:	  Tbx1	   and	  Fgf8	   in	   the	   endoderm	   do	   not	   appear	   to	   act	   synergistically	   during	   pouch	  
formation.	   (a-­‐d)	   Side	   views	   of	   Pax1	   expression	   in	   E10.5	   embryos,	   4x	   magnification.	   (a’-­‐d’)	   The	  pharyngeal	  apparatus	  of	  embryos	  a-­‐d	  viewed	  at	  6x	  magnification.	  Note	  that	  pouch	  morphology	  of	  

















	   180	  
4.4	  DISCUSSION	  
4.4.1	  Loss	  of	   Fgf8	   from	  the	  endoderm	  is	  not	  sufficient	   to	  
disrupt	  pharyngeal	  pouch	  formation	  
To	   the	   best	   of	  my	   knowledge,	   this	   thesis	   presents	   the	   first	   study	   addressing	   the	  requirement	   for	   Fgf8	   expression	   within	   the	   endoderm,	   during	   mammalian	  pharyngeal	  pouch	  morphogenesis.	  	  The	  expression	  of	  Fgf8	  in	  the	  endoderm	  during	  pouch	  evagination	  and	   the	  pouch	  defect	  observed	   in	  Fgf8	   hypomorphs	   indicated	  that	  Fgf8	  may	   function	   in	   the	   endoderm	   during	   pouch	  morphogenesis	   (Crossley	  and	  Martin,	   1995;	  Abu-­‐Issa	   et	   al.,	   2002;	   Frank	   et	   al.,	   2002).	   	   Conditional	  mutant	  lines	  support	  the	  inference	  that	  Fgf8	  may	  be	  required	  in	  the	  endoderm	  for	  pouch	  morphogenesis.	  Tissue	  specific	  deletions	  of	  Fgf8	  from	  the	  ectoderm	  or	  mesoderm	  were	   not	   reported	   to	   produce	   pharyngeal	   arch	   or	   pouch	   defects	   (Macatee	   et	   al.,	  2003;	  Park	  et	  al.,	  2006).	  Moreover,	  the	  deletion	  of	  Fgf8	  with	  Cre	  lines	  expressed	  in	  restricted	   regions	   of	   the	   endoderm,	   (i.e.	   Hoxa2Cre	   and	   Nxk2.5Cre)	   generated	  embryos	  with	   hypoplastic	   thymi,	   however,	   pouch	   formation	  was	   not	   specifically	  analysed	  in	  these	  mutants	  (Macatee	  et	  al.,	  2003;	  Ilagan	  et	  al.,	  2006).	  Consequently	  
Fgf8cKOSox17	  embryos	  provide	  the	  first	  evidence,	  in	  a	  mammalian	  model,	  to	  suggest	  that	  expression	  of	  Fgf8	  within	  the	  endoderm	  is	  not	  essential	  for	  pouch	  formation.	  	  	  The	   formation	   of	   the	   pharyngeal	   pouches	   by	   the	   evagination	   of	   the	   pharyngeal	  endoderm	   is	  only	   the	   initial	   step	  of	  pouch	  morphogenesis.	   	  The	  out-­‐pocketing	  of	  pharyngeal	   endoderm	  must	   also	   become	   constrained	   to	   form	   a	   narrow	   slit-­‐like	  morphology	  (Quinlan	  et	  al.,	  2004).	  The	  morphology	  of	  the	  pharyngeal	  pouches	  can	  be	  affected	  by	  the	  loss	  of	  many	  genes.	  	  Interestingly	  the	  latter	  often	  correlates	  with	  changes	   in	   Fgf8	   expression	   within	   the	   pharyngeal	   endoderm,	   as	   is	   observed	   in	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Shh-­‐/-­‐	  embryos	  and	  RA	  deficient	  embryos	  (Niederreither	  et	  al.,	  2003;	  Moore-­‐Scott	  and	  Manley,	  2005).	  This	   is	  also	  evident	   in	   the	  rostral	  pouches	  of	   the	  severe	  Fgf8	  hypomorphs	  that	  appear	  to	  be	  able	  to	  evaginate	  toward	  the	  ectoderm	  but	  maintain	  a	   splayed,	   diamond	   shaped	   morphology	   (Abu-­‐Issa	   et	   al.,	   2002).	   	   However,	   the	  
Fgf8cKOSox17	  data	  suggest	  that	  the	  formation	  of	  discreet	  pharyngeal	  pouches	  is	  not	  dependent	   on	   Fgf8	   expression	   within	   the	   endoderm.	   Furthermore	   the	   data	   in	  Chapter	  4	   suggests	   that	  endodermal-­‐Fgf8	   is	  not	   required	   for	   the	  pattering	  of	   the	  3rd	  pouch	  into	  prospective	  thymus	  and	  parathyroid	  domains.	  	  There	  are	  two	  (not	  mutually	  exclusive)	  reasons	  why	  the	  deletion	  of	  Fgf8	  from	  the	  endoderm	  does	   not	   cause	   defects	   in	   pharyngeal	   pouch	  morphogenesis.	   Fgf8	   is	   a	  secreted	   ligand	   and	   thus	   has	   the	   ability	   to	   elicit	   FGF	   signalling	   in	   a	   paracrine	  manner	   (Itoh	   and	   Ornitz,	   2011).	   The	   expression	   of	   Fgf8	   in	   adjacent	   pharyngeal	  tissues	  may	  be	  able	  to	  compensate	  for	  the	  loss	  of	  Fgf8	  from	  one	  tissue,	  such	  as	  the	  endoderm,	  during	  pouch	  formation.	  This	  is	  supported	  by	  the	  observation	  that	  the	  deletion	   of	   Fgf8	   from	   a	   single	   tissue	   type	   has	   not	   been	   reported	   to	   cause	  pouch/arch	   defects,	   (i.e.	   utilising	   the	   Mesp1Cre/+Fgf8flox/-­‐	   and	   Ap2alpha-­‐IRESCre/+Fgf8flox/-­‐	  embryos),	  (Macatee	  et	  al.,	  2003;	  Park	  et	  al.,	  2006).	  On	  the	  other	  hand,	   Nxk2.5Cre/+Fgf8f/-­‐	   embryos	   have	   hypoplastic	   arches	   at	   E9.5,	   which	   implies	  pouch	  development	  may	  also	  be	  disrupted	   in	   these	  mutants	   (Ilagan	  et	  al.,	  2006).	  Nxk2.5Cre	   is	  expressed	   in	   the	  endoderm	  but	   it	   is	  also	  active	   in	  a	  number	  of	  other	  pharyngeal	   tissues	   including	   the	   pharyngeal	   ectoderm	   (Moses	   et	   al.,	   2001).	   It	   is	  possible	  that	  the	  PA	  defects	  in	  the	  Nxk2.5Cre/+Fgf8flox/-­‐	  embryos	  arise	  because	  of	  an	  additive	   effect	   of	   loosing	   Fgf8	   in	   multiple	   PA	   domains.	   	   The	   second	   possible	  explanation	  for	  why	  pouch	  morphogenesis	   is	  grossly	  unperturbed	  in	  Fgf8cKOSox17	  embryos	   is	   that	  multiple	   FGF	   ligands	  may	   act	   redundantly	   in	   the	   PA	   to	   regulate	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pouch	  development,	  compensating	  for	  the	  loss	  of	  Fgf8	  in	  the	  endoderm.	  	  However,	  the	  expression	  of	  Fgf3	  and	  multiple	  FGF	  signalling	  readouts	  were	  not	  up-­‐regulated	  or	  expanded	  in	  the	  pharyngeal	  endoderm	  of	  Fgf8cKOSox17	  embryos,	  as	  assessed	  by	  
in	   situ	   hybridisation.	   The	   hypothesis	   that	   FGF	   ligands	   in	   the	   endoderm	   act	  redundantly	  to	  control	  pouch	  formation	  was	  tested	  in	  Chapter	  5.	  	  	  	  
4.4.2	   Fgf8	   in	   the	   endoderm	   is	   not	   required	   for	   thymus	  
organogenesis	  
Macatee	   et	   al.	   describe	   a	   requirement	   for	   Fgf8	   in	   the	   endoderm	   during	   thymus	  formation	  (Macatee	  et	  al.,	  2003).	  However,	  unlike	  the	  Hoxa2Cre/+Fgf8flox/-­‐	  embryos,	  
Fgf8cKOSox17	   thymi	   did	   not	   display	   unilateral	   or	   bilateral	   defects	   in	   thymus	   size.	  	  This	  suggests	   that	   there	  may	  be	  an	  additive	  affect	  of	   losing	  Fgf8	   from	  the	  caudal	  ectoderm	  and	  endoderm	  for	  thymus	  organogenesis.	  The	  thymus	  develops	  from	  the	  
Foxn1	   positive	   domain	   of	   the	   3rd	   pouch	   but	   it	   is	   also	   contributed	   to	   by	   CNCC	  (Blackburn	   and	   Manley,	   2004).	   Hoxa2Cre/+Fgf8flox/-­‐	   embryos	   are	   not	   reported	   to	  have	  pouch	  defects,	  and	  the	  data	  in	  this	  study	  indicates	  that	  the	  loss	  of	  Fgf8	  alone	  from	  the	  endoderm	  does	  not	  affect	  pouch	   formation.	  Thus,	   it	   is	  possible	   that	   the	  loss	  of	  Fgf8	  from	  the	  pharyngeal	  epithelia	  affects	  the	  CNCC	  that	  migrate	  into	  the	  PA	  and	  contribute	  to	  the	  thymus.	  	  
	  
Fgf8	   has	   been	   shown	   to	   act	   as	   guidance	   factor	   for	   NCC	   entering	   the	   PA.	   	  When	  cardiac	  NCC	  were	  exposed	  to	  exogenous	  sources	  of	  Fgf8	  in	  vitro,	  or,	  in	  vivo	  the	  cells	  migrated	  toward	  the	  source	  of	  this	  FGF	  ligand	  (Sato	  et	  al.,	  2011).	  Whether	  Fgf8	  is	  a	  general	   chemo-­‐attractant	   for	   all	   CNCC	   entering	   the	   PA	   is	   questionable.	   The	  migration	  of	  Crabp1	  and	  Ap2α	  expressing	  CNCC	  were	  grossly	  unperturbed	  in	  Fgf8-­‐
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severe	   hypomorphs	   (Abu-­‐Issa	   et	   al.,	   2002).	   Moreover,	   Hox	   gene	   expression	   is	  maintained	  in	  the	  pharyngeal	  mesenchyme	  of	  Fgf8cKOSox17	  embryos	  indicating	  that	  CNCC	  are	  able	  to	  populate	  the	  pharyngeal	  arches	  relatively	  normally.	  	  	  Alternatively,	  Fgf8	  in	  the	  endoderm	  may	  act	  as	  a	  survival	  factor	  for	  CNCC	  entering	  the	  caudal	  PA.	  Fgf8	   in	   the	  1st	   arch	  ectoderm	   is	   required	   for	   the	  survival	  of	  CNCC	  here	  (Trumpp	  et	  al.,	  1999).	  A	  reduced	  number	  CNCC	  also	  enter	  the	  caudal	  arches	  of	   Fgf8-­‐severe	   hypomorphs,	   this	   correlates	  with	   an	   increase	   in	   apoptosis	  within	  the	  PA	  of	  these	  embryos	  (Abu-­‐Issa	  et	  al.,	  2002).	  Presumably,	  if	  endodermal	  Fgf8	  is	  a	  survival	  cue	  for	  CNCC	  in	  the	  caudal	  PA,	  one	  would	  hypothesis	  that	  there	  would	  be	  more	  CNCC	  doubly	  labelled	  for	  a	  CNCC	  marker,	  such	  as	  Crabp1,	  and	  an	  apoptosis	  marker,	  such	  as	  CASPASE-­‐3	   in	  Fgf8cKOSox17	  embryos,	  relative	  to	  control	  embryos.	  	  Conversely,	   the	   re-­‐activation	  of	  Fgf8	   expression	   in	  Fgf8-­‐severe	  hypomorphs	  may	  also	   increase	   the	   number	   of	   CNCC	   in	   the	   caudal	   PA	   to	   that	   observed	   in	   control	  embryos.	  
	  
4.4.3	   Fgf8	   does	   not	   act	   downstream	   of	   Tbx1	   in	   the	  
endoderm	  during	  pouch	  formation	  	  
The	   endoderm	   specific	   loss	   of	   Fgf8	   expression	   in	   Tbx1cKOSox17	   embryos	  corroborated	   with	   data	   in	   the	   literature	   that	   suggested	   Tbx1	   regulates	   the	  expression	   of	  Fgf8	   in	   the	   pharyngeal	   endoderm	   (see	   1.3.2.4)	   (Vitelli	   et	   al.,	   2010,	  Vitelli	  et	  al.,	  2002,	  Lania	  et	  al.,	  2009).	  However,	  a	  comparison	  of	  Fgf8cKOSox17	  and	  
Tbx1cKOSox17	  embryos	  revealed	  that	  whilst	  endodermal	  Tbx1	  is	  essential	  for	  pouch	  formation,	  endodermal	  Fgf8	  is	  dispensable.	  Thus	  indicating	  that	  the	  tissue-­‐specific	  loss	   of	   Fgf8	   expression	   downstream	   of	   Tbx1	   in	   the	   endoderm	   may	   not	   be	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functionally	   relevant	   to	   pouch	  morphogenesis.	   This	   inference	  was	   supported	   by	  the	   observation	   that	   the	   Pax1	   delineated	   morphology	   of	   Fgf8;Tbx1cHetSox17	  embryos	   pharyngeal	   pouches	   are	   indistinguishable	   from	   those	   of	   Tbx1cHetSox17	  embryos.	   The	   epistasis	   data	   indicates	   that	  Fgf8	   and	  Tbx1	   do	   not	   function	   in	   the	  same	  endodermal	  pathway	  during	  pouch	  morphogenesis.	   	  The	  data	  presented	   in	  Chapter	   4	   may	   explain	   why	   the	   forced	   expression	   of	   Fgf8	   from	   the	   Tbx1	   allele	  (Tbx1fgf8/fgf8	   embryos)	   does	   not	   rescue	   the	   majority	   of	   caudal	   endoderm	   defects	  associated	  with	  loss	  of	  Tbx1.	  For	  example,	  the	  caudal	  PA	  of	  Tbx1fgf8/fgf8	  embryo’s	  is	  hypoplastic,	  like	  that	  of	  Tbx1-­‐/-­‐	  embryos	  (Vitelli	  et	  al.,	  2006).	  
	  There	  is	  evidence	  that	  Fgf8	  and	  Tbx1	  interact	  during	  the	  formation	  of	  the	  thyroid	  whose	   follicular	   cells	   are	   partially	   contributed	   to	   by	   the	   endoderm	   of	   the	   2nd	  pouch.	  	  The	  deletion	  of	  Fgf8flox/flox	  alleles	  by	  Tbx1Cre,	  (generating	  embryos	  that	  were	  
Fgf8	  null	   in	  Tbx1	  expression	  domains),	   caused	  a	   reduction	   in	   the	  Nkx2.1	  positive	  thyroid	  precursor	  cells	  in	  the	  pharyngeal	  endoderm	  and	  a	  subsequent	  reduction	  in	  the	  size	  of	  the	  thyroid	  at	  E18.5	  (Lania	  et	  al.,	  2009).	  Thyroid	  size	  was	  normalised	  by	  driving	  Fgf8	  expression	  from	  the	  Tbx1	  promoter.	  However,	  Tbx1	   is	  not	  expressed	  within	   the	   endodermal	   thyroid	   precursors	   per	   se.	   Thus	   it	   is	   predicted	   that	   Tbx1	  acts	   upstream	   of	   Fgf8	   in	   the	   mesoderm	   and	   that	   the	   loss	   of	   mesodermal	   Fgf8	  affects	  the	  proliferative	  capacity	  of	  the	  thyroid	  progenitor	  cells	  of	  the	  pharyngeal	  endoderm	  (Lania	  et	  al.,	  2009).	  	  The	   additive	   affect	   of	   the	   loss	   of	   Fgf8	   and	   Tbx1	   from	   multiple	   PA	   tissues	   may	  explain	  the	  increased	  incidence	  of	  thymus	  defects	  in	  Fgf8;Tbx1+/-­‐	  embryos,	  relative	  to	   single	   heterozygotes	   (Vitelli	   et	   al.,	   2002b).	   	   Certainly	   the	   loss	   of	  mesodermal	  
Tbx1	  has	  been	  shown	  to	  cause	  thymus	  hypoplasia	  (Zhang	  et	  al.,	  2006).	  On	  the	  other	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5.1	  Functional	   redundancy	  exists	  between	  Fgf3	   and	  Fgf8	  
in	  the	  pharyngeal	  endoderm	  during	  pouch	  formation	  
The	  process	  of	  pharyngeal	  pouch	  outgrowth	  was	  assumed	   to	  require	  a	   source	  of	  
Fgf8	  in	  the	  endoderm	  because:	  a)	  Fgf8	  is	  robustly	  expressed	  in	  the	  endoderm,	  most	  significantly	   in	   the	   caudal-­‐most	   forming	   pouch	   (Crossley	   and	   Martin,	   1995),	   b)	  
Fgf8	   hypomorphs	   have	   disorganised	   pouch	   development	   (Abu-­‐Issa	   et	   al.,	   2002;	  Frank	   et	   al.,	   2002)	   c)	   Fgf8	   expression	   is	   absent	   in	   the	   endoderm	   of	  Tbx1-­‐/-­‐	   and	  indeed	  Tbx1cKOSox17	  embryos	  (Fig	  17c)	  (Vitelli	  et	  al.,	  2002b).	  However,	  when	  this	  assumption	  was	  tested	  experimentally	  by	  the	  deletion	  of	  Fgf8	  from	  then	  endoderm	  it	   revealed	   that	   the	  deletion	  of	  Fgf8	   alleles	   from	   the	  endoderm	  does	  not	  perturb	  pharyngeal	  pouch	  morphogenesis.	  	  Current	  literature	  suggests	  that	  Fgf3	  may	  act	  redundantly	  with	  Fgf8	  during	  pouch	  morphogenesis.	   Fgf3	   and	   Fgf8	   have	   overlapping	   expression	   domains	   in	   the	  endoderm	   during	   PA	   formation	   (Vitelli	   et	   al.,	   2002b;	   Vincentz	   et	   al.,	   2005).	  Although	   the	   deletion	   of	   Fgf3	   from	   mouse	   lines	   (Fgf3-­‐/-­‐	   embryos)	   has	   not	  implicated	   this	   ligand	   in	   pouch	   formation,	   Fgf3-­‐/-­‐	   mutants	   display	   thymus	  hypoplasia	  (Aggarwal	  et	  al.,	  2006).	  Moreover,	  changes	   in	  the	   level	  and	  pattern	  of	  
Fgf3	   expression	   are	   associated	   with	   mouse	  mutants	   that	   have	   perturbed	   pouch	  outgrowth.	  	  For	  instance,	  mice	  exposed	  to	  exogenous	  RA	  display	  1st	  pouch	  aplasia	  and	  fusion	  of	  the	  1st	  and	  2nd	  arches	  and	  within	  the	  fused	  rostral	  arches	  expression	  domain	   of	   Fgf3	   was	   expanded	   (Mahmood	   et	   al.,	   1996).	   Tbx1-­‐/-­‐	   embryos	   lose	  expression	  of	  Fgf3	  in	  their	  un-­‐segmented	  caudal	  endoderm,	  (although	  this	  was	  not	  observed	   in	   Tbx1cKOSox17	   embryos),	   (Aggarwal	   et	   al.,	   2006).	   Finally,	   Fgf3	  expression	   is	   initiated	  but	  not	  maintained	   in	  the	  hypoplastic	  pharyngeal	  pouches	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of	  the	  foxi1	  (forkhead	  box	  I1,	  A	  transcription	  factor)	  zebrafish	  mutant	  (Nissen	  et	  al.,	  2003).	  	  	  Direct	   genetic	   evidence	   showing	   that	   FGF3	   functions	   redundantly	   in	   pouch	  formation	   with	   FGF8	   has	   been	   demonstrated	   in	   a	   non-­‐mammalian	   model.	  Zebrafish	  with	  a	  strong	  loss	  of	  function	  fgf8	  mutation,	  (also	  defined	  as	  Acerebellar	  or	   fgf8-­‐	  mutants)	  normally	   form	  misshapen,	  and/or,	  hypoplastic	  pouches	  (Crump	  et	   al.,	   2004).	   	   Exposing	   fgf8-­‐	   mutants	   to	   an	   fgf3	   morpholino	   (fgf8-­‐;fgf3-­‐MO)	  prevents	  all	  pouch	  formation,	  suggesting	  that	   fgf3	  can	  compensate	   for	  the	   loss	  of	  
fgf8	  during	  pouch	   formation	   (Crump	  et	   al.,	   2004).	  To	  examine	  whether	  Fgf3	   and	  
Fgf8	   function	   redundantly	   during	   mammalian	   pouch	   morphogenesis,	  
Sox17icre/+Fgf3flox/-­‐;Fgf8flox/-­‐	   (F3;F8cKOSox17)	   embryos	   were	   generated.	   Sets	   of	  
F3;F8Sox17	  mutant	   embryos	  were	  bred	  and	  kindly	  provided	  by	  Professor	  Suzanne	  Mansour	  from	  Utah,	  Salt	  Lake	  City.	  	  The	  following	  experiments	  were	  conducted	  to	  analyse	  pouch	  morphogenesis	  in	  F3;F8cKOSox17	  embryos:	  a) Pouch	  morphology	   of	   embryos	   deficient	   in	   the	   expression	   of	   endodermal	  
Fgf3	  and	  Fgf8	  were	  analysed	  at	  E10.5	  by	  Pax1	  expression.	  b) Erm	   expression	   was	   evaluated	   by	   whole	   mount	   in	   situ	   hybridisation	   to	  assess	  the	  level	  of	  FGF	  signalling	  in	  conditional	  F3:F8	  mutant	  embryos.	  	  
5.1.1	  Analysis	  of	  pharyngeal	  pouch	  formation	  in	  F3;F8Sox17	  
mutants	  
Pharyngeal	  pouch	  formation	  of	  embryos	  deficient	  in	  the	  endodermal	  expression	  of	  
Fgf3	   and	  Fgf8	  was	   analysed	  between	  E10.0	   and	  E10.5	  days	  of	  development.	  The	  loss	  of	  one	  allele	  of	  Fgf3	  and	  one	  allele	  of	  Fgf8	  from	  the	  endoderm	  has	  little	  effect	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on	   the	   formation	  of	   the	  pharyngeal	  pouches.	  Pouches	  1	   to	  3	   and	   the	   forming	  4th	  pouch	   are	   evident	   in	   Sox17icre/+Fgf3flox/+;Fgf8flox/+,	   (F3;F8cHetSox17)	   embryos.	   The	  level	   and	  pattern	  of	  Pax1	  expression	   in	   the	  pharyngeal	  pouches	  of	  F3;F8cHetSox17	  embryos	  and	  Cre	  negative	  embryos	  is	  indistinguishable	  (Fig	  	  28,	  solid	  arrows	  panel	  a	  and	  a’	  vs	  b	  and	  b’).	  However,	  if	  three	  or	  more	  alleles	  of	  a	  combination	  of	  Fgf3	  and	  
Fgf8	   are	   deleted	   from	   the	   endoderm,	   pouch	   morphogenesis	   no	   longer	   occurs	  normally.	   Sox17icre/+Fgf3flox/-­‐;Fgf8flox/+,	   (F3cKO;F8cHetSox17)	   and	  
Sox17icre/+Fgf3flox/+;Fgf8flox/-­‐,	   (F3cHet;F8cKOSox17)	   embryos	   display	   a	   unilateral	  fusion	   of	   the	   first	   and	   second	   pouches,	   with	   variable	   penetrance	   (identified	   by	  brackets	   in	   panels	   c’	   and	   d	   of	   Fig	   28,	   frequencies	   of	   pouch	   fusion	   are	   outline	   in	  Table	   6).	   The	   incidence	   of	   pouch	   fusion	   is	   greater	   in	   F3cHet;F8cKOSox17	   than	  
F3cKO;F8cHetSox17.	   Bilateral	   fusion	   of	   the	   rostral	   pouches,	   a	   more	   severe	   pouch	  phenotype	  than	  the	  unilateral	   fusion	  results	  when	  all	  alleles	  of	  Fgf3	  and	  Fgf8	  are	  deleted	   from	   the	  endoderm,	   (Fig	  28,	  panels	  e	   and	  e’,	   fusion	   in	   the	  F3;F8cKOSOX17	  embryos	  is	  highlighted	  by	  the	  brackets).	  Surprisingly,	  however,	  the	  penetrance	  of	  pouch	   fusion	   in	   F3;F8cKOSox17	   embryos	   is	   not	   higher	   than	   that	   observed	   in	  
F3cHet;F8cKOSox17	   embryos	   (Table	  6).	  Another	   interesting	  observation	   is	   that	   the	  proximal	   portion	   of	   the	   2nd	   arch	   appears	   hypoplastic	   wherever	   the	   1st	   and	   2nd	  pouch	   fusion	   is	  evident	  (compare	  outlined	  2nd	  arch	   in	  panels	  a’	  and	  e’	  of	  Fig	  28).	  For	  a	  summary	  of	  the	  incidence	  and	  type	  of	  rostral	  pouch	  fusion	  observed	  in	  each	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Table	  6:	   Incidence	  and	  type	  of	  rostral	  pouch	   fusion	   in	  E10.0/10.5	  F3;F8Sox17	  
mutants.	  
	  
	   (*)	  Indicates	  significance	  value	  of	  p<0.02,	  when	  comparing	  incidence	  of	  pouch	  fusion	  incidence	  in	  Cre	  negative	  embryos.	  L=left	  side,	  R	  =	  right	  side.	  
	  	  	  	  	  
	   Counts	  of	  pouch	  fusion	  observed	  per	  embryo	   Total	  pouch	  
fusion	  
observed	  
per	  side	  of	  
each	  
embryo	  





Cre	  Negative	   6/6	   0/6	   0/6	   0/6	   0/12	  
F3;F8cHetSox17	   2/2	   0/2	   0/2	   0/2	   0/4	  
F3cKO;F8cHetSox17	   3/4	   1/4	   0/4	   0/4	   1/8	  
F3cHet;F8cKOSox17	   0/2	   0/2	   2/2	  (*)	   0/2	   2/4	  
F3;F8cKOSox17	   3/6	   1/6	   0/6	   2/6	   5/12	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Fig	   28:	   Deletion	   of	   a	   combination	   of	   three	   or	   more	   alleles	   of	   Fgf3	   and	   Fgf8	   from	   the	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5.1.2	  Analysis	  of	  FGF	  signalling	  in	  the	  pharyngeal	  pouches	  
of	  F3;F8Sox17	  mutants	  
The	   level	   and	   pattern	   of	   FGF	   signalling	  within	   the	   PA	   of	   Fgf8cKOSox17	   embryos	  was	  not	  altered	  by	  the	  deletion	  of	  Fgf8	  from	  the	  endoderm	  (Fig	  23).	  Fgf3	  and	  Fgf8	  have	   been	   demonstrated	   to	   regulate	   the	   expression	   of	   Erm	   (a	   readout	   of	   FGF	  signalling)	   (Raible	   and	   Brand,	   2001).	   The	   presence	   of	   Fgf3	   in	   the	   endoderm	   of	  
Fgf8cKOSox17	   embryos	  may	   have	  maintained	   FGF	   signalling	   here,	   enabling	   pouch	  morphogenesis	  to	  proceed.	  It	  is	  tempting	  to	  predict	  that	  the	  level	  of	  FGF	  signalling	  in	  the	  endoderm	  of	  F3;F8Sox17	  mutants	  that	  display	  rostral	  pouch	  fusion	  would	  be	  reduced	   below	   a	   threshold	   that	   is	   required	   for	   normal	   pouch	  morphogenesis.	   A	  reduction	   in	  FGF	  signalling	  should	  be	  represented	  by	  a	   loss	  of	  Erm	  expression	   in	  the	  endoderm	  of	  the	  F3;F8Sox17	  mutants	  with	  fused	  pouches.	  	  	  To	  address	  the	  prediction	  that	  rostral	  pouch	  fusion	  in	  F3;F8Sox17	  mutants	  is	  caused	  by	  a	   reduction	   in	  FGF	  signalling	   in	   the	   rostral	  endoderm,	   sets	  of	  E9.25	  F3;F8Sox17	  embryos	   were	   analysed	   for	   the	   expression	   of	   Erm	   by	   whole	   mount	   in	   situ	  hybridisation.	  At	  this	  developmental	  time	  point	  2nd	  arch	  hypoplasia	  is	  identifiable	  and	  can	  be	  referenced	  as	  an	  indicator	  of	  rostral	  pouch	  fusion,	  at	  a	  time	  when	  the	  2nd	  pouch	  is	  still	  forming.	  	  Of	  those	  E9.25	  F3;F8Sox17	  mutants	  analysed,	  pharyngeal	  pouch	   fusion	   was	   only	   evident	   in	   the	   F3;F8cKOSox17	   embryos,	   (1/3	   displayed	  bilateral	   fusion	  [Fig	  29,	  panels	  e	  and	  e’],	  1/3	  displayed	  unilateral	   fusion).	   	  Erm	  at	  E9.25	  is	  expressed	  in	  a	  segmented	  pattern	  in	  the	  PA	  and	  is	  highly	  expressed	  in	  the	  posterior	   half	   of	   each	   pharyngeal	   pouch	   (high	   levels	   of	   Erm	   expression	   in	  pharyngeal	  pouches	  are	  indicated	  by	  labels	  pp1	  and	  2	  in	  Fig	  29).	  	  Surprisingly,	  the	  level	   of	   Erm	   does	   not	   appear	   to	   be	   reduced	   in	   the	   F3;F8cKOSox17	   embryos	   that	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Fig	   29:	   Erm	   expression	   does	   not	   appear	   to	   be	   reduced	   in	   the	   fused	   rostral	   pouches	   of	  
F3;8cKOSox17	   embryos.	   Whole	   mount	   in	   situ	   hybridization	   on	   E9.25	   Cre	   negative	   (a,a’),	  
F3;F8cHetSox17	   (b,b’)	   F3cKO;F8cHetSox17	   (c,c’),	   F3cHet;F8cKOSox17	   (d-­‐d’)	   and	   F3;F8cKOSox17	   (e,e’)	  embryos	  with	   an	   antisense	  mRNA	  probe	   for	  Erm.	   Brackets	   highlight	   the	   hypoplastic	   arch	   of	   the	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5.2	  A	  requirement	  for	  FGF	  signalling	  downstream	  of	  Fgfr1	  
and	   Fgfr2	   in	   the	   pharyngeal	   endoderm	   during	   pouch	  
formation	  
Rostral	   pouch	   fusion	   is	   not	   fully	   penetrant	   in	   F3;F8cKOSox17	   embryos	   and	   no	  reduction	  in	  FGF	  signalling	  was	  observed	  in	  the	  areas	  of	  fused	  rostral	  pharyngeal	  endoderm	   (as	   assessed	   by	   in	   situ	   hybridisation).	   	   This	   data	   suggests	   that	   FGF	  signalling	  elicited	   in	   the	  endoderm	  by	  FGF	   ligands	  other	   than	  Fgf3	   and	  Fgf8	  may	  enable	  some	  pouch	  morphogenesis	  to	  proceed.	  Pharyngeal	  pouch	  defects	  occur	  in	  
Fgfr1	   hypomorphs	   and	   in	   embryos	   that	   are	   unable	   to	   initiate	   Map	   Kinase	  signalling,	   through	   Frs2alpha,	   downstream	   of	   Fgfr1	   (Fgfr1∆Frs/∆Frs	   embryos)	  (Trokovic	   et	   al.,	   2003;	   Trokovic	   et	   al.,	   2005;	   Hoch	   and	   Soriano,	   2006).	   Bilateral	  rostral	  pouch	  fusion,	  identical	  to	  that	  observed	  in	  some	  F3;F8cKOSox17	  embryos,	  is	  100%	  penetrant	  in	  both	  of	  these	  Fgfr1	  mutants.	  This	  data	  supports	  the	  hypothesis	  that	  multiple	  FGF	   ligands	  act	   redundantly	   to	   elicit	   FGF	   signalling	  downstream	  of	  FGFR1	  binding,	  during	  pouch	  formation.	  	  	  	  Whether	  pouch	  evagination	  requires	  tissue	  specific	  expression	  of	  Fgfrs	  has	  not	  yet	  been	   tested.	   Fgfr1,	   Fgfr2	   and	   Fgfr3	   are	   all	   expressed	   in	   the	   PA	   during	   pouch	  morphogenesis	   (Walshe	   and	  Mason,	   2000).	   Thus,	   it	   was	   predicted	   that	  multiple	  FGFRs	  may	  function	  redundantly	  to	  regulate	  pharyngeal	  pouch	  out-­‐pocketing.	  The	  expression	  of	  Fgfr3	   in	  the	  PA	  is	  weaker	  and	  more	  restricted	  than	  Fgfr1	  and	  Fgfr2	  (Walshe	  and	  Mason,	  2000).	   Thus,	   it	  was	  predicted	   that	   little	   signalling	  would	  be	  elicited	  through	  this	  receptor	  during	  pouch	  morphogenesis.	  The	  deletion	  of	  Fgfr1	  or	   Fgfr2	   ubiquitously	   from	   all	   tissues	   arrests	   embryonic	   development	   during	  gastrulation	  (Deng	  et	  al.,	  1994;	  Yamaguchi	  et	  al.,	  1994;	  Arman	  et	  al.,	  1998).	  Thus,	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tissue	  specific	  Cre	  lines	  must	  be	  used	  to	  analyse	  the	  role	  of	  FGF	  signalling	  during	  pouch	   formation.	  To	  maximise	   the	  efficiency	  of	  Cre	  mediated	   recombination,	   the	  number	   of	  Fgfr	   genes	   targeted	   for	   deletion	  was	   limited	   to	   two,	  Fgfr1	   and	   Fgfr2.	  	  Pouch	  morphology	   of	   embryos	   deficient	   in	   the	   expression	   of	  Fgfr1	   and	   Fgfr2	   in	  either;	  endodermal	  cells,	  mesodermal	  cells	  or	  NCCs,	  was	  analysed	  at	  E10.0/10.5	  by	  
Pax1	  whole	  mount	  in	  situ	  hybridisation.	  	  
5.2.1	   Analysis	   of	   pharyngeal	   pouch	   morphology	   in	  
embryos	  with	  tissue	  specific	  deletions	  of	  Fgfr1	  and	  Fgfr2	  
	  
5.2.1a	   The	   recombination	   of	   Fgfr1	   and	   Fgfr2	   in	   the	  
endoderm	  by	  SOX17iCre	  results	  in	  rostral	  pouch	  fusion	  
In	   keeping	  with	   the	   previous	   analyses	   within	   this	   thesis,	   the	   SOX17iCre	   line	   was	  used	   to	  delete	   floxed	  Fgfr1	   and	  Fgfr2	   alleles	  specifically	   from	  the	  endoderm	  (see	  2.3.1	   for	   details	   of	   breeding	   strategies).	   Recombination	   of	   the	   floxed	   Rosa-­‐Fluorescent-­‐Yellow-­‐Protein	   (RYFP)	   by	   the	   activity	   of	   SOX17icre	   only	   occurred	   in	  endothelial	   and	  endodermal	   cells.	   	   Fluorescence	   is	  detected	  diffusely	   throughout	  the	   embryo,	   highlighting	   the	   endothelial	   cells	   of	   the	   vascular	   network	   (Fig	   30	  panels	  b	  and	  b’).	  A	  strong	  signal	  is	  emitted	  from	  the	  endoderm,	  in	  particular	  from	  each	  of	   the	  slit	   like	  pharyngeal	  pouches	  (Fig	  30,	  panels	  b’,	  b’’,	  strong	  RYFP	  in	  the	  pouches	  is	  indicated	  by	  the	  arrows).	  	  In	  the	  absence	  of	  SOX17iCre	  no	  fluorescence	  is	  detected	   in	   the	   embryo	   (Fig	   30,	   panel	   a).	   This	   data	   confirms	   that	   the	   activity	   of	  SOX17icre	  in	  the	  R1;R2Sox17	  line	  was	  specific	  to	  the	  tissues	  that	  Sox17	  is	  expressed	  in	  i.e.	  the	  endoderm	  and	  endothelial	  cells.	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Whole	  mount	  in	  situ	  hybridisation	  for	  Pax1	  revealed	  that	  rostral	  and	  caudal	  pouch	  defects	   manifest	   in	   Sox17icre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	   (R1;R2cKOSox17)	   embryos.	   	   All	  
R1;R2cKOSox17	   embryos	   display	   bilateral	   fusion	   of	   the	   1st	   and	   2nd	   pharyngeal	  pouches	  (brackets	  Fig	  31	  panels	  b,	  b’,	  c	  and	  c’)	  and	  thus	  bilateral	  hypoplasia	  of	  the	  2nd	   pharyngeal	   arch.	   	   Some	   variation	   in	   the	   severity	   of	   the	   pouch	   fusion	   is	  evidenced	   by	   the	   size	   of	   the	   second	   arch;	   compare	   the	   almost	   non-­‐existent	   2nd	  pharyngeal	  arch	  in	  the	  ‘severe’	  R1;R2cKOSox17	  embryo	  (Fig	  31,	  panels	  c	  and	  c’–	  the	  2nd	  arch	  is	  outlined	  to	  aid	  identification)	  to	  the	  mild	  R1;R2cKOSox17	  embryo	  that	  has	  a	  hypoplastic	  but	  still	  identifiable	  proximal	  2nd	  arch	  (Fig	  31,	  panels	  b	  and	  b’	  –	  the	  2nd	  arch	  is	  outlined	  to	  aid	  identification).	  Rostral	  pouch	  development	  is	  perturbed	  in	   the	   same	   way	   by	   the	   deletion	   of	   Fgf3	   and	   Fgf8	   or	   Fgfr1	   and	   Fgfr2	   from	   the	  endoderm.	   However,	   the	   penetrance	   and	   severity	   of	   rostral	   pouch	   fusion	   is	  significantly	  increased	  in	  R1;R2cKOSox17	  compared	  to	  F3;F8cKOSox17.	   	  The	  incidence	  of	   rostral,	   bilateral	   pouch	   fusion	   detected	   in	   embryos	   from	   E9.0	   to	   E10.5	   was	  almost	  50%	  more	  prevalent	  in	  R1;R2cKOSox17	  embryos	  than	  F3;F8cKOSox17	  embryos	  (respectively,	   n=12/12	   vs	   n=4/9,	   p=0.0016).	   Finally,	   the	   3rd	   pouch	   is	   also	  hypoplastic	   in	   the	  majority	   of	  R1;R2cKOSox17	   embryos,	   indicating	   that	   the	   loss	   of	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Fig	  30.	  SOX17iCre	  activity,	  identified	  by	  fluorescence	  from	  the	  RYFP	  reporter,	  is	  present	  only	  
in	  the	  endoderm	  and	  endothelial	  cells	  of	  the	  R1;R2Sox17	  line.	  	  Yellow	  fluorescence	  from	  the	  RYFP	  reporter,	  detected	  under	  UV	  light,	  is	  only	  present	  in	  embryos	  carrying	  the	  Sox17iCre	  allele	  (b-­‐b’’),	  no	  fluorescence	  is	  detected	  in	  Cre	  negative	  embryos	  (a).	  A	  diffuse	  fluorescent	  signal	  is	  detected	  in	  the	  endothelial	   cells	   of	   the	   blood	   vessels	   and	   a	   strong	   fluorescent	   signal	   is	   emitted	   from	   the	  endodermal	   pouches	   (white	   arrows	   b	   and	   b’’)	   of	   SOX17icre	   positive	   embryos.	   b-­‐b’’	   are	   the	   same	  embryo	  taken	  at	  low	  power	  (b),	  at	  high	  power	  (b’)	  and	  high	  power	  with	  low	  exposure	  to	  dampen	  the	  endothelial	  cell	  fluorescence	  (b’’).	  ???Annotations:	  Arrows	  to	  the	  right	  of	  the	  figure	  identify	  the	  orientation	  of	  the	  embryos:	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  	  Outlined	  area	  in	  panels	  b	  indicates	  the	  area	  magnified	  in	  panels	  b’	  and	  b’’.	   	  White	  arrowheads	  =	  strong	  fluorescent	  signal	  emitted	  fro	  the	  endodermal	  pouches,	  pp	  =	  pharyngeal	  pouches.	  
	  
Fig	   31:	  Pax1	   expression	   identifies	   bilateral	   rostral	   pouch	   fusion	   and	  3rd	   pouch	  hypoplasia	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5.2.1.b	   The	   recombination	   of	   Fgfr1	   and	   Fgfr2	   in	   the	  
mesoderm	   and	   CNCC	   does	   not	   cause	   defects	   in	   pouch	  
formation	  
To	   verify	   that	   FGF	   signalling	  within	   the	   endoderm	   is	   of	   primary	   importance	   for	  pharyngeal	  pouch	  morphogenesis,	  the	  requirement	  for	  Fgfr1	  and	  Fgfr2	  expression	  in	  other	  pharyngeal	  tissues	  during	  pouch	  evagination	  was	  analysed.	  
	  To	   analyse	   the	   role	   of	   FGF	   signalling	   in	   the	   mesoderm	   during	   pouch	  morphogenesis,	  floxed	  Fgfr1	  and	  Fgfr2	  alleles	  were	  genetically	  recombined	  in	  the	  mesoderm	   using	   MESP1Cre	   (see	   2.3.1	   for	   details)	   (Saga	   et	   al.,	   1999).	   The	   RYFP	  reporter	   illustrates	   that	   when	  Mesp1Cre	   is	   expressed	   that	   it	   is	   active	   only	   in	   the	  mesodermal	   cells	   of	   embryo	   (Fig	   32,	   panel	   b	   and	   b’).	   	   Of	   significance	   is	   the	  fluorescence	  detected	  in	  the	  mesodermal	  core	  that	  runs	  through	  each	  pharyngeal	  arch	   (arrows	   Fig	   32,	   panel	   b’).	   Fluorescence	   is	   not	   detected	   in	   Cre	   negative	  embryos	   (Fig	   32,	   panel	   a).	   	   Subsequently	   Pax1	   defined	   pouch	   morphology	   was	  analysed	  in	  mutants	  deficient	  of	  FGFRs	  in	  the	  mesoderm	  and	  in	  control	  embryos.	  
R1;R2cKOMesp1	   embryos	   were	   not	   recovered	   from	   the	   cross.	   	   It	   is	   possible	   that	  
R1;R2cKOMesp1	   embryos	   died	   before	   E9.5	   because	   they	   were	   unable	   to	   develop	  mesodermal	   cells	   at	   gastrulation.	   This	   prediction	   is	   based	   on	   Xenopus	   data	   that	  has	  shown	  that	  FGF	  signalling	  is	  required	  to	  induce	  mesoderm	  during	  gastrulation,	  (Deng	   et	   al.,	   1994).	   For,	   Xenopus	   embryos	   injected	   with	   a	   construct	   containing	  dominant-­‐negative	  FGFR1	  were	  observed	  to	  display	  gastrulation	  defects	  attributed	  to	  a	  lack	  of	  mesoderm	  induction	  during	  early	  embryogenesis	  (Deng	  et	  al.,	  1994).	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  An	   analysis	   of	   Pax1	   expression	   in	   the	   pharyngeal	   endoderm	   revealed	   normal	  pouch	  morphology	  in	  all	  embryos	  deficient	  for	  mesodermal	  Fgfr1	  and	  Fgfr2,	  even	  when	  only	  one	  allele	  of	  Fgfr1	  or	  Fgfr2	  was	  retained	  in	  the	  mesoderm	  (Fig	  33).	  The	  pharyngeal	  pouches	  of	  the	  mesodermal	  Fgfr	  mutants	  appear	  to	  be	  of	  the	  same	  size	  as	   Cre	   negative	   controls	   (Fig	   33	   a	   vs	   b).	   However,	   the	   2nd	   pouch	   of	  
R1cKO;R2cHetMesp1	   embryo,	   depicted	   in	   Fig	   33,	   panel	   c,	   appears	   slightly	   more	  splayed	   than	   the	   controls	   embryos	   pouch	   (the	   splayed	   2nd	   is	   denoted	   by	   the	  question	  mark	   in	   Fig	  33,	   panel	   c).	   	   As	   this	   is	   not	   an	  overt	   pouch	  phenotype	   it	   is	  unlikely	  that	  this	  mild	  perturbation	  of	  pouch	  morphology	  deviates	  beyond	  ‘normal	  variation’	   during	   development.	   	   However,	   to	   validate	   this	   a	   more	   extensive	  analysis	   of	   pouch	   morphogenesis	   and	   an	   analysis	   of	   thymus	   organogenesis	   in	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Fig	  32.	  MESP1Cre	  activity,	  identified	  by	  fluorescence	  from	  the	  RYFP	  reporter,	  is	  present	  only	  
in	   the	   mesodermal	   cells	   of	   the	   R1;R2Mesp1	   line.	   Yellow	   fluorescence	   from	   the	   RYFP	   reporter,	  detected	  under	  UV	  light,	   is	  only	  present	  in	  embryos	  carrying	  the	  Mesp1Cre	  allele	  (b-­‐b’),	  no	  RYFP	  is	  detected	  in	  Cre	  negative	  embryos	  (a).	  A	  fluorescent	  signal	  is	  detected	  in	  the	  mesodermal	  cells	  of	  the	  splanchic	  mesoderm	  and	  in	  the	  core	  mesoderm	  running	  through	  each	  pharyngeal	  arch	  (arrows	  b’).	  b-­‐b’	  are	  the	  same	  embryo	  taken	  at	  low	  power	  (b),	  at	  high	  power	  (b’).	  N=2	  Annotations:	  Arrows	  to	  the	  left	  of	  the	  figure	  identify	  the	  orientation	  of	  the	  embryos:	  A	  =	  anterior,	  P	  =	   posterior,	   L	   =	   lateral,	   M	   =	  medial,	   V=	   ventral,	   D	   =	   dorsal.	   pp	   =	   pharyngeal	   pouch,	   solid	   white	  arrowheads	   identify	   areas	   of	   fluorescence	   within	   the	   core	   mesoderm,	   sp.meso	   =	   splanchic	  mesoderm.	  
	  
Fig	  33:	  Pax1	  expression	  identifies	  normal	  pouch	  morphology	  in	  embryos	  that	  are	  deficient	  of	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Fig	  34:	  WNT1Cre	  activity,	  identified	  by	  fluorescence	  from	  the	  RYFP	  reporter,	  is	  present	  only	  
in	   the	   CNCC	   cells	   and	   their	   derivatives	   in	   the	   R1;R2Wnt1	   line.	   	   Yellow	   fluorescence	   from	   the	  RYFP	  reporter,	  detected	  under	  UV	  light,	  is	  only	  present	  in	  embryos	  expressing	  the	  Wnt1Cre	  allele	  (b-­‐b’),	  no	  RYFP	  is	  detected	  in	  Cre	  negative	  embryos	  (a).	  A	  fluorescent	  signal	  is	  detected	  in	  the	  streams	  of	  CNCC	  migrating	  into	  the	  arches	  (arrowheads)	  and	  in	  the	  PAA	  running	  through	  each	  pharyngeal	  arch	  (PAA)	  (	  b’).	  The	  same	  embryo	  is	  images	  in	  b-­‐b’,	  taken	  at	  low	  power	  (b),	  at	  high	  power	  (b’).	  N=2Annotations:	  Arrows	  to	  the	  left	  of	  the	  figure	  identify	  the	  orientation	  of	  the	  embryos:	  A	  =	  anterior,	  P	  =	   posterior,	   L	   =	   lateral,	   M	   =	  medial,	   V=	   ventral,	   D	   =	   dorsal.	   pp	   =	   pharyngeal	   pouch,	   solid	   white	  arrowheads	  identify	  streams	  of	  fluorescing	  CNCC,	  PAA	  labels	  fluorescing	  CNCC	  within	  the	  PAA.	  
	  
Fig	   35:	   Pouch	   morphology,	   as	   highlighted	   by	   Pax1	   expression,	   appears	   normal	   in	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5.2.2	   Assessment	   of	   3rd	   pouch	   development	   in	  
R1;R2cKOSox17	  embryos	  
The	  data	  presented	   thus	   far	   in	  Chapter	  5	   demonstrates	   that	  Fgfr1	  and	  Fgfr2	   are	  required	   in	   the	   endoderm	   (but	   not	   in	   the	   mesoderm	   or	   CNCC)	   for	   pouch	  morphogenesis	  to	  occur	  'normally’;	  the	  rostral	  pouch	  defects	  in	  the	  R1;R2cKOSox17	  embryos	   recapitulate	   those	   observed	   in	   Fgfr1	   hypomorphs.	   In	   addition	   to	  displaying	  fused	  rostral	  pouches	  the	  R1;R2cKOSox17	  embryos	  also	  appear	  to	  form	  a	  hypoplastic	  3rd	  pouch.	   	  The	   following	  experiments	  were	  conducted	   to	  analyse,	   in	  detail,	   the	   endoderm	   specific	   requirement	   for	   Fgfr1	   and	   Fgfr2	   during	   pouch	  morphogenesis:	  a) 3rd	  pouch	  development	  was	  assessed	  in	  endodermal	  Fgfr1;Fgfr2	  mutants.	  At	  E11.5	   the	   patterning	   of	   the	   3rd	   pouch	   into	   presumptive	   thymus	   (Foxn1	  expressing	  and	  parathyroid	   (Gcm2	  expressing)	  domains	  was	  evaluated	  by	  
in	  situ	  hybridisation.	  Thymus	  gland	  formation	  was	  assessed	  at	  E15.5.	  b) CNCC	   presence/migration,	   (assessed	   by	   the	   pattern	   and	   level	   of	   Dlx2	  expression)	   and	   cell	   death	   (assessed	   by	   Lysotracker	   and	   Caspase	   6	  staining)	  was	  assessed	  in	  endodermal	  Fgfr1;Fgfr2	  mutants	  c) FGF	  signalling	  readouts	  were	  analysed	  by	  in	  situ	  hybridisation	  to	  assess	  the	  level	  of	  FGF	  signalling	  in	  Fgfr1	  and	  2	  mutants.	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5.2.2a	   A	   severely	   aplastic	   3rd	   pouch,	   that	   is	   unable	   to	  
pattern	   correctly	   into	   presumptive	   thymus	   and	  
parathyroid	   domains,	   forms	   from	   Fgfr1;Fgfr2	   deficient	  
endoderm	  at	  E11.5.	  
Caudal	   pouch	   defects	   have	   not	   previously	   been	   reported	   in	   embryos	   that	   are	  deficient	   of	   FGF	   signalling	   (Fgfr1	   hypomorphs	   and	   Fgfr1∆Frs/∆Frs	   embryos)	  (Trokovic	   et	   al.,	   2003;	  Trokovic	   et	   al.,	   2005;	  Hoch	  and	  Soriano,	  2006).	   3rd	  pouch	  hypoplasia	  and	  aplasia	  does,	  however,	  respectively	  manifest	  in	  Fgf8-­‐mild	  and	  Fgf8-­‐severe	  hypomorphs	  (Abu-­‐Issa	  et	  al.,	  2002;	  Frank	  et	  al.,	  2002).	  Conversely,	  although	  the	   rostral	   pouches	   are	   described	   as	   ‘disorganised’	   in	   severe	   Fgf8	   hypomorphs,	  their	   bilateral	   fusion	   is	   not	   documented	   (Abu-­‐Issa	   et	   al.,	   2002).	   As	   such,	   the	  combination	   of	   both	   rostral	   pouch	   fusion	   and	   3rd	   pouch	   hypoplasia	   observed	   in	  
R1;R2cKOSox17	   embryos	   appears	   to	   be	   a	   unique	   pouch	   phenotype,	   or	   at	   the	  most	  resembles	   the	   pouch	   defects	   of	   Fgf8-­‐severe	   hypomorphs.	   	   To	   further	   assess	   the	  development	  of	  the	  3rd	  pouch	  in	  the	  absence	  of	  Fgfr1	  and	  Fgfr2,	  the	  patterning	  of	  this	  pouch	  and	  its	  morphogenesis	  into	  the	  thymus	  was	  analysed.	  	  No	  R1;R2cKOSox17	  embryos	  were	  recovered	  at	  E11.5	  (0/9	  embryos)	  or	  E15.5	  (0/14	  embryos),	  however,	  defects	   in	  3rd	  pouch	  development	  were	  observed	  in	  embryos	  with	  only	  one	  allele	  of	  Fgfr1	  or	  Fgfr2.	  At	  E11.5	  the	  3rd	  pouch	  should	  be	  patterned	  into	   presumptive	   thymus	   (Foxn1	   positive)	   and	   parathyroid	   (Gcm2	   positive)	  domains	  (see	  section	  1.1.1).	  Only	  a	  remnant	  of	  the	  3rd	  pouch	  can	  be	  detected	  in	  the	  
R1cHet;R2cKOSox17	   embryo	   analysed	   at	   E11.5.	   The	   3rd	   pouch	   remnant	   of	   the	   Fgf	  
receptor	  mutant	  did	  not	  express	  Gcm2	  (Fig	  36,	  panel	  c),	  and	  only	  contained	  a	  small	  patch	  of	  Foxn1	  positive	  cells	  that	  were	  still	  attached	  to	  the	  pharynx	  (Fig	  36,	  panel	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Fig	  36:	  Fgfr1	  and	  Fgfr2	  are	  required	  in	  the	  endoderm	  for	  the	  patterning	  of	  the	  3rd	  pouch	  into	  
Foxn1	   and	  Gcm2	   positive	   domains	   at	   E11.5.	   In	   situ	   hybridization	   on	   sagittal	   sections	   of	   E11.5	  embryos	  identifies	  the	  expression	  of	  Gcm2	  (a)	  in	  the	  anterior,	  dorsal	  domain	  of	  the	  3rd	  pouch	  and	  
Foxn1	  (d)	  in	  the	  posterior,	  ventral	  domain	  of	  the	  3rd	  pouch	  of	  Cre	  negative	  embryos	  n=1.	  Gcm2	  and	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5.2.3	   CNCC	   migration	   and	   mesenchyme	   patterning	   is	  
perturbed	  in	  the	  absence	  of	  endodermal	  Fgfr1	  and	  Fgfr2	  	  
In	  Fgfr1	  hypomorphs	  migrating	  CNCC	  are	  only	  evident	  in	  the	  very	  proximal	  aspect	  of	  the	  hypoplastic	  2nd	  arch	  (Trokovic	  et	  al.,	  2003).	  This	  defect	  was	  attributed	  to	  the	  loss	   of	   Fgfr1	   from	   the	   ectoderm,	   as	   arch	   development	   is	   not	   affected	   by	   a	   cell	  autonomous	   loss	   of	   Fgfr1	   expression	   from	   the	   CNNC	   (Trokovic	   et	   al.,	   2003).	  However,	   a	   loss	   of	   Fgfr1	   expression	   from	   the	   endoderm	   may	   also	   affect	   the	  migration	  and/or	  survival	  of	  CNCC	  migrating	  into	  the	  PA	  of	  Fgfr1	  hypomorphs.	  To	  assess	   the	   requirement	   for	   endoderm	   specific	   Fgfr	   expression	   during	   the	  colonisation	  of	  the	  PA	  by	  the	  CNCC,	  Dlx2	  expressing	  CNCC	  were	  analysed	  in	  the	  PA	  of	  embryos	  with	  Fgfr-­‐deficient	  pharyngeal	  endoderm.	  At	  E9.25	  Dlx2	  expression	  is	  evident	   in	   the	   1st	   and	   2nd	   arches	   of	   Cre	   negative,	   R1cKO;R2cHetSox17	   and	  
R1;R2cKOSox17	  embryos.	  	  This	  data	  is	  indicative	  of	  the	  CNCC	  being	  able	  to	  populate	  the	   arches	   despite	   the	   lack	   of	   Fgfrs	   in	   the	   adjacent	   endodermal	   niche	   (compare	  robust	  distal	  Dlx2	  expression	  in	  the	  rostral	  1st	  and	  2nd	  arches	  of	  all	  embryos	  in	  Fig	  38	  panels	  d-­‐e’).	   	   	  There	  is	  a	  slight	  reduction	  in	  the	  amount	  of	  Dlx2	  staining	  in	  the	  proximal	   aspect	   of	   the	   2nd	   arch	   of	   the	  R1;R2cKOSox17	  mutant,	   (compare	   the	   arch	  regions	   indicated	   by	   solid	   arrowheads	   in	   Fig	   38	   panels	   a	   -­‐	   b’	   to	   the	   regions	  indicated	  by	  unfilled	  arrowheads	  in	  panels	  c	  and	  c’).	  This	  suggests	  that	  their	  may	  be	  a	  reduction	  in	  the	  number	  of	  late	  migrating	  CNCC	  that	  are	  able	  to	  colonise	  the	  second	  arch	  of	  the	  R1;R2cKOSox17	  embryos.	  	  	  In	  Fgfr1	  hypomorphs	  and	  Fgfr1∆Frs/∆Frs	  embryos	  a	  stalling	  of	  the	  CNCC	  is	  observed	  in	  an	  area	  proximal	  to	  the	  2nd	  arch	  (Trokovic	  et	  al.,	  2003;	  Hoch	  and	  Soriano,	  2006).	  Trockovic	  et	  al.,	  correlated	  the	  accumulation	  of	  CNNCs	  just	  peripheral	  to	  the	  Fgfr1	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hypomorph’s	   2nd	   arch	   to	   an	   increase	   in	   apoptosis	   in	   this	   area,	   (Trokovic	   et	   al.,	  2003).	   Cell	   death	   was	   analysed	   in	   embryos	   deficient	   of	   endodermal	   Fgfr1	   and	  
Fgfr2	   using	   Lysotracker	   –	   a	   marker	   of	   acidic	   organelles	   that	   are	   abundant	   in	  apoptosing	  cells	  –	   to	   investigate	  whether	   the	  reduction	   in	  Dlx2	   correlated	  with	  a	  change	  in	  cell	  death	  (Birk	  et	  al.,	  2008).	  No	  increase	  in	  cell	  death	  was	  evident	  in	  the	  arches	  of	  Lysotracker	  stained	  control	  and	  conditional	  Fgf	  receptor	  mutants	  (Fig	  38	  panels	  a-­‐c’).	  	  This	  data	  is	  consistent	  with	  the	  observation	  that	  the	  Dlx2	  expressing	  CNCC	   are	   able	   to	   enter	   the	   arches	   of	   the	   mutants.	   	   An	   ectopic	   region	   of	  fluorescence	  emitted	  from	  the	  Lysotracker	  probe	  is	  visible	  in	  and	  around	  the	  otic	  vesicle	  of	  the	  R1;R2cKOSox17	  embryo	  in	  panels	  c	  and	  c’	  of	  Fig	  38,	  (identified	  by	  the	  question	  mark	  labelled	  arrowhead).	  	  It	  is	  unclear	  whether	  the	  dying	  cells	  in	  the	  otic	  region	  are	  the	  ectoderm	  and	  mesenchyme	  of	  the	  otic	  proper	  or	  of	  misrouted	  CNCC.	  	  	  It	   has	   been	   hypothesised	   that	   the	   CNCC	   are	   multipotent	   when	   they	   enter	   the	  arches	  and	  that	  their	  fate	  is	  influenced	  by	  the	  adjacent	  pharyngeal	  tissues	  (Trainor	  and	  Krumlauf,	  2001).	  FGF	  signalling	  within	  the	  branchial	  arches	  has	  been	  shown	  to	  affect	  the	  expression	  of	  Hox	  genes	  in	  the	  CNCC	  that	  colonise	  the	  PA	  (Trainor	  et	  al.,	  2002).	  Hox	   gene	   expression	   was	   analysed	   in	   the	   PA	   of	   conditional	   Fgf	   receptor	  mutants	   to	   investigate	   whether	   a	   loss	   of	   Fgfr	   expression	   specifically	   from	   the	  endoderm	   affects	   CNCC	   derived	   mesenchymal	   patterning.	   	   Hoxa2	   is	   strongly	  expressed	  in	  the	  CNCC	  derived	  mesenchyme	  of	  the	  2nd	  pharyngeal	  arch	  (refer	  to	  Cre	   negative	   in	   Fig	   39,	   panel	   a,	   anterior	   solid	   arrowhead	   indicates	   2nd	   arch	  expression).	  	  There	  is	  also	  a	  small	  region	  of	  Hoxa2	  expressing	  endodermal	  cells	  in	  the	   inter-­‐pouch	   region	   lining	   the	   medial	   aspect	   of	   the	   3rd	   arch	   (solid	   grey	  arrowhead	   indicates	   endodermal	   expression).	   Fusion	   of	   the	   rostral	   pharyngeal	  endoderm	  is	  evident	   in	   the	  R1cKO;R2cHetSox17	   (Fig	  39,	  panel	  c)	  and	  R1;R2cKOSox17	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(Fig	   39,	   panel	   d)	   mutants.	   	   Despite	   the	   hypoplasia	   of	   the	   2nd	   arch	   in	   these	   Fgf	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Fig	  38:	  Deleting	  Fgfr1	  and	  Fgfr2	  from	  the	  endoderm	  perturbs	  migration	  of	  the	  CNCC	  into	  the	  
proximal	  aspect	  of	  the	  2nd	  arch	  and	  results	  in	  ectopic	  cell	  death	  proximal	  to	  the	  otic.	  	  	  Embryos	   were	   processed	   for	   Lysotracker	   staining	   as	   an	   indication	   of	   cell	   death	   (a-­‐c’)	   and	  subsequently	  for	  whole	  mount	  in	  situ	  hybridization	  of	  Dlx2	  (d-­‐f’),	  as	  an	  indicator	  of	  CNCC	  migration.	  	  No	   overt	   differences	   in	   cell	   death	   in	   the	   arches	   of	   Fgf	   receptor	   mutants	   is	   observed	   in	   the	  Lysotracker	  stained	  embryo.	  	  However,	  the	  R1;R2cKOSox17	  embryo	  (panel	  c	  and	  c’)	  displays	  ectopic	  cell	  death	  in	  and	  around	  the	  otic,	  (‘question	  mark’	  denotes	  the	  ambiguity	  concerning	  the	  identity	  of	  the	  tissue	  in	  which	  cell	  death	  is	  observed,	  i.e.	  is	  it	  the	  CNCC	  in	  the	  otic	  or	  the	  otic	  tissue	  itself).	  Dlx2	  expressing	   CNCCs	   were	   detected	   in	   the	   arches	   of	   all	   embryos.	   	   However	   there	   appears	   to	   be	   a	  reduction	   in	   staining	   in	   the	  proximal	   aspect	  of	   the	  2nd	   arch	  of	   the	  R1;R2cKOSox17	   embryo	   (f	   and	   f’	  unfilled	  arrowhead).	  N=2Annotations:,	   solid	   black	   arrowheads	   identify	   robust	   Dlx2	   expression	   in	   the	   arches,	   unfilled	  arrowheads	  identify	  reduced	  Dlx2	  expression	  in	  the	  proximal	  aspect	  of	  the	  2nd	  arch,	  I-­‐III	  =	  arches	  1-­‐3.	  	  
Fig	   39:	   Fgf	   receptor	   mutants	   with	   perturbed	   pouch	   formation	   display	   a	   loss	   of	   Hox	   gene	  
expression	  in	  the	  pharyngeal	  endoderm	  and	  arches.	  Frontal	   sections	   of	   E9.5	   embryo’s	   pharyngeal	   apparatus	   show	   Hoxa2	   (a-­‐d),	   and	   Hoxb1	   (e-­‐h’)	  expression,	  detected	  by	  in	  situ	  hybridization,	  is	  severely	  reduced	  in	  the	  endoderm	  of	  R1;R2cKOSox17	  	  embryos	  (unfilled	  arrowheads	  in	  panels	  d,	  h	  and	  h’).	  Some	  Hox	  gene	  expression	  is	  maintained	  in	  the	  
R1;R2cKOSox17	  embryos	  mesenchyme	  and	  ectoderm,	  primarily	  Hoxa2	  expression	  in	  the	  mesenchyme	  of	   the	  2nd	  arch	  (yellow	  arrow	  panel	  d).	   	   	  Note	  also	   the	   fused	  rostral	  pouch	  phenotype	  and	   loss	  of	  
Hoxa2	  expression	  in	  the	  R1cKO;R2cHetSox17	  embryo	  (panels	  c,	  g,	  g’).	  N=1Annotations:	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  light	  blue	  arrowhead	  =	  ectodermal	  PA	  expression,	  unfilled	  arrowhead	  =	  endodermal	  pouch	  with	  no/little	  expression,	  green	  arrowhead	  =	  mesenchyme,	   grey	   arrowhead	  =	   inter	   pouch	   expression	   of	  Hoxa2,	   red	   arrowhead	  =	   absence	   of	  inter	  pouch	  expression	  of	  Hoxa2,	  pp	  =	  pharyngeal	  pouch,	  ?	  =	  presumptive	  pouch,	  ecto	  =	  ectoderm,	  mesen	  =	  mesenchyme.	  	  Arrows	  to	  the	  left	  of	  the	  figure	  illustrate	  the	  orientation	  of	  the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	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5.2.4	   Deletion	   of	   Fgfr1	   and	   Fgfr2	   from	   the	   endoderm	  
results	  in	  a	  severe	  decrease	  in	  the	  level	  of	  FGF	  signalling	  
within	  this	  pharyngeal	  epithelium	  
The	   data	   so	   far	   demonstrates	   that	   the	   deletion	   of	   Fgfr1	   and	   Fgfr2	   from	   the	  endoderm	  prevents	   the	  discreet	  evagination	  of	   the	  endoderm	  that	   in	   turn	  affects	  the	   formation	  of	   the	  thymus.	  The	  deletion	  of	  Fgfr1	  and	  Fgfr2	   from	  the	  endoderm	  was	  predicted	  to	  decrease	  the	  amount	  of	  FGF	  signalling	  specifically	   in	  this	  tissue.	  	  To	  test	  this	  hypothesis	  the	  expression	  of	  several	  FGF	  readouts	  were	  analysed	  by	  in	  
situ	  hybridisation	  in	  frontal	  sections	  of	  E9.5	  R1;R2cKOSox17	  embryo’s	  PA.	  	  	  	  An	  endoderm	  specific	  loss	  of,	  Erm,	  Pea3,	  Sprouty	  2	  and	  Sprouty	  1	  was	  observed	  in	  
R1;R2cKOSox17	   embryos,	   indicative	   of	   a	   tissue	   specific	   loss	   of	   FGF	   signalling	  downstream	  of	   the	   SOX17iCre	  mediated	   deletion	   of	  Fgfr1	   and	  2.	   FGF	   signalling	   is	  abundant	   throughout	   the	  endoderm	  of	   the	  PA	  but	  particularly	   in	   the	  evaginating	  3rd	  pouch	  of	  Cre	  negative	  embryos,	  as	  evidenced	  by	   the	  strong	  expression	  of	   the	  
Sprouty	   and	  Ets	   genes	   in	   the	  caudal	  endoderm,	   (Cre	  negative	   images	   in	  panels	  a’	  (or	  a’’)	  in	  Figs	  ).	  	  In	  clear	  contrast	  all	  FGF	  signalling	  readouts	  are	  markedly	  reduced	  in	  the	  endoderm	  of	  the	  R1;R2cKOSox17	  embryos,	  although	  the	  reduction	  in	  Sprouty1	  expression	   is	   less	  pronounced	  (R1;R2cKOSox17	   images	   in	  panels	  b’	   (or	  b’’)	   in	  Figs).	  The	  sparse	  distribution	  of	  mesenchyme	  in	  the	  R1;R2cKOSox17	  embryos	  (for	  example	  in	  Fig	  b’),	  relative	  to	  Cre	  negative	  embryos,	  likely	  accounts	  for	  the	  slight	  reduction	  FGF	  signalling	  in	  this	  tissue.	  	  
	  
224  
 Fig  40 
	   225	  
	  
Fig	   40:	   Expression	   of	   the	   FGF	   signalling	   readouts,	   Erm	   and	   Pea3,	   are	   absent	   from	   the	  
endoderm	  of	  R1;R2cKOSox17	  embryos.	  
In	  situ	  hybridization	  for	  Erm	  (a,	  a’,	  b	  ,b’,	  e	  and	  f)	  and	  Pea3	  (c,	  c’,	  d	  and	  d’)	  on	  frontal	  sections	  of	  E9.25	  Cre	  negative	  (a,	  a’,	  c,	  c’	  and	  e)	  and	  R1;R2cKOSox17	  (b,	  b’,	  d,	  d’	  and	  f),	  embryo’s	  pharyngeal	  apparatus	  shows	   there	   a	   is	   a	   tissue	   specific	   loss	   of	   FGF	   signalling	   in	   the	   endoderm	   of	   mutant	   embryos.	  Outlined	  area	  in	  panels	  a’,	  b’,	  c’	  and	  d’	  indicate	  the	  area	  magnified	  in	  panels	  a,	  b,	  c	  and	  d.	  	  Annotations:	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  light	  blue	  arrowhead	  =	  ectodermal	  PA	  expression,	  unfilled	  arrowhead	  =	  endodermal	  pouch	  with	  no	  expression,	  pp	  =	  pharyngeal	  pouch,	  ?	   =	   presumptive	   pouch.	   	   Arrows	   in	   the	   bottom	   right	   of	   Fig	   40	   illustrate	   the	   orientation	   of	   the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  N=2	  	  
Fig	  41:	  Expression	  of	  Sprouty1	  and	  Sprouty2,	  negative	  feedback	  regulators	  of	  FGF	  signalling,	  
is	  absent	  from	  the	  endoderm	  of	  R1;R2cKOSox17	  embryos.	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5.3	   Investigating	   the	   genetic	   interaction	   between	   TBX1	  
and	   FGF	   signalling	   in	   the	   pharyngeal	   endoderm	   during	  
pouch	  morphogenesis	  
Park	   et	   al.	   have	   demonstrated	   a	   dosage	   sensitive	   reduction	   in	   the	   expression	   of	  
Fgfr1	   in	   the	  PA	  of	  Tbx1+/-­‐	  and	  Tbx1-­‐/-­‐	  embryos	  (Park	  et	  al.,	  2006).	  From	  this	  data	  the	  group	  inferred	  that	  TBX1	  may	  regulate	  FGF	  signalling	  at	  multiple	  levels,	  i.e.	  not	  just	  at	  the	  level	  of	  Fgf8	  transcriptional	  control	  (Hu	  et	  al.,	  2004;	  Park	  et	  al.,	  2006).	  Alternatively,	  the	  loss	  of	  Fgfr1	  expression	  in	  Tbx1-­‐/-­‐	  embryos	  may	  be	  attributed	  to	  the	   TBX1	   dependent	   loss	   of	   Fgf8,	   for	   Moon	   et	   al.	   have	   demonstrated	   that	   Fgf8	  activates	  FGR1	  in	  vivo	  (Moon	  et	  al.,	  2006).	  	  The	  data	  presented	  in	  Chapter	  3	  and	  5	  is	   beginning	   to	   reveal	   that	   endodermal	   TBX1	   may	   not	   be	   an	   effector	   of	   FGF	  signalling	   within	   this	   tissue,	   for,	   FGF	   signalling	   readouts	   are	   maintained	   in	   the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17.	  Moreover,	  TBX1	  and	  FGF8	  do	  not	  appear	  to	  function	   in	   the	   same	   endodermal	   pathway	   during	   pouch	   morphogenesis.	   This	  inference	   is	   supported	   by	   a	   comparison	   of	   PA	   sections	   from	   R1;R2cKOSox17	   and	  
Tbx1cKOSox17	  embryos.	  	  	  
5.3.1	   A	   comparison	   of	   pouch	   defects	   in	  
R1;R2cKOSox17	  and	  Tbx1cKOSox17	  reveals	  that	  the	  two	  
mutants	  have	  distinct	  phenotypes	  
The	   in	   situ	  data	   presented	   in	   Fig	   40	   and	   Fig	   41	   adds	   to	   the	  Pax1	   assessment	   of	  pouch	  morphology	  in	  R1;R2cKOSox17	  embryos,	  (see	  Fig	  31).	   	  From	  PA	  sections	  one	  can	  identify	  for	  example	  that,	  in	  contrast	  to	  Tbx1cKOSox17	  embryos,	  the	  pharyngeal	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endoderm	   of	   R1;R2cKOSox17	   embryos	   appears	   to	   evaginate	   toward	   the	   ectoderm	  but	  does	  so	  without	  any	  focal	  point.	  	  A	  number	  of	  other	  marked	  differences	  in	  the	  pharyngeal	   phenotype	   of	   Tbx1cKOSox17	   and	   R1;R2cKOSox17	   embryos	   have	   been	  summarised	  in	  Table	  7. 	  These	  discrepancies	  in	  pouch	  morphogenesis	  suggests	  that	  the	   FGF	   signalling	   cascade	   does	   not	   act	   downstream	   of	   Tbx1	   in	   the	   endoderm	  during	  pharyngeal	  pouch	  morphogenesis.	  	  	  
	  
Table	  ?:	   A	  comparison	  of	  endodermal	  phenotypes	  in	  embryos	  lacking	  either	  
Tbx1	  or	  Fgfr1	  and	  Fgfr	  2	  expression	  in	  the	  endoderm	  	  	  	  
Phenotypes	   Tbx1cKOSox17	   R1;R2cKOSox17	  
1st	  pouch	  	   Formed	   Formed	  
2nd	  pouch	  	   Aplastic	   Fused	  to	  1st	  pouch,	  2nd	  arch	  is	  thus	  reduced	  
3rd	  pouch	  	   Aplastic	   Hypoplastic	  
Epithelial	  
morphology	  




None	  evident	   The	   rostral	   endoderm	   appears	   to	  move	   toward	   the	   ectoderm	  without	   as	   one	   mass	   rather	   than	  foci	  of	  evaginations	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5.3.2	  Genetically	   increasing	   the	   level	  of	   endodermal	  FGF	  
signalling	   does	   not	   rescue	   caudal	   pouch	   formation	   in	  
endoderm	  devoid	  of	  Tbx1	  expression	  
The	  phenotypes	  of	  R1;R2cKOSox17	  and	  Tbx1cKOSox17	  embryos	  summarised	  in	  Table	  7	  suggest	   that	   Tbx1	   and	   FGF	   signalling	   do	   not	   function	   in	   the	   same	   endodermal	  pathway	   during	   pouch	   morphogenesis.	   To	   directly	   test	   the	   genetic	   interaction	  between	   FGF	   signalling	   and	   TBX1	   in	   the	   endoderm	  
Sox17icre/+Sprouty1flox/+;Sprouty2flox/+;Tbx1flox/+	   (Spry1;Spry2cHet;Tbx1cHetSox17)	   and	  
Sox17icre/+Sprouty1flox/+;Sprouty2flox/+;Tbx1flox/-­‐	   (Spry1;Spry2;Tbx1cKOSox17)	   embryos	  were	   generated	   (see	   2.3.1	   for	   details	   of	   breeding).	   The	   literature	   predicts	   that	  TBX1	  functions	  upstream	  of	  FGF	  signalling	  because	  the	  expression	  of	  genes	  in	  the	  FGF	  pathway	  are	  reduced	  in	  Tbx1-­‐/-­‐	  embryos	  and	  because	  MEFs	  derived	  from	  Tbx1-­‐
/-­‐	   embryos	  are	  unable	   elicit	   a	   response	   to	  FGF8	   stimulation,	   (Vitelli	   et	   al.,	   2010).	  
Sprouty	   family	  members	   are	   negative	   feedback	   regulators	   of	   FGF	   signalling	   and	  their	  genetic	  deletion	  has	  been	  demonstrated	  to	  de-­‐regulate	  FGF	  signalling	  within	  the	   3rd	   pouch,	   perturbing	   its	   development	   to	   endocrine	   glands	   (Gardiner	   et	   al.,	  2012).	   If	   endodermal	  TBX1	   functions	   to	   positively	   regulate	   FGF	   signalling	   in	   the	  pharyngeal	   endoderm	   during	   pouch	   outgrowth,	   an	   increase	   in	   FGF	   signalling,	  (mediated	  by	   a	   loss	   of	   endodermal	  Sprouty	  expression)	  may	   compensate	   for	   the	  loss	   of	   Tbx1	   from	   this	   tissue,	   rescuing	   pouch	   outgrowth.	   This	   hypothesis	   was	  tested	  by:	  a) Evaluating	   pouch	   formation	   at	   E10.5	   in	   Spry1;Spry2cHet;Tbx1cKOSox17	  embryos	  by	  Pax1	  in	  situ	  hybridisation.	  b) Evaluating	   FGF	   signalling	   in	   the	   compound	   mutants	   by	   Erm	   in	   situ	  
hybridisation.	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Comparing	  the	  pouches	  of	  Tbx1cKOSox17	  and	  Spry1;Spry2cHet;Tbx1cKOSox17	  embryos	  to	  Spry1;2;Tbx1cHetSox17	  and	  Cre	  negative	  embryos	  it	  was	  evident	  that	  only	  the	  1st	  pharyngeal	  pouch	  forms	  in	  mutants	  null	  for	  endodermal-­‐Tbx1	  (Figure	  	  42,	  panels	  c	  and	   d,	   asterix	   mark	   where	   caudal	   pouches	   were	   expected	   to	   form).	   This	   data	  indicates	   that	   reducing	   the	   level	   of	   Sprouty	   in	   the	   endoderm	   is	   not	   sufficient	   to	  rescue	   caudal	   pouch	   aplasia	   in	  Tbx1-­‐deficient	   endoderm.	   However,	   surprisingly,	  the	  level	  of	  endodermal	  Erm	  and	  Pea3	  expression	  in	  Spry1;Spry2cHet;Tbx1cKOSox17	  does	   not	   appear	   to	   be	   increased	   compared	   to	   Cre	   negative	   embryos	   (Fig	   43,	  compare	   panels	   a	   vs	   c	   and	   panels	   d	   vs	   f).	   	   Moreover,	   in	   contrast	   to	   the	   un-­‐segmented	  endodermal	  expression	  pattern	  of	  Erm	   in	  Tbx1cKOSox17	  at	  E9.5	  (Fig	  19	  panels	   d	   and	   d’)	   the	   pattern	   of	   Erm	   and	   Pea3	   expression	   in	  























































































Fig	  43:	  The	  expression	  pattern	  of	  Ets	  genes	  Pea3	  and	  Erm	  is	  relatively	  segmented	  despite	  
the	  un-­‐segmented	  morphology	  of	  the	  endoderm	  of	  Spry1;Spry2cHet;Tbx1cKOSox17	  embryos.	  	  
In	  situ	  hybridization	  for	  Pea3	  (a-­‐c)	  and	  Erm	  	  (d-­‐f)	  on	  frontal	  sections	  of	  E9.25	  Cre	  negative	  (a	  and	  d)	   Spry1;2;Tbx1cHetSox17	   (b	   and	   e)	   and	   Spry1;Spry2cHet;Tbx1cKOSox17	   (c	   and	   f)	   embryos	  pharyngeal	   apparatus	   reveals	   that,	   surprisingly,	   FGF	   signalling	   is	   relatively	   segmented	   when	  endoderm	   that	   is	   devoid	   of	  Tbx1	   is	   also	   deficient	   in	   Spry1	  and	   Spry2	   expression.	   Arrowheads	  indicate	  the	  maintenance	  of	  FGF	  signalling	  within	  the	  endoderm.	  Annotations:	  Black	  arrowhead	  =	  endodermal	  pouch	  expression,	  unfilled	  arrowhead	  =	  reduced/no	  endodermal	  pouch	  expression,	  pp	   =	   pharyngeal	   pouch,	   ?	   =	   presumptive	   pouch.	   	   Arrows	   to	   the	   left	   of	   Fig	   43	   illustrate	   the	  orientation	   of	   the	   pharyngeal	   apparatus	   sections;	   A	   =	   anterior,	   P	   =	   posterior,	   L	   =	   lateral,	   M	   =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  N=1	  	  
	  







 Fig  44 
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5.4	  DISCUSSION	  
A	   thorough	   analysis	   of	   pharyngeal	   pouch	   development	   in	   a	   range	   of	   conditional	  FGF	   mutants	   has	   revealed	   that	   FGF	   signalling	   is	   required	   in	   the	   endoderm	   for	  pharyngeal	   pouch	   morphogenesis	   to	   proceed	   normally.	   Functional	   redundancy	  amongst	  FGF	   ligands	  and	  FGF	   receptors	   appears	   to	   ensure	   that	  FGF	   signalling	   is	  maintained	  within	  the	  endoderm	  during	  pouch	  development.	  	  
	  
5.4.1.	   Functional	   redundancy	   of	   FGF	   ligands	   and	   FGF	  
receptors	   in	   the	   endoderm	   regulates	   pharyngeal	   pouch	  
evagination	  
Pouch	   morphogenesis	   occurs	   normally	   in	   Fgf8-­‐deficient	   endoderm,	   however,	  (unlike	   Tbx1-­‐deficeint	   endoderm),	   rostral	   pouch	   fusion	   manifests	   in	   endoderm	  deficient	   of	   Fgf8	   and	   Fgf3	   expression.	   This	   data	   indicates	   that	   FGF3	   and	   FGF8	  function	   redundantly	   within	   the	   pharyngeal	   endoderm	   during	   rostral	   pouch	  morphogenesis.	  	  Functional	  redundancy	  between	  FGF3	  and	  FGF8	  ligands	  has	  been	  demonstrated	  in	  many	  developmental	  contexts,	  for	  instance:	  in	  the	  formation	  and	  patterning	  of	  the	  otic	  vesicle	  and	  hindbrain	  and	  during	  the	  induction	  of	  the	  three	  epibranchial	  placodes	  (Maroon	  et	  al.,	  2002;	  Walshe	  et	  al.,	  2002;	  Nechiporuk	  et	  al.,	  2005).	  Of	  most	  significance	  to	  this	  thesis	  is	  the	  observation	  that	  FGF3	  and	  FGF8	  act	  redundantly	   during	   zebrafish	   pouch	   morphogenesis.	   Variably	   penetrant	   and	  expressive	  pouch	  defects	  manifest	  in	  fgf8-­‐	  zebrafish	  mutants	  (Crump	  et	  al.,	  2004).	  Inhibiting	   the	   expression	   of	   fgf3	   in	   fgf8-­‐	   zebrafish	   (fgf8-­‐;fgf3-­‐MO	   embryos)	  increases	  the	  severity	  of	  pharyngeal	  pouch	  defects,	  for,	  no	  pharyngeal	  pouches	  are	  able	  to	  form	  in	  the	  fgf8-­‐;fgf3-­‐MO	  embryos	  (Crump	  et	  al.,	  2004).	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  However,	   in	   contrast	   to	   the	   zebrafish	   fgf8-­‐;fgf3-­‐MO	   mutants,	   the	   penetrance	   of	  pouch	  defects	  in	  F3;F8cKOSOX17	  embryos	  is	  variable.	  	  This	  data	  suggests	  that	  either;	  	  
	  a)	   Multiple	   FGF	   ligands	   in	   the	   endoderm	   function	   to	  maintain	   pouch	   evagination.	  Endodermal	   expression	   domains	   of	   Fgf15	   and	   Fgf4	   both	   overlap	   with	   Fgf3	   and	  
Fgf8,	  highlighting	  these	  ligands	  as	  additional	  candidates	  that	  may	  function	  during	  pouch	  morphogenesis	  (Dracker	  and	  Goldfarb,	  1993).	  
	  	  b)	   FGF	   ligands	   in	   adjacent	   (non-­‐endodermal)	   PA	   tissue	   may	   be	   able	   to	   maintain	  
pouch	  evagination.	  
	  This	   is	   thought	   to	   be	   the	   case	   in	   fgf8-­‐;fgf3-­‐MO	   zebrafish	   mutants	   whose	   pouch	  outgrowth	  was	  surprisingly	  rescued	  by	  a	  combination	  of	  neural	  and	  mesodermal	  ‘wild	   type’	   cells,	   rather	   than	   by	   transplantation	   of	   ‘wild	   type’	   endodermal	   cells	  (Crump	  et	  al.,	  2004).	  To	  determine	  which	  tissue-­‐specific	  source	  of	  Fgf3	  and	  Fgf8	  is	  
sufficient	  to	  drive	  pouch	  morphogenesis	  requires	  an	  analysis	  of	  pouch	  formation	  in	   embryos	  null	   for	  Fgf3	   and	  hypomorphic	   for	  Fgf8	   that	   have	  had	  Fgf3	   and	  Fgf8	  expression	   re-­‐activated	   in	   one	   tissue	   type,	   such	   as	   the	   endoderm.	   	   This	   type	   of	  experiment	   is	   required	   before	   it	   can	   be	   conclusively	   determined	   which	   tissue	  source	  of	  Fgf3	  and	  Fgf8	  is	  essential	  for	  pouch	  morphogenesis.	  
	  
c)	  FGF	  signalling	  in	  adjacent	  (non-­‐endodermal)	  tissues	  in	  the	  PA	  may	  be	  capable	  of	  
maintaining	  pharyngeal	  pouch	  evagination.	  The	  absence	  of	  pouch	  defects	   in	  embryos	  that	   lack	  Fgfr1	  and	  Fgfr2	   in	  CNCC	  or	  in	  mesodermal	  cells,	  (as	  determined	  by	  this	  thesis),	  suggests	  that	  this	  is	  not	  the	  case.	  	  The	  absence	  of	  pouch	  defects	  in	  the	  R1;R2cKOWnt1	  embryos	  is	  consistent	  with	  data	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which	   demonstrated	   that	   CNCC	   specific	   deletions	   of	   Fgfr1	   do	   not	   cause	   pouch	  defects	  and	  that	  the	  reactivation	  of	  Fgfr1	  in	  the	  CNCC	  of	  Fgfr1	  hypomorphs	  is	  not	  sufficient	   to	   rescue	   the	   pouch	   fusion	   (Trokovic	   et	   al.,	   2003).	   Trokovic	   et	   al.	  proposed	   that	   the	   loss	  an	  ectodermal	   signalling	  centre	  was	   the	  cause	  of	  2nd	  arch	  hypoplasia	  (and	  thus	   likely	  rostral	  pouch	   fusion)	   in	  Fgfr1	  hypomorphs	  (Trokovic	  et	  al.,	  2003;	  Trokovic	  et	  al.,	  2005).	  Regrettably	  an	  assessment	  of	  the	  requirement	  for	   Fgfr1	   and	   Fgfr2	   in	   the	   ectoderm	   during	   pouch	   and	   arch	   formation	   was	   not	  tested.	  This	  could	  have	  been	  achieved	  by	  the	  generation	  of	  Ap2alphaCre/+;Fgfr1flox/-­‐;Fgfr2flox/-­‐	   embryos.	   Incidentally,	   however,	   the	   maintenance	   of	   FGF	   signalling	  within	  the	  ectoderm	  of	  R1;R2cKOSox17	  embryos	  is	  not	  sufficient	  to	  maintain	  pouch	  morphogenesis	  in	  Fgfr1;Fgfr2-­‐deficient	  pharyngeal	  endoderm.	  	  In	   contrast,	   the	   deletion	   of	   Fgfr1	   and	   Fgfr2	   from	   the	   endoderm	   during	  embryogenesis	   is	   sufficient	   to	   recapitulate	   the	   fully	   penetrant,	   bilateral	   rostral	  pouch	   fusion,	   observed	   in	   Fgfr1	   hypomorphs.	   The	   pouch	   defects	   of	   the	  
R1;R2cKOSox17	   embryos	   are	  due	   to	   the	   loss	  of	   FGF	   signalling	   specifically	   from	   the	  endoderm,	   (as	   determined	   from	   the	   observed	   loss	   of	   FGF	   signalling	   effector	  expression	   in	   this	   tissue).	   This	   data	   suggests	   that	   FGF	   signalling	   is	   specifically	  required	  within	  the	  endoderm	  during	  pharyngeal	  pouch	  morphogenesis.	  	  	  
5.4.2	   Rostral	   pouch	   evagination	   appears	   more	   sensitive	  
to	   reductions	   in	   the	   level	   of	   endodermal	   FGF	   signalling	  
than	  caudal	  pouch	  evagination	  
Bilateral	   fusion	   of	   the	   rostral	   pouches	   and	   2nd	   arch	   hypoplasia	   are	   evident	   in	  
F3;8cKOSox17,	  R1cKO;R2cHetSox17	  and	  R1;R2cKOSox17	  embryos	  and	  Fgfr1	  hypomorphs.	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Interestingly,	   the	  compound	  deletion	  of	  Fgfr1	   and	   Fgfr2	   from	   the	  endoderm	  also	  results	   in	   3rd	   pouch	   hypoplasia.	   This	   observation	   suggests	   that	   caudal	   pouch	  development	   is	   less	   susceptible	   to	   reductions	   in	   the	   level	   of	   FGF	   signalling	   than	  rostral	   pouch	   development.	   	   It	   is	   unclear	   why	   the	   rostral	   apparatus	   is	   highly	  sensitive	  to	  the	   loss	  of	  FGF	  signalling.	  The	  caudal	  PA	  gives	  rise	  to	  structures	  that	  are	  essential	  for	  postnatal	  viability	  including;	  the	  3rd-­‐	  6th	  PAA	  that	  give	  rise	  to	  the	  thoracic	  vessels	  of	  the	  heart,	  CNCC	  that	  migrate	  through	  the	  caudal	  PA	  to	  form	  the	  cushions	   of	   the	   aortic	   sac	   and	   the	   3rd	   pouch	   from	   which	   the	   thymus	   and	  parathyroid	   are	   derived	   (Hiruma	   et	   al.,	   2002;	   Blackburn	   and	   Manley,	   2004;	  Vincentz	   et	   al.,	   2005).	   It	   is	   tempting	   to	   speculate	   that	   functional	   redundancy	  between	   Fgfr1	   and	   Fgfr2	   in	   the	   caudal	   endoderm	   exists	   to	   ensure	   the	   correct	  formation	   of	   these	   postnatal	   structures.	   Supporting	   this	   inference	   is	   the	  observation	   that	   thymus	   aplasia	   presents	   in	   R1cKO;R2cHetSox17	   and	  
R1cHet;R2cKOSox17	  embryos	  but	  has	  not	  reported	  in	  Fgfr1	  hypomorphs	  (Trokovic	  et	  al.,	  2003;	  Trokovic	  et	  al.,	  2005).	  On	  the	  other	  hand,	  thymus	  aplasia	  may	  manifest	  in	  compound	  endodermal	  FGF	  receptor	  mutants	  because	  FGF	  signalling	  downstream	  of	   FGFR2	   in	   the	   endoderm	   is	   required	   for	   the	   organogenesis	   of	   these	   organs.	  Supporting	  this	  view	  is	  the	  observation	  that	  Fgfr2IIIb	  null	  mice	  develop	  thymus	  and	  cardiac	  defects	  (Dooley	  et	  al.,	  2007).	  
	  
5.4.3	  CNCC	  migration	  and	  differentiation	  is	  perturbed	  by	  
the	  loss	  of	  FGF	  signalling	  from	  the	  endoderm	  	  
The	   2nd	   arch	   hypoplasia	   in	   Fgfr1	   hypomorphs	   and	   Fgfr1∆Frs/∆Frs	   embryos	   is	  attributed	  to	  a	  loss	  of	  CNCC	  migration	  and	  survival	  (Trokovic	  et	  al.,	  2003;	  Hoch	  and	  Soriano,	   2006).	   For	   instance,	   the	   hypoplastic	   2nd	   arch	   of	  Fgfr1∆Frs/∆Frs	  mutants	   is	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completely	  devoid	  of	  Sox10	  expressing	  CNCC.	  This	  CNCC	  defect	  is	  correlated	  with	  an	   increase	   in	   cell	   death	   and	   a	   decrease	   in	   proliferation	   in	   the	   2nd	   arch	   of	   the	  
Fgfr1∆Frs/∆Frs	   embryos	   (Hoch	   and	   Soriano,	   2006).	   Interestingly,	   although	   the	   2nd	  arch	   is	   hypoplastic	   in	   the	  R1;R2cKOSox17	   embryos,	   similar	   CNCC	  defects	  were	  not	  observed	  in	  these	  mutants.	  For,	  R1;R2cKOSox17	  embryos	  appear	  to	  have	  a	  reduction	  in	   the	   amount	   of	  Dlx2	   expressing	   CNCC	   in	   the	   proximal	   aspect	   of	   their	   2nd	   arch,	  rather	   than	   a	   complete	   loss	   of	   CNCC	   specific	   markers.	   Thus,	   the	   lack	   of	   CNCC	  infiltration	  into	  the	  2nd	  arch	  of	  Fgfr1	  hypomorphs	  and	  Fgfr1∆Frs/∆Frs	  embryos	  may	  be	  due	   to	   the	   loss	   of	   ectodermal	   FGF	   signalling,	   (or	   indeed	   due	   to	   a	   loss	   of	   FGF	  signalling	  from	  both	  pharyngeal	  epithelia),	  rather	  than	  from	  the	  endoderm	  alone.	  	  	  CNCC	  infiltration	  is	  also	  reduced	  in	  Sox3	  null	  embryos	  (Sox3-­‐/-­‐)	  that	  also	  display	  2nd	  arch	   hypoplasia	   (Rizzoti	   and	   Lovell-­‐Badge,	   2007).	   Sox3,	   like	   Fgfr1	   and	   Fgfr2,	   is	  expressed	  in	  both	  pharyngeal	  epithelia	  and	  the	  loss	  of	  Sox3	  perturbs	  the	  formation	  of	  the	  rostral	  pouches.	  	  Rizzoti	  et	  al.	  predict	  that	  it	  is	  the	  perturbed	  morphology	  of	  the	  Sox3-­‐/-­‐	  embryo’s	  2nd	  pouch	  that	  restricts	  the	  amount	  of	  CNCC	  migration	  into	  the	  2nd	  arch	  (Rizzoti	  and	  Lovell-­‐Badge,	  2007).	  It	  is	  possible	  that	  the	  fused	  morphology	  of	  the	  R1;R2cKOSox17	  mutants	  rostral	  pouches	  may	  be	  restricting	  the	  amount	  of	  late-­‐migrating	  CNCC	  that	  are	  able	  to	  enter	  the	  2nd	  arch.	  The	  ectopic	  region	  of	  cell	  death	  visible	   in	  and	  around	   the	  otic	  vesicle	  of	   the	  R1;R2cKOSox17	   embryo	  may	  represent	  misrouted	  CNCC	  destined	  for	  the	  2nd	  arch.	  	  Although	  Dlx2	  expressing	  CNCCs	  are	  not	  detected	  in/around	  the	  otic	  vesicle,	  double	  staining	  for	  alternative	  CNCC	  markers	  i.e.	  Crabp1	  and	  Caspase	  antigens,	  or,	  otic	  cell	  markers	  and	  Caspase	  antigens	  would	  be	  necessary	   to	  confirm	  the	   identity	  of	   these	  dying	  cells.	  FGF	  signalling	   from	  the	  endoderm	  also	  appears	  to	  be	  required	  for	  the	  maintenance	  of	  Hox	  gene	  expression	  in	   the	  caudal	  CNCC-­‐derived	  mesenchyme.	   It	   is	   interesting	  to	  note	   that	   the	   loss	  of	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Hoxb1	   from	   the	   endoderm	   of	   R1;R2cKOSox17	   embryos	   correlates	   with	   a	   loss	   of	  
Hoxb1	   expression	   in	   the	  mesenchyme,	  whereas	   the	   loss	  of	  Hoxa2	   from	  the	   inter-­‐pouch	   endoderm	   covering	   the	   2nd	   arch	   does	   not	   affect	   the	   maintenance	   Hoxa2	  expression	   in	   the	   adjacent	  mesenchyme.	  This	   data	   fits	  with	   the	   observation	   that	  regions	   of	   endoderm	   with	   distinct	   signalling	   profiles	   are	   able	   to	   direct	   and/or	  influence	  the	  development	  of	  the	  CNCC,	   for	   instance	  into	  visceral	  skeleton	  (Couly	  et	   al.,	   2002).	   It	   is	   possible	   that	   domains	   of	   FGF	   signalling	   within	   the	   pouch	  endoderm,	   rather	   than	   the	   inter-­‐pouch	   endoderm,	   may	   be	   required	   to	   form	   a	  permissive	  environment	  for	  CNCC	  differentiation.	  	  	  
5.4.4	   TBX1	   and	   FGF	   signalling	   appear	   to	   function	   in	  
parallel	   pathways	   within	   the	   endoderm	   during	  
pharyngeal	  pouch	  morphogenesis	  
Literature	   suggests	   that	   TBX1	   is	   able	   to	   positively	   regulate	   FGF	   signalling.	  	  However,	   in	   Chapter	   3	   it	   was	   observed	   that	   FGF	   signalling	   is	  maintained	   in	   the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	  	  The	  following	  two	  hypotheses	  aim	  to	  resolve	  this	  dichotomy:	  1) FGF	  signalling	  is	  reduced	  in	  Tbx1cKOSox17	  embryos	  but	  the	  reduction	  cannot	  be	  detected	  by	  in	  situ	  hybridisation	  	  2) FGF	   signalling	   is	   not	   regulated	   in	   a	   TBX1	   dependent	   manner	   within	   the	  endoderm	  during	  pouch	  morphogenesis	  	  It	  was	  reasoned	  that	  increasing	  FGF	  signalling	  (by	  reducing	  Sprouty	  expression,	  a	  negative	  regulator	  of	  FGF	  signalling)	  in	  Tbx1-­‐deficient	  endoderm	  would	  test	  these	  hypotheses.	  If	  caudal	  pouches	  formed	  in	  Spry1;Spry2cHet;Tbx1cKOSox17	  embryos	  it	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would	  support	  hypothesis	  (1);	  that	  a	  specific	  level	  of	  FGF	  signalling	  maintained	  by	  TBX1	   is	   required	   for	   caudal	   pouch	   formation.	   	   Alternatively,	   if	   the	   pouch	  phenotype	   of	   Spry1;Spry2cHet;Tbx1cKOSox17	   and	   Tbx1cKOSox17	   embryos	   was	  identical,	   this	   would	   support	   hypothesis	   (2).	   The	   caudal	   pouches	   of	  
Spry1;Spry2cHet;Tbx1cKOSox17	   embryos	   are	   aplastic;	   however,	   the	   expression	   of	  
Erm	  within	  the	  un-­‐segmented	  endoderm	  appears	  patterned,	  unlike	  the	  expression	  of	  Erm	  in	  Tbx1cKOSox17	  embryos.	  	  The	  finding	  that	  caudal	  pouch	  formation	  does	  not	  manifest	   in	  Spry1;Spry2cHet;Tbx1cKOSox17	  embryos	  suggests	   that	  FGF	  signalling	   is	  unlikely	   to	   function	   downstream	   of	   TBX1	   in	   the	   endoderm	   during	   pouch	  outgrowth.	   	   This	   inference	   is	   supported	   by	   the	   observation	   that	   R1;R2cKOSox17	  embryos	  and	  Tbx1cKOSox17	  embryos	  have	  distinct	  pouch	  phenotypes	  (see	  Table	  7),	  indicative	  of	  TBX1	  and	  FGF	  signalling	  having	  unique	  roles	  in	  the	  endoderm	  during	  caudal	  pouch	  formation.	  On	  the	  other	  hand,	  the	  partial	  rescue	  in	  the	  pattern	  of	  FGF	  signalling	   expression	   within	   the	   pharyngeal	   endoderm	   of	  
Spry1;Spry2cHet;Tbx1cKOSox17	  embryos	  suggests	  that	  that	  TBX1	  and	  FGF	  signalling	  may	  interact	  in	  parallel	  pathways	  to	  control	  pouch	  outgrowth.	  	  A	  recent	  paper	  by	  Simrick	  et	  al.	  demonstrated	  that	  the	  interaction	  between	  TBX1	  and	  FGF	  signalling	  may	  not	  be	   linear.	  When	  one	  allele	  of	  Tbx1	   is	  deleted	  from	  all	  tissues	  in	  a	  Spry1;2+/-­‐	  or	  Spry1;2-­‐/-­‐	  embryo,	  Erm	  expression	  (normally	  decreased	  in	  
Tbx1+/-­‐	   embryos)	   is	   up-­‐regulated	   (Simrick	   et	   al.,	   2012).	   Surprisingly,	   in	   an	  endoderm-­‐specific	  context,	  the	  loss	  of	  one	  allele	  of	  both	  Sprouty1	  and	  Sprouty2	  in	  a	  
Tbx1	  null	  background	  appears	  to	  normalise	  Erm	  expression	  in	  this	  tissue.	  This	  data	  supports	  the	  inference	  of	  Simrick	  et	  al.,	  that	  the	  interaction	  between	  TBX1	  and	  FGF	  signalling	  is	  not	  linear	  and	  adds	  an	  extra	  layer	  of	  complexity	  to	  the	  mechanism	  of	  this	  interaction.	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  If	  FGF	  signalling	  is	  not	  directly	  regulated	  by	  TBX1	  during	  pouch	  formation,	  which	  signalling	   cascades	   or	   cellular	   mechanisms	   could	   TBX1	   be	   affecting	   in	   the	  endoderm	   to	   drive	   pouch	   morphogenesis?	   	   This	   question	   was	   addressed	   in	  Chapter	  6.	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6.1	   TBX1	   may	   regulate	   pouch	   morphogenesis	   in	   the	  
endoderm	   independently	   from	   its	   effects	   on	   FGF	  
signalling	  
The	  data	  presented	  so	  far	  suggests	  that	  TBX1	  and	  FGF	  signalling	  are	  both	  required	  in	   the	  endoderm	   for	   the	  process	  of	  pharyngeal	  pouch	  morphogenesis.	   	  However,	  the	  loss	  of	  TBX1	  or	  FGF	  signalling	  from	  the	  endoderm	  has	  a	  different	  effect	  on	  the	  formation	   of	   the	   pharyngeal	   pouches.	   Deletion	   of	   Tbx1	   from	   the	   endoderm	  prevents	   the	   initiation	   of	   caudal	   pouch	   outgrowth,	   whereas	   the	   loss	   of	   FGF	  signalling	   from	   the	   endoderm	   results	   in	   rostral	   pouch	   fusion	   and	   caudal	   pouch	  hypoplasia.	  These	  data	   indicates	   that	  TBX1	   in	   the	  endoderm	  may	  regulate	  pouch	  morphogenesis	   independently	   from	   its	  effects	  on	  FGF	  signalling.	  The	  next	  aim	  of	  this	   study	  was	   to	   identify	   a	   TBX1-­‐dependent	   regulator	   of	   pouch	  morphogenesis.	  	  The	   first	   part	   of	   this	   chapter	   focuses	   on	   signalling	   cascades	   that	   may	   be	  transcriptional	   targets	   of	   TBX1,	   such	   as	   the	   RA	   signalling	   pathway.	   	   The	   second	  part	  of	  this	  chapter	  focuses	  on	  how	  deletion	  of	  Tbx1	  from	  the	  endoderm	  may	  affect	  the	   endoderm	   at	   the	   cellular	   level	   by	   altering	   	   its	   proliferation	   or	   proteins	  associated	  with	  the	  cells	  architecture.	  
	  
6.2	   Loss	   of	   endodermal	   Tbx1	   affects	   the	   expression	   of	  
genes	   in	   signalling	   pathways	   predicted	   to	   act	   up	   and	  
down	  stream	  of	  Tbx1	  expression	  	  
Retinoic	  acid	  (RA),	  the	  active	  form	  of	  Vitamin	  A,	  is	  a	  small	  lipophilic	  molecule	  that	  if	   absent,	   or	  present	   in	  excess,	  during	  embryogenesis	   can	  affect	   the	   formation	  of	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the	   pharyngeal	   pouches.	   Caudal	   pouch	   aplasia	   similar	   to	   that	   exhibited	   in	  
Tbx1cKOSox17	   embryos,	   manifests	   in	   embryos	   that	   lack,	   or	   have	   increased,	   RA	  signalling	   (Wendling	  et	   al.,	   2000;	  Niederreither	  et	   al.,	   2003;	  Roberts	   et	   al.,	   2005;	  Roberts	  et	  al.,	  2006).	  Data	  in	  the	  literature	  demonstrates	  that	  there	  is	  a	  reciprocal	  inhibition	   of	   Tbx1	   expression	   and	   RA	   signalling	   during	   development.	   Retinol-­‐soaked	   beads	   grafted	   into	   the	   pharyngeal	   pouches	   of	   quail	   embryos	   results	   in	   a	  decrease	  in	  the	  level	  of	  Tbx1	  expression	  around	  the	  bead	  and	  Vitamin	  A	  Deficient	  (VAD)	   quails	   lack	   Tbx1	   expression	   (Quinlan	   et	   al.,	   2002).	   Conversely,	   the	  expression	  of	  Raldh2	  (an	  enzyme	  that	  synthesises	  RA)	  is	  extended	  anteriorly	  in	  the	  PA	   of	   Tbx1-­‐/-­‐	   embryos.	   	   The	   latter	   coincides	   with	   a	   loss	   in	   expression	   of	   the	  catabolic	   enzymes	   Cyp26a1,	   Cyp26b1	   and	   Cyp26c1	   which	   function	   to	   clear	   RA	  (Niederreither	   et	   al.,	   2003).	   However,	   Roberts	   et	   al.	   demonstrated	   that	   in	   cell	  culture	   the	  application	  of	  exogenous	  RA	  did	  not	  elicit	  an	   immediate	   inhibition	  of	  
Tbx1	   expression	   (Roberts	   et	   al.,	   2005).	   Moreover,	   Tbx1	   expression	   was	   only	  partially	   repressed	   in	   embryos	   exposed	   to	   a	   drug	   that	   inhibits	   expression	  of	   the	  
Cyp26	   genes	   (Roberts	   et	   al.,	   2006).	   These	   data	   indicate	   that	   the	   interaction	  between	  TBX1	  and	  RA	  during	  pouch	  morphogenesis	  may	  be	  more	  complex	  than	  a	  direct	  reciprocal	  inhibition,	  which	  is	  further	  highlighted	  by	  the	  complex	  interaction	  between	  Tbx1,	  RA	  and	  Hox	  genes	  during	  PA	  development.	  	  RA	   is	  able	   to	   regulate	   the	  expression	  of	   a	  number	  of	  Hox	   genes,	   including	  Hoxb1	  and	  Hoxa2	  (Guris	  et	  al.,	  2006;	  Diman	  et	  al.,	  2011).	  In	  the	  case	  of	  Hoxb1	  expression,	  regulation	   by	   RA	   is	   likely	   to	   be	   direct,	   by	   virtue	   of	   the	   Hoxb1	   retinoic	   acid	  responsive	   enhancer	   (Langston	   et	   al.,	   1997).	   Reducing	   the	   level	   of	   RA	   during	  embryonic	  development	  results	   in	  a	   loss	  or	  reduction	   in	  Hoxb1	  expression	   in	  the	  caudal	  PA	  (Wendling	  et	  al.,	  2000;	  Vermot	  et	  al.,	  2003)	  Conversely,	  embryos	  treated	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with	   a	   specific	   Cyp26	   inhibitor	   (R115866)	   display	   expanded	   domains	   of	  Raldh2	  expression,	  indicative	  of	  increased	  RA	  levels,	  and	  a	  reciprocal	  expansion	  of	  Hoxb1	  (Roberts	   et	   al.,	   2006).	   Similarly,	   Hoxa2	   expression	   is	   induced	   in	   NCC	   cultures	  exposed	  to	  exogenous	  RA	  and	  in	  the	  pharyngeal	  endoderm	  of	  embryos	  implanted	  with	  RA-­‐soaked	  beads	  (Bayha	  et	  al.,	  2009;	  Ishikawa	  and	  Ito,	  2009).	  	  The	  relationship	  between	  Tbx1,	  RA	  and	  Hox	  gene	  expression	  is	  complex	  and	  varies	  depending	  on	  the	  specific	  member	  of	  the	  Hox	  family	  and	  the	  tissue	  being	  analysed.	  Despite	   the	   elevated	   levels	   of	   RA	   in	   Tbx1-­‐/-­‐	   embryos	   and	   the	   sensitivity	   of	   the	  
Hoxa3	   promoter	   to	   RA,	   Hoxa3	   expression	   is	   not	   altered	   in	   the	   PA	   of	   Tbx1-­‐/-­‐	  embryos	  (Ivins	  et	  al.,	  2005).	  Moreover,	  the	  expression	  of	  Hoxa2	   is	  reduced	  in	  the	  2nd	  pharyngeal	  arch	  of	  Tbx1-­‐/-­‐	  embryos,	  despite	  the	  observation	  that	  RA	  signalling	  is	  expanded	  into	  the	  rostral	  PA	  of	  these	  mutants	  (Guris	  et	  al.,	  2006;	  Aggarwal	  et	  al.,	  2010).	   In	   contrast,	   the	   expansion	   of	   RA	   signalling	   results	   in	   a	   corresponding	  expansion	  of	  Hoxb1	  in	  the	  PA	  expression	  whether	  the	  former	  occurs	  as	  a	  result	  of	  
Tbx1	  deletion,	  or,	  due	  to	  the	  application	  of	  exogenous	  RA	  (Guris	  et	  al.,	  2006;	  Bayha	  et	  al.,	  2009).	  	  In	   contrast,	   SONIC	  HEDGEHOG	  (SHH)	  has	  been	  demonstrated	   to	  act	  upstream	  of	  
Tbx1,	  regulating	  its	  expression	  via	  Forkhead	  transcription	  factor	  (Foxa2)	  (Garg	  et	  al.,	  2001;	  Yamagishi	  et	  al.,	  2003).	  However,	  whether	  this	  interaction	  is	  relevant	  to	  pouch	  morphogenesis	   is	  questionable.	   	  The	  deletion	  of	  either	  Tbx1	  or	  Shh	  during	  embryogenesis	   generates	  pouch	  defects,	   yet	   the	  defects	   are	  distinct,	   respectively	  having	   the	  most	   severe	   affects	   on	   either	   caudal	   or	   rostral	   pouch	  morphogenesis	  (see	   section	   1.9.2	   for	   a	   more	   detailed	   explanation)	   (Jerome	   and	   Papaioannou,	  2001;	   Moore-­‐Scott	   and	   Manley,	   2005).	   The	   dorsal-­‐ventral	   patterning	   of	   the	   3rd	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pouch	  is	  thought	  to	  be	  established,	  in	  part,	  by	  the	  opposing	  effects	  of	  Shh	  and	  Bmp4	  mediated	   signals	   (Moore-­‐Scott	   and	   Manley,	   2005).	   In	   E10.5	   Shh-­‐/-­‐	   embryos	   the	  expression	  of	  Bmp4	  is	  expanded	  in	  the	  3rd	  pouch.	  	  A	  consequence	  of	  the	  expanded	  
Bmp4	   expression	   domain	   is	   that	   the	   3rd	   pouch	   is	   no	   longer	   able	   to	   maintain	  expression	   of	   the	   presumptive	   parathyroid	   marker,	   Gcm2	   (Moore-­‐Scott	   and	  Manley,	  2005).	  
	  
Bmp4	   is	   expressed	   within	   the	   pharyngeal	   endoderm	   and	   mesenchyme	   during	  pouch	  morphogenesis	  (Patel	  et	  al.,	  2006).	  A	  tissue-­‐specific	  requirement	  for	  Bmp4	  within	  the	  endoderm	  during	  pouch	  morphogenesis	  has	  not	  yet	  been	  reported	  (Liu	  et	   al.,	   2004;	   Gordon	   et	   al.,	   2010).	   However,	  Bmp4	   is	   required	   in	   the	   pharyngeal	  epithelia	  for	  the	  correct	  morphogenesis	  and	  migration	  of	  endocrine	  glands	  that	  are	  derived	  from	  the	  pharyngeal	  endoderm	  (Gordon	  et	  al.,	  2010).	  Loss	  of	  Tbx1	  from	  all	  pharyngeal	  tissues	  results	  in	  a	  proximal	  shift	  of	  the	  Bmp4	  expression	  domain	  in	  the	  1st	   arch	   ectoderm,	  where	   it	   reciprocally	   restricts	   the	   domain	   of	  Fgf8	   expression	  (Aggarwal	   et	   al.,	   2010).	   Whether	   Bmp4	   expression	   domains	   in	   the	   caudal	  apparatus	  are	  shifted	  or	  lost	  in	  response	  to	  a	  loss	  of	  Tbx1	  expression	  has	  not	  been	  determined.	  
	  
6.2.1	   Deletion	   of	   Tbx1	   from	   the	   endoderm	   affects	   the	  
endodermal	   expression	   of	   genes	   in	   the	   RA	   signalling	  
pathway	  but	  not	  the	  RA	  targets	  Hoxb1	  and	  Hoxa2	  
To	  assess	  the	  interaction	  of	  Tbx1	  and	  RA	  signalling	  in	  the	  endoderm,	  expression	  of	  genes	   in	   the	  RA	  pathway	  and	  their	   targets	  were	  compared	  between	  Tbx1cKOSox17	  and	  control	  embryos.	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6.2.1.1	  Rarb	  expression	  is	  expanded	  anteriorly	  in	  the	  endoderm	  of	  
Tbx1cKOSox17	   embryos,	   despite	   the	   maintained	   mesenchymal	  
expression	  domain	  of	  Raldh2	  	  The	  expansion	  and	  up-­‐regulation	  of	  RA	  signalling	  in	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos	  is	  proposed	   by	   Guris	   et	   al.	   to	   account	   for	   the	   un-­‐segmented	  morphology	   of	   this	  structure	  (Guris	  et	  al.,	  2006).	  It	  was	  hypothesised	  that	  the	  deletion	  of	  Tbx1	  from	  the	   endoderm	   would	   result	   in	   a	   tissue-­‐specific	   disruption	   of	   retinoid	  homeostasis,	  which	  may	  account	  for	  the	  loss	  of	  caudal	  pouch	  morphogenesis	  in	  
Tbx1cKOSox17	  embryos.	   To	   investigate	  whether	   the	   synthesis	   of	   RA	   is	   altered	   in	  
Tbx1cKOSox17	   embryos,	   the	   expression	   of	   Raldh2	   was	   analysed	   by	   in	   situ	  hybridization	  performed	  on	  mutant	  and	  control	  PA	  sections.	  RALDH2	  catalyses	  synthesis	   of	   RA	   by	   the	   oxidation	   of	   retinaldehyde.	   As	   this	   oxidative	   step	   is	  irreversible	  any	  changes	  to	  the	  level	  of	  Raldh2	  expression	  will	  be	  reflected	  in	  the	  amount	  of	  RA	  produced	  (Kam	  et	  al.,	  2012).	   	  Raldh2	  expression	  is	   limited	  to	  the	  very	   caudal	   mesenchyme	   only,	   just	   caudal	   to	   the	   forming	   3rd	   pouch	   (green	  arrowhead	   on	   Fig	   45	   panel	   a	   identifies	   the	   anterior	   limit	   of	   Raldh2	   in	   the	  mesenchyme	   in	  Cre	  negative	   embryos).	  The	  pharyngeal	   endoderm	   is	   absent	  of	  
Raldh2	   expression.	   In	   Tbx1cKOSox17	   embryos	   the	   level	   and	   pattern	   of	   Raldh2	  expression	   in	   the	   mesenchyme	   is	   identical	   to	   that	   observed	   in	   Cre	   negative	  embryos	  (Figure	  45	  compare	  panel	  b	  to	  panel	  a,	  green	  arrows	  depict	  the	  anterior	  limit	  of	  Raldh2	  expression	  in	  the	  mesenchyme).	  It	  is	  significant	  to	  note	  that	  there	  is	   no	   extension	   to	   the	   anterior	   limit	   of	   Raldh2	   expression	   domain	   in	   the	   un-­‐segmented	  mesenchyme	  of	  Tbx1cKOSox17	  embryos.	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For	   active	   RA	   signalling	   to	   occur,	   retinol,	   synthesised	   by	  Raldh2,	  must	   bind	   to	  one	   of	   its	   receptor	   targets,	   such	   as	   Rarb.	   High	   levels	   of	   Rarb	   expression	   are	  detected	   in	   the	   caudal	   PA	   at	   E9.5.	   In	   particular,	   robust	   endodermal	   Rarb	  expression	   is	  detected	   in	   the	   evaginating	  3rd	  pouch,	  proximal	   to	   the	  domain	  of	  mesenchymal	   Raldh2	   expression	   (Fig	   45,	   compare	   endodermal	   expression	   of	  
Rarb	   in	   panels	   c	   to	   mesenchymal	   Raldh2	   expression	   in	   panel	   a).	   Active	   RA	  signalling	   indicated	   by	   the	   expression	   of	   Rarb	   is	   extended	   throughout	   Tbx1-­‐devoid	  endoderm	  (Fig	  45,	  panel	  d).	   	   In	  addition	   the	   level	  of	  Rarb	  expression	   in	  the	   rostral	   endoderm	   is	   significantly	   increased,	   (Fig	   45,	   compare	   the	   two	  posterior	  unfilled	  arrows	  in	  panel	  c	  with	  the	  2	  posterior	  black	  arrows	  in	  panel	  d).	  In	  keeping	  with	  the	  endoderm-­‐specific	  deletion	  of	  Tbx1,	  there	  is	  no	  change	  to	  the	  mesenchymal	   domain	   of	  Rarb	  expression	   (Fig	   45,	   compare	   the	   rostral	   limit	   of	  mesenchymal	  expression	  in	  panels	  c	  and	  d	  marked	  by	  green	  arrows).	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Fig	  45:	  Tbx1cKOSox17	  embryos	  display	  an	  anterior	  expansion	  of	  active	  RA	  signalling	  in	  the	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6.2.2.2	   Cyp26	   genes	   are	   maintained	   in	   Tbx1cKOSox17	   embryos	  
pharyngeal	  endoderm	  The	  expansion	  of	  RA	  signalling	  throughout	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos	  cannot	  be	  explained	  by	  changes	   in	   the	  extent	  of	  RALDH2	  mediated	  RA	  synthesis.	  	  An	   alternative	   possibility	   is	   that	   the	   loss	   of	   Tbx1	   in	   the	   endoderm	   results	   in	   a	  reciprocal	   down-­‐regulation,	   or	   loss,	   of	   RA	   catabolisers	   (mediated	   by	   the	   Cyp26	  genes),	  as	  is	  observed	  in	  Tbx1-­‐/-­‐	  embryos	  (Guris	  et	  al.,	  2006;	  Roberts	  et	  al.,	  2006).	  	  
Cyp26c1	   is	   restricted	   to	   the	   1st	   pouch	   of	   the	   PA	   and	   diffusely	   within	   the	  mesenchyme	   rostral	   to	   the	   1st	   arch.	   Considering	   the	   1st	   pouch	   forms	   in	  
Tbx1cKOSox17	   embryos,	   it	   is	   perhaps	   not	   surprising	   that	   Cyp26c1	   expression	   is	  maintained	  here,	   (Fig	  41,	   compare	  black	  arrowheads	  which	   indicate	  endodermal	  expression	   of	   Cyp26a1	   in	   panels	   a	   and	   b).	   Cyp26a1	   is	   expressed	   diffusely	  throughout	  the	  pharyngeal	  endoderm	  and	  mesenchyme.	  There	  appears	  to	  be	  some	  evidence	  of	  Cyp26a1	  enrichment	  in	  the	  inter-­‐pouch	  regions	  and	  in	  the	  third	  pouch	  and	  reduced	  expression	  in	  the	  lateral	  tip	  of	  the	  first	  and	  second	  pouches	  (indicated	  by	  unfilled	  arrowheads	   in	  panel	  c),	  however,	   this	  pattern	   is	  not	  clear.	  Guris	  et	  al.	  and	  Roberts	  et	  al.	  reported	  that	  Cyp26a1	  expression	  was	  down	  regulated	  in	  the	  PA	  of	   Tbx1-­‐/-­‐	   embryos	   (Guris	   et	   al.,	   2006;	   Roberts	   et	   al.,	   2006).	   In	   contrast,	   the	  expression	  of	  Cyp26a1	  appears	  to	  be	  maintained	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos	  at	   a	   level	   comparable	   to	   that	  of	  Cre	  negative	  embryos,	   (Fig	  46	  panels	   c	  and	  d).	  However,	  small	  reductions	  in	  Cyp26a1	  expression	  may	  not	  be	  detected	  by	  
in	  situ	  hybridisation.	  The	  diffuse	  pattern	  of	  endodermal	  Cyp26a1	  expression	  makes	  it	   difficult	   to	   determine	  whether	   the	   pattern	   of	  Cyp26a1	   expression	   is	   altered	   in	  
Tbx1cKOSox17	  embryos,	  however	  this	  gene	  may	  be	  extended	  throughout	  the	  rostral	  apparatus	   (black	   arrowhead	   labelled	   as	   ‘?2’	   in	   panel	   d	   marks	   the	   possible	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extension	   of	   Cyp26a1	   expression	   in	   the	   rostral	   endoderm	   of	   Tbx1cKOSox17	  embryos).	  	  In	  contrast	   to	   the	  expression	  of	  Cyp26a1	  and	  Cyp26c1	  (that	  appear	   to	  show	   little	  change	   in	   the	   PA	   of	   Tbx1cKOSox17	   embryos),	   the	   expression	   of	   Cyp26b1	   in	  
Tbx1cKOSox17	   embryos	   epithelia	   is	   striking	   (Fig	   46,	   compare	   panels	   e	   and	   f).	  
Cyp26b1	  expression	  is	  normally	  observed	  in	  endodermal	  domains	  complementary	  to	  the	  expression	  of	  Rarb.	  	  In	  contrast,	  Cyp26b1	  transcripts	  extended	  anteriorly	  in	  	  
Tbx1-­‐deficient	  endoderm	  to	  overlap	   the	  ectopic,	   rostral	  areas	  of	  Rarb	   expression	  (compare	   the	   extent	   of	   ‘posteriorised’	   Rarb	   and	   Cyp26b1	   expression	   in,	  respectively,	   Fig	   45	   panel	   d	   and	   46	   panel	   f).	   Interestingly,	   the	   endodermal	  expansion	   of	   Cyp26b1	   is	   mirrored	   in	   the	   ectoderm	   of	   Tbx1cKOSox17	   embryos	  (compare	  the	  blue	  brackets	  marking	  the	  ectodermal	  Cyp26b1	  expression	  domains	  in	   Fig	   46	   e	   and	   f).	   In	   addition,	   the	   level	   of	  Rarb	   and	   Cyp26b1	   expression	   in	   the	  rostral	  endoderm	  appears	  equivalent	  to	  that	  normally	  observed	  in	  the	  evaginating	  3rd	   pouch.	   This	   observation	   was	   surprising	   because	   Cyp26b1	   expression	   was	  strongly	  down	  regulated	  in	  the	  endoderm	  of	  Tbx1-­‐/-­‐	  embryos	  (Roberts	  et	  al.,	  2006).	  	  The	   observation	   that	   genes	   encoding	   an	   enzyme	   that	   degrades	   retinol	   and	   a	  receptor	  that	  is	  responsive	  to	  retinol	  are	  both	  expanded	  anteriorly	  within	  the	  same	  ectopic	   expression	   domain	   suggests	   that	   overall	   there	  may	   be	   no	   change	   in	   the	  amount	   of	   RA	   signalling.	   If	   RA	   signalling	   is	   not	   altered	   in	   the	   endoderm	   of	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Fig	   46:	   Tbx1cKOSox17	   embryos	   display	   an	   anterior	   expansion	   of	   Cyp26b1	   expression	   that	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6.2.2.3	   Hoxb1	   and	   Hoxa2	   gene	   expression	   is	   not	   altered	   in	   the	  
pharyngeal	   endoderm	   of	   Tbx1cKOSox17	   embryos,	   despite	   the	  
observed	  expansion	  in	  RA	  signalling	  At	   E9.5,	  Hoxb1	   is	   expressed	   in	   the	   3rd	   pouch	   endoderm,	   in	   the	   adjacent	   caudal	  mesenchyme	   and	   caudal	   ectoderm	   covering	   the	   presumptive	   4th	   arch.	   In	  Tbx1-­‐/-­‐	  embryos	   the	   domain	   of	   Hoxb1	   expression	   is	   expanded	   anteriorly	   (Guris	   et	   al.,	  2006).	  In	  contrast,	  no	  change	  is	  distinguishable	  between	  the	  expression	  of	  Hoxb1	  in	   Cre	   negative	   and	  Tbx1cKOSox17	   embryos	   (Fig	   47	   compare	   panels	   a	   and	   b).	   As	  expected,	  mesenchymal	  Hoxb1	   transcripts	  were	  restricted	   to	   their	  normal	  caudal	  domain	  in	  Tbx1cKOSox17	  embryos,	  coinciding	  with	  the	  maintenance	  of	  RA	  signalling	  in	  this	  tissue.	  	  Surprisingly,	  no	  change	  to	  the	  rostral	  limit	  of	  Hoxb1	  expression	  was	  observed	   in	   the	  un-­‐segmented	  endoderm	  and	  ectoderm	  of	  Tbx1cKOSox17	   embryos	  (endodermal	   expression	   is	   identified	   by	   black	   arrowheads	   and	   ectodermal	  expression	  by	  blue	  arrowheads	  Fig	  47	  a	   and	  b),	  despite	   the	   rostral	   expansion	  of	  
Rarb	  expression	  in	  these	  pharyngeal	  epithelia.	  	  Similarly,	  Hoxa2	  expression	  remains	  unchanged	   in	  Tbx1cKOSox17	  embryos,	  despite	  the	  loss	  of	  Tbx1	  and	  the	  presumed	  gain	  of	  RA	  signalling	  in	  the	  mutant’s	  endoderm.	  In	  the	  un-­‐segmented	  rostral	  PA	  of	  Tbx1cKOSox17	  embryos	  a	  mesenchymal	  domain	  of	  
Hoxa2	   expression	   is	   maintained	   in	   an	   area	   equivalent	   to	   the	   2nd	   arch	   of	   Cre	  negative	   embryos,	   (highlighted	   by	   green	   arrowheads	   in	   Fig	   47	   panels	   c	   and	   d).	  
Hoxa2	   positive	   cells	   are	   also	   visible	   in	   the	  pharyngeal	   endoderm	  of	  Tbx1cKOSox17	  embryos	  at	  a	  level	  equivalent	  to	  the	  inter-­‐pouch	  region	  covering	  the	  2nd	  arch	  of	  Cre	  negative	  embryos	  (indicated	  by	  grey	  arrowheads	  in	  Fig	  47	  c’	  and	  d’).	  Again,	  there	  appears	   to	   be	   no	   change	   to	   the	   level	   of	   Hoxa2	   expression	   in	   this	   discreet	  population	  of	  Hoxa2	  expression	  endodermal	  cells	  in	  Tbx1cKOSox17	  embryos.	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  The	   maintenance	   of	   discrete	   domains	   of	   Hox	   gene	   expression	   in	   Tbx1cKOSox17	  embryos	   endoderm	   indicates	   that	   the	   level	   of	   RA	   in	   this	   epithelium	  may	   not	   be	  increased.	  It	  is	  possible	  that	  the	  expanded	  endodermal	  expression	  domains	  of	  Rarb	  and	   Cyp26b1	   occur	   as	   a	   secondary	   consequence	   of	   the	   perturbed	   endodermal	  morphology	  of	  Tbx1cKOSox17	  embryos,	  rather	  than	  a	  direct	  response	  to	  the	   loss	  of	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Fig	  47:	  Hox	  gene	  expression	  domains	  are	  not	  expanded	  anteriorly	  in	  the	  pharyngeal	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6.3	   Deletion	   of	   Tbx1	   from	   the	   endoderm	   affects	   the	  
endodermal	   expression	  of	   genes	   in	   the	   SHH,	  but	  not	   the	  
BMP	  pathway	  
To	  assess	  whether	  an	   interaction	  between	  Tbx1	   and	  SHH	  signalling	   is	  present	   in	  the	  pharyngeal	  endoderm	  during	  pouch	  formation,	  the	  expression	  of	  genes	  in	  the	  SHH	   cascade	   were	   analysed	   in	   Tbx1cKOSox17	   embryos.	   	   If	   SHH	   signalling	   acts	  upstream	  of	  Tbx1	   in	  the	  endoderm,	  as	  the	  literature	  suggests,	   there	  should	  be	  no	  change	   to	   the	   expression	  of	   genes	   in	   this	   cascade.	   If	   genes	   in	   the	   SHH	   signalling	  cascade	   are	   altered	   in	   the	   endoderm	   of	   Tbx1cKOSox17	   embryos	   this	   may	   be	  indicative	  of	  a	  feedback	  loop	  between	  Tbx1	  and	  SHH	  signalling	  in	  this	  tissue.	  	  The	  latter	  inference	  would	  be	  supported	  by	  data	  showing	  that	  genes	  that	  interact	  with	  SHH,	  such	  as	  Bmp4,	  also	  have	  altered	  expression	  in	  Tbx1	  deficient	  endoderm.	  	  	  
6.3.1	   Shh	   expression	   is	   expanded	   in	   the	   pharyngeal	  
endoderm	  of	  Tbx1cKOSox17	  embryos	  
The	  expression	  pattern	  of	  Shh	  in	  the	  pharyngeal	  endoderm	  at	  E9.5	  is	  similar	  to	  the	  expression	   of	   Cyp26b1	   (compare	   Fig	   48,	   panel	   a,	   with	   Fig	   46,	   panel	   e).	   Shh	  transcripts	   in	   Cre	   negative	   embryos	   are	   detected	   in	   the	   inter-­‐pouch	   regions	   of	  endoderm	  that	  line	  the	  medial	  aspects	  of	  the	  2nd	  and	  3rd	  pharyngeal	  arches	  (Fig	  48	  panel	   a,	   bracket	   identifies	   the	   Shh	   positive	   inter-­‐pouch	   region	   in	   the	   endoderm	  lining	   the	   2nd	   arch,	   unfilled	   arrowhead	   mark	   Shh	   devoid	   pouch	   endoderm).	   	   In	  contrast,	   the	   expression	   of	   Shh	   is	   expanded	   in	   the	   rostral	   endoderm	   of	  
Tbx1cKOSox17	  particularly	  at	  the	  level	  of	  the	  presumptive	  2nd	  arch.	  The	  expansion	  of	  the	  Shh	  expression	  domain	  is	  similar	  to	  the	  altered	  expression	  pattern	  of	  Cyp26b1	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observed	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	  	  This	  data	  suggests	  that	  Tbx1	  may	   reciprocally	   regulate	   the	   expression	   of	   Shh	   and	   thus	   the	   amount	   of	   SHH	  signalling	   in	   the	   pharyngeal	   endoderm.	   	   Alternatively,	   the	   loss	   of	   Shh	   negative	  domains	   may	   reflects	   the	   loss	   of	   pharyngeal	   endoderm	   identity	   in	   Tbx1cKOSox17	  embryos.	  	  	  	  
6.3.2	  A	  reciprocal	  expansion	  of	  the	  SHH	  signalling	  targets	  
Gli1	   and	  Ptch1	   is	   observed	   in	  Tbx1-­‐deficient	   pharyngeal	  
endoderm	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Fig	  48:	   Expression	  of	   genes	   in	   the	   SHH	  signalling	   cascade	  are	   expanded	   in	   the	  pharyngeal	  
endoderm	  of	  Tbx1cKOSox17	  embryos.	  Frontal	  sections	  of	  E9.5	  embryo’s	  PA	  show	  Shh	  (a-­‐b),	  Ptch1	  (c-­‐d)	   and	   Gli1	   (e-­‐f)	   expression,	   detected	   by	   in	   situ	   hybridization,	   is	   maintained	   in	   a	   perturbed	  expression	  pattern	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	  Whilst	  the	  expression	  pattern	  of	  Shh	  in	   Tbx1cKOSox17	   embryos	   shows	   some	   segmentation	   (note	   Shh	   absence	   in	   the	   presumptive	   3rd	  pouch	  and	  in	  the	  1st	  pouch	  of	  Tbx1cKOSox17	  embryos	  indicated	  by	  unfilled	  arrowheads	  in	  panels	  b),	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6.3.3	   Bmp4	   expression	   in	   unchanged	   in	   the	   caudal	  
pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos	  
Bmp4	   is	  expanded	  in	  the	  caudal	  pharyngeal	  endoderm	  of	  Shh-­‐/-­‐	  embryos	  (Moore-­‐Scott	   and	   Manley,	   2005).	   If	   the	   SHH	   pathway	   is	   expanded	   in	   the	   pharyngeal	  endoderm	   of	   Tbx1cKOSox17	   embryos	   it	   would	   be	   predicted	   that	   Bmp4	   would	  conversely	   be	   reduced.	   The	   relationship	   between	   Tbx1	   and	   Bmp4	   in	   the	   caudal	  pharyngeal	  endoderm	  has	  not	  previously	  been	  analysed.	  	  In	  contrast	  to	  the	  1st	  arch	  ectoderm	   of	   the	   Tbx1-­‐/-­‐	   embryos	   there	   does	   not	   appear	   to	   be	   any	   shift	   in	   the	  expression	   domain	   of	   Bmp4	   in	   the	   caudal	   PA	   of	   Tbx1cKOSox17	   embryos.	   The	  expression	  of	  Bmp4	  in	  the	  caudal	  PA	  appears	  to	  mimic	  that	  of	  control	  embryos.	  In	  both	   mutant	   and	   control	   embryos	   Bmp4	   is	   most	   robustly	   expressed	   in	   ventral	  endoderm,	  caudal	  to	  the	  2nd	  arch	  (panels	  a’’	  and	  b’’	  of	  Fig	  49,	  robust	  endodermal	  expression	   domains	   are	   highlighted	   by	   brackets).	  Medially,	   small	   areas	   of	  Bmp4	  positive	   inter-­‐pouch	  regions	  covering	  the	  medial	  aspect	  of	   the	  pharyngeal	  arches	  are	  evident	  in	  Cre	  negative	  embryos.	  The	  medial	  areas	  of	  Bmp4	  expression	  are	  also	  identifiable	   in	   medial	   sections	   of	   the	   Tbx1cKOSox17	   embryos	   un-­‐segmented	  endoderm	  (Fig	  49	  arrows	  in	  panels	  a’	  and	  b’).	  The	  deletion	  of	  Shh	  (and	  presumably	  its	   downstream	   transcriptional	   targets)	   results	   in	   an	   expansion	   of	   Bmp4	   in	   the	  caudal	   endoderm	   at	   E10.5	   (Moore-­‐Scott	   and	  Manley,	   2005).	   	   Thus	   a	   decrease	   in	  
Bmp4	  expression	  would	  be	  predicted	  in	  pharyngeal	  endoderm	  exposed	  to	  ectopic	  SHH	  signalling.	  The	  maintenance	  of	   the	   level	  and	  discreet	  pattern	  of	  endodermal	  
Bmp4	  expression	  in	  Tbx1cKOSox17	  embryos	  suggests	  that	  the	  SHH	  pathway	  may	  not	  be	   expanded	   in	   these	  mutants.	   The	   expanded	   expression	   of	   Shh	   pathway	   genes,	  and	  similarly	  RA	  pathway	  genes,	  may	  not	  be	  a	  transcriptional	  response	  to	  the	  loss	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Fig	  49:	  The	  level	  and	  pattern	  of	  Bmp4	  expression	  is	  unchanged	  in	  the	  pharyngeal	  endoderm	  
of	  Tbx1cKOSox17	  embryos.	  Frontal	  sections	  of	  E9.5	  embryo’s	  PA	  reveal	  Bmp4	  expression,	  detected	  by	   in	   situ	   hybridization,	   in	   Tbx1cKOSox17	   embryos	   (b-­‐b’’)	   is	   indistinguishable	   from	   Cre	   negative	  embryos	  (a-­‐a’’)	   in	   level	  and	  pattern.	  The	  extent	  of	  endodermal	  Bmp4	  expression	   in	  both	  embryos	  increases	  from	  dorsal	  to	  ventral	  aspects	  of	  the	  PA.	   	  Brackets	  delineate	  the	  most	  robust	  domain	  of	  
Bmp4	  expression	  in	  the	  ventral	  PA	  sections,	  (a’’	  and	  b’’).	   	  Solid	  arrowheads	  identify	  more	  discreet	  areas	  of	  Bmp4	  expression	  in	  medial	  sections	  (	  a’	  and	  b’).	  N	  =	  2.	  Annotations:	   Grey	   arrowhead	   =	   endodermal	   inter-­‐pouch	   expression,	   unfilled	   arrowhead	   =	  endodermal	   pouch	  with	   no	   expression,	   pp	  =	   pharyngeal	   pouch,	   ?	   =	   presumptive	   pouch,	   brackets	  identify	  the	  domain	  of	  endodermal	  expression	  of	  each	  gene.	  	  Arrows	  to	  the	  left	  of	  Fig	  49	  illustrate	  the	  orientation	  of	   the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	   lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	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6.4	  Tbx1-­‐dependent	  changes	  to	  the	  cells	  of	  the	  pharyngeal	  
endoderm	  
The	   formation	   of	   discreet,	   slit-­‐like	   pouches	   in	   the	   chick	   embryo	   has	   been	  demonstrated	  to	  require	  a	  network	  of	  actin	  cables	  enriched	  along	  the	  apical	  side	  of	  the	  evaginating	  endoderm	  (Quinlan	  et	  al.,	  2004).	  The	  ectopic	  accumulation	  of	  actin	  has	  been	  found	  to	  prevent	  morphogenetic	  movements	  in	  an	  ectodermal	  epithelium	  (Sai	   and	   Ladher,	   2008).	   A	   crucial	   step	   in	   the	   formation	   of	   the	   inner	   ear	   is	   the	  invagination	  of	  the	  otic	  placode,	  a	  thickening	  of	  ectoderm	  between	  the	  pharyngeal	  arches	   and	   the	   hindbrain,	   to	   form	   the	   otic	   cup	   (Sai	   and	   Ladher,	   2008).	   Sai	   et	   al.	  have	   shown	   that	   actin	   must	   become	   polarized	   along	   the	   apical	   edge	   of	   the	   otic	  placode	   at	   the	   13-­‐somite	   stage	   of	   chick	   development	   for	   invagination	   to	   occur.	  Active	  myosin	  II	  (pMLC)	  is	  able	  to	  function	  in	  a	  ‘non-­‐canonical’	  capacity	  as	  an	  actin	  depolymerisation	  factor	  (ADF)	  (Haviv	  et	  al.,	  2008).	  The	  presence	  of	  pMLC	  prevents	  the	  formation	  of	  F-­‐actin	  along	  the	  basal	  edge	  of	  the	  otic	  placode	  and	  the	  resulting	  polarity	  in	  the	  actin	  network	  enables	  the	  ectoderm	  to	  invaginate	  (Sai	  and	  Ladher,	  2008).	   An	   FGF	   dependent	   depletion	   of	   pMLC	   in	   the	   otic	   placode	   results	   in	   the	  accumulation	  of	  F-­‐actin	  along	  the	  apical	  and	  basal	  edges	  of	  the	  placode.	  	  The	  loss	  in	  actin	   polarity	   prevents	   the	   invagination	   of	   the	   ectodermal	   epithelium	   (Sai	   and	  Ladher,	  2008).	  	  	  	  The	   polarisation	   of	   the	   actin	   network,	   that	   constrains	   the	   formation	   of	   the	   otic	  placode,	   is	   thought	   to	  occur	   independently	  of	  ectodermal	  cell	  polarity.	   	  However,	  loss	  of	  endodermal	  cell	  polarity	  in	  the	  pharyngeal	  endoderm	  could	  also	  play	  a	  role	  in	  preventing	  pharyngeal	  pouch	  evagination.	  Laminins	  are	  integral	  components	  of	  the	  basal	  membrane	  as	  they	  act	  as	  anchors	  upon	  which	  cytoskeletal	  assembly	  can	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occur	  (Li	  et	  al.,	  2003;	  Miner	  and	  Yurchenco,	  2004).	  The	  loss	  of	  laminin	  in	  flies	  and	  worms	  has	  been	  found	  to	  disrupt	  cell	  polarity,	  perturbing	  the	  association	  between	  neighbouring	   cells	   (Li	   et	   al.,	   2003).	   The	   latter	   can	   affect	   the	   morphogenesis	   of	  structures	  during	  development.	   	  For	  instance,	  cleft	  formation	  in	  salivary	  glands	  is	  perturbed	   by	   the	   loss	   of	   laminin,	   as	   is	   observed	   from	   E13.0	   in	   Laminin-­‐α-­‐5-­‐/-­‐	  mouse	   embryos	   (Rebustini	   et	   al.,	   2007).	   E-­‐cadherin	   is	   also	   involved	   in	   the	  regulation	  of	  epithelial	  apico-­‐basal	  polarity.	  For	   instance,	  when	  cells	  are	  cultured	  with	   a	   virus	   carrying	   dominant	   negative	   E-­‐cadherin	   they	   orientate	   randomly	   i.e.	  unpolarised	  (Desai	  et	  al.,	  2009).	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6.4.1	   Loss	   of	   actin	   polarity	   in	   Tbx1cKOSox17	   embryos	  
endoderm	  may	  account	  for	  caudal	  pouch	  aplasia	  
The	   polarisation	   of	   actin	   within	   an	   epithelium	   has	   been	   suggested	   to	   underlie	  morphogenetic	   processes	   including	   otic	   placode	   invagination	   and	   pharyngeal	  pouch	   formation	   in	   avian	   embryos.	   The	   distribution	   of	   F-­‐actin	   (detected	   using	   a	  phalloidin-­‐conjugated	   fluorophore)	   was	   analysed	   in	   Tbx1cKOSox17	   embryos	   to	  determine	   if	   the	   deletion	   of	   Tbx1	   from	   the	   endoderm	   results	   in	   a	   loss	   of	   actin	  polarity	   within	   this	   tissue.	   In	   accordance	   with	   avian	   data,	   actin	   accumulates	  strongly	   in	   the	   pharyngeal	   pouches	   of	   murine	   embryos,	   particularly	   in	   the	   3rd	  pouch	  (Quinlan	  et	  al.,	  2004).	  Phalloidin-­‐marked	  actin	  accumulates	  primarily	  along	  the	  apical	  edge	  of	  the	  evaginating	  mammalian	  pouch	  (red	  arrows	  Fig	  50	  panels	  a	  and	   c).	   	   The	   phalloidin	   staining	   appears	   robust	   and	   continuous	   along	   the	   apical	  edge	  of	  pharyngeal	  endoderm.	  F-­‐actin	  was	  also	  visible	  along	  the	  basal	  edge	  of	  the	  evaginating	   endoderm,	   primarily	   concentrated	   around	   the	   apex	   of	   the	   pouch	  (white	  arrows	  Fig	  50	  panels	  a	  and	  c).	  	  The	  phalloidin	  staining	  at	  the	  basal	  edge	  of	  the	  3rd	  pouch	  endoderm	   is	   less	   intense	  and	   is	  punctate	   in	  nature	   (highlighted	  by	  short	  dashed	  lines	  in	  Fig	  50	  panel	  c’).	  The	  differences	  in	  phalloidin	  staining	  along	  the	  apical	  and	  basal	  edge	  of	  the	  3rd	  pouch	  demonstrates	  that	  actin	  is	  polarised	  in	  the	   evaginating	   endoderm,	   akin	   to	   the	   invaginating	   ectoderm	   of	   the	   otic	   vesicle	  (Sai	  and	  Ladher,	  2008).	  	  	  	  The	  absence	  of	  Tbx1	  from	  endodermal	  cells	  perturbs	  the	  distribution	  of	  actin	  in	  the	  caudal	  pharyngeal	  endoderm.	   	  The	  accumulation	  of	  actin	  along	  the	  apical	  edge	  of	  
Tbx1cKOSox17	   embryos	   endoderm	   is	   relative	   to	   that	   observed	   in	   the	   3rd	   pouch	   of	  controls	  (Fig	  50,	  compare	  apical	  actin	  identified	  by	  red	  arrows	  in	  panels	  b	  and	  d	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[Tbx1cKOSox17]	   to	   panels	   a	   and	   c	   [Cre	  negative]).	   	   In	   contrast,	   actin	   accumulation	  along	   the	   basal	   edge	   of	   the	   mutant’s	   endoderm	   is	   markedly	   increased	   (Fig	   50,	  compare	  basal	  actin	  identified	  by	  white	  arrows	  in	  panels	  b	  and	  d	  to	  panels	  a	  and	  c).	  	  The	   normally	   punctate,	   weak	   staining	   along	   the	   basal	   edge	   of	   the	   endoderm	   is	  stronger	   and	   more	   continuous	   in	   appearance,	   reflecting	   the	   type	   of	   staining	  normally	  observed	  at	  the	  apical	  edge	  (highlighted	  by	  longer	  dashed	  lines	  in	  Fig	  45	  panel	  d’).	   	  The	  observations	   suggest	   that	  TBX1	   in	   the	  endoderm	   functions	   in	   the	  endoderm	  to	  regulate	  the	  polarity	  of	  the	  actin	  network.	  	  It	   is	  possible	   that	   the	   loss	  of	  actin	  polarity	  observed	   in	   the	  Tbx1cKOSox17	   embryos	  reflects	  a	  loss	  in	  polarity	  of	  the	  endodermal	  cells,	  thus	  other	  cytoskeletal	  proteins	  known	   to	   influence	   cell	   polarity	   were	   analysed	   in	   the	   Tbx1-­‐deficient	   endoderm.	  	  However,	   in	   contrast	   to	   the	   actin	   network,	   the	   endodermal	   cells	   of	  Tbx1cKOSox17	  embryos	  PA	   appear	   to	   be	  polarised,	   indicated	  by	   the	  maintenance	  of	   laminin,	   E-­‐cadherin	  and	  polarised	  cell	  proliferation	  in	  this	  epithelium.	  	  	  Although	   the	   basal	   lamina	   of	   Tbx1cKOSox17	   embryos	   appears	   thicker,	   perhaps	  indicative	   of	   cell	   stacking,	   there	   is	   no	   loss	   or	   change	   to	   the	   location	   of	   laminin	  protein	   (Fig	   51,	   compare	   panels	   a	   and	   a’	   to	   panels	   b	   and	   b’,	   arrows	   indicate	  equivalent	  areas	  of	  basement	  membrane	  in	  control	  and	  mutant’s	  endoderm).	  This	  indicates	   that	   the	   laminin	   is	   not	   dependent	   on	   TBX1	   for	   its	   accumulation	   in	   the	  basal	   lamina	   of	   the	   pharyngeal	   endoderm.	   The	   observation	   that	   E-­‐cadherin	  appears	   unchanged	   in	   the	   endoderm	   of	   Tbx1cKOSox17	   embryos	   further	   indicates	  that	   the	   pharyngeal	   endoderm	   is	   polarised	   in	   the	   absence	   of	   TBX1.	   (Fig	   51	  compare	  overall	  E-­‐cadherin	  staining	  in	  panels	  c	  and	  d).	  	  Small	  areas	  of	  enriched	  E-­‐cadherin	   staining	   are	   visible	   in	   the	   unsegmented	   endoderm	   of	   Tbx1cKOSox17	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Fig	  50:	  	  Actin	  accumulates	  at	  the	  basal	  edge	  of	  Tbx1cKOSox17	  embryo’s	  pharyngeal	  endoderm.	  Phalloidin	  marked	   F-­‐actin	   is	   enriched	   along	   the	   apical	   edge	   of	   Cre	   negative	   embryos	   pharyngeal	  endoderm,	  (red	  arrows	  panels	  a	  and	  c),	  at	  the	  basal	  edge	  actin	  staining	  is	  limited.	  	  Basal	  phalloidin	  staining	  is	  punctate	  in	  appearance	  (highlighted	  by	  dashes	  in	  panel	  c’)	  and	  concentrated	  around	  the	  apex	  of	   the	   evaginating	  pouch	   (white	   arrows	  panels	   a	   and	   c).	   	   In	   contrast,	   phalloidin	  marked,	   F-­‐actin	  is	  enriched	  along	  the	  apical	  and	  basal	  edges	  of	  Tbx1cKOSox17	  embryos	  pharyngeal	  endoderm	  (highlighted,	   respectively,	   by	   red	   and	  white	   arrows	   in	   panels	   b	   and	   d	   that	  mirror	   each	   other	   in	  distribution).	  Areas	  of	  basal	  phalloidin	  staining	  are	  elongated	  in	  appearance	  (highlighted	  by	  dashes	  in	  panel	  d’)	  and	  present	  along	  the	  length	  of	  the	  caudal	  pharyngeal	  endoderm	  (white	  arrows	  panel	  d).	  N	  =10.	  	  Annotations:	  White	  arrowhead	  =	  basal	  F-­‐actin	  in	  the	  endoderm,	  red	  arrowhead	  =	  apical	  F-­‐actin	   in	   the	  endoderm	   ,	  pp	  =	  pharyngeal	  pouch,	  ?	  =	  presumptive	  pouch,	  PAA	  =	  pharyngeal	  arch	  artery,	   dashes	   identify	   the	   concentration	   of	   actin	   filaments	   at	   the	   basal	   edge	   of	   the	   pharyngeal	  endoderm.	   	   Arrows	   to	   the	   left	   of	   Fig	   50	   illustrate	   the	   orientation	   of	   the	   pharyngeal	   apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  	  
Fig	  51:	  	  E-­‐cadherin	  and	  laminin	  are	  maintained	  in	  the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	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Fig	   52:	   The	   amount	   and	   location	   of	   cell	   proliferation	   is	   unchanged	   in	   the	   pharyngeal	  









Location	  of	  proliferating	  endodermal	  cells	  for	  each	  genotype	   Mean	  number	  of	  proliferating	  endodermal	  cells/embryo	   SEM	  Cre	  negative	  apical	   6.5	   +	  0.950	  
Tbx1cKOSox17	  apical	   7.6	   +	  0.902	  Cre	  negative	  basal	   2.1	   +	  0.454	  
Tbx1cKOSox17	  basal	   1.6	   +	  0.351	  Cre	  negative	  total	   8.6	   +	  1.24	  
Tbx1cKOSox17	  total	   9.2	   +	  1.05	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6.4.2	   Active	  myosin	   light	   chain	   is	   absent	   from	   the	   basal	   edge	   of	  
TBX1-­‐deficient	  endoderm	  	  Actin	   polarity	  must	   be	   established	   in	   the	   otic	   placode	   for	   invagination	   to	   occur.	  	  Polarity	  in	  the	  actin	  network	  is	  achieved	  by	  a	  pMLC	  mediated	  depolymerisation	  of	  F-­‐actin	  at	  the	  basal	  edge	  of	  the	  otic	  placode	  (Sai	  and	  Ladher,	  2008).	  	  It	  is	  possible	  that	   a	   lack	   of	   pMLC	   at	   the	   basal	   edge	   of	   Tbx1cKOSox17	   embryos	   pharyngeal	  endoderm	   may	   enable	   actin	   to	   accumulate	   here	   ectopically.	   	   Alternatively,	   the	  accumulation	  of	  F-­‐actin	  along	  the	  basal	  edge	  of	  TBX1-­‐deficient	  endoderm	  may	  be	  caused	  by	  the	  loss	  of	  a	  canonical	  actin	  depolymerising	  factor	  (ADF),	  such	  as	  cofilin	  (Arber	  et	  al.,	  1998).	  	  However,	  akin	  to	  the	  otic	  placode,	  cofilin	  was	  not	  detected	  at	  the	   basal	   edge	   of	   the	   pharyngeal	   endoderm	   of	   Cre	   negative	   or	   Tbx1cKOSox17	  embryos	  (Fig	  53,	  illustrates	  that	  cofilin	  staining	  is	  robust	  in	  the	  apical	  but	  not	  the	  basal	  edge	  of	  the	  pharyngeal	  endoderm	  of	  all	  embryos	  [panels	  a	  and	  b]).	  Thus,	  the	  depolymerisation	  of	  actin	  at	  the	  basal	  edge	  of	  the	  evaginating	  pharyngeal	  pouch	  is	  unlikely	  to	  be	  facilitated	  by	  cofilin.	  	  In	  contrast,	  a	  difference	  in	  the	  amount	  of	  basal	  pMLC	  staining	  was	  visible	  in	  the	  caudal	  pharyngeal	  endoderm	  of	  the	  Cre	  negative	  embryo	   and	   the	   Tbx1cKOSox17	   embryo.	   At	   the	   basal	   edge	   of	   the	   Tbx1cKOSox17	  embryo’s	   caudal	   pharyngeal	   endoderm	   pMLC	   staining	   is	   not	   observed	   (Fig	   54;	  compare	  basal	  pMLC	  staining	  present	   in	   the	  endoderm	  of	  Cre	  negative	  embryos,	  indicated	  by	  solid	  arrows	  [panel	  a],	  with	  the	  relative	  area	  absent	  of	  pMLC	  indicated	  by	  unfilled	  arrows	  in	  the	  Tbx1cKOSox17	  embryo	  [panel	  b]).	   	  The	  loss	  of	  basal	  pMLC	  staining	   correlates	  with	  an	   increase	   in	   the	  extent	   and	   level	  of	  phalloidin	  marked	  actin	  along	  the	  same	  basal	  edge	  of	  Tbx1cKOSox17	  embryos	  endoderm	  (Fig	  54,	  panel	  b’	  white	  arrowheads).	   	  Conversely,	   in	   the	  Cre	  negative	  embryo	   there	   is	  a	  distinct	  lack	   of	   phalloidin-­‐marked	   actin	   along	   the	   pMLC	   positive,	   basal	   edge	   of	   the	  evaginating	  3rd	  pouch,	  relative	  to	  the	  apical	  edge	  (Fig	  54,	  panel	  a’	  unfilled	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Fig	  53:	  Cofilin	  is	  not	  detected	  at	  the	  basal	  edge	  of	  the	  pharyngeal	  endoderm	  of	  Cre	  negative	  
or	  Tbx1cKOSox17	   embryos.	  Cofilin	   staining,	   (red	   fluorescence)	   in	  Cre	  negative	   (panels	  a,	   c	  and	  e)	  and	  Tbx1cKOSox17	  embryos	  (panels	  b,	  d	  and	  f)	  is	  robust	  at	  the	  apical	  edge	  but	  not	  visible	  at	  the	  basal	  edge	  of	  the	  pharyngeal	  endoderm,	  (unfilled	  arrows	  panels	  a	  and	  b).	  There	  does	  not	  appear	  to	  be	  an	  inverse	  correlation	  in	  the	  presence	  of	  actin	  (phalloidin	  staining,	  green	  fluorescence)	  and	  cofilin	  at	  the	  basal	   edge	  of	   the	  pharyngeal	  endoderm.	   	   Solid	  white	  arrows	  highlight	  discreet	  areas	  of	  basal	  actin	   in	   the	  Cre	  negative	  embryo	   (panels	   c	  and	  d)	  and	   larger	  areas	  of	  basal	   actin	   in	  Tbx1cKOSox17	  embryo	  (panels	  e	  and	  f).	  	  Cofilin	  staining	  is	  not	  enriched	  in	  the	  adjacent	  phalloidin-­‐negative	  areas	  of	  basal	  endoderm	  (unfilled	  arrowheads).	  N=2.	  	  Annotations:	  White	   arrowhead	   =	   F-­‐actin	   at	   the	   basal	   edge	   of	   the	   pharyngeal	   endoderm,	   unfilled	  arrowhead	  =	  absence	  of	  cofilin	  at	  the	  basal	  edge	  of	  the	  pharyngeal	  endoderm.	  	  Arrows	  to	  the	  left	  of	  Fig	  53	  illustrate	  the	  orientation	  of	  the	  pharyngeal	  apparatus	  sections;	  A	  =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	  
	  
Fig	   54:	   Active	   myosin	   light	   chain	   is	   not	   detected	   along	   the	   basal	   edge	   of	   Tbx1cKOSox17	  
embryo’s	  pharyngeal	  endoderm.	  Active	  myosin	  light	  chain	  (pMLC,	  red	  fluorescence)	  is	  visible	  at	  the	  basal	  edge	  of	  Cre	  negative	  embryo’s	  pharyngeal	  endoderm,	  (panel	  a,	  solid	  white	  arrow)	  but	  is	  absent	  from	  the	  basal	  edge	  of	  Tbx1cKOSox17	  embryo’s	  pharyngeal	  endoderm	  (panel	  b,	  unfilled	  white	  arrow).	  	  The	  presence	  of	  pMLC	  in	  the	  Cre	  negative	  embryos	  endoderm	  correlates	  with	  an	  absence	  of	   F-­‐actin	   (phalloidin	  marked,	   green	   fluorescence)	   at	   the	   same	   location	   (panel	   a’,	   unfilled	   white	  arrow).	  	  Conversely	  the	  absence	  of	  pMLC	  in	  Tbx1cKOSox17	  embryos	  correlates	  with	  the	  accumulation	  of	   F-­‐actin	   along	   the	   basal	   edge	   of	   the	   mutant’s	   endoderm	   (panel	   b’,	   solid	   white	   arrow).	   	   The	  differences	   in	  pMLC	  and	  F-­‐actin	  staining	  between	  the	  Tbx1cKOSox17	  and	  Cre	  negative	  embryos	  are	  highlighted	  in	  panels	  b’’	  and	  a’’	  respectively	  (red	  arrow	  in	  a’’	  highlights	  basal	  pMLC	  ,	  green	  arrow	  in	  b’’	   highlights	  basal	   actin).	   	  Note	   that	   the	  blood	   cells	   in	  panel	   a	   have	  been	   removed	   in	  Photoshop	  because	   their	   auto-­‐fluorescence	  detracted	   from	   the	   specific,	  weaker,	  pMLC	  staining.	  Annotations:	  Arrows	   to	   the	   left	   of	   Fig	   54	   illustrate	   the	   orientation	   of	   the	   pharyngeal	   apparatus	   sections;	   A	   =	  anterior,	  P	  =	  posterior,	  L	  =	  lateral,	  M	  =	  medial,	  V=	  ventral,	  D	  =	  dorsal.	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6.4.3	   TBX1	   regulates	   the	   expression	   of	   the	   LIM	   domain	  
protein	  Fhl1,	  an	  actin	  effector	  	  
A	   microarray	   comparing	   gene	   expression	   in	   Tbx1	   null	   and	   control	   embryos	  revealed	   a	   number	   of	   proteins	   containing	   LIM	   domain	   proteins	   were	   down	  regulated	   in	   the	  Tbx1-­‐deficient	   PA	   (Ivins	   et	   al.,	   2005).	   It	   is	   possible	   that	   a	  Tbx1-­‐dependent	  change	  to	  the	  level	  or	  location	  of	  Lim	  gene	  expression	  in	  the	  pharyngeal	  endoderm	   may	   affect	   actin	   accumulation	   within	   the	   pouches.	   	   The	   expression	  pattern	  of	  each	  Lim	  protein	  down	  regulated	  in	  Tbx1	  null	  embryos	  was	  analysed	  in	  the	   PA	   to	   identify	   their	   place	   of	   expression	   at	   E9.5	   within	   the	   PA.	   Lim	   genes	  expressed	  in	  the	  pharyngeal	  endoderm	  were	  then	  further	  analysed	  in	  Tbx1cKOSox17	  embryos	  to	  determine	  if	  their	  expression	  is	  altered	  in	  the	  absence	  of	  Tbx1.	  	  
6.4.3.1	  Expression	  analysis	  of	  Lim	  genes	  in	  the	  PA	  of	  E9.5	  embryos	  Table	   8	   lists	   the	  Lim	   genes	   that	  were	   down	   regulated	   a	  microarray	   of	  Tbx1	  null	  embryos	  (Ivins	  et	  al.,	  2005).	  	  The	  expression	  pattern	  of	  each	  Lim	  gene	  in	  the	  PA	  of	  E9.5	  wild	  type	  embryos	  was	  assessed	  by	   in	  situ	  hybridisation.	  Whilst	  Lim	  domain	  
only	  protein	  4	  (Lmo4),	  Pdz	  and	  Lim	  domain	  3	  (Pdlim3),	  Lim	  homeobox	  2	  (Lhx2)	  and	  
Four	  and	  a	  half	  Lim	  domains	  2	  (Fhl2)	  are	  all	  expressed	  in	  the	  PA,	  the	  majority	  of	  the	  expression	  appears	  to	  be	  in	  non-­‐endodermal	  tissues	  (Fig	  55).	  Pdlim3	  is	  expressed	  robustly	  throughout	  the	  mesenchyme	  of	  the	  pharyngeal	  arches	  but	  is	  absent	  from	  the	  pharyngeal	  epithelia	  (Fig	  55,	  panel	  c).	  Pdlim3	  transcripts	  are	  also	  present	  in	  the	  heart	   at	   E9.5	   (Fig	   55,	   panel	   c’).	   Lmo4	   is	   also	   restricted	   to	   the	   CNCC	   derived	  mesenchyme	  but	  its	  expression	  is	  less	  ubiquitous	  than	  Pdlim3,	  being	  most	  robustly	  detected	   in	   the	   1st	   arch	  mesenchyme	   (Fig	   55,	   panel	   b	   and	   b’).	   	   Lhx2	   transcripts	  appear	  to	  be	  localised	  in	  the	  core	  mesoderm	  of	  each	  pharyngeal	  arch	  (Fig	  55,	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Table	   8:	   Lim	   genes	   down	   regulated	   in	   a	  microarray	   of	   the	   PA	   of	  Tbx1	   null	  
embryos	  
	  Gene	   bank	  Accession	   Gene	  description	   Relative	  expression	  to	  control	  embryos	  (Dfl/+;Tbx1+/-­‐)	  NM_01070	   Lim	  homeobox	  protein	  2	  (Lhx2)	   0.653	  N	  	  NM_010212	   Four	  and	  a	  half	  LIM	  domains	  (Fhl2)	   0.713	  	  NM_010723	   Lim	  domain	  only	  protein	  4	  (Lmo4)	   0.754	  NM_016798	   PDZ	  and	  LIM	  domain	  3	  (Pdlim3)	   0.654	  	  NM024223	  	   Heart	  LIM	  protein	  (Hlp)	  *	   0.714	  *	  The	  mRNA	  probe	  for	  this	  gene	  did	  not	  generate	  an	  interpretable	  signal.	  
	  
	  
Fig	  55:	  Lim	  domain	  genes	  down-­‐regulated	  in	  Tbx1	  null	  embryos	  are	  not	  robustly	  expressed	  
in	   the	   pharyngeal	   endoderm	   at	   E9.5.	   Frontal	   sections	   of	   E9.5	   control	   embryo’s	   PA	   displaying	  expression	  of	  Fhl2	  	  (a	  and	  a’),	  Lmo4,	  (b	  and	  b’),	  PDlim3	  (c	  and	  c’)	  and	  Lhx2	  (d	  and	  d’)	  detected	  by	  in	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6.4.3.2	   The	   expression	   of	   Fhl1	   is	   increased	   in	   the	   pharyngeal	  
endoderm	  of	  Tbx1cKOSox17	  embryos	  	  
	  The	   FHL	   family	   of	   LIM	   proteins	   are	   highly	   conserved	   and	   a	   literature	   search	  revealed	  that,	  (as	  was	  revealed	  in	  Fig	  55	  for	  Fhl2),	  Fhl1	  at	  E10.5	  is	  also	  expressed	  within	  the	  pharyngeal	  endoderm	  (Chu	  et	  al.,	  2000;	  Kadrmas	  and	  Beckerle,	  2004).	  As	   the	   actin	   analyses	   in	   TBX1-­‐deficient	   endoderm	  were	   performed	   at	   E9.5,	   at	   a	  time	   when	   the	   3rd	   pouch	   is	   still	   ‘out-­‐pocketing’	   it	   was	   therefore	   required	   to	  establish	   whether	   Fhl1	   was	   expressed	   in	   the	   PA	   a	   day	   earlier	   at	   E9.5.	   Fhl1	  transcripts	  are	  visible	  in	  the	  pharyngeal	  endoderm	  at	  E9.5	  (Fig	  56,	  panel	  a).	  Fhl1	  is	  most	  robustly	  expressed	   in	   the	   inter-­‐pouch	  regions	  of	   the	  pharyngeal	  endoderm,	  adjacent	  to	  the	  actin	  rich	  evaginating	  pouches	  (grey	  arrowheads	  in	  Fig	  56	  panel	  a	  identifies	   inter-­‐pouch	   Fhl1	   expression,	   compare	   this	   to	   the	   actin	   staining	   in	   the	  pouch	   endoderm	   of	   Cre	   negative	   embryos,	   Fig	   50	   panels	   a,	   a’,	   c	   and	   c’).	   In	   the	  absence	  of	  Tbx1,	   the	  expression	  of	  Fhl1	  in	   the	  pharyngeal	  endoderm	  is	   increased	  (Fig	  56,	  panel	  b).	  	  The	  expression	  of	  Fhl1	  in	  the	  Tbx1cKOSox17	  embryo	  also	  appears	  to	   be	   continuous	   throughout	   the	   endoderm,	   however,	   the	   obtuse	   angle	   at	  which	  the	  PA	  of	  the	  mutant	  embryo	  was	  sectioned	  requires	  this	  to	  be	  confirmed.	  The	  FHL	  family	  of	  proteins	  are	  not	  transcription	  factors,	  however,	  their	  ability	  to	  associate	  with	  actin	  enables	  them	  to	  associate	  with	  other	  proteins	  that	  are	  able	  to	  regulate	  gene	   expression	   (Kadrmas	   and	   Beckerle,	   2004).	   The	   observation	   that	   Fhl1	   and	  actin	  are	  both	  up-­‐regulated	  in	  the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos	  may	   link	   the	   changes	   in	   endoderm	  morphology	   to	   the	  observed	   changes	   in	   gene	  expression.	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6.5	  DISCUSSION	  
The	   experiments	   presented	   in	   Chapter	   6	   aimed	   to	   identify	   possible	  mechanisms	  that	   could	   account	   for	   the	   failure	   of	   caudal	   pouch	   formation	   in	   Tbx1cKOSox17	  embryos.	  The	  analysis	  of	  RA	  and	  SHH	  pathways	  in	  Tbx1cKOSox17	  embryos	  suggests	  that	   changes	   in	   endodermal	   gene	   expression	   may	   be	   secondary	   to	   the	   TBX1-­‐dependent	   loss	   of	   endoderm	   morphology.	   Polymerised	   actin	   is	   an	   effector	   of	  epithelial	   morphology.	   The	   striking	   loss	   of	   actin	   polarity	   observed	   in	   TBX1-­‐deficient	  endoderm	  likely	  perturbs	  the	  formation	  of	  the	  pharyngeal	  pouches.	  	  Two	  possible	   mechanisms	   may	   account	   for	   the	   accumulation	   of	   ectopic	   actin	   at	   the	  basal	   edge	   of	   the	  TBX1-­‐deficient	   endoderm,	   the	   loss	   of	   the	  ADF	  pMLC	   along	   the	  basal	  edge	  of	  the	  endoderm	  and/or	  the	  up-­‐regulation	  of	  Fhl1	  an	  actin	  mediator.	  	  
6.5.1	  Transcriptional	  changes	  in	  TBX1-­‐deficient	  endoderm	  The	   anterior	   expansion	   of	   Rarb	   through	   the	   anterior	   endoderm	   of	   Tbx1cKOSox17	  embryos	  is	  in	  agreement	  with	  the	  hypothesis	  that	  TBX1	  is	  a	  negative	  regulator	  of	  RA	   signalling	   (Guris	   et	   al.,	   2006).	   	   Although	   the	   expansion	   of	   Rarb	   in	   TBX1-­‐deficient	  endoderm	  was	  not	  surprising,	  it	  was	  unexpected	  in	  context	  of	  maintained	  
Raldh2	  and	  Cyp26	  gene	  expression.	  These	  data	  indicate	  that	  TBX1	  in	  the	  mesoderm	  and/or	   ectoderm	   may	   be	   sufficient	   to	   regulate	   Raldh2	   expression	   in	   the	  mesenchyme.	   	   Moreover,	   it	   suggests	   that	   TBX1	   may	   be	   a	   cell	   autonomous	   RA	  signalling	   antagonist,	   acting	   to	   regulate	   this	   pathway	   at	   the	   level	   of	   Rarb	  expression	  within	   the	   pharyngeal	   endoderm.	   	   The	   similarity	   in	   the	   expansion	   of	  
Cyp26b1	  and	  Rarb	  expression	  in	  Tbx1cKOSox17	  embryos	  indicates	  that	  Cyp26b1	  may	  be	  a	  readout	  of	  RA	  signalling	  in	  the	  pharyngeal	  endoderm.	  Certainly,	  Cyp26b1	  
	   289	  
expression	   is	   induced	   in	   naïve	   T-­‐cells	   exposed	   to	   all-­‐trans-­‐RA	   (Takeuchi	   et	   al.,	  2011).	   If	  Raldh2	   (when	   in	   excess)	   also	   negatively	   regulates	  Cyp26b1	   expression,	  this	  would	  explain	  why	  Cyp26b1	  expression	  is	  lost	  from	  the	  PA	  of	  Tbx1-­‐/-­‐	  embryos,	  (where	  Raldh2	   is	  expanded)	  but	  maintained	   in	   the	  Tbx1cKOSox17	  embryos	   (where	  
Raldh2	   is	   maintained)	   (Guris	   et	   al.,	   2006).	   Finally,	   if	   RA	   is	   cleared	   to	   the	   same	  extent	   it	   is	   binding	   to	   RARB,	   the	   amount	   of	   active	   ectopic	   RA	   signalling	   in	   the	  rostral	  endoderm	  may	  be	  negligible.	   If	   the	   level	  of	  RA	  signalling	   is	  altered	   in	   the	  endoderm	   of	   Tbx1cKOSox17	   embryos	   it	   is	   not	   sufficient	   to	   change	   Hox	   gene	  expression.	  	  Surprisingly,	   genes	   in	   the	   SHH	   signalling	   cascade,	   that	   are	   hypothesised	   to	   act	  upstream	  of	  Tbx1,	  were	  also	  expanded	   in	   the	  endoderm	  of	  Tbx1cKOSox17	  embryos	  (Garg	  et	  al.,	  2001;	  Yamagishi	  et	  al.,	  2003).	  One	  explanation	  may	  be	  that	  a	  feedback	  loop	  exists	  between	  TBX1	  and	  the	  SHH	  pathway	  in	  the	  pharyngeal	  endoderm.	  	  Shh	  expression	  in	  the	  floorplate,	  (a	  signalling	  centre	  in	  the	  neural	  tube	  required	  for	  the	  specification	   and	   guidance	   of	   neural	   progenitors),	   is	   regulated	   by	   the	   binding	   of	  FOXA2	  and	  T-­‐BOX	  proteins	  to	  sites	  within	  the	  Sonic	  hedgehog	  floor	  plate	  enhancer	  
2	  (Sfpe2)	  (Jeong	  and	  Epstein,	  2003).	  	  The	  binding	  of	  the	  T-­‐box	  consensus	  motifs	  in	  
Sfpe2	  inhibits	  the	  expression	  of	  Shh	  in	  specific	  areas	  of	  the	  central	  nervous	  system,	  such	   as	   the	   ventral	   diencephalon	   (Jeong	   and	   Epstein,	   2003).	   In	   the	   pharyngeal	  endoderm	   the	   expression	   domains	   of	  Tbx1	   and	   Shh	   are	   largely	   complementary;	  
Tbx1	   is	   expressed	   highly	   in	   the	   evaginating	   3rd	   pouch	   at	   E9.5	   whereas	   Shh	   is	  excluded	  from	  this	  region	  of	  endoderm.	  	  This	  observation	  indicates	  that	  TBX1	  may	  also	  act	  to	  negatively	  regulate	  Shh	  expression	  in	  the	  pharyngeal	  pouches.	  	  The	   expansion	  of	   the	  Shh,	   Gli1	  and	   Ptch	   expression	   into	   the	   caudal	   endoderm	  of	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Tbx1cKOSox17	  embryos	   is	   ectopic.	   It	   is	   possible	   that	   ectopic	   SHH	   signalling	   in	   the	  caudal	   endoderm	  may	   prevent	   the	   endoderm	   from	   evaginating.	   Deletion	   of	   Shh	  from	   all	   tissues	   only	   mildly	   perturbs	   the	   formation	   of	   the	   caudal	   pouches,	  suggesting	   that	   this	   morphogen	   is	   not	   normally	   required	   for	   pouch	   outgrowth	  (Moore-­‐Scott	   and	  Manley,	   2005).	   Furthermore,	   no	   pouch	   defects	   were	   reported	  when	   Smoothened	   and	   Patched	   were	   conditionally	   deleted	   from	   the	   endoderm	  using	  NKX2.5Cre	  (Goddeeris	  et	  al.,	  2007).	  	  If	  caudal	  pouch	  formation	  requires	  a	  SHH	  free	   environment,	   TBX1	   may	   facilitate	   this	   by	   repressing	   Shh	   expression	   in	   the	  evaginating	  endoderm.	  Conserved	  non-­‐coding	  sequences,	  have	  been	   identified	  as	  long-­‐range	   enhancers	   of	   Shh	   expression	   in	   epithelial	   linings,	   including	   the	  pharyngeal	   endoderm	   (Sagai	   et	   al.,	   2009).	   If	  T-­‐box	   consensus	   sites	   exist	   in	   these	  long-­‐range	  enhancers,	   this	  may	  be	  a	  mechanism	  by	  which	  TBX1	  can	  regulate	   the	  expression	  of	  Shh	   in	   the	  pharyngeal	  endoderm.	  Alternatively,	  TBX1	  may	  regulate	  SHH	  signalling	  at	   the	   level	  of	  SHH	  target	  genes,	   such	  as	  Gli1.	   	  For	   instance,	  TBX1	  family	  members,	  T-­‐BOX	  2	  and	  T-­‐BOX	  3,	  have	  been	  implicated	  in	  the	  repression	  of	  Gli-­‐mediated	  SHH	  signalling	  during	  Xenopus	  eye	  development	  (Takabatake	  et	  al.,	  2002).	  If	  this	  hypothesis	  is	  correct,	  pouch	  formation	  should	  be	  rescued	  by	  reducing	  the	   level	   of	   Gli1	   expression	   the	   endoderm	   of	   Tbx1cKOSox17	   embryos,	   (i.e.	   by	  generating	  Sox17icre/+;Gli1flox/-­‐;Tbx1flox/-­‐	  embryos).	  	  The	   expression	   of	   the	  Shh	  agonist,	   Bmp4,	   is	   not	   altered	   in	  Tbx1cKOSox17	   embryos	  indicating	  that,	  overall,	  there	  may	  be	  no	  change	  to	  the	  amount	  and	  extent	  of	  active	  SHH	  signalling	  in	  the	  endoderm.	  A	  quantitative	  analysis	  of	  SHH	  signalling	  in	  the	  PA	  of	   Tbx1cKOSox17	   embryos	   by	   real-­‐time	   quantitative	   PCR	   (qPCR)	   would	   help	   to	  clarify	  whether	  this	  pathway	  is	  up-­‐regulated	  in	  the	  absence	  of	  Tbx1.	  Alternatively,	  the	   proposed	   SHH-­‐mediated	   inhibition	   of	   Bmp4	   expression	   in	   the	   caudal	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endoderm	  may	  be	   stage	   specific	   and	   thus	  not	  observed	  until	  E10.5	   (Moore-­‐Scott	  and	  Manley,	  2005).	  	  	  	  
6.5.2	  TBX1	  affects	  the	  polarity	  of	  the	  actin	  cytoskeleton	  within	  the	  
pharyngeal	  endoderm	  	  Data	  presented	  here	  suggest	  that	  TBX1	  may	  act	  as	  a	  tissue	  specific	  transcriptional	  repressor	  or	  activator	  of	  multiple	  genes	  in	  each	  of	  the	  FGF,	  RA	  and	  SHH	  pathways.	  	  However,	  a	  more	  parsimonious	  explanation	  may	  be	  that	  the	  expanded	  expression	  of	  multiple	  genes	  is	  a	  consequence	  of	  the	  change	  to	  the	  morphology	  of	  Tbx1cKOSox17	  embryo’s	   endoderm.	   Actin	   supracables	   in	   the	   pharyngeal	   endoderm	   of	   chick	  embryos	  are	  thought	  to	  provide	  constraining	  forces	  that	  direct	  pharyngeal	  pouch	  formation	  (Quinlan	  et	  al.,	  2004).	  Disrupting	  the	  formation	  of	  organised	  actin	  cables	  in	   the	   pharyngeal	   endoderm	   causes	   pouches	   to	   form	   in	   a	   splayed	   or	   convoluted	  manner	   (Quinlan	   et	   al.,	   2004).	   The	  Tbx1cKOSox17	  data	   supports	   the	   inference	   that	  actin	   influences	   the	  morphogenesis	  of	   the	  pharyngeal	  endoderm	   into	  pharyngeal	  pouches.	   The	   deletion	   of	   Tbx1	   from	   the	   endoderm	   enables	   actin	   to	   accumulate	  along	   the	  basal	   edge	  of	   this	   epithelium.	  Presumably,	   the	   accumulation	  of	   ectopic	  actin	  at	  the	  basal	  edge	  of	  the	  pharyngeal	  endoderm	  puts	  an	  excessive	  constraining	  force	  on	  the	  endodermal	  cells	  that	  in	  turn	  prevents	  their	  evagination.	  	  Correlating	   with	   the	   un-­‐polarised	   accumulation	   of	   actin	   in	   the	   pharyngeal	  endoderm	  of	  Tbx1cKOSox17	  embryos	  was	  an	  observed	  up-­‐regulation	  of	  Fhl1	   and	  a	  loss	   of	   pMLC.	  Active	  myosin	   is	   able	   to	   depolymerise	   F-­‐actin	   (Haviv	   et	   al.,	   2008).	  	  Thus,	  the	  loss	  of	  basal	  pMLC	  in	  TBX1-­‐deficient	  pharyngeal	  endoderm	  may	  enable	  actin	  to	  accumulate	  along	  the	  edge	  of	  this	  epithelia.	  	  In	  the	  otic	  placode	  the	  pMLC	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mediated	   mechanism	   of	   achieving	   actin	   polarity	   is	   dependent	   on	   the	  phospholipase	   C	   (PLC)	   branch	   of	   the	   FGF	   signalling	   pathway	   (Sai	   and	   Ladher,	  2008).	  FGF	   signalling	  appears	   to	  be	  maintained	   in	   the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	   	   However,	   a	   detailed	   analysis	   of	   the	   PLC	   pathway	   specific	   genes	   is	  required	   to	  determine	  whether	   this	  branch	  of	   the	  FGF	  pathway	   is	  maintained	   in	  the	  absence	  of	  endodermal	  TBX1.	  	  Loss	  or	  reduction	  of	  the	  PLC	  pathway	  could	  also	  account	  for	  the	  loss	  of	  pMLC	  in	  TBX1-­‐deficient	  pharyngeal	  endoderm.	  	  The	  increased	  Fhl1	  expression	  may	  be	  a	  direct	  response	  to	  the	  loss	  of	  Tbx1.	  	  T-­‐BOX	  proteins	  and	  LIM	  proteins	  are	  able	  to	  interact	  (Krause	  et	  al.,	  2004,	  Krcmery	  et	  al.,	  2010).	  However,	  to	  the	  best	  of	  my	  knowledge,	  an	  interaction	  between	  these	  factors	  at	  a	  transcriptional	  level	  has	  not	  been	  determined.	  	  An	  association	  between	  LMP4	  and	   TBX5	   has	   been	   established	   at	   the	   level	   of	   the	   protein,	   where	   the	   former	  mediates	   the	   shuttling	  of	  TBX5	   from	   the	  nucleus	   to	  actin	   fibres	   in	   the	  cytoplasm	  (Krcmery	  et	  al.,	  2010).	  	  Yet,	  the	  interaction	  has	  only	  been	  established	  for	  the	  PDZ-­‐LIM	  subgroup	  of	  LIM	  proteins.	  	  Alternatively,	  the	  increase	  in	  Fhl1	  expression	  may	  be	   a	   result	   of	   the	   TBX1	   dependent	   accumulation	   of	   actin	   in	   the	   pharyngeal	  endoderm	   (Kadrmas	   and	   Beckerle,	   2004).	   For	   instance	   an	   increase	   in	   actin	  polymerisation	  has	  been	  shown	   to	  enable	  myocardin-­‐related	   transcription	   factor	  (MAL),	   a	   co-­‐activator	   of	   serum	   response	   factor	   (SRF)	   to	   shuttle	   to	   the	   nucleus	  (Miralles	  et	  al.,	  2003).	  	  One	  of	  the	  transcriptional	  targets	  of	  SRF/MAL	  is	  Fhl1.	  	  It	  has	  been	   shown	   that	   the	   stable	   expression	   of	   MAL	   (and	   thus	   the	   expression	   of	   its	  target	  genes)	   reduces	   the	  migration	  of	   epithelial	   cells	   (Leitner	  et	   al.,	   2011).	   	  The	  inhibition	  of	  epithelial	  migration	  can	  be	  partially	  relieved	  by	  reducing	  FHL1	  in	  the	  cells	   constitutively	   expressing	  MAL	   (Leitner	   et	   al.,	   2011).	   	   It	   is	   possible	   that	   the	  accumulation	   of	   F-­‐actin	   at	   the	   basal	   edge	   of	   the	   pharyngeal	   endoderm	   (in	   the	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7.1.	   TBX1	   regulates	   pharyngeal	   pouch	   morphogenesis	  
independently	   from	  its	  effect	  on	   the	  expression	  of	  genes	  
in	  the	  FGF	  signalling	  cascade	  
The	  PA	   is	   a	   transient	  but	   complex	   structure	   contributed	   to	  by	   four	  different	   cell	  types,	   ectoderm,	   endoderm,	   CNCC	   and	  mesoderm,	   the	   two	   latter	   cell	   types	   also	  differentiate	   into	   endothelial	   and	   mesenchymal	   tissue	   (Graham,	   2003).	   	   The	  correct	   formation	   of	   the	   PA	   is	   essential	   for	   the	   development	   of	   many	   of	   its	  derivatives	   later	   in	   gestation,	   such	   as	   the	   thymus.	   It	   is	   emerging	   that	   the	  pharyngeal	   endoderm	   plays	   a	   prominent	   role	   in	   directing	   the	  morphogenesis	   of	  the	   PA.	   During	   PA	   formation,	   the	   pharyngeal	   endoderm	   evaginates	   toward	   the	  ectoderm	  to	  produce	  discreet	  ‘slit-­‐like’	  pouches	  (Quinlan	  et	  al.,	  2004).	  The	  process	  of	  pharyngeal	  pouch	  morphogenesis	   is	  perturbed	  by	   the	  deletion	  of	  many	  genes,	  including	   Tbx1	   and	   Fgf8.	   Caudal	   pharyngeal	   pouches	   do	   not	   develop	   in	   Tbx1-­‐/-­‐,	  
Tbx1	   hypomorphic	   and	   Fgf8	   hypomorphic	   embryos	   (Jerome	   and	   Papaioannou,	  2001;	   Hu	   et	   al.,	   2004).	   The	   observation	   that	   Fgf8	   expression	   is	   lost	   in	   the	  pharyngeal	   endoderm	   of	   Tbx1-­‐/-­‐	   embryos	   has	   led	   to	   the	   hypothesis	   that	   FGF8	  functions	  downstream	  of	  Tbx1	  in	  the	  endoderm	  to	  regulate	  pouch	  morphogenesis	  (Vitelli	   et	   al.,	   2002b).	   However,	   a	   lack	   of	  mouse	  models	  with	   endoderm-­‐specific	  CRE	  activity	  prevented	   this	  hypothesis	   from	  being	   tested.	   	  This	   thesis	   addressed	  whether	   Tbx1,	   Fgf8	   and	   FGF	   signalling	   is	   required	   specifically	   in	   the	   endoderm	  during	  pouch	  morphogenesis	  using	  a	  new	  endoderm	  specific	  Sox17iCre	  mouse	  line	  (Engert	   et	   al.,	   2009).	   Surprisingly,	   data	   presented	   in	   this	   thesis	   suggests	   that	  neither	   FGF8	   not	   the	   FGF	   pathway	   acts	   directly	   downstream	   of	   Tbx1	   in	   the	  endoderm	   during	   pouch	   morphogenesis.	   	   In	   light	   of	   these	   findings,	   alternative	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mechanisms	   by	   which	   TBX1	   may	   regulate	   pouch	   morphogenesis	   within	   the	   PA	  were	  examined.	   	  
7.1.1	  Pharyngeal	  pouch	  defects	  caused	  by	  the	  loss	  of	  Tbx1	  
from	   the	   endoderm	  are	  distinct	   from	   the	  defects	   caused	  
by	  deficiencies	  in	  endodermal	  FGF	  signalling	  
The	  deletion	  of	  Tbx1	  during	  development	  has	  demonstrated	  that	  this	  transcription	  factor	   is	   essential	   to	   the	   formation	   of	   the	   PA	   (Baldini,	   2005;	   Scambler,	   2010).	  Tissue-­‐specific	   functions	  of	  TBX1	   in	   the	  PA	  have	  begun	   to	  be	  elucidated	   through	  the	   analysis	   of	   mouse	   lines	   in	   which	   this	   transcription	   factor	   had	   been	   deleted	  from	  one	  or	  more	  cell	  types	  during	  development	  (Baldini,	  2006).	  The	  studies	  found	  that	   the	   pharyngeal	   arch	   arteries	   and	   cranial	   nerves	   require	   a	   source	   of	  ectodermal	  Tbx1	  for	  their	  development	  (Zhang	  et	  al.,	  2005;	  Calmont	  et	  al.,	  2009).	  Mesodermal	  Tbx1	   is	   important	   for	   the	   formation	  of	   the	  cardiac	  outflow	  tract	  and	  the	  patterning	  of	  the	  proximal	  mandible	  (Zhang	  et	  al.,	  2006;	  Aggarwal	  et	  al.,	  2010).	  The	   deletion	   of	   Tbx1	   from	   the	   endoderm	   mediated	   by	   FOXG1Cre	   on	   a	   Swiss-­‐Webster	   (S-­‐W)	   genetic	   background	   (PE-­‐KO	   embryos)	   fully	   recapitulates	   the	  pharyngeal	  pouch	  defects	  observed	   in	  Tbx1-­‐/-­‐	  embryos	  (Arnold	  et	  al.,	  2006),	   thus	  indicating	   that	   the	   expression	   of	   Tbx1	   in	   the	   endoderm	   is	   essential	   for	   caudal	  pouch	  morphogenesis.	  	  Surprisingly,	  however,	   the	  deletion	  of	  Tbx1	   from	  the	  mesoderm	  (M-­‐KO	   embryos)	  affects	  pouch	  and	  thymus	  formation.	  M-­‐KO	  embryos	  display	  pouch	  defects	  that	  are	  similar	  to	  Tbx1-­‐/-­‐	  embryos	  and	  reactivation	  of	  mesodermal	  Tbx1	  expression	  in	  Tbx1	  hypomorphic	   embryos	   partially	   rescues	   pouch	   formation	   (Zhang	   et	   al.,	   2006).	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Thymus	  hypoplasia	  was	  also	  evident	   in	  PSE-­‐KO	   embryos,	  although	  pouch	  defects	  were	  not	  documented	  in	  these	  mutants	  (Randall	  et	  al.,	  2009).	  These	  results,	  taken	  together	   with	   the	   finding	   that	   the	   Foxg1Cre	   is	   non-­‐specifically	   expressed	   in	   PA	  tissue	   on	   genetic	   backgrounds	   other	   than	   S-­‐W,	   questioned	   whether	   Tbx1	   was	  required	  specifically	   in	   the	  endoderm	  during	  pouch	  morphogenesis	  (Zhang	  et	  al.,	  2005).	   The	   data	   in	   Chapter	   3	   supports	   the	   conclusion	   that	   caudal	   pouch	  morphogenesis	   requires	   Tbx1	   expression	   in	   the	   endoderm,	   as	   Tbx1cKOSox17	  embryos	  display	  caudal	  pouch	  aplasia.	  	  In	   contrast	   to	   hypotheses	   in	   the	   field,	   the	   data	   in	   this	   thesis	   does	   not	   provide	  evidence	   to	   support	   the	   prediction	   that	   TBX1	   in	   the	   endoderm	   controls	   pouch	  morphogenesis	  via	  transcriptional	  regulation	  of	  the	  FGF	  pathway.	  Many	  pieces	  of	  evidence	   indicated	   that	   TBX1,	   a	   cell-­‐autonomous	   manner,	   would	   regulate	   the	  expression	  of	  genes	  in	  the	  FGF	  pathway.	  The	  promoter	  elements	  of	  Fgf8	  and	  Fgf10	  contain	  T-­‐box	   consensus	   sites	   to	  which	   TBX1	   can	   bind.	   	   In	   vitro	   TBX1	   has	   been	  demonstrated	   to	  activate	   luciferase	  expression	  driven	   from	   these	  FGF	  promoters	  (Hu	  et	  al.,	  2004;	  Xu	  et	  al.,	  2004).	  The	  observation	  that	  Fgf3,	  Fgf8	  and	  Fgf10	  are	  all	  absent	   from	   the	   endoderm	   of	  Tbx1-­‐/-­‐	   and	   PE-­‐KO	   embryos	   further	   indicated	   that	  FGF	  signalling	  in	  vivo	  may	  be	  regulated	  by	  TBX1	  (Vitelli	  et	  al.,	  2002b;	  Aggarwal	  et	  al.,	  2006;	  Arnold	  et	  al.,	  2006).	  Yet,	  data	  in	  Chapter	  3	  show	  that	  only	  Fgf8	  expression	  is	  lost	  from	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	  	  The	  maintained	  expression	  of	  multiple	   Fgf	   ligands	   and	   Fgf	   signalling	   targets	   in	   Tbx1-­‐deficient	   endoderm	  represents	  the	  first	  indication,	  to	  my	  knowledge,	  that	  the	  FGF	  pathway	  and	  TBX1	  may	  only	   interact	   indirectly,	  within	   the	  endoderm,	  during	  pouch	  morphogenesis.	  Further	  evidence	  to	  support	  the	  conclusion	  that	  the	  FGF	  pathway	  and	  TBX1	  do	  not	  interact	  directly	  within	  the	  endoderm	  during	  pouch	  morphogenesis	  came	  from	  the	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observation	  that	  a	  compound	  deletion	  of	  Fgf3	  and	  Fgf8	  or	  Fgfr1	  and	  Fgfr2	  from	  the	  endoderm	   generates	   pouch	   defects	   that	   are	   distinct	   from	   those	   of	   Tbx1cKOSox17	  embryos.	  	  The	   deletion	   of	   Fgf8	   from	   the	   endoderm	   did	   not	   have	   an	   effect	   on	   pharyngeal	  pouch	   formation	   (see	   Chapter	   4).	   	   However,	   the	   compound	   deletion	   of	  Fgf3	   and	  
Fgf8	  or	  Fgfr1	  and	  Fgfr2	  from	  the	  endoderm	  generated	  rostral	  pouch	  defects	  similar	  to	   those	   observed	   in	   Fgfr1	   hypomorph	   (Trokovic	   et	   al.,	   2003;	   Trokovic	   et	   al.,	  2005).	  This	  data	  demonstrates	  that	  FGF	  signalling	  in	  the	  endoderm,	  maintained	  by	  FGF	   ligand	   and	   FGF	   receptor	   redundancy,	   regulates	   pouch	   morphogenesis.	   The	  similarity	   of	   pouch	   defects	   in	   R1;R2cKOSox17,	   severe-­‐Fgf8	   hypomorphs	   and	   Fgfr1	  hypomorphs	   and	   the	   incomplete	   penetrance	   of	   pouch	   defects	   in	   F3;F8cKOSox17	  embryos	   indicates	   that	   FGF	   signalling	   in	   the	   endoderm	  may	   also	   be	   elicited	   and	  maintained,	   in	   part,	   by	   FGF	   ligands	   from	   adjacent	   PA	   tissues.	   It	   would	   be	  interesting	  to	  determine	  whether	   it	   is	   the	  amount	  of	   ligand,	   the	  type	  of	   ligand	  or	  the	  location	  of	  the	  FGF	  ligand	  that	   is	  critical	   for	  directed	  pouch	  evagination.	   	  One	  possible	  approach	   to	   test	   the	  requirements	  of	  FGF	   ligands	   in	   the	  PA	  would	  be	   to	  drive	   the	   expression	   of	   Fgf3	   from	   the	   Fgf8	   promoter	   in	   an	   Fgf8	   hypomorphic	  background.	   	   If	   the	  expression	  of	  Fgf3	   in	  Fgf8	  expression	  domains	  did	  not	  rescue	  pouch	   morphogenesis,	   this	   would	   suggest	   that	   it	   is	   the	   FGF8	   protein	   that	   is	  specifically	  required	  for	  pouch	  outgrowth,	  rather	  than	  a	  certain	  amount	  or	  location	  of	   FGF	   signalling	   that	   could	   be	   elicited	   by	   any	   FGF	   ligand	  with	   the	   same	   spatio-­‐temporal	  expression	  as	  Fgf8.	  	  	  Analysis	  of	   the	  pharyngeal	  endoderm	  of	  Tbx1cKOSox17	   and	  R1;R2cKOSox17	   embryos	  revealed	   that	   these	   mutants	   have	   distinct	   pouch	   phenotypes.	   	   The	   loss	   of	   Tbx1	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prevents	   the	   caudal	   endoderm	   from	   evaginating	   laterally	   toward	   the	   ectoderm.	  	  Conversely,	   in	   endoderm	   deficient	   of	   FGF	   signalling,	   the	   epithelium	   appears	   to	  evaginate	   toward	   the	   ectoderm	  but	  does	   so	  without	  direction.	   In	   addition	   to	   the	  contrasting	   pouch	   phenotypes,	   the	   pharyngeal	   arches	   of	   each	   mutant	   also	   form	  with	  distinct	  defects.	  In	  Tbx1cKOSox17	  the	  lack	  of	  caudal	  pouch	  evagination	  prevents	  all	   but	   the	  1st	   and	  occasionally	   a	   severely	  hypoplastic	  2nd	   arch	   from	   forming.	   	   In	  contrast,	   the	   proximal	   portion	   of	   the	   2nd	   arch	   is	   most	   severely	   affected	   in	  endodermal	   FGF	  mutants	   because	   of	   the	   disorganised	   evagination	   of	   the	   rostral	  endoderm.	   Interestingly,	   comparing	   the	   Pax1	   delineated	   pouch	   defects	   of	   Fgf8-­‐severe	   hypomorphs	   and	   Fgfr1	   hypomorphs	  with	   Tbx1	   hypomorphs	   and	   Tbx1-­‐/-­‐	  embryos	   similar	   distinctions	   in	   pouch	   morphology	   are	   evident.	   	   The	   rostral	  pouches	  of	  Fgf8	  and	  Fgfr1	  hypomorphs	  are	  evident	  but	  appear	  splayed	  and	  fused,	  whereas	  the	  pharyngeal	  endoderm	  caudal	  to	  the	  1st	  pouch	  is	  unable	  to	  evaginate	  in	  
Tbx1	  null	  and	  Tbx1	  hypomorphic	  embryos	  (Jerome	  and	  Papaioannou,	  2001;	  Abu-­‐Issa	  et	  al.,	  2002;	  Trokovic	  et	  al.,	  2003;	  Hu	  et	  al.,	  2004).	  	  
	  
7.1.2	   Tbx1	   does	   not	   genetically	   interact	   with	   the	   FGF	  
pathway,	   in	   the	   pharyngeal	   endoderm,	   during	   pouch	  
morphogenesis	  
The	  prediction	  that	  FGF8	  might	  act	  downstream	  of	  TBX1	  in	  the	  endoderm	  during	  pharyngeal	   pouch	   development	  was	   also	   borne	   from	   the	   evidence	   that	  Fgf8	  and	  
Tbx1	   genetically	   interact	  during	  other	  aspects	  of	  PA	  development.	  The	  combined	  deletion	  of	   one	   allele	   of	  Tbx1	   and	  one	   allele	   of	  Fgf8	  during	  development	   (Fgf8+/-­‐
;Tbx1+/-­‐	   embryos)	   results	   in	   an	   increased	   incidence	   of	   4th	   PAA	   defects	   and	   an	  
	  	  
incidence	   of	   aortic	   arch	   defects	   compared	   to	   Tbx1+/-­‐	   and	   Fgf8+/-­‐	   embryos	  (Aggarwal	  et	  al.,	  2006).	  Furthermore,	  the	  deletion	  or	  forced	  expression	  of	  Fgf8	   in	  the	  Tbx1	   expression	  domain	  modifies	   aortic	   arch	   and	  OFT	  phenotypes	  of	  Tbx1-­‐/-­‐	  embryos,	   respectively	   recapitulating	   or	   rescuing	   the	   defects	   observed	   in	   the	  mutant.	   Tbx1	   and	   Fgf8	   have	   also	   been	   demonstrated	   to	   interact	   during	   the	  organogenesis	   of	   endocrine	   organs	   derived	   from	   the	   pharyngeal	   endoderm.	   	   An	  increase	   in	   the	   incidence	   of	   thymus	   hypoplasia	   is	   reported	   in	   Fgf8+/-­‐;Tbx1+/-­‐	  embryos	   relative	   to	   Tbx1+/-­‐	   embryos	   (Brown	   et	   al.,	   2004;	   Vitelli	   et	   al.,	   2010).	  Moreover,	   thyroid	  hypoplasia	  manifests	  when	  Fgf8	   is	  deleted	   from	  Tbx1	  positive	  cells	   and	   is	   partially	   rescued	   by	   driving	   Fgf8	   transcription	   in	   Tbx1	   expression	  domains	   (Lania	   et	   al.,	   2009).	   Pouch	   morphogenesis	   has	   not	   been	   analysed	   in	  embryos	  deficient	  of	  both	  Fgf8	  and	  Tbx1.	  	  The	  observation	  that	  pouch	  formation	  in	  
Fgf8;Tbx1cHetSox17	   embryos	   is	   relative	   to	   pouch	   formation	   in	   Fgf8cHetSox17	   and	  
Tbx1cHetSox17	   embryos	   is	   thus	  a	  novel	   finding.	  The	   lack	  of	  epistasis	  between	  Fgf8	  and	   Tbx1	   in	   the	   endoderm	   during	   pouch	   morphogenesis	   further	   supports	   the	  inference	   that	   TBX1	   and	   FGF8	   function	   in	   parallel	  within	   this	   epithelium	  during	  pouch	   outgrowth.	   Whether	   Fgf8	   and	   Tbx1	   interact	   in	   the	   endoderm	   during	  pharyngeal	   pouch	   patterning	   or	   thymus	   organogenesis	   requires	   an	   analysis	   of	  
Fgf8;Tbx1cHetSox17	  embryos	  later	  in	  gestation.	  	  	  The	  data	  in	  this	  thesis	  demonstrates	  that	  it	  is	  unlikely	  that	  a	  loss	  of	  FGF	  signalling	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos	  is	  preventing	  caudal	  pouch	  evagination.	  The	   genetic	   interaction	   between	   FGF	   signalling	   and	   TBX1	   in	   the	   endoderm	  was	  assessed	   by	   generating	   Spry1;Spry2cHet;Tbx1cKOSox17	   embryos	   and	   analysing	   the	  extent	   of	   pouch	   formation	   in	   these	   mutants,	   (see	   section	   5.3.2).	   It	   was	  demonstrated	  that	  the	  caudal	  pouch	  aplasia	  of	  Tbx1cKOSox17	  embryos	  could	  not	  be	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rescued	  by	   genetically	   de-­‐regulating	  FGF	   signalling	   in	   the	  pharyngeal	   endoderm.	  	  This	   data	   fits	   with	   the	   observation	   that	   the	   expression	   of	   FGF	   target	   genes	   are	  maintained	  in	  the	  endoderm	  of	  Tbx1cKOSox17	  embryos.	   	  Aggawarl	  et	  al.,	  found	  that	  the	   compound	   deletion	   of	  Fgf3,Fg8	   and	  Tbx1	   (i.e.	  Fgf3-­‐/-­‐;Fgf8+/-­‐;Tbx1+/-­‐	   embryos)	  did	  not	   increase	   the	   incidence	  or	   severity	  of	   thymus	  defects	   compared	   to	  Fgf8+/-­‐
;Tbx1+/-­‐	   embryos	   (Aggarwal	   et	   al.,	   2006).	   	   They	   hypothesised	   that	   multiple	   FGF	  ligands	   in	   the	   pharyngeal	   endoderm,	   in	   addition	   to	   Fgf3,	   Fgf8	   and	   Fgf10,	   act	  redundantly	  during	  thymus	  organogenesis	  (Aggarwal	  et	  al.,	  2006).	  The	  data	  in	  this	  thesis	  presents	  an	  alternative	   theory;	  TBX1	  does	  not	  act	   in	   the	  same	  pathway	  as	  the	  FGF	  signalling	  cascade,	  within	   the	  endoderm,	  during	  pouch	  morhogenesis.	   	  A	  lack	   of	   genetic	   interaction	   between	   these	   factors	  within	   the	   endoderm	  may	   also	  occur	  during	  the	  organogenesis	  of	  derivatives	  of	  the	  pharyngeal	  endoderm,	  such	  as	  the	  thymus.	  	  
7.2	   TBX1	   may	   control	   pouch	   morphogenesis	   by	  
regulating	  the	  activity	  of	  several	  signalling	  pathways	  
The	   present	   study	   has	   demonstrated	   that	   genes	   within	   the	   FGF,	   RA	   and	   SHH	  signalling	  pathways	  are	  all	  perturbed	  by	   the	  endoderm	  specific	  deletion	  of	  Tbx1.	  	  Whilst	   TBX1	  may	   directly	   affect	   the	   transcription	   of	   all	   the	   anteriorly	   expanded	  genes	   in	   the	  pharyngeal	   endoderm	   (i.e.	  Shh,	   Ptch,	   Erm,	   Fgf3,	   Rarb,	   Cyp26b1),	   the	  number	  of	  genes	  affected	  and	   the	  similarity	   in	   the	  change	   to	   the	  pattern	  of	   their	  expression	  suggests	  that	  these	  defects	  may	  not	  be	  direct.	  	  	  Alternatively	  it	  possible	  that	  TBX1	  in	  the	  endoderm	  controls	  pouch	  morphogenesis	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by	  positively	  regulating	  the	  transcription	  of	  a	  genes	  that	  time	  did	  not	  permit	  a	  full	  analysis	   of	   within	   this	   study.	   For	   instance,	   literature	   suggests	   that	   both	   Serum	  
response	   factor	   (Srf)	  and	  homeobox	  domain	  containing	  (Gbx2)	  may	  be	  associated	  with	   Tbx1	   during	   PA	   development	   (Byrd	   and	   Meyers,	   2005;	   Chen	   et	   al.,	   2009).	  Microarray	  and	  expression	  analysis	  has	  demonstrated	  that	  Gbx2	  is	  down	  regulated	  in	   the	  PA	  of	  Tbx1	   null	   embryos,	   including	   the	  pharyngeal	   endoderm	  (Ivins	  et	   al.,	  2005).	   However,	   an	   initial	   analysis	   of	   Gbx2	   in	   Tbx1cKOSox17	   embryos	   did	   not	  identify	  a	  significant	  loss	  of	  endodermal	  expression.	  	  Whilst	  this	  result	  needs	  to	  be	  confirmed,	  it	  fits	  with	  the	  observation	  that	  Gbx2-­‐/-­‐	  embryos	  appear	  to	  have	  normal	  pouch	   morphogenesis	   (Byrd	   and	   Meyers,	   2005).	   Moreover,	   although	   Gbx2	  expression	   was	   maintained	   in	   the	   endoderm	   of	   the	   Tbx1cKOSox17	   embryos	   it	  appeared	  un-­‐segmented,	  akin	   to	   the	  expression	  of	  genes	   in	   the	  SHH,	  RA	  and	  FGF	  pathways.	  	  	  	  Similarly,	   an	   initial	   analysis	   of	   (Eya1)	   expression	   in	   Tbx1cKOSox17	   embryos	   also	  found	   transcripts	   to	   be	   expressed	   in	   an	   un-­‐segmented	   manner	   throughout	   the	  pharyngeal	   endoderm.	   The	   expression	   of	   Tbx1	   is	   reduced	   in	   the	   pharyngeal	  endoderm	  of	  Eya1	  null	  mutants,	  indicating	  that	  EYA1	  likely	  acts	  upstream	  of	  Tbx1	  during	  pouch	  morphogenesis	  (Zou	  et	  al.,	  2006).	  The	  latter	  inference	  was	  supported	  by	  microarray	  and	  in	  situ	  data	  that	  showed	  no	  change	  in	  the	  expression	  of	  Eya1	  in	  the	  pharyngeal	  region	  of	  embryos	  null	  for	  Tbx1	  (Ivins	  et	  al.,	  2005).	  Thus,	  like	  Shh,	  
Eya1	   expression	   was	   not	   predicted	   to	   change	   in	   the	   endoderm	   of	   Tbx1cKOSox17	  embryos.	   	   The	   observation	   that	  multiple	   genes	   in	   the	   endoderm	   of	  Tbx1cKOSox17	  embryos	   display	   an	   un-­‐segmented,	   expanded	   pattern	   of	   expression,	   (especially	  those	  predicted	  to	  act	  upstream	  of	  TBX1),	  indicates	  that	  this	  may	  be	  a	  response	  to	  the	  perturbed	  morphology	  of	   the	  endoderm,	   rather	   than	  being	  evidence	  of	  TBX1	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acting	  as	  a	  transcriptional	  regulator	  of	  multiple	  genes	  in	  the	  pharyngeal	  endoderm.	  	  
7.3	   TBX1	   may	   control	   pouch	   morphogenesis	   by	  
regulating	   the	   polarity	   of	   actin	   within	   the	   pharyngeal	  
endoderm	  
The	   data	   presented	   in	   Chapter	   6	   indicates	   that	   TBX1	   may	   control	   the	  morphogenesis	  of	   the	  pharyngeal	  pouches	  by	   regulating	   the	  polarity	  of	   the	  actin	  cytoskeleton	   within	   the	   endoderm.	   Disruption	   of	   the	   actin	   network	   has	   been	  demonstrated	   to	   perturb	   the	   morphogenesis	   of	   a	   number	   of	   structures	   in	  development.	  The	  formation	  of	  disorganised	  actin	  cables	  prevents	  the	  formation	  of	  ‘slit	   like’	  pharyngeal	  pouches	   in	   the	  chick	  (Quinlan	  et	  al.,	  2004).	  The	   loss	  of	  actin	  polarity	  in	  the	  otic	  placode	  prevents	  the	  invagination	  of	  this	  thickened	  ectodermal	  epithelium	   (Sai	   and	   Ladher,	   2008).	   Furthermore,	   the	   coordinated	   forward	  movement	  of	  epithelial	  cells	  at	  the	  leading	  edge	  during	  dorsal	  closure	  of	  Drosophila	  embryos	  is	  regulated	  and	  enabled,	  in	  part,	  by	  the	  constraining	  force	  of	  actin	  cables	  (Jacinto	  et	  al.,	  2002).	  	  It	  is	  possible	  that	  TBX1	  may	  directly	  affect	  actin	  dynamics	  and	  polarity	  within	  the	  pharyngeal	   endoderm.	  Optomotor-­‐blind	   (omb)	   is	   a	   Drosophila	   homologue	   of	   the	  mammalian	  Tbx2	  gene	  family.	  A	  graded	  concentration	  of	  omb	  exists	  along	  the	  A-­‐P	  axis	  of	   the	  Drosophila	  embryos	  wing	  disc	  pouch	  (Shen	  et	  al.,	  2010).	  The	  gradient	  influences	   epithelial	   cell	   shape	   by	   mediating	   actin	   dynamics,	   the	   resulting	   cell-­‐shape	  in	  turn	  determines	  the	  affinity	  between	  neighbouring	  cells.	  The	  clonal	  loss	  of	  
omb	   results	   in	   a	   cell-­‐autonomous	   accumulation	   of	   F-­‐actin,	   causing	   the	   mutant	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clones	  to	  become	  more	  rounded	  in	  shape	  (Shen	  et	  al.,	  2010).	  	  As	  a	  consequence	  of	  this	  shape	  change,	  the	  rounded	  mutant	  clone	  retracts	  away	  from	  the	  less	  rounded	  adjacent	  wild	   type	  cells	  at	   their	  apical	   surface.	  The	  study	  by	  Shen	  et	  al.	  does	  not	  determine	   how	   the	   loss	   of	   omb	   function	   causes	   a	   rearrangement	   of	   the	   actin	  cytoskeleton.	  	  However,	  it	  does	  show	  that	  the	  clonal	  cytoskeleton	  re-­‐arrangements	  are	  independent	  from	  the	  transcriptional	  effect	  omb	  has	  on	  its	  downstream	  target	  
sal	   (Shen	   et	   al.,	   2010).	   The	   ability	   of	   this	   T-­‐BOX	   homologue	   to	   maintain	  independent	   functions	   as	   a	   direct	   regulator	   of	   transcription	   and	   as	   a	   direct	  regulator	   of	   cytoskeletal	   re-­‐arrangements	   may	   be	   a	   characteristic	   of	   all	   T-­‐BOX	  proteins.	   	  If	  so,	  this	  characteristic	  could	  explain	  why	  in	  Tbx1-­‐deficient	  pharyngeal	  endoderm	  the	  actin	  network	  is	  un-­‐polarised	  but	  the	  expression	  of	  genes	  predicted	  to	  act	  downstream	  of	  TBX1	  (i.e.	  Cyp26b1,	  Erm)	  are	  maintained.	  	  The	  expanded	  expression	  of	  genes	  in	  the	  RA,	  SHH	  and	  FGF	  signalling	  cascade	  may	  be	   indirect	   changes	   caused	   by	   actin-­‐induced	   alterations	   to	   the	   Tbx1-­‐deficient	  endoderm.	   Alternatively,	   actin-­‐associated	   proteins	  may	   actively	   alter	   the	   genetic	  profile	   of	   the	   pharyngeal	   endoderm	   of	   Tbx1cKOSox17	   embryos.	   It	   has	   been	  demonstrated	   that	   the	   re-­‐distribution	   of	   myocardin-­‐related	   transcription	   factor	  (MAL/MRTF),	   a	   co-­‐activator	   of	   SRF,	   from	   the	   cytoplasm	   to	   the	   nucleus	   is	  dependent	  on	  (Rho	  dependent)	  actin	   treadmilling,	   (the	  polymerisation	  of	  G-­‐actin	  to	   F-­‐actin)	   (Miralles	   et	   al.,	   2003).	   For	   instance,	   endogenous	  MAL	  was	   prevented	  from	   accumulating	   in	   the	   nucleus	   when	   ß-­‐actin	   was	   overexpressed.	   Conversely,	  the	   stabilisation	   of	   F-­‐actin	   by	   the	   drug	   Jasplakinolide	   induces	   a	   nuclear	  accumulation	  of	  MAL.	  From	  this	  data	  it	  was	  predicted	  that	  the	  polymerisation	  of	  G-­‐actin	   in	   the	   cytoplasm	   releases	   the	   associated	   MAL	   protein	   that	   subsequently	  translocates	  to	  the	  nucleus	  and	  forms	  a	  transcriptional	  complex	  with	  SRF	  (Miralles	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et	  al.,	  2003).	  	  	  It	  is	  possible	  that	  the	  increase	  in	  F-­‐actin	  in	  Tbx1-­‐deficient	  endoderm	  may	   also	   initiate	   the	   transcription	   of	   SRF	   target	   genes,	   one	   of	  which	   is	  Fhl1,	   by	  inducing	  ectopic	  or	  elevated	  levels	  of	  MAL	  in	  the	  nucleus.	  	  LIM	   domain	   proteins	   are	   also	   attractive	   candidates	   for	   actin-­‐associated	   proteins	  that	   could	   alter	   the	   genetic	   profile	   of	   the	   pharyngeal	   endoderm	   of	   Tbx1cKOSox17	  embryos.	  	  LIM	  domain	  proteins	  are	  able	  to	  associate	  with	  actin	  and,	  in	  the	  case	  of	  the	   FHL	   family,	   can	   also	   modulate	   the	   assembly	   of	   transcriptional	   complexes	  (Kadrmas	   and	   Beckerle,	   2004;	   Krause	   et	   al.,	   2004).	   T-­‐BOX	   proteins	   and	   LIM	  domain	   proteins	   have	   been	   found	   to	   interact	   during	   heart	   and	   lim	   bud	  development	   (Krause	   et	   al.,	   2004;	   Bimber	   et	   al.,	   2007).	   Interestingly,	   co-­‐transfection	  of	  Tbx5	  and	  Lmp4	  into	  COS-­‐7	  cells,	  (that	  do	  not	  express	  either	  factor),	  inhibited	  the	  TBX5	  dependent	  activation	  of	  FGF10	  luciferase	  reporters	  (Camarata	  et	   al.,	   2006;	   Bimber	   et	   al.,	   2007).	   This	   data	   links	   T-­‐BOX	  mediated	   transcription	  with	  actin	  associated	  LIM	  proteins.	  The	  effect	  deleting	  T-­‐BOX	  proteins	  has	  on	  the	  function	  of	  LIM	  domain	  proteins	  has	  not	   yet	  been	   investigated.	   	  The	  data	   in	   this	  thesis	   shows	   Fhl1	   expression	   is	   increased	   in	   the	   actin-­‐rich	   endoderm	   of	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7.4	  Proposed	  model	  of	  pharyngeal	  pouch	  morphogenesis	  
The	   work	   in	   this	   thesis	   presents	   a	   number	   of	   novel	   and	   interesting	   results	  revealing	  how	  genes	  expressed	  in	  the	  pharyngeal	  endoderm	  interact	  during	  pouch	  morphogenesis.	   	   The	  most	   significant	   finding	   being	   that	   FGF	   signalling	   does	   not	  appear	   to	   act	   directly	   downstream	   of	   Tbx1	   in	   the	   pharyngeal	   endoderm	   during	  pouch	  morphogenesis.	  	  The	  next	  challenge	  is	  to	  identify	  FGF-­‐dependent	  and	  TBX1-­‐dependent	  mechanisms	  of	  endodermal	  evagination	  that,	  when	  integrated,	  explain	  how	  pouch	  morphogenesis	  occurs.	  A	  model	  for	  pharyngeal	  pouch	  morphogenesis	  is	   emerging	   based	   on	   the	   findings	   of	   this	   thesis	   and	   literature	   in	   the	   field.	   	   It	   is	  loosely	  based	  on	  the	  inference	  of	  Takeuchi	  et	  al.	  that	  T-­‐box	  and	  Fgf	  genes	  are	  both	  required	   for	   limb	   bud	   outgrowth.	   However	   the	   role	   of	   the	   former	   is	   to	   initiate	  outgrowth	  whereas	  the	  role	  of	   the	   latter	   is	   to	  maintain	  growth	  (Takeuchi,	  2003).	  The	   model	   below	   similarly	   proposes	   that	   TBX1	   initiates	   pouch	   outgrowth	   by	  regulating	   actin	   polarity.	   	   TBX1,	   directly	   or	   indirectly,	   induces	   the	   activation	   of	  myosin	   (as	   an	   ADF)	   at	   the	   basal	   edge	   of	   the	   pharyngeal	   endoderm	   and	   Fgf8	  expression	   within	   the	   pharyngeal	   endoderm.	   The	   TBX1	   mediated	   regulation	   of	  actin	  bundling	   in	  the	  3rd	  pouch	  may	  also	  regulate	  the	  amount	  of	  Fhl1	  expression,	  alternatively	   TBX1	  may	   directly	   inhibit	   transcription	   of	   this	   LIM	   domain	   factor.	  	  Endodermal	  evagination	  occurs	  because	  the	  cells	  are	  not	  constrained	  by	  the	  actin	  network.	   In	   parallel	   FGF	   signalling,	   induced	   by	   FGF	   ligands	   other	   than	   FGF8,	   is	  elicited	   in	   a	   TBX1-­‐independent	   manner.	   	   The	   FGF	   signalling	   in	   the	   evaginating,	  
Tbx1	  positive	  endoderm	  maintains	  directed	  pouch	  outgrowth.	  	  In	  TBX1-­‐deficient	  endoderm	  there	  is	  a	  loss	  of	  activated	  MLC	  and	  an	  up-­‐regulation	  of	  Fhl1	  that	  enables	  actin	  to	  accumulate	  along	  the	  basal	  edge	  of	  the	  pharyngeal	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endoderm,	  preventing	   the	  epithelial	  cells	   from	  evaginating.	   It	   is	  possible	   that	   the	  loss	  of	  TBX1	  dependent	  Fgf8	  expression	  reduces	  signalling	  from	  the	  Plugs	  pathway	  of	  the	  FGF	  signalling	  cascade.	   	  The	  Plugs	  pathway	  has	  been	  shown	  to	  be	  required	  for	   pMLC	   accumulation	   at	   the	   basal	   edge	   of	   the	   otic	   placode.	   Signalling	  downstream	   of	   FGF3	   is	   maintained	   because	   Fgf3	   transcription	   is	   initiated	  independently	   of	   TBX1	   in	   the	   pharyngeal	   endoderm,	   however,	   this	   signalling	  cascade	   is	   not	   sufficient	   to	   initiate	   pouch	   evagination,	   only	   to	   maintain	   	   pouch	  outgrowth.	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Fig	  57.	  A	  model	  proposing	  mechanisms	  through	  which	  pharyngeal	  pouch	  morphogenesis	  
is	  regulated.	  	  
(a)	  The	  initiation	  of	  endodermal	  evagination	  is	  dependent	  on	  TBX1	  functioning	  in	  the	  endoderm	  as	  a	  regulator	  of	  actin	  polarity.	  	  TBX1	  may	  achieve	  this	  by	  positively	  influencing	  the	  activation	  of	  the	  ADF,	  pMLC,	  at	  the	  basal	  edge	  of	  the	  endoderm.	  	  The	  TBX1-­‐dependent	  activation	  of	  MLC	  may	  be	  achieved	  via	  FGF8,	  a	   transcriptional	   target	  of	  TBX1.	   	  pMLC	  accumulation	   in	   the	  otic	  placode	  requires	  signalling	   from	  the	  Plugs	  pathway,	   it	   is	  possible	   that	  FGF8	  activates	   this	  pathway	  and	  thus	   MLC	   in	   the	   pharyngeal	   endoderm.	   	   TBX1	   may	   also	   control	   actin	   polymerisation	   by	  negatively	   regulating	   the	   actin	   effector	   FHL1.	   Polarised	   actin	  within	   the	   pharyngeal	   endoderm	  enables	   evagination	   to	   occur.	   	   This	   process	   appears	   to	   be	   maintained	   and	   directed	   by	   FGF	  signalling	   in	   the	   endoderm	   that	   is	   activated	   either	   a)	   independently	   of	   TBX1	   e.g.	   through	  signalling	   elicited	   by	   FGF3,	   or,	   b)	   from	   FGF	   ligands	   present	   in	   the	   adjacent	   pharyngeal	   tissue,	  such	  as	  the	  mesenchyme,	  that	  could	  bind	  to	  FGFRs	  in	  the	  endoderm.	  	  
(b)	   In	  TBX1	  deficient	  endoderm	  actin	  becomes	  polymerised	  along	  the	  apical	  and	  basal	  edges	  of	  the	  pharyngeal	  endoderm.	  	  The	  presence	  of	  unpolarised	  actin	  is	  correlated	  with	  an	  up-­‐regulation	  of	  Fhl1	  in	  the	  endoderm	  and	  a	  loss	  of	  pMLC	  at	  the	  basal	  edge	  of	  the	  epithelium.	  	  The	  loss	  of	  pMLC	  may	   be	   attributed	   to	   the	   severely	   diminished	   expression	   of,	   (or	   absence	   of),	   Fgf8	   in	   the	  endoderm	  that	  likely	  would	  be	  unable	  to	  activate	  PLCg	  signalling	  that	  has	  been	  demonstrated	  to	  act	   upstream	   of	   pMC	   in	   the	   avian	   otic	   vesicle.	   	   In	   contrast	   FGF	   signalling	   is	  maintained	   in	   the	  
Tbx1-­‐deficient	  endoderm.	  	  It	  is	  possible	  that	  the	  expression	  of	  FGF	  targets	  such	  as	  Erm	  is	  elicited	  through	  either	  a)	  endodermal-­‐FGF3	  that	   is	  maintained	   in	   the	  absence	  of	  TBX1,	  or,	  b)	   from	  FGF	  ligands	   present	   in	   the	   adjacent	   pharyngeal	   tissue,	   such	   as	   the	  mesenchyme.	   	   However,	   in	   the	  absence	  of	  TBX1,	  FGF	  signalling	  is	  not	  sufficient	  for	  pharyngeal	  pouch	  morphogenesis	  to	  occur.	  	  In	   a	   and	   b,	   yellow	  depicts	   the	   pharyngeal	   endoderm,	   pink	   is	   the	   pharyngeal	  mesenchyme	   and	  grey	   is	   the	  pharyngeal	   cavity.	  Green	   strands	   represent	  F-­‐actin	  and	   red	   represents	  pMLC	   in	   the	  Tbx1-­‐positive	  endoderm.	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7.5	  Future	  work	  
The	  data	   in	   this	   thesis	  has	   identified	  new	  potential	  mechanisms	  whereby	   loss	  of	  
Tbx1	   could	   affect	   pouch	   outgrowth.	   My	   findings	   reveal	   that	   for	   pouch	  morphogenesis	   to	   occur	   TBX1	   and	   FGF	   signalling	   are	   both	   required	   in	   the	  endoderm.	   FGF	   ligands	   and	   receptors	   act	   redundantly	   within	   the	   endoderm	   to	  maintain	  FGF	  signalling	   that	  drives	  directed	  pouch	  outgrowth.	   	   In	   the	  absence	  of	  endodermal	  Tbx1,	  FGF	  signalling	  is	  elicited	  through	  FGF	  ligands	  other	  than	  FGF8,	  the	  expression	  of	  which	  is	  TBX1-­‐dependent.	  The	  latter	  indicates	  that	  FGF	  signalling	  does	   not	   act	   directly	   downstream	   of	   TBX1	   in	   the	   endoderm	   to	   regulate	   pouch	  outgrowth.	  TBX1	  appears	  to	  control	  pouch	  morphogenesis,	  independently	  from	  its	  effects	  on	  the	  expression	  of	  genes	  in	  the	  FGF	  signalling	  cascade,	  by	  regulating	  the	  polarisation	  of	   the	  actin	  cytoskeleton	  within	   the	  pharyngeal	  endoderm.	  To	  verify	  and	  expand	  this	  pouch	  paradigm	  future	  work	  should	  test	  the	  novel	  predictions	  that	  are	  implicit	  in	  the	  ‘proposed	  model	  of	  pharyngeal	  pouch	  morphogenesis’	  (Fig	  57).	  	  The	  model	  assumes	  that	  the	  loss	  of	  endodermal-­‐Tbx1	  has	  a	  cell	  autonomous	  effect	  on	  the	  morphogenesis	  of	  the	  pharyngeal	  endoderm.	  	  The	  data	  in	  this	  thesis	  shows	  that	  Tbx1	   is	  required	  in	  the	  endoderm	  for	  pouch	  formation.	  However,	   it	  does	  not	  demonstrate	   that	   Tbx1	   in	   the	   pharyngeal	   endoderm	   is	   a)	   sufficient	   to	   drive	  pharyngeal	   pouch	   morphogenesis	   or	   b)	   acting	   cell	   autonomously	   during	   pouch	  morphogenesis.	   The	   reactivation	   of	   mesodermal	   Tbx1	   expression	   in	   a	   Tbx1	  hypomorphic	   background	   (M-­‐KO	   embryos)	   partially	   rescues	   pouch	   formation.	  (Zhang	  et	  al.,	  2006).	  	  This	  indicates	  that	  Tbx1	  in	  the	  mesoderm	  is	  sufficient	  to	  drive	  pouch	   outgrowth.	   This	   observation	   is	   surprising,	   for	   expression	   of	   Tbx1	   in	   the	  mesoderm	   is	   not	   sufficient	   to	   maintain	   pouch	   morphogenesis	   in	   TbxcKOSox17	  embryos.	  To	  prove	  that	  endodermal	  Tbx1	  is	  sufficient	  for	  pouch	  formation	  Tbx1	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expression	  should	  be	  re-­‐introduced	  into	  the	  endoderm	  of	  Tbx1-­‐/-­‐	  embryos	  in	  a	  CRE-­‐dependent	  manner.	   	  The	  use	  of	  a	  mosaic	  CRE	  line	  to	  delete	  Tbx1	  in	  the	  endoderm	  would	   also	   begin	   to	   test	   whether	   TBX1	   functions	   cell	   autonomously	   in	   this	  epithelium	   to	   regulate	   pouch	   morphogenesis.	   	   The	   tamoxifen	   inducible	  
Foxa2CreERT2	  mouse	  line,	  in	  our	  hands,	  displayed	  mosaic	  activity	  in	  the	  pharyngeal	  endoderm	  and	  was	  not	  used	  further	  in	  this	  project.	  However	  the	  mosaic	  activity	  of	  the	   Foxa2CreERT2	   line	   could	   be	   used	   to	   delete	  Tbx1	   from	   individual	   cells	   in	   the	  pharyngeal	   endoderm.	   	   If	   TBX1	   acts	   cell	   autonomously,	   Tbx1	   null	   cells	   should	  display	   the	  defects	   observed	   throughout	   the	   endoderm	  of	  Tbx1cKOSox17	  embryos,	  particularly	  an	  unpolarised	  accumulation	  of	  actin.	  	  The	  surrounding	  Tbx1	  positive	  cells	  should	  not	  be	  affected.	  	  The	  model	   (based	   on	   findings	   from	   this	   thesis)	   proposes	   that	   endodermal	   TBX1	  facilitates	   pouch	   outgrowth	   by	   regulating	   the	   polarisation	   of	   the	   actin	   in	   the	  pharyngeal	  endoderm.	  Experiments	  were	   initiated	  to	  confirm	  that	  the	  changes	   in	  actin	   dynamics	   were	   directly	   attributable	   to	   the	   loss	   of	   Tbx1.	   	   Gut	   epithelial	  (CACO2)	   cells	   were	   to	   be	   transfected	   with	   a	  Tbx1	   expression	   vector	   or	   with	   an	  expression	   vector	   carrying	   a	   dominant	   negative	   form	   of	   Tbx1.	   Subsequently	  phalloidin-­‐marked	  changes	  in	  F-­‐actin	  in	  the	  transfected	  cells	  were	  to	  be	  analysed	  by	   confocal	  microscopy.	   	  Unfortunately,	   this	  assay	  was	  not	  optimised	   in	   time	   for	  the	   completion	   of	   this	   thesis	   but	   it	   would	   be	   an	   effective	   way	   to	   begin	   to	  experimentally	  address	  whether	  TBX1	   is	  able	   to	  directly	   facilitate	  changes	   in	   the	  actin	  cytoskeleton.	  	  	  Alternatively,	  R26R	  expressing	  endodermal	  cells	  isolated	  by	  FACS	  from	  the	  PA	  of	  
Sox17icre/+;R26R2	   and	   Sox17icre/+;Tbx1flox/-­‐;R26R2	   embryos	   may	   provide	   more	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relevant	  cell	  lines	  to	  address	  the	  cell	  autonomous	  role	  of	  TBX1	  as	  a	  regulator	  of	  the	  actin	   cytoskeleton.	   	   In	   vitro	   cultures	   of	   the	   FACS	   sorted	  Tbx1	   positive	   and	   Tbx1	  negative	   cells	   should,	   respectively,	   display	   polarised	   and	   un-­‐polarised	   actin.	  Transfecting	   the	   Tbx1cKOSox17	   endodermal	   cells	   with	   a	   Tbx1	   expression	   vector	  should	  re-­‐establish	  actin	  polarity	  in	  these	  mutant	  cells,	  perhaps	  by	  activating	  basal	  pMLC,	  if	  TBX1	  directly	  regulates	  F-­‐actin	  distributing	  in	  the	  pharyngeal	  endoderm.	  	  The	  possibility	  that	  there	  is	  a	  link	  between	  the	  changes	  in	  F-­‐actin,	  Fhl1,	  TBX1	  and	  the	   de-­‐regulated	   expression	   of	   multiple	   genes	   in	   the	   endoderm	   of	   Tbx1cKOSox17	  embryos	   is	   very	   speculative.	   	   To	   begin	   to	   address	   this	   possibility,	   first,	   a	   direct	  interaction	   between	   FHL1	   and	   TBX1	   in	   the	   pharyngeal	   endoderm	   needs	   to	   be	  determined.	   From	   the	   data	   in	   this	   study	   it	   appears	   that	   TBX1	   may	   be	   able	   to	  regulate	  the	  transcription	  of	  Fhl1.	  	  If	  this	  transcriptional	  regulation	  is	  direct	  T-­‐box	  consensus	   sites	   should	   be	   evident	   upstream	   of	   the	   Fhl1	   promoter.	   	   If	   TBX1	  negatively	  regulates	  the	  transcription	  of	  Fhl1	  via	  the	  binding	  of	  such	  a	  consensus	  site,	  mutagenesis	  of	   this	  motif	  would	  render	  Fhl1	   expression	   insensitive	   to	  TBX1	  regulation.	   	   This	   could	   be	   tested	   in	   vitro	   by	   assessing	   the	   amount	   of	   luciferase	  expression	  driven	  from	  an	  Fhl1	  promoter	  construct	  in	  the	  presence,	  or	  absence,	  of	  a	   Tbx1	   expression	   construct.	   One	   would	   hypothesise	   that	   there	   would	   be	   less	  luciferase	  expression	   in	   the	  presence	  of	  TBX1	   if	   this	  protein	  negatively	  regulates	  
Fhl1	   transcription.	   There	   should	   be	   no	   inhibition	   of	   luciferase	   expression	   when	  repeating	   the	   experiment	   with	   a	   Tbx1	   expression	   construct	   lacking	   the	   T-­‐box	  domain,	   or,	   with	   an	   Fhl1	   promoter	   construct	   lacking	   the	   T-­‐box	   consensus	   site.	  Alternatively	  TBX1	  and	  FHL1	  proteins	  may	  associate,	   as	  has	  been	  observed	  with	  LMP4	   and	  TBX5.	   	   To	   determine	  whether	  TBX1	   and	   FHL1	   form	   a	   complex	   in	   the	  pharyngeal	   endoderm	   co-­‐precipitation	   experiments	   could	   be	   performed,	   using	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TBX1	   as	   bait	   to	   pull	   down	   FHL1	   from	   endodermal	   cells	   sorted	   by	   FACS	   from	  mutant	  and	  control	  embryos	  	  (as	  described	  above).	  	  If	  FHL1	  and	  TBX1	  do	  complex	  it	  would	   be	   interesting	   to	   determine	  whether	   the	   complex	   localises	   to	   actin	   (by	  confocal	  microscopy)	  and	  what	  affect	   this	  has	  on	  gene	  expression.	   	   It	   is	  possible	  that	   the	   expanded	   expression	   of	   genes	   such	   as	   Shh	   and	   Rarb	   in	   Tbx1-­‐deficient	  endoderm	   may	   elicited	   downstream	   of	   FHL1.	   Transfecting	   cells	   absent	   of	  endogenous	   Tbx1	   or	  Fhl1	  with	   these	   expression	   constructs	   carrying	   these	  genes,	  singly	   and	   in	   combination,	   and	   subsequently	   analysing	   levels	   of	   gene	   expression	  (such	  as	  Shh)	  by	  qPCR	  would	  indicate	  whether	  the	  in	  vivo	  transcriptional	  changes	  are	  the	  result	  of	  unregulated	  FHL1.	  	  
	   	  
7.5	  Concluding	  remarks	  
This	   study	   has	   revealed	   a	   number	   of	   novel	   and	   exciting	   findings	   that	   further	  elucidate	  mechanisms	  that	  regulate	  pharyngeal	  pouch	  morphogenesis	  specifically	  within	   the	  endoderm.	   	  The	  observation	   that	  pharyngeal	  pouch	  morphogenesis	   is	  maintained	   by	   multiple	   FGF	   ligands	   and	   FGF	   receptors	   in	   the	   pharyngeal	  endoderm,	  highlights	  the	  importance	  of	  using	  conditional	  mouse	  lines	  to	  study	  PA	  development.	   	   FGF8	   is	   clearly	   important	   for	   the	   development	   of	   the	   PA	   and	   the	  pouches	  within.	  However,	  surprisingly,	  the	  requirement	  for	  Fgf8	  expression	  within	  the	  endoderm	  is	  negligible	  for	  pouch	  formation.	  Furthermore,	  if	  Tbx1	  had	  not	  been	  tissue	   specifically	   analysed	   in	   the	   endoderm,	   its	   effect	   on	   the	   actin	   cytoskeleton	  may	  not	  have	  been	  revealed	  because	  the	  positive	  regulation	  of	  FGF	  signalling,	  on	  a	  ‘global’	  scale,	  within	  the	  PA	  is	  so	  pronounced.	  	  The	   observation	   that	   TBX1	   mediates	   actin	   dynamics	   within	   the	   pharyngeal	  endoderm	  opens	  up	  new	  avenues	  of	  research	  with	  regards	  to	  understanding	  pouch	  morphogenesis	   (as	   highlighted	   in	   Chapter	   6).	   The	   data	   also	   has	   a	   broader	  implication	  for	  understanding	  other	  structures	  that	  form	  by	  epithelial	  invagination	  or	   evagination,	   such	   as	   the	   pancreatic	   bud	   and	   the	   pronephric	   duct	   of	   the	   early	  kidney.	  Most	  significantly,	  the	  link	  between	  TBX1,	  the	  FHL	  family	  of	  LIM	  proteins	  and	   the	   actin	   cytoskeleton	   may	   be	   highly	   relevant	   for	   the	   formation	   of	   the	  cardiovascular	  system,	  defects	  of	  which	  are	  the	  main	  cause	  of	  morbidity	  in	  patients	  with	   DiGeorge	   syndrome	   (Scambler,	   2010).	   An	   association	   between	   T-­‐BOX	  proteins	   and	   LIM	   domain	   proteins	   has	   already	   been	   established	   during	  cardiogenesis.	  In	  epicardial	  cells	  (that	  form	  smooth	  muscle	  cells	  that	  line	  aspects	  of	  the	   heart,	   such	   as	   the	   myocardial	   wall)	   this	   interaction	   was	   related	   to	   the	  developmental	   state	   of	   the	   cell.	   TBX5	   translocated	   from	   the	   nucleus	   to	   the	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APPENDIX	   A:	   Oligonucleotide	   sequences,	   requisite	   PCR	   master	  
mixes	  and	  PCR	  product	  band	  size	  DNA	  sequences	  were	  obtained	  from	  the	  Entrez	  Nucleotide	  database	  and	  transferred	  to	  Mac	  vector	  primer	  design	  software.	  	  Forward	  and	  reverse	  primer	  pairs	  with	  the	  highest	  efficiency	  and	  lowest	  duplex	  probability,	  as	  determined	  by	  the	  software,	  were	  selected.	  RNA	  polymerase	  promoter	  binding	  sites	  were	  added	  to	  the	  3’	  end	  of	  	  forward	  primers	  used	  to	  synthesis	  PCR	  probes	  for	  RNA	  in	  situ	  hybridisation	  (see	  2.4.5).	  If	  the	  primers	  were	  for	  PCR,	  no	  promoter	  binding	  sites	  were	  added.	  	  Oligonucleotides	  were	  synthesised	  by	  Millipore	  (MGW)	  and	  re-­‐suspended	  in	  RNase	  free	  PCR	  grade	  H2O	  to	  a	  concentration	  of	  100mM.	  	  For	  working	  solutions	  dilute	  olio’s	  1:10.	  	  
APPENDIX	  A:	  Oligonucleotides	  and	  PCR	  parameters	  
Name	   of	  
oligonucleotid
es	   (primers),	  
(**denote	   PCR	  
probe	  
primers)	  






Band	   size	  
expected	  
(bp)	  
Fgf	  Receptor	  1	   (A)GTATTGCTGGCCCACTGTTC	  (B)CTGGTATCCTGTGCCTATC	  (C)CAATCTGATCCCAAGACCAC	  	  	  
Roche/AB55	  X	  40	   Floxed	  (B+C):	  387	  Null	   (C):	  300	  Wild	   Type	  (B+C):327	  	  	  Fgf	  Receptor	  2	   (A)TGCAAGAGGCGACCAGTCAG	  (B)	  ATAGGAGCAACAGGCGG	  (C)CATAGCACAGGCCAGGTTG	   Roche/AB55	  X	  40	   Floxed	  (A+B):	  207	  Null	  (A+C):	  471	  Wild	   Type	  (A+B):	  327	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  PCR	  programme	  parameters:	  	  	  
	  
	   	  	  	  	  	  	  	  
	  
	  
Fhl2	  (T7)	   Fwd:	  GTAAGAAGTGCTCCCTGTCTCTGG	  Rev:	  ATTGTAATACGACTCACTATAGGGAGAAAACATCCGAATCTCTGCG	  	  
Roche/AB55X40	   138	  bp	  
Lmo3(T7)	   Fwd:	  TTGCCAGACAGACTACGAGGAAG	  Rev:	  ATTGTAATACGACTATAGGGGGTTATGACAAGAACGC	  
Roche/AB55X40	   700	  bp	  
Lmo4	  (T7)	   Fwd:	  AGAATGCGTGCCTTCATCTCAG	  Rev:	  ATTGTAATACGACTACGGAGCAACATCAGGACAAGAAC	  
Roche/AB55X40	   552bp	  
R262	   (A)AAAGTCGCTCTGAGTTGTTAT	  (B)GCGAAGAGTTTGTCCTCAACC	  (C)GGAGCGGGAGAAATGGATATG	   Roche/AB55	   R26R	  band	  	  	  (A	   +	   B):	  250	  	  Wild	   Type	  (A+C):	  500	  Sprouty	  1	   (A)GGGAAAACCGTGTTCTAAGGAGTAGC	  (B)GTTCTTTGTGGCAGACACTCTTCATTC	  (C)CTCAATAGGAGTGGACTGTGAAACTGC	  
Promega/AB55	  X	  40	   Floxed	   (A	  +C):	   342	  bp	  Null	   (A	  +B):	   150	  Wild	   Type	  	  	  	  	  	  	  	  (A	   +C):	  311	  Sprouty	  2	   (A)GGATGGCTCTGATCTGATCC	  (B)TTGAGAACATGCCTCGACC	  (C)GCATGGGCTATTCACAAAC	   Promega/AB57	  X	  40	   Floxed	   –	  500	  Null	  -­‐	  255	  Wild	   Type	  –	  350	  Tbx1	   (A)TGACTGTGCTGAAGTGCATC	  (B)TCTTCTTGGGGCTGTAGACT	  (C)AGCGCAATGGCTTTTAAGGG	   Roche	  (requires	  GC-­‐rich)	   Floxed	  (A+B):	  580	  Wild	   Type	  (A+B):	  532	  Null	  (A+C):415	  
Programme	  :	  AB55	  x	  40/	  AB57	  x	  40	  (Lid=100˚C)	  
1	   T=95.0˚C	   	   	   0:10:00	  
2	   T=94.0˚C	   	   	   0:00:45	  
3	   T=55.0/57˚C	  	   	   0:00:45	  
4	   T=72.0˚C	   	   	   0:01:00	  
5	   GOTO	  2	  	   	   	   39	  cycles	  
6	   T=72.0˚C	   	   	   0:07:00	  
7	   HOLD	  8.0˚C	   	   	  	  	  	  	  	  	  
	  Programme:	  AB55	  	  1=94oC,	  00:45	  2=55oC,	  00:45	  3=72oC,	  01:00	  35	  cycles	  7min	  72oC	  final	  elongation	  step	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APPENDIX	  B:	  Staining	  solutions	  
Protocol	   Solution	   Reagents	   Storage	  
conditions	  X-­‐gal	  staining	   Xgal	  base	   49.2mg	  K3Fe(CN)6	  	  63mg	  K4Fe(CN)6	  	  30mL	  PBS.	  	  	  
4oC,	  protect	  from	  light.	  
WMISH	   Block	  1	   2%	  BBR	  diluted	  in	  MABT.	   Store	  at	  -­‐20oC,	  thaw	  at	  65oC,	  cool	  before	  use.	  WMISH	   Block	  2	   2%	  BBR,	  20%	  HI	  GS	  diluted	  in	  MABT.	   Store	  at	  -­‐20oC,	  thaw	  at	  65oC,	  cool	  before	  use.	  WMISH	   10%	  Boehringer	  Blocking	  Reagent	  (BBR)	   Add	  BBR	  to	  MAB,	  dissolve	  by	  heating	  in	  a	  microwave,	  cool	  before	  freezing.	  	  
Store	  at	  -­‐20oC.	  
WMISH	   Detergent	  mix	   1%	  Igepal	  (Sigma),	  1%	  SDS,	  0.5%	  Sodium	  deoxycholate	  (Sigma),	  50mM	  Tris-­‐pH	  8.2,	  1mM	  EDTA	  and	  150mM	  NaCl	  in	  DepC	  H2O.	  
Store	  at	  RToC.	  
WMISH	   Hybridisation	  mix	  (50ml)	   25ml	  Deionized	  formamide,	  10ml	  20x	  SSC,	  1%	  Boehringer	  block,	  1ml	  of	  5%CHAPs,	  50ul	  yeast	  tRNA	  (20mg/ml),	  100µl	  heparin	  (50mg/ml),	  0.5ml	  of	  0.5M	  EDTA,	  500ul	  Tween-­‐20	  (Sigma),	  make	  up	  to	  50ml	  with	  DepC	  H2O.	  	  	  
Store	  at	  -­‐20oC,	  warm	  to	  65oC	  before	  use.	  
WMISH	   10x	  Maleic	  acid	  wash	  buffer	  pH7.5	  (MAB)	   11.6g	  maleic	  acid,	  8.75g	  NaCl,	  7.5g	  NaOH,	  top	  up	  with	  800ml	  DepC	  H2O	  and	  pH	  to	  7.5	  with	  maleic	  acid.	  	  Once	  at	  pH7.5,	  top	  up	  with	  DepC	  H2O	  to	  1L	  
Store	  at	  RToC,	  dilute	  to	  1x	  before	  use.	  	  
NB.	  pH	  can	  
increase,	  after	  long	  
term	  storage	  
before	  use	  check	  
pH	  is	  7.5.	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and	  autoclave.	  	  WMISH	   MABT	   Add	  1%	  Tween-­‐20	  to	  1x	  MAB	  post	  autoclaving.	  	  
Store	  at	  RToC.	  
WMISH	   NTMT	  (50ml)	   1ml	  5M	  NaCl,	  1M	  5ml	  Tris-­‐HCL	  pH9.5,	  5ml	  1M	  MgCl2,	  500µl	  Tween-­‐20,	  38.5ml	  H2O.	  	  
Prepare	  no	  earlier	  than	  the	  day	  before	  signal	  detection	  and	  store	  at	  4oC	  as	  CO2	  can	  alter	  the	  buffers	  pH.	  WMISH	   Solution	  X	  (250ml)	   125ml	  Formamide,	  25ml	  20x	  SSC	  pH4.5,	  25ml	  10%	  SDS,	  100ml	  sterile	  ddH2O.	  
Store	  at	  RToC,	  warm	  to	  65oC	  before	  use.	  
Section	  ISH	   Acetylation	  mix	   625µl	  Triethaloamine	  (TEA	  SIGMA),	  130µl	  30%	  	  hydrochloric	  acid	  (sigma)	  in	  50ml	  DepC	  H20,	  adding	  125µl	  acetic	  anhydride	  (VWR)	  to	  the	  solution	  just	  prior	  to	  incubating	  with	  the	  slides.	  	  
Prepare	  on	  the	  day	  of	  ISH	  at	  RToC.	  
Section	  ISH	   Hybridisation	  mix	  (50ml).	  	   25ml	  Deionized	  formamide,	  10ml	  Dextran	  sulfate,	  1ml	  50x	  Denhardt’s,	  1.25ml	  yeast	  tRNA	  (10mg/ml),	  3ml	  5M	  NaCl,	  1ml	  1M	  Tris-­‐HCL	  pH8,	  500ul	  0.5M	  EDTA,	  500ul	  1M	  Di-­‐sodium	  hydrogen	  phosphate	  Dihydrate,	  2.5ml	  20%	  N-­‐lauroylsarcosine,	  11.5ml	  DepC	  H2O.	  	  
Store	  at	  -­‐20oC,	  warm	  to	  65oC	  before	  use.	  
Section	  ISH	   High	  Stringency	  Wash	  (HIS)	   160ml	  H2O,	  40ml	  20x	  SSC	  incubated	   Make	  fresh	  each	  time.	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(200ml)	   at	  65oC	  overnight	  (at	  the	  end	  of	  day	  1),	  add	  200ml	  formamide	  just	  prior	  to	  use.	  	  Section	  ISH	   N-­‐lauroylsarcosine	  (Levamisole,	  Sigma)	  	   For	  25ml	  dilute	  0.5g	  in	  25ml	  of	  sterile	  ddH2O	  (20mg/ml).	  	  
Store	  at	  4oC.	  
Section	  ISH	   NTMT	  (200ml)	   5ml	  5M	  NaCl,	  10ml	  1M	  Tris-­‐HCL	  pH9.5,	  20ml	  1M	  MgCl2,	  200µl	  Tween-­‐20,	  2ml	  Levamisole,	  sterile	  ddH2O	  to	  bring	  volume	  to	  200ml.	  	  
Prepare	  no	  earlier	  than	  the	  day	  before	  signal	  detection	  and	  store	  at	  4oC	  as	  CO2	  can	  alter	  the	  buffers	  pH.	  
Section	  ISH	   RNase	  buffer	  (1L)	   100ml	  5M	  NaCl,	  10ml	  1M	  TRIS-­‐HCL	  pH7.5,	  10ml	  0.5M	  EDTA.	  pH8.0	  in	  880ml	  H20.	  	  	  	  
Store	  at	  RToC,	  incubate	  at	  37oC	  prior	  to	  use.	  
Section	  ISH	   Saline-­‐sodium	  citrate	  buffer	  (SCC)	   Dilute	  20X	  SSC	  (Fisher)	  to	  5x,	  2x	  and	  0.1x	  SSC	  with	  sterile	  ddH2O.	  	  
Store	  at	  RToC.	  At	  the	  end	  of	  day	  1	  incubate	  5xSSC	  at	  65oC,	  2x	  and	  0.1x	  SSC	  at	  37oC.	  	  IHC	   0.5%	  PBT	   As	  for	  PBT,	  (see	  2.1)	  but	  add	  0.5%	  Tween-­‐20.	   Store	  at	  RToC.	  IHC	   Wax	  blocking	  solution	  (*)	   10%GS	  in	  PBT2	   Store	  aliquots	  at	  	  	  	  	  -­‐20oC.	  IHC	   Wax	  Primary/secondary	  antibody	  diluent	  (*)	  
5%GS	  in	  PBT2	   Store	  aliquots	  at	  	  	  	  	  -­‐20oC.	  
IHC	   Cryosection	  blocking	  solution	  (*)	   10%	  GS,	  0.5%	  bovine	  albumin	  serum	  (BSA,	  Sigma)	  in	  PBT.	  
Store	  aliquots	  at	  	  	  	  	  -­‐20oC.	  
IHC	   Cryosection	  Primary/secondary	  antibody	  diluent	  (*)	  
5%	  GS,	  0.5%	  bovine	  albumin	  serum	  (BSA,	  Sigma)	  in	  PBT	  
Store	  aliquots	  at	  	  	  	  	  -­‐20oC.	  
IHC	   100mM	  sodium	  citrate	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APPENDIX	   C:	   Antibody	   suppliers	   and	   the	   dilutions	   used	   during	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APPENDIX	  D:	  Probes	  
Gene	   Linearizing	  enzyme	   for	  antisense	  probes	  
Polymerases	   enzyme	  for	  antisense	  probes	   Insert	   size	  (bp)	   Reference	  
Bmp4	   Accl	   T7	   1550	   Unknown	  
Cyp26a1	   Kpn1	   T7	   1500	   Akira	  Imamoto	  
Cyp26b1	   Kpn1	  	   T3	   1600	   Akira	  Imamoto	  
Cyp26c1	   EcoRI	   T7	   1000	   Pete	  Scambler	  
Fgf10	  	   BamHI	  RV	  (FL)	  NcoI	  (short)	  
T3	  T7	  (FL)	  Sp6	  (short)	  	  
	  	   UGA	  	  	  
Fgf15	   NotI	   T7	   806	   John	  R.	  McWhirter	  
Fgf3	  	  
	  
HindIII	   T7	   1000	   Peters	  et	  al,	  Dev.Bio,	  155:	  423-­‐443	  
Fgf8	  (exon2,3)	   XhoI	   T7	   266	   Elaine	  Storm	  
Fgf8	  	   BamHI	   T7	   875	   Crossley	   and	   Martin,	   1995	  Development	  121:439-­‐451	  
Foxn1	   AccIII	   T3	   1120	   N.	  Manly	  
Gcm2	   NcoI	   SP6	   926	   N.	  Manly	  
Gli1	  	   NotI	   T3	   1600	   Harland	  Lab	  
Hoxa2	   EcoRI	   T7	   300	   Unknown	  
Hoxa3	  
	  
XhoI	   T3	   650	   N.Manley	  
Hoxb1	   XbaI	   T7	   300	   Akira	  Imamoto	  
Erm	  	   HindIII	   T3	   	   Hippenmeyer	  et	  al.	  
Spry1	   EcoRI	   T7	   1500	   Minowada/G.Martin	  
Spry2	   SacII	   T3	   1500	   Minowada/G.Martin	  
Shh	   EcoRI	   T7	   1600	   Epstein,	  McMahon	  
Pea3	  	   ApaI	   SP6	   500	   Unknown	  
Pax1	   XbaI	   T3	   	   Deutsch	  et	  al	  Cell	  53:617-­‐	  (1988)	  from	  N.	  Manley	  
Ptc1	   BamHI	   T3	   841	   GRM131	  
Raldh2	   EcoRI	   T3	   468	   Akira	  Imamoto	  (P.Dolle)	  
Rarb	   EcoRI	   T3	   620	   Akira	  Imamoto	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APPENDIX	  E:	  Mouse	  lines	  utilised	  as	  tools	  in	  this	  thesis	  
Nomenclature	  (symbol)	   MGI	  ID	   Abbreviated	  
Alleles	  
Description	   Reference	  
Fibroblast	  growth	  factor	  8;	  targeted	  
mutation	  1.3,	  Gail	  R	  Martin	  (Fgf8tm1.3Mrt)	  
MGI:2150347	   Fgf8flox/flox	   Double	  homozygous	  for	  conditional	  (floxed)	  Fgf8	  alleles	   Meyers	  et	  al	  (1998)	  Nat	  Genet	  18:136-­‐41	  
Fibroblast	  growth	  factor	  receptor	  1;	  
targeted	  mutation	  3,	  Chu-­‐Xia	  Deng	  
(Fgfr1tm3Cxd)	  
MGI:2181471	   Fgfr1flox/flox	   Double	  homozygous	  for	  conditional	  (floxed)	  Fgfr1	  alleles	   Xu	  et	  al	  (2002)	  Genesis	  32:	  85-­‐86	  	  
Fibroblast	  growth	  factor	  receptor	  2;	  
targeted	  mutation	  1.1,	  David	  M	  Ornitz	  
(Fgfr2tm1.1Dor)	  
MGI:3044427	   Fgfr2flox/flox	   Double	  homozygous	  for	  conditional	  Fgfr2flox	  alleles	   Yu	  et	  al	  (2003)	  Development	  130:3063-­‐74	  
Mesoderm	  posterior	  1;	  targeted	  mutation	  
2,	  Yumiko	  Saga	  (Mesp1tm2(cre)Ysa)	  
MGI:2176467	   Mesp1Cre/+	   Cre	  transgene	  expressed	  under	  control	  of	  Mesp1	  	  (core	  mesoderm-­‐specific	  expression).	  
Saga	  et	  al	  (1999)	  
Development	  126:3437-­‐47	  
Gene	  trap	  ROSA	  26,	  Philippe	  Soriano;	  
targeted	  mutation	  1,	  Philippe	  Soriano	  
(Gt(ROSA)26Sortm1Sho)	  
MGI:1861932	   R26R2	   Double	  homozygous	  for	  the	  Rosa26	  lacZ	  Cre	  reporter	  allele	   Soriano	  (1999)	  Nat	  Genet	  21:70-­‐71	  
Gene	  trap	  ROSA	  26,	  Philippe	  Soriano;	  
targeted	  mutation	  1.1,	  Frank	  Costantini	  
(Gt(ROSA)26Sortm1.1(EYFP)Cos)	  
MGI:2449041	   Rosa-­‐YFP2	   Double	  homozygous	  for	  the	  Rosa26	  eYFP	  Cre	  reporter	  allele.	   Srinivas	  et	  al	  (2001)	  BMC	  Dev	  Biol	  1:4	  
Sprouty	  homolog	  1	  (Drosophila);	  
targeted	  mutation	  1,	  Jonathan	  D	  Licht	  
(Spry1tm1Jdli)	  
MGI:3574403	   Spry1flox/flox	   Conditional	  (floxed)	  
Spry1	  allele.	   Basson	  et	  al	  (2005)	  Dev	  Cell	  8:229-­‐239	  
Sprouty	  homolog	  2	  (Drosophila);	  
targeted	  mutation	  1.1,	  Gail	  R	  Martin	  
(Spry2tm1.1Mrt)	  
MGI:3578633	   Spry2flox/flox	   Conditional	  (floxed)	  
Spry2	  allele.	   Shim	  et	  al	  (2005)	  Dev	  Cell	  8:	  553-­‐564	  
SRY-­‐box	  containing	  gene	  17;	  targeted	  
mutation	  2.1,	  Heiko	  Lickert	  
(Sox17tm2.1(icre)Heli)	  	  
	  
MGI:4418897	   Sox172A-­‐icre/+	   A	  knock	  in	  of	  a	  cre	  transgene	  (precede	  by	  the	  self	  cleaving	  viral	  peptide	  2A)	  expressed	  under	  control	  of	  Sox17	  (endoderm	  and	  endothelial	  cell	  specific	  expression).	  
Engert	  et	  al	  (2009)	  
Genesis	  47(9):	  603-­‐10	  
T-­‐box	  1;	  targeted	  mutation	  1.1,	  Bernice	  E	  
Morrow	  	  
(Tbx1tm1.1Bem)	  
MGI:3619149	   Tbx1flox/flox	   Double	  homozygous	  for	  the	  conditional	  
Tbx1	  (floxed)	  allele.	   Arnold	  et	  al	  (2006)	  Development	  133:977-­‐87	  
Transgene	  insertion	  10,	  David	  H	  Rowitch	  
(Tg(Wnt1-­‐cre/Esr1*)10Rth)	  
MGI:2447684	   Wnt1Cre/+	   Cre	  transgene	  expressed	  under	  control	  of	  Wnt1	  (neural	  crest-­‐specific	  expression).	  
Danielian	  et	  al	  (1998)	  Curr	  Biol	  8:1323-­‐1326	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